Illinois 2025-2026 Regular Session

Illinois Senate Bill SB2184 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB2184 Introduced 2/7/2025, by Sen. Rachel Ventura SYNOPSIS AS INTRODUCED: See Index Creates the Compassionate Use and Research of Entheogens Act. Establishes the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation for the purpose of advising and making recommendations to the Department regarding the provision of psilocybin and psilocybin services. Provides that the Department shall begin receiving applications for the licensing of persons to manufacture or test psilocybin products, operate service centers, or facilitate psilocybin services. Contains licensure requirements and prohibitions. Provides that a licensee or licensee representative may manufacture, deliver, or possess a psilocybin product. Provides that a licensee or licensee representative may not sell or deliver a psilocybin product to a person under 21 years of age. Provides that a person may not sell, give, or otherwise make available a psilocybin product to a person who is visibly intoxicated. Creates the Psilocybin Control and Regulation Fund and the Illinois Psilocybin Fund and makes conforming changes in the State Finance Act. Requires the Department of Agriculture, the Department of Financial and Professional Regulation, and the Department of Revenue to perform specified duties. Contains provisions concerning rulemaking, taxes, fees, zoning, labeling, and penalties. Provides that beginning January 1, 2026, a tax is imposed upon purchasers for the privilege of using psilocybin at a rate of 15% of the purchase price. Preempts home rule powers. Contains other provisions. Amends the Illinois Vehicle Code. Provides that a person shall not drive or be in actual physical control of any vehicle within the State while there is any amount of a drug, substance, or compound in the person's breath, blood, other bodily substance, or urine resulting from the unlawful use or consumption of psilocybin as defined in the Compassionate Use and Research of Entheogens Act. Amends the Illinois Controlled Substances Act. Removes psilocybin and psilocin from the list of Schedule I controlled substances. Amends the Illinois Independent Tax Tribunal Act of 2012. Provides that the Tax Tribunal shall have original jurisdiction over all determinations of the Department of Revenue reflected on specified notices issued under the Compassionate Use and Research of Entheogens Act. Amends the Freedom of Information Act to exempt specific records from disclosure. Effective immediately. LRB104 11945 RLC 22038 b A BILL FOR 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB2184 Introduced 2/7/2025, by Sen. Rachel Ventura SYNOPSIS AS INTRODUCED: See Index See Index Creates the Compassionate Use and Research of Entheogens Act. Establishes the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation for the purpose of advising and making recommendations to the Department regarding the provision of psilocybin and psilocybin services. Provides that the Department shall begin receiving applications for the licensing of persons to manufacture or test psilocybin products, operate service centers, or facilitate psilocybin services. Contains licensure requirements and prohibitions. Provides that a licensee or licensee representative may manufacture, deliver, or possess a psilocybin product. Provides that a licensee or licensee representative may not sell or deliver a psilocybin product to a person under 21 years of age. Provides that a person may not sell, give, or otherwise make available a psilocybin product to a person who is visibly intoxicated. Creates the Psilocybin Control and Regulation Fund and the Illinois Psilocybin Fund and makes conforming changes in the State Finance Act. Requires the Department of Agriculture, the Department of Financial and Professional Regulation, and the Department of Revenue to perform specified duties. Contains provisions concerning rulemaking, taxes, fees, zoning, labeling, and penalties. Provides that beginning January 1, 2026, a tax is imposed upon purchasers for the privilege of using psilocybin at a rate of 15% of the purchase price. Preempts home rule powers. Contains other provisions. Amends the Illinois Vehicle Code. Provides that a person shall not drive or be in actual physical control of any vehicle within the State while there is any amount of a drug, substance, or compound in the person's breath, blood, other bodily substance, or urine resulting from the unlawful use or consumption of psilocybin as defined in the Compassionate Use and Research of Entheogens Act. Amends the Illinois Controlled Substances Act. Removes psilocybin and psilocin from the list of Schedule I controlled substances. Amends the Illinois Independent Tax Tribunal Act of 2012. Provides that the Tax Tribunal shall have original jurisdiction over all determinations of the Department of Revenue reflected on specified notices issued under the Compassionate Use and Research of Entheogens Act. Amends the Freedom of Information Act to exempt specific records from disclosure. Effective immediately. LRB104 11945 RLC 22038 b LRB104 11945 RLC 22038 b A BILL FOR
2	2	104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB2184 Introduced 2/7/2025, by Sen. Rachel Ventura SYNOPSIS AS INTRODUCED:
3	3	See Index See Index
4	4	See Index
5	5	Creates the Compassionate Use and Research of Entheogens Act. Establishes the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation for the purpose of advising and making recommendations to the Department regarding the provision of psilocybin and psilocybin services. Provides that the Department shall begin receiving applications for the licensing of persons to manufacture or test psilocybin products, operate service centers, or facilitate psilocybin services. Contains licensure requirements and prohibitions. Provides that a licensee or licensee representative may manufacture, deliver, or possess a psilocybin product. Provides that a licensee or licensee representative may not sell or deliver a psilocybin product to a person under 21 years of age. Provides that a person may not sell, give, or otherwise make available a psilocybin product to a person who is visibly intoxicated. Creates the Psilocybin Control and Regulation Fund and the Illinois Psilocybin Fund and makes conforming changes in the State Finance Act. Requires the Department of Agriculture, the Department of Financial and Professional Regulation, and the Department of Revenue to perform specified duties. Contains provisions concerning rulemaking, taxes, fees, zoning, labeling, and penalties. Provides that beginning January 1, 2026, a tax is imposed upon purchasers for the privilege of using psilocybin at a rate of 15% of the purchase price. Preempts home rule powers. Contains other provisions. Amends the Illinois Vehicle Code. Provides that a person shall not drive or be in actual physical control of any vehicle within the State while there is any amount of a drug, substance, or compound in the person's breath, blood, other bodily substance, or urine resulting from the unlawful use or consumption of psilocybin as defined in the Compassionate Use and Research of Entheogens Act. Amends the Illinois Controlled Substances Act. Removes psilocybin and psilocin from the list of Schedule I controlled substances. Amends the Illinois Independent Tax Tribunal Act of 2012. Provides that the Tax Tribunal shall have original jurisdiction over all determinations of the Department of Revenue reflected on specified notices issued under the Compassionate Use and Research of Entheogens Act. Amends the Freedom of Information Act to exempt specific records from disclosure. Effective immediately.
6	6	LRB104 11945 RLC 22038 b LRB104 11945 RLC 22038 b
7	7	LRB104 11945 RLC 22038 b
8	8	A BILL FOR
9	9	SB2184LRB104 11945 RLC 22038 b SB2184 LRB104 11945 RLC 22038 b
10	10	SB2184 LRB104 11945 RLC 22038 b
11	11	1 AN ACT concerning health.
12	12	2 Be it enacted by the People of the State of Illinois,
13	13	3 represented in the General Assembly:
14	14	4 Section 1. Short title. This Act may be cited as the
15	15	5 Compassionate Use and Research of Entheogens Act.
16	16	6 Section 5. Findings. The General Assembly finds that:
17	17	7 (1) The War on Drugs has given rise to significant
18	18	8 financial and social costs, and the policies behind the
19	19	9 War on Drugs reflect neither a modern understanding of
20	20	10 substance use nor the actual risks or potential
21	21	11 therapeutic benefits of the substances that have been
22	22	12 criminalized.
23	23	13 (2) Moreover, criminalization has not deterred drug
24	24	14 use. Instead, it has made drug use less safe and has
25	25	15 created an unregulated, underground market in which
26	26	16 dosages are difficult to verify and dangerous adulterants,
27	27	17 such as fentanyl, are common.
28	28	18 (3) Lack of honest drug education has laid the
29	29	19 groundwork for decades of misinformation, stigma, and
30	30	20 cultural appropriation, which have all contributed to
31	31	21 increasing the dangers of drug use.
32	32	22 (4) Emerging research supports the use of
33	33	23 psychedelics, such as psilocybin, when combined with
34	34
35	35
36	36
37	37	104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB2184 Introduced 2/7/2025, by Sen. Rachel Ventura SYNOPSIS AS INTRODUCED:
38	38	See Index See Index
39	39	See Index
40	40	Creates the Compassionate Use and Research of Entheogens Act. Establishes the Illinois Psilocybin Advisory Board within the Department of Financial and Professional Regulation for the purpose of advising and making recommendations to the Department regarding the provision of psilocybin and psilocybin services. Provides that the Department shall begin receiving applications for the licensing of persons to manufacture or test psilocybin products, operate service centers, or facilitate psilocybin services. Contains licensure requirements and prohibitions. Provides that a licensee or licensee representative may manufacture, deliver, or possess a psilocybin product. Provides that a licensee or licensee representative may not sell or deliver a psilocybin product to a person under 21 years of age. Provides that a person may not sell, give, or otherwise make available a psilocybin product to a person who is visibly intoxicated. Creates the Psilocybin Control and Regulation Fund and the Illinois Psilocybin Fund and makes conforming changes in the State Finance Act. Requires the Department of Agriculture, the Department of Financial and Professional Regulation, and the Department of Revenue to perform specified duties. Contains provisions concerning rulemaking, taxes, fees, zoning, labeling, and penalties. Provides that beginning January 1, 2026, a tax is imposed upon purchasers for the privilege of using psilocybin at a rate of 15% of the purchase price. Preempts home rule powers. Contains other provisions. Amends the Illinois Vehicle Code. Provides that a person shall not drive or be in actual physical control of any vehicle within the State while there is any amount of a drug, substance, or compound in the person's breath, blood, other bodily substance, or urine resulting from the unlawful use or consumption of psilocybin as defined in the Compassionate Use and Research of Entheogens Act. Amends the Illinois Controlled Substances Act. Removes psilocybin and psilocin from the list of Schedule I controlled substances. Amends the Illinois Independent Tax Tribunal Act of 2012. Provides that the Tax Tribunal shall have original jurisdiction over all determinations of the Department of Revenue reflected on specified notices issued under the Compassionate Use and Research of Entheogens Act. Amends the Freedom of Information Act to exempt specific records from disclosure. Effective immediately.
41	41	LRB104 11945 RLC 22038 b LRB104 11945 RLC 22038 b
42	42	LRB104 11945 RLC 22038 b
43	43	A BILL FOR
44	44
45	45
46	46
47	47
48	48
49	49	See Index
50	50
51	51
52	52
53	53	LRB104 11945 RLC 22038 b
54	54
55	55
56	56
57	57
58	58
59	59
60	60
61	61
62	62
63	63	SB2184 LRB104 11945 RLC 22038 b
64	64
65	65
66	66	SB2184- 2 -LRB104 11945 RLC 22038 b SB2184 - 2 - LRB104 11945 RLC 22038 b
67	67	SB2184 - 2 - LRB104 11945 RLC 22038 b
68	68	1 psychotherapy, to treat mental health conditions including
69	69	2 treatment-resistant depression, anxiety, PTSD, substance
70	70	3 use disorder, and end-of-life psychological distress. The
71	71	4 United States Food and Drug Administration has:
72	72	5 (A) determined that preliminary clinical evidence
73	73	6 indicates that psilocybin may demonstrate substantial
74	74	7 improvement over available therapies for
75	75	8 treatment-resistant depression; and
76	76	9 (B) granted a "Breakthrough Therapy" designation
77	77	10 for a treatment that uses psilocybin as a therapy for
78	78	11 such depression.
79	79	12 (5) Voters of the city and county of Denver, Colorado
80	80	13 approved Ordinance 301 in May of 2019, making the personal
81	81	14 possession and use of the natural medicine psilocybin by
82	82	15 adults the lowest level of law enforcement priority in
83	83	16 Denver and to prohibit the city and county from spending
84	84	17 resources enforcing related penalties.
85	85	18 (6) Measures 109 and 110 in Oregon, which both passed
86	86	19 in November 2020, established a regulated psilocybin
87	87	20 therapy system in Oregon to provide people therapeutic
88	88	21 access to psilocybin and decriminalized the personal
89	89	22 possession of all drugs.
90	90	23 (7) Almost 20 countries around the world, including
91	91	24 Portugal, the Czech Republic, and Spain, have expressly or
92	92	25 effectively decriminalized the personal use of all
93	93	26 substances.
94	94
95	95
96	96
97	97
98	98
99	99	SB2184 - 2 - LRB104 11945 RLC 22038 b
100	100
101	101
102	102	SB2184- 3 -LRB104 11945 RLC 22038 b SB2184 - 3 - LRB104 11945 RLC 22038 b
103	103	SB2184 - 3 - LRB104 11945 RLC 22038 b
104	104	1 (8) The City of Oakland, California, and the City of
105	105	2 Santa Cruz, California have passed resolutions
106	106	3 decriminalizing or deprioritizing the enforcement of laws
107	107	4 regulating the possession, use, and propagation of
108	108	5 psychedelic plants and fungi. Since June 2019, the
109	109	6 following cities have also decriminalized the possession,
110	110	7 use, and propagation of psychedelic plants and fungi at
111	111	8 the local level: Ann Arbor, Michigan; Somerville,
112	112	9 Massachusetts; and Cambridge, Massachusetts. In 2020,
113	113	10 Washington, D.C., passed Initiative 81 to decriminalize
114	114	11 and deprioritize the enforcement of laws regulating the
115	115	12 possession and use of psychedelic plants and fungi with
116	116	13 76% voter approval.
117	117	14 (9) The State of Colorado passed Proposition 122 in
118	118	15 November of 2022, decriminalizing the possession of
119	119	16 psychedelic plants and fungi and eventually allowing
120	120	17 state-licensed treatment centers to administer the
121	121	18 compounds of psychedelic plants and fungi under the
122	122	19 supervision of trained staff.
123	123	20 (10) To transition away from criminalization models
124	124	21 while protecting people who use or may use drugs and
125	125	22 reduce negative environmental or cultural impacts, it is
126	126	23 necessary to review the full legal context in which these
127	127	24 changes to the law are made. It is also necessary to
128	128	25 incorporate evidence-based policy, consult with experts,
129	129	26 and maintain open discourse based in harm reduction,
130	130
131	131
132	132
133	133
134	134
135	135	SB2184 - 3 - LRB104 11945 RLC 22038 b
136	136
137	137
138	138	SB2184- 4 -LRB104 11945 RLC 22038 b SB2184 - 4 - LRB104 11945 RLC 22038 b
139	139	SB2184 - 4 - LRB104 11945 RLC 22038 b
140	140	1 reciprocity, and human rights during the process of
141	141	2 developing alternative regulatory systems.
142	142	3 (11) Criminalizing psychedelic plants and fungi has
143	143	4 denied people access to accurate education and harm
144	144	5 reduction information related to the use of psychedelic
145	145	6 compounds and limited the development of appropriate
146	146	7 training for first responders and multi-responders,
147	147	8 including law enforcement, emergency medical services, and
148	148	9 fire services.
149	149	10 (12) Illinoisans deserve equitable access to more
150	150	11 tools to address mental health issues, including
151	151	12 approaches using psychedelic plants and fungi that
152	152	13 prioritize community-based healing, cultural competency,
153	153	14 and recovery over criminalization and punishment.
154	154	15 (13) The purpose of this Act is to develop a licensing
155	155	16 and regulatory framework to ensure the safe and effective
156	156	17 use of psychedelics, starting with psilocybin, for
157	157	18 therapeutic purposes.
158	158	19 (14) Decriminalizing and regulating psychedelics has
159	159	20 the potential to reduce incarceration rates, alleviate
160	160	21 burdens on the criminal justice system, and generate tax
161	161	22 revenue. These resources can be reinvested into education,
162	162	23 harm reduction, and mental health services.
163	163	24 (15) These changes in law will not displace any
164	164	25 restrictions on driving or operating a vehicle while
165	165	26 impaired, an employer's ability to restrict the use of
166	166
167	167
168	168
169	169
170	170
171	171	SB2184 - 4 - LRB104 11945 RLC 22038 b
172	172
173	173
174	174	SB2184- 5 -LRB104 11945 RLC 22038 b SB2184 - 5 - LRB104 11945 RLC 22038 b
175	175	SB2184 - 5 - LRB104 11945 RLC 22038 b
176	176	1 controlled substances by its employees, or the legal
177	177	2 standard for negligence.
178	178	3 (16) Peyote is specifically excluded from this Act,
179	179	4 including any cultivation, harvest, extraction, tincture,
180	180	5 or other product manufactured or derived from it, because
181	181	6 of the nearly endangered status of the peyote plant and
182	182	7 the special significance peyote holds in Native American
183	183	8 spirituality. Furthermore, this Act does not amend or
184	184	9 repeal paragraph (12) of subsection (d) of Section 204 of
185	185	10 the Illinois Controlled Substances Act, which identifies
186	186	11 peyote and its derivatives as a Schedule I drug.
187	187	12 (17) The State fully respects and supports the
188	188	13 continued Native American possession and use of peyote
189	189	14 under federal law, 42 U.S.C. 1996a, understanding that
190	190	15 Native Americans in the United States were persecuted and
191	191	16 prosecuted for their ceremonial practices, including the
192	192	17 use of peyote, for more than a century, and had to fight
193	193	18 numerous legal and political battles to achieve the
194	194	19 current protected status. The enactment of this
195	195	20 legislation does not intend to explicitly or implicitly
196	196	21 undermine that status.
197	197	22 (18) Research conducted by domestic and international
198	198	23 medical institutions indicates that psilocybin is
199	199	24 efficacious and safe for the treatment of a variety of
200	200	25 mental health conditions, including, but not limited to,
201	201	26 addiction, depression, anxiety disorders, headache
202	202
203	203
204	204
205	205
206	206
207	207	SB2184 - 5 - LRB104 11945 RLC 22038 b
208	208
209	209
210	210	SB2184- 6 -LRB104 11945 RLC 22038 b SB2184 - 6 - LRB104 11945 RLC 22038 b
211	211	SB2184 - 6 - LRB104 11945 RLC 22038 b
212	212	1 disorders, and end-of-life psychological distress.
213	213	2 (19) This Act encourages the advancement of research,
214	214	3 education, and harm reduction strategies in the State to
215	215	4 promote an evidence-based, harm-reduction framework
216	216	5 grounded in reciprocity, human rights, and public health
217	217	6 priorities. It emphasizes collaboration with experts and
218	218	7 open discourse to develop an effective regulatory system
219	219	8 that addresses both individual and societal needs.
220	220	9 (20) During the program development period, the
221	221	10 Department of Public Health, the Department of
222	222	11 Agriculture, the Department of Financial and Professional
223	223	12 Regulation, the Illinois State Police, and the Department
224	224	13 of Revenue shall:
225	225	14 (A) examine, publish, and distribute to the public
226	226	15 available medical, psychological, and scientific
227	227	16 studies, research, and other information relating to
228	228	17 the safety and efficacy of psilocybin in treating
229	229	18 mental health conditions; and
230	230	19 (B) adopt rules and regulations for the eventual
231	231	20 implementation of a comprehensive regulatory framework
232	232	21 that will allow persons 21 years of age and older in
233	233	22 this State to be provided psilocybin services.
234	234	23 (21) An Advisory Board shall be established for the
235	235	24 purpose of advising and making recommendations for program
236	236	25 development.
237	237
238	238
239	239
240	240
241	241
242	242	SB2184 - 6 - LRB104 11945 RLC 22038 b
243	243
244	244
245	245	SB2184- 7 -LRB104 11945 RLC 22038 b SB2184 - 7 - LRB104 11945 RLC 22038 b
246	246	SB2184 - 7 - LRB104 11945 RLC 22038 b
247	247	1 Section 10. Purposes.
248	248	2 (a) The purpose of this Act is to establish a new,
249	249	3 compassionate, and effective approach to entheogens by:
250	250	4 (1) adopting a public health and harm reduction
251	251	5 approach to natural medicines by creating a regulatory
252	252	6 system to facilitate the supported adult use of
253	253	7 entheogens, starting with psilocybin, by those who are 21
254	254	8 years of age or older;
255	255	9 (2) developing and promoting public education related
256	256	10 to the use of entheogens and appropriate training for
257	257	11 first responders;
258	258	12 (3) reducing the prevalence of behavioral health
259	259	13 disorders among adults in this State to improve the
260	260	14 physical, mental, and social well-being of all people in
261	261	15 this State;
262	262	16 (4) promoting health and healing by shifting away from
263	263	17 punitive responses to personal possession and establishing
264	264	18 regulated access to natural medicines through a humane,
265	265	19 cost-effective, and responsible approach;
266	266	20 (5) developing a long-term strategic plan for ensuring
267	267	21 that psilocybin services will become and remain a safe,
268	268	22 accessible, and affordable option for all persons 21 years
269	269	23 of age and older in this State for whom psilocybin may be
270	270	24 appropriate with particular attention to underserved and
271	271	25 marginalized communities;
272	272	26 (6) protecting the safety, welfare, health, and peace
273	273
274	274
275	275
276	276
277	277
278	278	SB2184 - 7 - LRB104 11945 RLC 22038 b
279	279
280	280
281	281	SB2184- 8 -LRB104 11945 RLC 22038 b SB2184 - 8 - LRB104 11945 RLC 22038 b
282	282	SB2184 - 8 - LRB104 11945 RLC 22038 b
283	283	1 of the people of this State by prioritizing this State's
284	284	2 limited law enforcement resources in the most effective,
285	285	3 consistent, and rational way; and
286	286	4 (7) after the program development period:
287	287	5 (A) permitting persons licensed, controlled, and
288	288	6 regulated by this State to legally manufacture
289	289	7 psilocybin products and provide psilocybin services to
290	290	8 persons 21 years of age and older, subject to the
291	291	9 provisions of this Act;
292	292	10 (B) establishing a comprehensive regulatory
293	293	11 framework concerning psilocybin products and
294	294	12 psilocybin services under State law; and
295	295	13 (C) preparing proposed rules for the addition of
296	296	14 botanical forms of dimethyltryptamine,
297	297	15 methylenedioxymethamphetamine, ibogaine (except
298	298	16 ibogaine from iboga), and mescaline (except mescaline
299	299	17 from peyote) to substances regulated under this Act on
300	300	18 or before June 1, 2027.
301	301	19 (b) The People of the State intend that the provisions of
302	302	20 this Act, together with other provisions of State law, will
303	303	21 prevent:
304	304	22 (1) the distribution of psilocybin products to other
305	305	23 persons who are not permitted to possess psilocybin
306	306	24 products under the provisions of this Act and rules
307	307	25 adopted under this Act, including, but not limited to,
308	308	26 persons under 21 years of age; and
309	309
310	310
311	311
312	312
313	313
314	314	SB2184 - 8 - LRB104 11945 RLC 22038 b
315	315
316	316
317	317	SB2184- 9 -LRB104 11945 RLC 22038 b SB2184 - 9 - LRB104 11945 RLC 22038 b
318	318	SB2184 - 9 - LRB104 11945 RLC 22038 b
319	319	1 (2) the diversion of psilocybin products from this
320	320	2 State to other states.
321	321	3 Section 15. Construction. This Act may not be construed
322	322	4 to:
323	323	5 (1) Require a government medical assistance program or
324	324	6 private health insurer to reimburse a person for costs
325	325	7 associated with the use of psilocybin products.
326	326	8 (2) Amend or affect State or federal law pertaining to
327	327	9 employment matters.
328	328	10 (3) Amend or affect State or federal law pertaining to
329	329	11 landlord-tenant matters.
330	330	12 (4) Prohibit a recipient of a federal grant or an
331	331	13 applicant for a federal grant from prohibiting the
332	332	14 manufacture, delivery, possession, or use of psilocybin
333	333	15 products to the extent necessary to satisfy federal
334	334	16 requirements for the grant.
335	335	17 (5) Prohibit a party to a federal contract or a person
336	336	18 applying to be a party to a federal contract from
337	337	19 prohibiting the manufacture, delivery, possession, or use
338	338	20 of psilocybin products to the extent necessary to comply
339	339	21 with the terms and conditions of the contract or to
340	340	22 satisfy federal requirements for the contract.
341	341	23 (6) Require a person to violate a federal law.
342	342	24 (7) Exempt a person from a federal law or obstruct the
343	343	25 enforcement of a federal law.
344	344
345	345
346	346
347	347
348	348
349	349	SB2184 - 9 - LRB104 11945 RLC 22038 b
350	350
351	351
352	352	SB2184- 10 -LRB104 11945 RLC 22038 b SB2184 - 10 - LRB104 11945 RLC 22038 b
353	353	SB2184 - 10 - LRB104 11945 RLC 22038 b
354	354	1 (8) Amend or affect State law to the extent that a
355	355	2 person does not manufacture, deliver, or possess
356	356	3 psilocybin products in accordance with the provisions of
357	357	4 this Act and rules adopted under this Act.
358	358	5 Section 20. Definitions. In this Act:
359	359	6 "Administration session" means a structured session held
360	360	7 under the direct supervision of a licensed facilitator where a
361	361	8 client consumes and experiences the effects of a psilocybin
362	362	9 product, as per the provisions of this Act.
363	363	10 "Advisory Board" or "Board" means the Illinois Psilocybin
364	364	11 Advisory Board established under this Act.
365	365	12 "Client" means an individual who has received a referral
366	366	13 for psilocybin service and who consumes a psilocybin product
367	367	14 in an administration session in this State.
368	368	15 "Culturally and linguistically responsive services" means
369	369	16 psilocybin services offered by service centers and
370	370	17 facilitators that are responsive to diverse cultural beliefs
371	371	18 and practices, preferred languages, literacy, and other
372	372	19 communication needs of clients.
373	373	20 "Entheogen" or "entheogenic substance" means the following
374	374	21 substances in any form, regardless of whether the substance is
375	375	22 regulated under the federal Controlled Substances Act or the
376	376	23 Illinois Controlled Substances Act:
377	377	24 (1) Dimethyltryptamine;
378	378	25 (2) Ibogaine, except ibogaine from iboga;
379	379
380	380
381	381
382	382
383	383
384	384	SB2184 - 10 - LRB104 11945 RLC 22038 b
385	385
386	386
387	387	SB2184- 11 -LRB104 11945 RLC 22038 b SB2184 - 11 - LRB104 11945 RLC 22038 b
388	388	SB2184 - 11 - LRB104 11945 RLC 22038 b
389	389	1 (3) Mescaline, except mescaline from peyote;
390	390	2 (4) Psilocybin; and
391	391	3 (5) Psilocin.
392	392	4 "Facilitator" means an individual who facilitates the
393	393	5 provision of a psilocybin service in this State.
394	394	6 "Integration session" means a meeting between a client and
395	395	7 a facilitator that may occur after the client completes an
396	396	8 administration session.
397	397	9 "Legal entity" means a corporation, limited liability
398	398	10 company, limited partnership, or other legal entity that is
399	399	11 registered with the office of the Secretary of State or with a
400	400	12 comparable office of another jurisdiction.
401	401	13 "Licensee" means a person who holds a license issued under
402	402	14 Section 80, 95, 105, or 275.
403	403	15 "Licensee representative" means an owner, director,
404	404	16 officer, manager, employee, agent, or other representative of
405	405	17 a licensee, to the extent that the person acts in a
406	406	18 representative capacity.
407	407	19 "Manufacture" means the manufacture, planting,
408	408	20 cultivation, growing, harvesting, production, preparation,
409	409	21 propagation, compounding, conversion, or processing of a
410	410	22 psilocybin product, directly or indirectly, by extraction from
411	411	23 substances of natural origin, independently by means of
412	412	24 chemical synthesis or by a combination of extraction and
413	413	25 chemical synthesis. "Manufacture" includes any packaging or
414	414	26 repackaging of the psilocybin product or labeling or
415	415
416	416
417	417
418	418
419	419
420	420	SB2184 - 11 - LRB104 11945 RLC 22038 b
421	421
422	422
423	423	SB2184- 12 -LRB104 11945 RLC 22038 b SB2184 - 12 - LRB104 11945 RLC 22038 b
424	424	SB2184 - 12 - LRB104 11945 RLC 22038 b
425	425	1 relabeling of its container.
426	426	2 "Post-administration evaluation session" means a meeting
427	427	3 between a client and a facilitator that must occur immediately
428	428	4 following the conclusion of an administration session and
429	429	5 prior to the client's release from the service center.
430	430	6 "Premises" includes the following areas of a location
431	431	7 licensed under this Act:
432	432	8 (1) All public and private enclosed areas at the
433	433	9 location that are used in the business operated at the
434	434	10 location, including offices, kitchens, restrooms, and
435	435	11 storerooms.
436	436	12 (2) All areas outside of a building that the
437	437	13 Department has specifically licensed for the manufacturing
438	438	14 of psilocybin products or the operation of a service
439	439	15 center.
440	440	16 (3) For a location that the Department has
441	441	17 specifically licensed for the operation of a service
442	442	18 center outside of a building, that portion of the location
443	443	19 used to operate the service center and provide a
444	444	20 psilocybin service to a client.
445	445	21 "Premises" does not include a primary residence, unless a
446	446	22 primary residence is necessary for the provision of a
447	447	23 psilocybin service to a recipient who is a hospice patient or
448	448	24 who is unable to travel to a service center due to a chronic,
449	449	25 life-threatening illness.
450	450	26 "Preparation session" means a meeting between a client and
451	451
452	452
453	453
454	454
455	455
456	456	SB2184 - 12 - LRB104 11945 RLC 22038 b
457	457
458	458
459	459	SB2184- 13 -LRB104 11945 RLC 22038 b SB2184 - 13 - LRB104 11945 RLC 22038 b
460	460	SB2184 - 13 - LRB104 11945 RLC 22038 b
461	461	1 a facilitator that must occur before the client participates
462	462	2 in an administration session.
463	463	3 "Program development period" means the period beginning on
464	464	4 January 1 of the year following the year of enactment of this
465	465	5 Act and ending no later than 24 months after the beginning
466	466	6 date.
467	467	7 "Psilocybin" means psilocybin or psilocin.
468	468	8 "Psilocybin product" means:
469	469	9 (1) psilocybin-producing fungi; or
470	470	10 (2) mixtures or substances containing a detectable
471	471	11 amount of psilocybin naturally produced from
472	472	12 psilocybin-producing fungi.
473	473	13 "Psilocybin product" does not include a psilocybin service.
474	474	14 "Psilocybin product manufacturer" means a person who
475	475	15 manufactures a psilocybin product in this State.
476	476	16 "Psilocybin service" means a service provided to a client
477	477	17 before, during, or after the client's consumption of a
478	478	18 psilocybin product, including any of the following:
479	479	19 (1) a preparation session;
480	480	20 (2) an administration session;
481	481	21 (3) an integration session; or
482	482	22 (4) a post-administration evaluation session.
483	483	23 "Psychedelic" means a substance that alters perception,
484	484	24 mood, and cognition, often used for therapeutic and
485	485	25 introspective purposes. "Psychedelic" primarily refers to
486	486	26 entheogens like psilocybin and other compounds.
487	487
488	488
489	489
490	490
491	491
492	492	SB2184 - 13 - LRB104 11945 RLC 22038 b
493	493
494	494
495	495	SB2184- 14 -LRB104 11945 RLC 22038 b SB2184 - 14 - LRB104 11945 RLC 22038 b
496	496	SB2184 - 14 - LRB104 11945 RLC 22038 b
497	497	1 "Referral" means a recommendation in writing by a licensed
498	498	2 physician, psychiatrist, professional counselor, clinical
499	499	3 professional counselor, prescribing psychologist, clinical
500	500	4 psychologist, clinical social worker, or an advanced practice
501	501	5 registered nurse or physician's assistant who has prescribing
502	502	6 authority through a collaborative agreement with a physician,
503	503	7 provided to a patient for whom they determine psilocybin
504	504	8 service to be appropriate as a treatment or intervention for a
505	505	9 medical or mental health condition.
506	506	10 "Service center" means an establishment at which:
507	507	11 (1) an administration session is held;
508	508	12 (2) a psilocybin product is purchased; or
509	509	13 (3) other psilocybin services may be provided.
510	510	14 "Service center operator" means a person who operates a
511	511	15 service center in this State.
512	512	16 Section 25. Illinois Psilocybin Advisory Board; members;
513	513	17 terms; meetings; compensation.
514	514	18 (a) The Illinois Psilocybin Advisory Board is established
515	515	19 within the Department of Financial and Professional Regulation
516	516	20 for the purpose of advising and making recommendations for the
517	517	21 administration of this Act. The Illinois Psilocybin Advisory
518	518	22 Board shall consist of the following members:
519	519	23 (1) the Secretary of Financial and Professional
520	520	24 Regulation or the Secretary's designee;
521	521	25 (2) the Director of Agriculture or the Director's
522	522
523	523
524	524
525	525
526	526
527	527	SB2184 - 14 - LRB104 11945 RLC 22038 b
528	528
529	529
530	530	SB2184- 15 -LRB104 11945 RLC 22038 b SB2184 - 15 - LRB104 11945 RLC 22038 b
531	531	SB2184 - 15 - LRB104 11945 RLC 22038 b
532	532	1 designee;
533	533	2 (3) the Director of the Illinois State Police or the
534	534	3 Director's designee;
535	535	4 (4) the Director of Revenue or the Director's
536	536	5 designee;
537	537	6 (5) the Secretary of Human Services or the Secretary's
538	538	7 designee;
539	539	8 (6) the Secretary of Veterans Affairs or the
540	540	9 Secretary's designee;
541	541	10 (7) the Illinois Chief Behavioral Health Officer;
542	542	11 (8) an expert in the field of public health, community
543	543	12 sciences, or a related health field, or an individual who
544	544	13 is a member of or represents a group that provides public
545	545	14 health services directly to members of the public;
546	546	15 (9) a local health official, appointed by the Governor
547	547	16 with the advice and consent of the Senate;
548	548	17 (10) a psychologist who has experience engaging in the
549	549	18 diagnosis or treatment of mental, emotional, and
550	550	19 behavioral conditions, appointed by the Governor with the
551	551	20 advice and consent of the Senate;
552	552	21 (11) a psychiatrist licensed to practice in this State
553	553	22 who has experience engaging in the diagnosis or treatment
554	554	23 of mental, emotional, and behavioral conditions, appointed
555	555	24 by the Governor with the advice and consent of the Senate;
556	556	25 (12) a counselor licensed to practice this State who
557	557	26 has experience engaging in the diagnosis or treatment of
558	558
559	559
560	560
561	561
562	562
563	563	SB2184 - 15 - LRB104 11945 RLC 22038 b
564	564
565	565
566	566	SB2184- 16 -LRB104 11945 RLC 22038 b SB2184 - 16 - LRB104 11945 RLC 22038 b
567	567	SB2184 - 16 - LRB104 11945 RLC 22038 b
568	568	1 mental, emotional, and behavioral conditions, appointed by
569	569	2 the Governor with the advice and consent of the Senate;
570	570	3 (13) a physician licensed to practice medicine in all
571	571	4 its branches, appointed by the Governor with the advice
572	572	5 and consent of the Senate;
573	573	6 (14) a doctor of osteopathic medicine licensed to
574	574	7 practice this State, appointed by the Governor with the
575	575	8 advice and consent of the Senate;
576	576	9 (15) a physician representing an organization this
577	577	10 State engaged in naturopathy, as defined by the American
578	578	11 Association of Naturopathic Physicians, appointed by the
579	579	12 Governor with the advice and consent of the Senate;
580	580	13 (16) a licensed social worker or a licensed clinical
581	581	14 social worker, appointed by the Governor with the advice
582	582	15 and consent of the Senate;
583	583	16 (17) a representative of the Behavioral Health
584	584	17 Workforce Education Center of Illinois, appointed by the
585	585	18 Governor with the advice and consent of the Senate;
586	586	19 (18) A representative of a local organization
587	587	20 advocating for the equitable implementation of psychedelic
588	588	21 policies, appointed by the Governor with the advice and
589	589	22 consent of the Senate.
590	590	23 (19) at least 3 individuals who meet at least one of
591	591	24 the following qualifications, appointed by the Governor
592	592	25 with the advice and consent of the Senate:
593	593	26 (A) professional experience conducting scientific
594	594
595	595
596	596
597	597
598	598
599	599	SB2184 - 16 - LRB104 11945 RLC 22038 b
600	600
601	601
602	602	SB2184- 17 -LRB104 11945 RLC 22038 b SB2184 - 17 - LRB104 11945 RLC 22038 b
603	603	SB2184 - 17 - LRB104 11945 RLC 22038 b
604	604	1 research regarding the use of psychedelic compounds in
605	605	2 clinical therapy;
606	606	3 (B) experience in the field of mycology;
607	607	4 (C) experience in the field of ethnobotany;
608	608	5 (D) experience in the field of psychopharmacology;
609	609	6 or
610	610	7 (E) experience in the field of psilocybin harm
611	611	8 reduction;
612	612	9 (20) a current member of the Senate, appointed by the
613	613	10 President of the Senate;
614	614	11 (21) a current member of the Senate, appointed by the
615	615	12 Minority Leader of the Senate;
616	616	13 (22) a current member of the House, appointed by the
617	617	14 Speaker of the House; and
618	618	15 (23) a current member of the House, appointed by the
619	619	16 Minority Leader of the House.
620	620	17 (c) The term of office for an Advisory Board member
621	621	18 appointed under this Section is 4 years, but a member serves at
622	622	19 the pleasure of the Governor. Before the expiration of the
623	623	20 term of a member, the Governor shall appoint a successor whose
624	624	21 term begins on January 1 of the following calendar year.
625	625	22 Members may be eligible for reappointment. If there is a
626	626	23 vacancy for any reason, the Governor shall make an appointment
627	627	24 to serve in an acting capacity until approved by the Senate for
628	628	25 the remainder of the unexpired term.
629	629	26 (d) A majority of the voting members of the Advisory Board
630	630
631	631
632	632
633	633
634	634
635	635	SB2184 - 17 - LRB104 11945 RLC 22038 b
636	636
637	637
638	638	SB2184- 18 -LRB104 11945 RLC 22038 b SB2184 - 18 - LRB104 11945 RLC 22038 b
639	639	SB2184 - 18 - LRB104 11945 RLC 22038 b
640	640	1 constitutes a quorum for the transaction of business.
641	641	2 (e) Official action by the Advisory Board requires the
642	642	3 approval of a majority of the voting members of the board.
643	643	4 (f) The Advisory Board shall elect one of its voting
644	644	5 members to serve as chairperson.
645	645	6 (g) During the program development period, the Advisory
646	646	7 Board shall meet at least once every 2 calendar months at a
647	647	8 time and place determined by the chairperson, or a majority of
648	648	9 the voting members of the Advisory Board. After the program
649	649	10 development period, the Advisory Board shall meet at least
650	650	11 once every calendar quarter at a time and place determined by
651	651	12 the chairperson or a majority of the voting members of the
652	652	13 Advisory Board. The Advisory Board may also meet at other
653	653	14 times and places specified by the call of the chairperson or of
654	654	15 a majority of the voting members of the board.
655	655	16 (h) The Advisory Board may adopt policies and procedures
656	656	17 necessary for the operation of the board.
657	657	18 (i) The Advisory Board may establish committees or
658	658	19 subcommittees necessary for the operation of the board.
659	659	20 (j) Members of the Advisory Board shall not be paid a
660	660	21 salary but shall be reimbursed for travel and other reasonable
661	661	22 expenses incurred while fulfilling the responsibilities of the
662	662	23 Advisory Board.
663	663	24 Section 30. Duties of the Illinois Psilocybin Advisory
664	664	25 Board.
665	665
666	666
667	667
668	668
669	669
670	670	SB2184 - 18 - LRB104 11945 RLC 22038 b
671	671
672	672
673	673	SB2184- 19 -LRB104 11945 RLC 22038 b SB2184 - 19 - LRB104 11945 RLC 22038 b
674	674	SB2184 - 19 - LRB104 11945 RLC 22038 b
675	675	1 (a) The Illinois Psilocybin Advisory Board shall perform
676	676	2 the following duties:
677	677	3 (1) Provide advice to the Department of Agriculture,
678	678	4 the Department of Financial and Professional Regulation,
679	679	5 the Illinois State Police, and the Department of Revenue
680	680	6 with respect to the administration of this Act as it
681	681	7 relates to accurate public health approaches regarding
682	682	8 use, effect, and risk reduction of entheogens and the
683	683	9 content and scope of educational campaigns related to
684	684	10 entheogens.
685	685	11 (2) Make summary reports or recommendations on
686	686	12 available medical, psychological, and scientific studies,
687	687	13 research, and other information relating to the safety and
688	688	14 efficacy of psilocybin in treating various health
689	689	15 conditions, including, but not limited to, addiction,
690	690	16 depression, anxiety and trauma disorders, headache
691	691	17 disorders, and end-of-life psychological distress.
692	692	18 (3) Study and review the Oregon Psilocybin Services
693	693	19 Act (Measure 109), the Colorado Natural Medicine Health
694	694	20 Act of 2022 (Proposition 122), and relevant initiatives to
695	695	21 legalize or decriminalize entheogen use in other states
696	696	22 and units of local government in an effort to determine
697	697	23 successes and pitfalls that may be applied to the
698	698	24 rulemaking process this State.
699	699	25 (4) Make summary reports or recommendations on the
700	700	26 medical efficacy of ibogaine (except ibogaine from iboga),
701	701
702	702
703	703
704	704
705	705
706	706	SB2184 - 19 - LRB104 11945 RLC 22038 b
707	707
708	708
709	709	SB2184- 20 -LRB104 11945 RLC 22038 b SB2184 - 20 - LRB104 11945 RLC 22038 b
710	710	SB2184 - 20 - LRB104 11945 RLC 22038 b
711	711	1 mescaline (except mescaline from peyote), and botanical
712	712	2 forms of dimethlyltryptamine based on medical,
713	713	3 psychological, and scientific studies, research, and other
714	714	4 information related to the safety and efficacy of each
715	715	5 compound, and make recommendations concerning whether
716	716	6 these substances may be included in this Act or a similar
717	717	7 appropriate regulatory framework to avoid an unregulated
718	718	8 de facto market for entheogenic substances other than
719	719	9 psilocybin.
720	720	10 (5) Make summary reports or recommendations concerning
721	721	11 naturally occurring psilocybin and synthetic psilocybin
722	722	12 and the safety and efficacy of these substances.
723	723	13 (6) Make recommendations on the requirements,
724	724	14 specifications, and guidelines for providing psilocybin
725	725	15 services to a client, including the following:
726	726	16 (A) The requirements, specifications, and
727	727	17 guidelines for holding and verifying the completion of
728	728	18 a preparation session, an administration session, and
729	729	19 an integration session.
730	730	20 (B) The contents of the client information and
731	731	21 consent forms that a client must complete and sign
732	732	22 before the client participates in an administration
733	733	23 session, giving particular consideration to the
734	734	24 following:
735	735	25 (i) The information that should be solicited
736	736	26 from the client to determine whether the client
737	737
738	738
739	739
740	740
741	741
742	742	SB2184 - 20 - LRB104 11945 RLC 22038 b
743	743
744	744
745	745	SB2184- 21 -LRB104 11945 RLC 22038 b SB2184 - 21 - LRB104 11945 RLC 22038 b
746	746	SB2184 - 21 - LRB104 11945 RLC 22038 b
747	747	1 should participate in the administration session,
748	748	2 including information that may identify risk
749	749	3 factors and contraindications.
750	750	4 (ii) The information that should be solicited
751	751	5 from the client to assist the service center
752	752	6 operator and the facilitator in meeting any public
753	753	7 health and safety standards and industry best
754	754	8 practices during the administration session.
755	755	9 (iii) The health and safety warnings and other
756	756	10 disclosures that should be made to the client
757	757	11 before the client participates in the
758	758	12 administration session.
759	759	13 (7) Make recommendations on public health and safety
760	760	14 standards and industry best practices for each type of
761	761	15 licensee under this Act.
762	762	16 (8) Make recommendations on the formulation of a code
763	763	17 of professional conduct for facilitators, giving
764	764	18 particular consideration to a code of ethics, cultural
765	765	19 responsibility, and outlining a clear process for
766	766	20 reporting complaints of unethical conduct by facilitators
767	767	21 or service center employees.
768	768	22 (9) Make recommendations on the education, experience,
769	769	23 and training that facilitators must achieve, giving
770	770	24 particular consideration to the following and including
771	771	25 whether such education, experience, and training should be
772	772	26 available through online resources:
773	773
774	774
775	775
776	776
777	777
778	778	SB2184 - 21 - LRB104 11945 RLC 22038 b
779	779
780	780
781	781	SB2184- 22 -LRB104 11945 RLC 22038 b SB2184 - 22 - LRB104 11945 RLC 22038 b
782	782	SB2184 - 22 - LRB104 11945 RLC 22038 b
783	783	1 (A) Facilitation skills that are affirming,
784	784	2 nonjudgmental, nondirective, trauma-informed, and
785	785	3 rooted in informed consent.
786	786	4 (B) Support skills for clients during an
787	787	5 administration session, including specialized skills
788	788	6 for the following:
789	789	7 (i) client safety;
790	790	8 (ii) clients who may have a mental health
791	791	9 condition;
792	792	10 (iii) appropriate boundaries, heightened
793	793	11 transference in expanded states of consciousness,
794	794	12 and special precautions related to the use of
795	795	13 touch in psilocybin sessions;
796	796	14 (iv) crisis assessment and appropriate
797	797	15 referral for those who need ongoing support if
798	798	16 challenging mental health issues emerge in
799	799	17 psilocybin sessions;
800	800	18 (C) the environment in which psilocybin services
801	801	19 should occur;
802	802	20 (D) social and cultural considerations; and
803	803	21 (E) affordable, equitable, ethical, and culturally
804	804	22 responsible access to entheogens and requirements to
805	805	23 ensure that the regulated entheogen access program is
806	806	24 equitable and inclusive.
807	807	25 (10) Make recommendations on the examinations that
808	808	26 facilitators must pass.
809	809
810	810
811	811
812	812
813	813
814	814	SB2184 - 22 - LRB104 11945 RLC 22038 b
815	815
816	816
817	817	SB2184- 23 -LRB104 11945 RLC 22038 b SB2184 - 23 - LRB104 11945 RLC 22038 b
818	818	SB2184 - 23 - LRB104 11945 RLC 22038 b
819	819	1 (11) Make recommendations on public health and safety
820	820	2 standards and industry best practices for holding and
821	821	3 completing an administration session, including the
822	822	4 following:
823	823	5 (A) best practices surrounding group
824	824	6 administration;
825	825	7 (B) how clients can safely access common or
826	826	8 outside areas on the premises at which the
827	827	9 administration session is held;
828	828	10 (C) the circumstances under which an
829	829	11 administration session is considered complete; and
830	830	12 (D) the transportation needs of the client after
831	831	13 the completion of the administration session.
832	832	14 (12) Develop a long-term strategic plan for ensuring
833	833	15 that psilocybin services will become and remain a safe,
834	834	16 accessible, and affordable therapeutic option for all
835	835	17 persons 21 years of age and older in this State for whom
836	836	18 psilocybin may be appropriate.
837	837	19 (13) On an ongoing basis, monitor and study federal
838	838	20 laws, regulations, and policies regarding entheogens and
839	839	21 make summary reports with actionable recommendations
840	840	22 tailored for clinicians, public behavioral health clinics,
841	841	23 and any other entities that may issue referrals for
842	842	24 psilocybin services. These reports should also provide
843	843	25 guidance on the State's role in supporting safe,
844	844	26 equitable, and effective regulation of entheogens.
845	845
846	846
847	847
848	848
849	849
850	850	SB2184 - 23 - LRB104 11945 RLC 22038 b
851	851
852	852
853	853	SB2184- 24 -LRB104 11945 RLC 22038 b SB2184 - 24 - LRB104 11945 RLC 22038 b
854	854	SB2184 - 24 - LRB104 11945 RLC 22038 b
855	855	1 (14) On an ongoing basis, review and evaluate existing
856	856	2 research studies and real-world data related to entheogens
857	857	3 and make recommendations to the General Assembly and
858	858	4 relevant State agencies as to whether entheogens and
859	859	5 associated services provisioned by this Act should be
860	860	6 covered under any State health insurance or other
861	861	7 insurance program as a cost-effective intervention for
862	862	8 various health conditions, including, but not limited to,
863	863	9 anxiety, substance use disorder, alcoholism, depressive
864	864	10 disorders, neurological disorders, post-traumatic stress
865	865	11 disorder, other painful conditions, including, but not
866	866	12 limited to, cluster headaches, migraines, cancer, and
867	867	13 phantom limbs, and comfort care, including palliative
868	868	14 care, support care, and hospice care.
869	869	15 (15) Make summary reports and recommendations on the
870	870	16 availability of Medicaid coverage for entheogens and
871	871	17 associated services provisioned by this Act.
872	872	18 (16) On an ongoing basis, review and evaluate
873	873	19 sustainability issues related to natural entheogens and
874	874	20 their impact on indigenous cultures and document existing
875	875	21 reciprocity efforts and continuing support measures that
876	876	22 are needed as part of the Advisory Board's annual report.
877	877	23 (17) Publish an annual report describing the Advisory
878	878	24 Board's activities, including, but not limited to, any
879	879	25 recommendations and advice to the Department of Public
880	880	26 Health, the Department of Agriculture, the Department of
881	881
882	882
883	883
884	884
885	885
886	886	SB2184 - 24 - LRB104 11945 RLC 22038 b
887	887
888	888
889	889	SB2184- 25 -LRB104 11945 RLC 22038 b SB2184 - 25 - LRB104 11945 RLC 22038 b
890	890	SB2184 - 25 - LRB104 11945 RLC 22038 b
891	891	1 Financial and Professional Regulation, the Illinois State
892	892	2 Police, the Department of Revenue, or the General
893	893	3 Assembly.
894	894	4 (b) The Department of Financial and Professional
895	895	5 Regulation shall provide technical, logistical, and other
896	896	6 support to the Advisory Board, as requested by the Advisory
897	897	7 Board, to assist the Advisory Board with its duties and
898	898	8 obligations.
899	899	9 Section 35. General powers and duties; rules.
900	900	10 (a) The Department of Agriculture, the Department of
901	901	11 Financial and Professional Regulation, the Illinois State
902	902	12 Police, and the Department of Revenue have the duties,
903	903	13 functions, and powers necessary or proper to enable each
904	904	14 agency to carry out their duties, functions, and powers under
905	905	15 this Act. This includes the duty to regulate the
906	906	16 manufacturing, transportation, delivery, sale, and purchase of
907	907	17 psilocybin products and the provision of psilocybin services
908	908	18 in this State in accordance with the provisions of this Act.
909	909	19 The Department of Agriculture, the Department of Financial and
910	910	20 Professional Regulation, the Illinois State Police, and the
911	911	21 Department of Revenue may adopt, amend, or repeal rules as
912	912	22 necessary to carry out the intent and provisions of this Act,
913	913	23 including emergency rules necessary to protect public health
914	914	24 and safety.
915	915	25 (b) The Department of Agriculture, the Department of
916	916
917	917
918	918
919	919
920	920
921	921	SB2184 - 25 - LRB104 11945 RLC 22038 b
922	922
923	923
924	924	SB2184- 26 -LRB104 11945 RLC 22038 b SB2184 - 26 - LRB104 11945 RLC 22038 b
925	925	SB2184 - 26 - LRB104 11945 RLC 22038 b
926	926	1 Financial and Professional Regulation, the Illinois State
927	927	2 Police, and the Department of Revenue shall enter into
928	928	3 intergovernmental agreements, as necessary, to carry out the
929	929	4 provisions of this Act, including, but not limited to, the
930	930	5 provisions relating to the registration and oversight of any
931	931	6 person who produces, possesses, transports, delivers, sells,
932	932	7 or purchases a psilocybin product in this State or who
933	933	8 provides a psilocybin service in this State. There shall be no
934	934	9 requirement that a client be diagnosed with or have any
935	935	10 particular medical condition as a prerequisite to being
936	936	11 provided psilocybin services.
937	937	12 (c) The Department of Agriculture and the Department of
938	938	13 Financial and Professional Regulation may suspend, revoke, or
939	939	14 impose other penalties upon a person licensed under this Act
940	940	15 for violations of this Act and any rules adopted in accordance
941	941	16 with this Act. The suspension or revocation of a license or
942	942	17 imposition of any other penalty upon a licensee is a final
943	943	18 Agency action subject to judicial review. Jurisdiction and
944	944	19 venue for judicial review are vested in the circuit court.
945	945	20 (d) The Department of Agriculture shall issue, renew,
946	946	21 suspend, revoke, or refuse to issue or renew licenses for the
947	947	22 manufacturing and testing of psilocybin products and to
948	948	23 permit, at the Department of Agriculture's discretion, the
949	949	24 transfer of licenses. There shall be no requirement that a
950	950	25 psilocybin product be manufactured by means of chemical
951	951	26 synthesis.
952	952
953	953
954	954
955	955
956	956
957	957	SB2184 - 26 - LRB104 11945 RLC 22038 b
958	958
959	959
960	960	SB2184- 27 -LRB104 11945 RLC 22038 b SB2184 - 27 - LRB104 11945 RLC 22038 b
961	961	SB2184 - 27 - LRB104 11945 RLC 22038 b
962	962	1 (e) The Department of Financial and Professional
963	963	2 Regulation shall issue, renew, suspend, revoke, or refuse to
964	964	3 issue or renew licenses for the sale of psilocybin products,
965	965	4 the provision of psilocybin services, or other licenses
966	966	5 related to the consumption of psilocybin products, and to
967	967	6 permit, at the Department's discretion, the transfer of a
968	968	7 license between persons.
969	969	8 (f) Any fees collected pursuant to this Section shall be
970	970	9 deposited into the Psilocybin Control and Regulation Fund.
971	971	10 Section 40. Authority to purchase, possess, seize,
972	972	11 transfer to a licensee, or dispose of psilocybin products.
973	973	12 Subject to any applicable provision of State law, the
974	974	13 Department of Agriculture, the Department of Financial and
975	975	14 Professional Regulation, the Illinois State Police, and the
976	976	15 Department of Revenue may purchase, possess, seize, transfer
977	977	16 to a licensee, or dispose of psilocybin products as is
978	978	17 necessary to ensure compliance with and enforce the provisions
979	979	18 of this Act and any rule adopted under this Act.
980	980	19 Section 45. Program development period; dates.
981	981	20 (a) Unless the General Assembly provides otherwise, the
982	982	21 Department may not issue any licenses under this Act during
983	983	22 the program development period.
984	984	23 (b) On or before February 28 of the year following the
985	985	24 effective date of this Act, the Governor, the Senate
986	986
987	987
988	988
989	989
990	990
991	991	SB2184 - 27 - LRB104 11945 RLC 22038 b
992	992
993	993
994	994	SB2184- 28 -LRB104 11945 RLC 22038 b SB2184 - 28 - LRB104 11945 RLC 22038 b
995	995	SB2184 - 28 - LRB104 11945 RLC 22038 b
996	996	1 President, and the Speaker of the House shall appoint the
997	997	2 individuals specified in subsection (b) of Section 25 to the
998	998	3 Advisory Board.
999	999	4 (c) On or before March 31 of the year following the
1000	1000	5 effective date of this Act, the Advisory Board shall hold its
1001	1001	6 first meeting at a time and place specified by the Governor.
1002	1002	7 (d) On or before June 30 of the year following the
1003	1003	8 effective date of this Act, and every year after that date, the
1004	1004	9 Advisory Board shall submit its findings and recommendations
1005	1005	10 to the General Assembly.
1006	1006	11 (e) No more than 18 months after the effective date of this
1007	1007	12 Act, the Advisory Board shall submit its findings and
1008	1008	13 recommendations concerning the following:
1009	1009	14 (1) rules and regulations for the implementation of
1010	1010	15 this Act;
1011	1011	16 (2) a long-term strategic plan for ensuring that
1012	1012	17 psilocybin services will become and remain a safe,
1013	1013	18 accessible, and affordable therapeutic option for all
1014	1014	19 persons 21 years of age and older in this State for whom
1015	1015	20 psilocybin may be appropriate; and
1016	1016	21 (3) with respect to federal laws, regulations, and
1017	1017	22 policies regarding psilocybin and other entheogens.
1018	1018	23 (f) No more than 2 years after the effective date of this
1019	1019	24 Act, the Department of Public Health, the Department of
1020	1020	25 Agriculture, the Department of Revenue, and the Department of
1021	1021	26 Financial and Professional Regulation shall prescribe forms
1022	1022
1023	1023
1024	1024
1025	1025
1026	1026
1027	1027	SB2184 - 28 - LRB104 11945 RLC 22038 b
1028	1028
1029	1029
1030	1030	SB2184- 29 -LRB104 11945 RLC 22038 b SB2184 - 29 - LRB104 11945 RLC 22038 b
1031	1031	SB2184 - 29 - LRB104 11945 RLC 22038 b
1032	1032	1 and adopt such rules as the Departments deem necessary for the
1033	1033	2 implementation of this Act. The Department of Public Health,
1034	1034	3 the Department of Agriculture, the Department of Revenue, the
1035	1035	4 Illinois State Police, and the Department of Financial and
1036	1036	5 Professional Regulation shall hold at least one public hearing
1037	1037	6 regarding this rulemaking prior to the submission of rules.
1038	1038	7 The public hearing may be held jointly or the Departments may
1039	1039	8 hold individual hearings.
1040	1040	9 Section 50. Licensing.
1041	1041	10 (a) No later than 30 months after the effective date of
1042	1042	11 this Act:
1043	1043	12 (1) The Department of Financial and Professional
1044	1044	13 Regulation shall begin receiving applications for the
1045	1045	14 licensing of persons to:
1046	1046	15 (A) operate a service center; and
1047	1047	16 (B) facilitate psilocybin services.
1048	1048	17 (2) The Department of Agriculture shall begin
1049	1049	18 receiving applications for the licensing of persons to:
1050	1050	19 (A) manufacture psilocybin products; and
1051	1051	20 (B) test psilocybin products.
1052	1052	21 (a-5) No later than 36 months after the effective date of
1053	1053	22 this Act, the Department of Financial and Professional
1054	1054	23 Regulation and the Department of Agriculture shall begin
1055	1055	24 issuing approvals or denials for license applications received
1056	1056	25 under subsection (a).
1057	1057
1058	1058
1059	1059
1060	1060
1061	1061
1062	1062	SB2184 - 29 - LRB104 11945 RLC 22038 b
1063	1063
1064	1064
1065	1065	SB2184- 30 -LRB104 11945 RLC 22038 b SB2184 - 30 - LRB104 11945 RLC 22038 b
1066	1066	SB2184 - 30 - LRB104 11945 RLC 22038 b
1067	1067	1 (b) Except as provided in subsection (c), an applicant for
1068	1068	2 a license or renewal of a license issued under this Act shall
1069	1069	3 apply to the appropriate Department in the form required by
1070	1070	4 that Department, by rule, showing the name and address of the
1071	1071	5 applicant, the location of the facility that is to be operated
1072	1072	6 under the license, and other pertinent information required by
1073	1073	7 the Department. The Department may not issue or renew a
1074	1074	8 license until the applicant has complied with the provisions
1075	1075	9 of this Act and rules adopted under this Act.
1076	1076	10 (b-5) If an application does not meet the technical
1077	1077	11 standards set forth by the applicable Department, the
1078	1078	12 Department must notify the applicant and provide the applicant
1079	1079	13 with at least 30 days after the applicant receives notice of
1080	1080	14 the deficiency to rectify the application materials.
1081	1081	15 (c) A Department may reject any application that is not
1082	1082	16 submitted in the form required by the Department by rule. The
1083	1083	17 approval or denial of any application is a final decision of
1084	1084	18 the Department subject to judicial review. Jurisdiction and
1085	1085	19 venue are vested in the circuit court.
1086	1086	20 (d) Except as provided in subsection (c), a revocation of
1087	1087	21 or refusal to issue or renew a license issued under this Act is
1088	1088	22 a final decision of the Department subject to judicial review.
1089	1089	23 Jurisdiction and venue are vested in the circuit court.
1090	1090	24 (e) An applicant for a facilitator license or renewal of a
1091	1091	25 facilitator license issued under Section 105 need not show the
1092	1092	26 location of any premises.
1093	1093
1094	1094
1095	1095
1096	1096
1097	1097
1098	1098	SB2184 - 30 - LRB104 11945 RLC 22038 b
1099	1099
1100	1100
1101	1101	SB2184- 31 -LRB104 11945 RLC 22038 b SB2184 - 31 - LRB104 11945 RLC 22038 b
1102	1102	SB2184 - 31 - LRB104 11945 RLC 22038 b
1103	1103	1 (f) The Department of Financial and Professional
1104	1104	2 Regulation or the Department of Agriculture shall not license
1105	1105	3 an applicant under the provisions of this Act if the applicant
1106	1106	4 is under 21 years of age.
1107	1107	5 (g) The Department of Financial or Professional Regulation
1108	1108	6 or the Department of Agriculture shall refuse to issue a
1109	1109	7 license or may issue a restricted license to an applicant
1110	1110	8 under the provisions of this Act if the Department finds that
1111	1111	9 the applicant meets any of the following conditions:
1112	1112	10 (1) has failed to complete any of the education or
1113	1113	11 training required by the provisions of this Act or rules
1114	1114	12 adopted under this Act;
1115	1115	13 (2) has failed to complete any of the examinations
1116	1116	14 required by the provisions of this Act or rules adopted
1117	1117	15 under this Act;
1118	1118	16 (3) is in the habit of using alcoholic beverages,
1119	1119	17 habit-forming drugs, or controlled substances to excess as
1120	1120	18 determined by the Department;
1121	1121	19 (4) has made false statements to the Department;
1122	1122	20 (5) is incompetent or physically unable to carry on
1123	1123	21 the management of the establishment proposed to be
1124	1124	22 licensed as determined by the Department;
1125	1125	23 (6) has been convicted of violating a federal law,
1126	1126	24 State law, or local ordinance if the conviction is
1127	1127	25 substantially related to the fitness and ability of the
1128	1128	26 applicant to lawfully carry out activities under the
1129	1129
1130	1130
1131	1131
1132	1132
1133	1133
1134	1134	SB2184 - 31 - LRB104 11945 RLC 22038 b
1135	1135
1136	1136
1137	1137	SB2184- 32 -LRB104 11945 RLC 22038 b SB2184 - 32 - LRB104 11945 RLC 22038 b
1138	1138	SB2184 - 32 - LRB104 11945 RLC 22038 b
1139	1139	1 license;
1140	1140	2 (7) is not of good repute and moral character as
1141	1141	3 determined by the Department;
1142	1142	4 (8) does not have a good record of compliance with
1143	1143	5 this Act or any rule adopted under this Act;
1144	1144	6 (9) is not the legitimate owner of the premises
1145	1145	7 proposed to be licensed or has not disclosed that any
1146	1146	8 other person has an ownership interest in the premises
1147	1147	9 proposed to be licensed;
1148	1148	10 (10) has not demonstrated financial responsibility
1149	1149	11 sufficient to adequately meet the requirements of the
1150	1150	12 premises proposed to be licensed; or
1151	1151	13 (11) is unable to understand the laws of this State
1152	1152	14 relating to psilocybin products, psilocybin services, or
1153	1153	15 the rules adopted under this Act.
1154	1154	16 (h) Notwithstanding paragraph (6) of subsection (g), in
1155	1155	17 determining whether to issue a license or a restricted license
1156	1156	18 to an applicant, the Department of Financial and Professional
1157	1157	19 Regulation or the Department of Agriculture shall not consider
1158	1158	20 the prior conviction of the applicant or any owner, director,
1159	1159	21 officer, manager, employee, agent, or other representative of
1160	1160	22 the applicant for the following:
1161	1161	23 (1) The manufacture of psilocybin or the manufacture
1162	1162	24 of cannabis, as defined under Section 1-10 of the Cannabis
1163	1163	25 Regulation and Tax Act, or cannabis product if any of the
1164	1164	26 following apply:
1165	1165
1166	1166
1167	1167
1168	1168
1169	1169
1170	1170	SB2184 - 32 - LRB104 11945 RLC 22038 b
1171	1171
1172	1172
1173	1173	SB2184- 33 -LRB104 11945 RLC 22038 b SB2184 - 33 - LRB104 11945 RLC 22038 b
1174	1174	SB2184 - 33 - LRB104 11945 RLC 22038 b
1175	1175	1 (A) The date of the conviction is 2 or more years
1176	1176	2 before the date of the application.
1177	1177	3 (B) The person has not been convicted more than
1178	1178	4 once for the manufacture of psilocybin.
1179	1179	5 (2) The possession of a controlled substance, as
1180	1180	6 defined in the Illinois Controlled Substances Act, if any
1181	1181	7 of the following apply:
1182	1182	8 (A) The date of the conviction is 2 or more years
1183	1183	9 before the date of the application.
1184	1184	10 (B) The person has not been convicted more than
1185	1185	11 once for the possession of a controlled substance.
1186	1186	12 (i) The Department of Financial and Professional
1187	1187	13 Regulation and the Department of Agriculture shall not issue a
1188	1188	14 license pursuant to this Act if the licensee, principal
1189	1189	15 officer, board member, or person having a financial or voting
1190	1190	16 interest of 5% or greater in the licensee or applicant, or the
1191	1191	17 agent thereof is delinquent in filing any required tax returns
1192	1192	18 or paying any amounts owed to the State.
1193	1193	19 Section 55. Authority to require fingerprints. The
1194	1194	20 Department of Agriculture or the Department of Financial and
1195	1195	21 Professional Regulation, through the Illinois State Police,
1196	1196	22 may require the fingerprints of any individual listed on an
1197	1197	23 application to perform any of the functions listed in
1198	1198	24 subsection (a) of Section 50 for purposes of conducting a
1199	1199	25 background check. The Department of Agriculture or the
1200	1200
1201	1201
1202	1202
1203	1203
1204	1204
1205	1205	SB2184 - 33 - LRB104 11945 RLC 22038 b
1206	1206
1207	1207
1208	1208	SB2184- 34 -LRB104 11945 RLC 22038 b SB2184 - 34 - LRB104 11945 RLC 22038 b
1209	1209	SB2184 - 34 - LRB104 11945 RLC 22038 b
1210	1210	1 Department of Financial and Professional Regulation may
1211	1211	2 require fingerprints to be submitted for a background check
1212	1212	3 prior to or after the submission of an application. The
1213	1213	4 Illinois State Police shall charge a fee for conducting the
1214	1214	5 criminal history record check, which shall be deposited in the
1215	1215	6 State Police Services Fund and shall not exceed the actual
1216	1216	7 cost of the record check. In order to carry out this provision,
1217	1217	8 each person applying to perform one of the functions listed in
1218	1218	9 subsection (a) of Section 50 may be required to submit a full
1219	1219	10 set of fingerprints to the Illinois State Police for the
1220	1220	11 purpose of obtaining a State and federal criminal records
1221	1221	12 check. These fingerprints shall be checked against the
1222	1222	13 fingerprint records now and hereafter, to the extent allowed
1223	1223	14 by law, filed in the Illinois State Police and Federal Bureau
1224	1224	15 of Investigation criminal history records databases. The
1225	1225	16 Illinois State Police shall furnish, following positive
1226	1226	17 identification, all State conviction information to the
1227	1227	18 Department of Agriculture or the Department of Financial and
1228	1228	19 Professional Regulation. The Department of Agriculture or the
1229	1229	20 Department of Financial and Professional Regulation, through
1230	1230	21 the Illinois State Police, may require the fingerprints of the
1231	1231	22 following persons:
1232	1232	23 (1) If the applicant is a limited partnership, each
1233	1233	24 general partner of the limited partnership.
1234	1234	25 (2) If the applicant is a manager-managed limited
1235	1235	26 liability company, each manager of the limited liability
1236	1236
1237	1237
1238	1238
1239	1239
1240	1240
1241	1241	SB2184 - 34 - LRB104 11945 RLC 22038 b
1242	1242
1243	1243
1244	1244	SB2184- 35 -LRB104 11945 RLC 22038 b SB2184 - 35 - LRB104 11945 RLC 22038 b
1245	1245	SB2184 - 35 - LRB104 11945 RLC 22038 b
1246	1246	1 company.
1247	1247	2 (3) If the applicant is a member-managed limited
1248	1248	3 liability company, each voting member of the limited
1249	1249	4 liability company.
1250	1250	5 (4) If the applicant is a corporation, each director
1251	1251	6 and officer of the corporation.
1252	1252	7 (5) Any individual who holds a financial interest of
1253	1253	8 10% or more in the person applying for the license.
1254	1254	9 Section 60. Properties of license. A license issued under
1255	1255	10 this Act is all of the following:
1256	1256	11 (1) a personal privilege;
1257	1257	12 (2) renewable in the manner provided under Section 50,
1258	1258	13 except for a cause that would be grounds for refusal to
1259	1259	14 issue the license under Section 50;
1260	1260	15 (3) subject to revocation or suspension as provided in
1261	1261	16 Section 185;
1262	1262	17 (4) except for a license issued to a facilitator under
1263	1263	18 Section 105, transferable from the premises for which the
1264	1264	19 license was originally issued to another premises subject
1265	1265	20 to the provisions of this Act, applicable rules adopted
1266	1266	21 under this Act, and applicable local ordinances;
1267	1267	22 (5) subject to expiration upon the death of the
1268	1268	23 licensee, if the license was issued to an individual
1269	1269	24 except as provided under subsection (p) of Section 155;
1270	1270	25 (6) not considered property;
1271	1271
1272	1272
1273	1273
1274	1274
1275	1275
1276	1276	SB2184 - 35 - LRB104 11945 RLC 22038 b
1277	1277
1278	1278
1279	1279	SB2184- 36 -LRB104 11945 RLC 22038 b SB2184 - 36 - LRB104 11945 RLC 22038 b
1280	1280	SB2184 - 36 - LRB104 11945 RLC 22038 b
1281	1281	1 (7) not alienable;
1282	1282	2 (8) not subject to attachment or execution; and
1283	1283	3 (9) not subject to descent by the laws of testate or
1284	1284	4 intestate succession.
1285	1285	5 Section 65. Duties of the Departments with respect to
1286	1286	6 issuing licenses.
1287	1287	7 (a) The Department of Financial and Professional
1288	1288	8 Regulation or the Department of Agriculture shall approve or
1289	1289	9 deny an application to be licensed under this Act. Upon
1290	1290	10 receiving an application under Section 50, the Department may
1291	1291	11 not unreasonably delay processing, approving, or denying the
1292	1292	12 application or, if the application is approved, issuing the
1293	1293	13 license.
1294	1294	14 (b) The licenses described in this Act must be issued by
1295	1295	15 the Department of Financial and Professional Regulation or the
1296	1296	16 Department of Agriculture subject to the provisions of this
1297	1297	17 Act and rules adopted under this Act.
1298	1298	18 (c) The Department of Financial and Professional
1299	1299	19 Regulation may not license premises that do not have defined
1300	1300	20 boundaries. Premises do not need to be enclosed by a wall,
1301	1301	21 fence, or other structure, but the Department of Financial and
1302	1302	22 Professional Regulation may require premises to be enclosed as
1303	1303	23 a condition of issuing or renewing a license. The Department
1304	1304	24 of Financial and Professional Regulation may not license
1305	1305	25 mobile premises.
1306	1306
1307	1307
1308	1308
1309	1309
1310	1310
1311	1311	SB2184 - 36 - LRB104 11945 RLC 22038 b
1312	1312
1313	1313
1314	1314	SB2184- 37 -LRB104 11945 RLC 22038 b SB2184 - 37 - LRB104 11945 RLC 22038 b
1315	1315	SB2184 - 37 - LRB104 11945 RLC 22038 b
1316	1316	1 Section 70. Lawful manufacture, delivery, and possession
1317	1317	2 of psilocybin products. A licensee or licensee representative
1318	1318	3 may manufacture, deliver, or possess a psilocybin product
1319	1319	4 subject to the provisions of this Act and rules adopted under
1320	1320	5 this Act. The manufacture, delivery, or possession of a
1321	1321	6 psilocybin product by a licensee or a licensee representative
1322	1322	7 in compliance with this Act and rules adopted under this Act
1323	1323	8 does not constitute a criminal or civil offense under the laws
1324	1324	9 of this State.
1325	1325	10 Section 75. Restriction on financial interests in multiple
1326	1326	11 licensees.
1327	1327	12 (a) An individual may not have a financial interest in
1328	1328	13 either of the following:
1329	1329	14 (1) More than one psilocybin product manufacturer.
1330	1330	15 (2) More than 5 service center operators.
1331	1331	16 (b) Subject to subsection (a), a person may hold multiple
1332	1332	17 service center operator licenses under Section 95 and may hold
1333	1333	18 both a manufacturer license under Section 80 and a service
1334	1334	19 center operator license under Section 95 at the same or
1335	1335	20 different premises.
1336	1336	21 Section 80. License to manufacture psilocybin products.
1337	1337	22 (a) The manufacture of psilocybin products is subject to
1338	1338	23 regulation by the Department of Agriculture.
1339	1339
1340	1340
1341	1341
1342	1342
1343	1343
1344	1344	SB2184 - 37 - LRB104 11945 RLC 22038 b
1345	1345
1346	1346
1347	1347	SB2184- 38 -LRB104 11945 RLC 22038 b SB2184 - 38 - LRB104 11945 RLC 22038 b
1348	1348	SB2184 - 38 - LRB104 11945 RLC 22038 b
1349	1349	1 (b) A psilocybin product manufacturer must have a
1350	1350	2 manufacturer license issued by the Department of Agriculture
1351	1351	3 for the premises at which the psilocybin products are
1352	1352	4 manufactured. To hold a manufacturer license issued under this
1353	1353	5 Section, a psilocybin product manufacturer must comply with
1354	1354	6 the following:
1355	1355	7 (1) apply for a license in the manner described in
1356	1356	8 Section 50; and
1357	1357	9 (2) provide proof that the applicant is 21 years of
1358	1358	10 age or older.
1359	1359	11 (c) If the applicant is not the owner of the premises at
1360	1360	12 which the psilocybin is to be manufactured, the applicant
1361	1361	13 shall submit to the Department of Agriculture signed informed
1362	1362	14 consent from the owner of the premises to manufacture
1363	1363	15 psilocybin at the premises. The Department of Agriculture may
1364	1364	16 adopt rules regarding the informed consent described in this
1365	1365	17 subsection.
1366	1366	18 (d) The Department of Agriculture shall adopt rules that
1367	1367	19 comply with the following:
1368	1368	20 (1) require a psilocybin product manufacturer to
1369	1369	21 annually renew a license issued under this Section;
1370	1370	22 (2) establish application, licensure, and renewal of
1371	1371	23 licensure fees for psilocybin product manufacturers; and
1372	1372	24 (3) require psilocybin products manufactured by
1373	1373	25 psilocybin product manufacturers to be tested in
1374	1374	26 accordance with Section 270.
1375	1375
1376	1376
1377	1377
1378	1378
1379	1379
1380	1380	SB2184 - 38 - LRB104 11945 RLC 22038 b
1381	1381
1382	1382
1383	1383	SB2184- 39 -LRB104 11945 RLC 22038 b SB2184 - 39 - LRB104 11945 RLC 22038 b
1384	1384	SB2184 - 39 - LRB104 11945 RLC 22038 b
1385	1385	1 Section 81. Psilocybin product manufacturer license; fees.
1386	1386	2 (a) Psilocybin product manufacturer licenses shall expire
1387	1387	3 one year from the date they are issued.
1388	1388	4 (b) Licensees shall submit a renewal application as
1389	1389	5 provided by the Department of Agriculture and pay the required
1390	1390	6 renewal fee. No license shall be renewed if it is currently
1391	1391	7 under revocation or suspension for violation of this Act or
1392	1392	8 any rules that may be adopted under this Act or the licensee,
1393	1393	9 principal officer, board member, person having a financial or
1394	1394	10 voting interest of 5% or greater in the licensee, or agent is
1395	1395	11 delinquent in filing any required tax returns or paying any
1396	1396	12 amounts owed to the State.
1397	1397	13 (c) The license fee for a psilocybin product manufacturer
1398	1398	14 license shall be $10,000, to be deposited into the Psilocybin
1399	1399	15 Control and Regulation Fund.
1400	1400	16 (d) If a psilocybin product manufacturer fails to renew
1401	1401	17 its license before expiration, the psilocybin product
1402	1402	18 manufacturer shall cease operations until the license is
1403	1403	19 renewed.
1404	1404	20 (e) Any psilocybin product manufacturer that continues to
1405	1405	21 operate after failing to renew its license is subject to
1406	1406	22 penalty as provided in this Act, or any rules that may be
1407	1407	23 adopted pursuant to this Act.
1408	1408	24 (f) The Department of Agriculture shall not renew a
1409	1409	25 license if the applicant is delinquent in filing any required
1410	1410
1411	1411
1412	1412
1413	1413
1414	1414
1415	1415	SB2184 - 39 - LRB104 11945 RLC 22038 b
1416	1416
1417	1417
1418	1418	SB2184- 40 -LRB104 11945 RLC 22038 b SB2184 - 40 - LRB104 11945 RLC 22038 b
1419	1419	SB2184 - 40 - LRB104 11945 RLC 22038 b
1420	1420	1 tax returns or paying any amounts owed to the State.
1421	1421	2 (g) Three years after the effective date of this Act, the
1422	1422	3 Department of Agriculture may by rule modify any fee
1423	1423	4 established under this Section.
1424	1424	5 Section 85. Psilocybin product manufacturers;
1425	1425	6 endorsements.
1426	1426	7 (a) The Department of Agriculture shall adopt rules that
1427	1427	8 designate different types of manufacturing activities. A
1428	1428	9 psilocybin product manufacturer may only engage in a type of
1429	1429	10 manufacturing activity if the psilocybin product manufacturer
1430	1430	11 has received an endorsement from the Department for that type
1431	1431	12 of manufacturing activity.
1432	1432	13 (b) An applicant must request an endorsement upon
1433	1433	14 submission of an initial application but may also request an
1434	1434	15 endorsement at any time following licensure.
1435	1435	16 (c) Only one application and license fee is required
1436	1436	17 regardless of how many endorsements an applicant or licensee
1437	1437	18 requests or at what time the request is made.
1438	1438	19 (d) A psilocybin product manufacturer licensee may hold
1439	1439	20 multiple endorsements.
1440	1440	21 (e) The Department of Agriculture may deny a psilocybin
1441	1441	22 product manufacturer's request for an endorsement or revoke an
1442	1442	23 existing endorsement if the psilocybin product manufacturer
1443	1443	24 cannot or does not meet the requirements for the endorsement
1444	1444	25 that is requested.
1445	1445
1446	1446
1447	1447
1448	1448
1449	1449
1450	1450	SB2184 - 40 - LRB104 11945 RLC 22038 b
1451	1451
1452	1452
1453	1453	SB2184- 41 -LRB104 11945 RLC 22038 b SB2184 - 41 - LRB104 11945 RLC 22038 b
1454	1454	SB2184 - 41 - LRB104 11945 RLC 22038 b
1455	1455	1 Section 90. Psilocybin product quantities; rules. The
1456	1456	2 Department of Agriculture shall adopt rules restricting the
1457	1457	3 quantities of psilocybin products at premises for which a
1458	1458	4 license has been issued under Section 80. In adopting rules
1459	1459	5 under this Section, the Department shall take into
1460	1460	6 consideration the demand for psilocybin services in this
1461	1461	7 State, the number of psilocybin product manufacturers applying
1462	1462	8 for a license under Section 80, the number of psilocybin
1463	1463	9 product manufacturers that hold a license issued under Section
1464	1464	10 80, and whether the availability of psilocybin products in
1465	1465	11 this State is commensurate with the demand for psilocybin
1466	1466	12 services.
1467	1467	13 Section 95. License to operate a service center.
1468	1468	14 (a) The operation of a service center is subject to
1469	1469	15 regulation by the Department of Financial and Professional
1470	1470	16 Regulation.
1471	1471	17 (b) A service center operator must have a service center
1472	1472	18 operator license issued by the Department of Financial and
1473	1473	19 Professional Regulation for the premises at which psilocybin
1474	1474	20 services are provided. To hold a service center operator
1475	1475	21 license under this Section, a service center operator must
1476	1476	22 comply with the following:
1477	1477	23 (1) apply for a license in the manner described in
1478	1478	24 Section 50;
1479	1479
1480	1480
1481	1481
1482	1482
1483	1483
1484	1484	SB2184 - 41 - LRB104 11945 RLC 22038 b
1485	1485
1486	1486
1487	1487	SB2184- 42 -LRB104 11945 RLC 22038 b SB2184 - 42 - LRB104 11945 RLC 22038 b
1488	1488	SB2184 - 42 - LRB104 11945 RLC 22038 b
1489	1489	1 (2) provide proof that the applicant is 21 years of
1490	1490	2 age or older;
1491	1491	3 (3) ensure that the service center is located in an
1492	1492	4 area that is not within the limits of an area zoned
1493	1493	5 exclusively for residential use;
1494	1494	6 (4) ensure that the service center is not located
1495	1495	7 within 1,000 feet of a public, private, or parochial
1496	1496	8 school; and
1497	1497	9 (5) meet the requirements of any rule adopted by the
1498	1498	10 Department of Financial and Professional Regulation under
1499	1499	11 subsection (c).
1500	1500	12 (c) The Department of Financial and Professional
1501	1501	13 Regulation shall adopt rules that comply with the following:
1502	1502	14 (1) require a service center operator to annually
1503	1503	15 renew a license issued under this Section;
1504	1504	16 (2) establish application, licensure, and renewal of
1505	1505	17 licensure fees for service center operators;
1506	1506	18 (3) require psilocybin products sold by a service
1507	1507	19 center operator to be tested in accordance with Section
1508	1508	20 270; and
1509	1509	21 (4) require a service center operator to meet any
1510	1510	22 public health and safety standards and industry best
1511	1511	23 practices established by the Department by rule;
1512	1512	24 (5) require a service center operator to collect a
1513	1513	25 completed and signed client information form, as provided
1514	1514	26 in Section 134, prior to providing any psilocybin service.
1515	1515
1516	1516
1517	1517
1518	1518
1519	1519
1520	1520	SB2184 - 42 - LRB104 11945 RLC 22038 b
1521	1521
1522	1522
1523	1523	SB2184- 43 -LRB104 11945 RLC 22038 b SB2184 - 43 - LRB104 11945 RLC 22038 b
1524	1524	SB2184 - 43 - LRB104 11945 RLC 22038 b
1525	1525	1 (d) Before receiving a service center operator license, a
1526	1526	2 service center operator shall indicate the Entheogen Social
1527	1527	3 Equity Inclusion Plan that the applicant plans to achieve
1528	1528	4 before the expiration of the service center operator license
1529	1529	5 from the following list:
1530	1530	6 (1) make a contribution of 3% of total sales from the
1531	1531	7 service center's first year of operation, or $25,000,
1532	1532	8 whichever is less, to the Psilocybin Control and
1533	1533	9 Regulation Fund. This is in addition to the fees required
1534	1534	10 by Section 96;
1535	1535	11 (2) make a grant of 3% of total sales from the service
1536	1536	12 center's first year of operation, or $25,000, whichever is
1537	1537	13 less, to a psilocybin facilitator education or training
1538	1538	14 program approved by the Department of Financial and
1539	1539	15 Professional Regulation; or
1540	1540	16 (3) make a donation of $25,000 or more to a program
1541	1541	17 approved by the Department of Financial and Professional
1542	1542	18 Regulation that provides mental health services to
1543	1543	19 veterans.
1544	1544	20 Section 96. Service center license; fees.
1545	1545	21 (a) Service center licenses shall expire one year from the
1546	1546	22 date they are issued.
1547	1547	23 (b) Licensees shall submit a renewal application as
1548	1548	24 provided by the Department of Financial and Professional
1549	1549	25 Regulation and pay the required renewal fee. No license shall
1550	1550
1551	1551
1552	1552
1553	1553
1554	1554
1555	1555	SB2184 - 43 - LRB104 11945 RLC 22038 b
1556	1556
1557	1557
1558	1558	SB2184- 44 -LRB104 11945 RLC 22038 b SB2184 - 44 - LRB104 11945 RLC 22038 b
1559	1559	SB2184 - 44 - LRB104 11945 RLC 22038 b
1560	1560	1 be renewed if it is currently under revocation or suspension
1561	1561	2 for violation of this Act or any rules that may be adopted
1562	1562	3 under this Act or the licensee, principal officer, board
1563	1563	4 member, person having a financial or voting interest of 5% or
1564	1564	5 greater in the licensee, or agent is delinquent in filing any
1565	1565	6 required tax returns or paying any amounts owed to the State.
1566	1566	7 (c) The license fee for a service center license shall be
1567	1567	8 $10,000, to be deposited into the Psilocybin Control and
1568	1568	9 Regulation Fund.
1569	1569	10 (d) If a service center fails to renew its license before
1570	1570	11 expiration, the service center shall cease operations until
1571	1571	12 the license is renewed.
1572	1572	13 (e) Any service center that continues to operate after
1573	1573	14 failing to renew its license is subject to penalty as provided
1574	1574	15 in this Act, or any rules that may be adopted pursuant to this
1575	1575	16 Act.
1576	1576	17 (f) The Department of Financial and Professional
1577	1577	18 Regulation shall not renew a license if the applicant is
1578	1578	19 delinquent in filing any required tax returns or paying any
1579	1579	20 amounts owed to the State.
1580	1580	21 (g) Three years after the effective date of this Act, the
1581	1581	22 Department of Financial and Professional Regulation may by
1582	1582	23 rule modify any fee established under this Section.
1583	1583	24 Section 100. Establishment of schools after issuance of
1584	1584	25 license.
1585	1585
1586	1586
1587	1587
1588	1588
1589	1589
1590	1590	SB2184 - 44 - LRB104 11945 RLC 22038 b
1591	1591
1592	1592
1593	1593	SB2184- 45 -LRB104 11945 RLC 22038 b SB2184 - 45 - LRB104 11945 RLC 22038 b
1594	1594	SB2184 - 45 - LRB104 11945 RLC 22038 b
1595	1595	1 (a) If a school described under paragraph (5) of
1596	1596	2 subsection (b) of Section 95 that has not previously been
1597	1597	3 attended by children is established within 1,000 feet of
1598	1598	4 premises for which a license has been issued under Section 95,
1599	1599	5 the service center operator located at that premises may
1600	1600	6 remain at that location unless the Department of Financial and
1601	1601	7 Professional Regulation revokes the license of the service
1602	1602	8 center operator under Section 175.
1603	1603	9 (b) The Department of Financial and Professional
1604	1604	10 Regulation may adopt rules establishing the circumstances
1605	1605	11 under which the Department may require a service center
1606	1606	12 operator that holds a license issued under Section 95 to use an
1607	1607	13 age verification scanner or any other equipment used to verify
1608	1608	14 a person's age for the purpose of ensuring that the service
1609	1609	15 center operator does not sell psilocybin products to a person
1610	1610	16 under 21 years of age. Information obtained under this
1611	1611	17 subsection may not be retained after verifying a person's age
1612	1612	18 and may not be used for any purpose other than verifying a
1613	1613	19 person's age.
1614	1614	20 Section 105. License to facilitate psilocybin services.
1615	1615	21 (a) The facilitation of psilocybin services is subject to
1616	1616	22 regulation by the Department of Financial and Professional
1617	1617	23 Regulation.
1618	1618	24 (b) A facilitator must have a facilitator license issued
1619	1619	25 by the Department of Financial and Professional Regulation. To
1620	1620
1621	1621
1622	1622
1623	1623
1624	1624
1625	1625	SB2184 - 45 - LRB104 11945 RLC 22038 b
1626	1626
1627	1627
1628	1628	SB2184- 46 -LRB104 11945 RLC 22038 b SB2184 - 46 - LRB104 11945 RLC 22038 b
1629	1629	SB2184 - 46 - LRB104 11945 RLC 22038 b
1630	1630	1 hold a facilitator license issued under this Section, a
1631	1631	2 facilitator must comply with the following:
1632	1632	3 (1) apply for a license in the manner described in
1633	1633	4 Section 50;
1634	1634	5 (2) provide proof that the applicant is 21 years of
1635	1635	6 age or older;
1636	1636	7 (3) have either:
1637	1637	8 (A) a baccalaureate degree from an accredited
1638	1638	9 university or college;
1639	1639	10 (B) a high school diploma or its equivalent and
1640	1640	11 demonstrable experience administering psilocybin in a
1641	1641	12 manner of cultural significance as part of a
1642	1642	13 tradition, ceremony, or rite that is more than merely
1643	1643	14 recreational use; or
1644	1644	15 (C) a high school diploma or its equivalent and be
1645	1645	16 licensed or certified as at least one of the following
1646	1646	17 in good standing in this State:
1647	1647	18 (i) licensed behavior analyst as defined under
1648	1648	19 the Behavior Analyst Licensing Act;
1649	1649	20 (ii) clinical psychologist or prescribing
1650	1650	21 psychologist as defined under the Clinical
1651	1651	22 Psychologist Licensing Act;
1652	1652	23 (iii) licensed clinical social worker or
1653	1653	24 licensed social worker as defined under the
1654	1654	25 Clinical Social Work and Social Work Practice Act;
1655	1655	26 (iv) licensed marriage and family therapist as
1656	1656
1657	1657
1658	1658
1659	1659
1660	1660
1661	1661	SB2184 - 46 - LRB104 11945 RLC 22038 b
1662	1662
1663	1663
1664	1664	SB2184- 47 -LRB104 11945 RLC 22038 b SB2184 - 47 - LRB104 11945 RLC 22038 b
1665	1665	SB2184 - 47 - LRB104 11945 RLC 22038 b
1666	1666	1 defined under the Marriage and Family Therapy
1667	1667	2 Licensing Act;
1668	1668	3 (v) licensed professional music therapist as
1669	1669	4 defined under the Music Therapy Licensing and
1670	1670	5 Practice Act;
1671	1671	6 (vi) physician as defined under the Medical
1672	1672	7 Practice Act of 1987;
1673	1673	8 (vii) certified nurse midwife or licensed
1674	1674	9 certified professional midwife as defined under
1675	1675	10 the Licensed Certified Professional Midwife
1676	1676	11 Practice Act;
1677	1677	12 (viii) advanced practice registered nurse,
1678	1678	13 license-pending registered nurse, licensed
1679	1679	14 practical nurse, or registered nurse as defined
1680	1680	15 under the Nurse Practice Act;
1681	1681	16 (ix) occupational therapist as defined under
1682	1682	17 the Illinois Occupational Therapy Practice Act;
1683	1683	18 (x) licensed pharmacist under the Pharmacy
1684	1684	19 Practice Act;
1685	1685	20 (xi) physician assistant as defined under the
1686	1686	21 Physician Assistant Practice Act of 1987;
1687	1687	22 (xii) licensed professional counselor or
1688	1688	23 licensed clinical professional counselor as
1689	1689	24 defined under the Professional Counselor and
1690	1690	25 Clinical Professional Counselor Licensing and
1691	1691	26 Practice Act;
1692	1692
1693	1693
1694	1694
1695	1695
1696	1696
1697	1697	SB2184 - 47 - LRB104 11945 RLC 22038 b
1698	1698
1699	1699
1700	1700	SB2184- 48 -LRB104 11945 RLC 22038 b SB2184 - 48 - LRB104 11945 RLC 22038 b
1701	1701	SB2184 - 48 - LRB104 11945 RLC 22038 b
1702	1702	1 (xiii) naprapath as defined under the
1703	1703	2 Naprapathic Practice Act;
1704	1704	3 (xiv) licensed orthoptist, licensed
1705	1705	4 pedorthist, a licensed podiatric physician, or a
1706	1706	5 licensed prosthetist as defined under the
1707	1707	6 Orthotics, Prosthetics, and Pedorthics Practice
1708	1708	7 Act;
1709	1709	8 (xv) certified Recovery Support Specialist
1710	1710	9 certified by the Illinois Certification Board;
1711	1711	10 (xvi) certified Peer Recovery Specialist; or
1712	1712	11 (xvii) certified alcohol and drug counselor.
1713	1713	12 (4) submit evidence of completion of education and
1714	1714	13 training prescribed and approved by the Department;
1715	1715	14 (5) have passed an examination prescribed and approved
1716	1716	15 or recognized by the Department; and
1717	1717	16 (6) meet the requirements of any rule adopted by the
1718	1718	17 Department under subsection (d).
1719	1719	18 (c) The Department of Financial and Professional
1720	1720	19 Regulation shall adopt rules that comply with the following:
1721	1721	20 (1) require a facilitator to annually renew a license
1722	1722	21 issued under this Section;
1723	1723	22 (2) establish application, licensure, and renewal of
1724	1724	23 licensure fees for facilitators;
1725	1725	24 (3) require a facilitator to meet any public health
1726	1726	25 and safety standards and industry best practices
1727	1727	26 established by the Department by rule.
1728	1728
1729	1729
1730	1730
1731	1731
1732	1732
1733	1733	SB2184 - 48 - LRB104 11945 RLC 22038 b
1734	1734
1735	1735
1736	1736	SB2184- 49 -LRB104 11945 RLC 22038 b SB2184 - 49 - LRB104 11945 RLC 22038 b
1737	1737	SB2184 - 49 - LRB104 11945 RLC 22038 b
1738	1738	1 (d) A facilitator may be, but need not be, an employee,
1739	1739	2 manager, director, officer, partner, member, shareholder, or
1740	1740	3 direct or indirect owner of one or more service center
1741	1741	4 operators.
1742	1742	5 (e) A license issued to a facilitator under this Section
1743	1743	6 is not limited to any one or more premises.
1744	1744	7 Section 106. Facilitator license; fees.
1745	1745	8 (a) Facilitator licenses shall expire one year from the
1746	1746	9 date they are issued.
1747	1747	10 (b) Licensees shall submit a renewal application as
1748	1748	11 provided by the Department of Financial and Professional
1749	1749	12 Regulation and pay the required renewal fee. No license shall
1750	1750	13 be renewed if it is currently under revocation or suspension
1751	1751	14 for violation of this Act or any rules that may be adopted
1752	1752	15 under this Act or the licensee is delinquent in filing any
1753	1753	16 required tax returns or paying any amounts owed to the State.
1754	1754	17 (c) The license fee for a facilitator license shall be
1755	1755	18 $2,000, to be deposited into the Psilocybin Control and
1756	1756	19 Regulation Fund.
1757	1757	20 (d) If a facilitator fails to renew his or her license
1758	1758	21 before its expiration, he or she shall cease to perform duties
1759	1759	22 authorized by this Act at a service center until his or her
1760	1760	23 license is renewed.
1761	1761	24 (e) Any facilitator that continues to perform duties
1762	1762	25 authorized by this Act after failing to renew his or her
1763	1763
1764	1764
1765	1765
1766	1766
1767	1767
1768	1768	SB2184 - 49 - LRB104 11945 RLC 22038 b
1769	1769
1770	1770
1771	1771	SB2184- 50 -LRB104 11945 RLC 22038 b SB2184 - 50 - LRB104 11945 RLC 22038 b
1772	1772	SB2184 - 50 - LRB104 11945 RLC 22038 b
1773	1773	1 license is subject to penalty as provided in this Act, or any
1774	1774	2 rules that may be adopted pursuant to this Act.
1775	1775	3 (f) Any facilitator that continues to perform duties
1776	1776	4 authorized by this Act at a dispensing organization that fails
1777	1777	5 to renew its license is subject to penalty as provided in this
1778	1778	6 Act, or any rules that may be adopted pursuant to this Act.
1779	1779	7 (g) The Department of Financial and Professional
1780	1780	8 Regulation shall not renew a license if the applicant is
1781	1781	9 delinquent in filing any required tax returns or paying any
1782	1782	10 amounts owed to the State.
1783	1783	11 (h) Three years after the effective date of this Act, the
1784	1784	12 Department of Financial and Professional Regulation may by
1785	1785	13 rule modify any fee established under this Section.
1786	1786	14 Section 107. Facilitator license; fee waivers.
1787	1787	15 (a) The Department of Financial and Professional
1788	1788	16 Regulation shall waive 50% of any nonrefundable license
1789	1789	17 application fees, any nonrefundable fees associated with
1790	1790	18 purchasing a facilitator license, and any surety bond or other
1791	1791	19 financial requirements, provided an applicant meets the
1792	1792	20 following qualifications at the time the payment is due:
1793	1793	21 (1) the applicant has less than a total of $45,000 of
1794	1794	22 income in the previous calendar year; or
1795	1795	23 (2) the applicant meets the qualifications of a
1796	1796	24 veteran as defined by Section 45-57 of the Illinois
1797	1797	25 Procurement Code.
1798	1798
1799	1799
1800	1800
1801	1801
1802	1802
1803	1803	SB2184 - 50 - LRB104 11945 RLC 22038 b
1804	1804
1805	1805
1806	1806	SB2184- 51 -LRB104 11945 RLC 22038 b SB2184 - 51 - LRB104 11945 RLC 22038 b
1807	1807	SB2184 - 51 - LRB104 11945 RLC 22038 b
1808	1808	1 (b) The Department of Financial and Professional
1809	1809	2 Regulation may require applicants to attest that they meet the
1810	1810	3 requirements for a fee waiver as provided in subsection (a)
1811	1811	4 and to provide evidence of annual total income in the previous
1812	1812	5 calendar year.
1813	1813	6 (c) If the Department of Financial and Professional
1814	1814	7 Regulation determines that an applicant who applied for a fee
1815	1815	8 waiver is not eligible a fee waiver, the applicant shall be
1816	1816	9 provided an additional 10 days to provide alternative evidence
1817	1817	10 that he or she qualifies for a fee waiver. Alternatively, the
1818	1818	11 applicant may pay the remainder of the waived fee and be
1819	1819	12 considered as a standard candidate. If the applicant cannot do
1820	1820	13 either, then the Department may keep the initial application
1821	1821	14 fee and the application shall not be graded.
1822	1822	15 Section 110. License examinations; rules. The Department
1823	1823	16 of Financial and Professional Regulation shall, either
1824	1824	17 themselves or via a third-party administrator, offer an
1825	1825	18 examination for applicants for licenses to facilitate
1826	1826	19 psilocybin services at least twice a year. An applicant who
1827	1827	20 fails any part of the examination may retake the failed
1828	1828	21 section in accordance with rules adopted by the Department.
1829	1829	22 The rules adopted by the Department in accordance with this
1830	1830	23 Section shall require that applicants for facilitator licenses
1831	1831	24 retake any training program required for licensure by the
1832	1832	25 Department if the applicant has failed an examination twice in
1833	1833
1834	1834
1835	1835
1836	1836
1837	1837
1838	1838	SB2184 - 51 - LRB104 11945 RLC 22038 b
1839	1839
1840	1840
1841	1841	SB2184- 52 -LRB104 11945 RLC 22038 b SB2184 - 52 - LRB104 11945 RLC 22038 b
1842	1842	SB2184 - 52 - LRB104 11945 RLC 22038 b
1843	1843	1 a row prior to being permitted to retake the test for a third
1844	1844	2 time. Such retraining shall be required after any subsequent
1845	1845	3 instances of an applicant failing the examination twice in a
1846	1846	4 row.
1847	1847	5 Section 115. Age verification. The Department of
1848	1848	6 Financial and Professional Regulation may adopt rules
1849	1849	7 establishing the circumstances under which the Department may
1850	1850	8 require a facilitator that holds a license issued under
1851	1851	9 Section 105 to use an age verification scanner or any other
1852	1852	10 equipment used to verify a person's age for the purpose of
1853	1853	11 ensuring that the facilitator does not provide psilocybin
1854	1854	12 services to a person under 21 years of age. Information
1855	1855	13 obtained under this Section may not be retained after
1856	1856	14 verifying a person's age and may not be used for any purpose
1857	1857	15 other than verifying a person's age.
1858	1858	16 Section 120. Psilocybin services. The Department of
1859	1859	17 Financial and Professional Regulation shall adopt by rule the
1860	1860	18 requirements, specifications, and guidelines for the
1861	1861	19 following:
1862	1862	20 (1) providing psilocybin services to a client;
1863	1863	21 (2) holding and verifying the completion of a
1864	1864	22 preparation session;
1865	1865	23 (3) having a client complete, sign, and deliver a
1866	1866	24 client information form to a service center operator and a
1867	1867
1868	1868
1869	1869
1870	1870
1871	1871
1872	1872	SB2184 - 52 - LRB104 11945 RLC 22038 b
1873	1873
1874	1874
1875	1875	SB2184- 53 -LRB104 11945 RLC 22038 b SB2184 - 53 - LRB104 11945 RLC 22038 b
1876	1876	SB2184 - 53 - LRB104 11945 RLC 22038 b
1877	1877	1 facilitator;
1878	1878	2 (4) holding and verifying the completion of an
1879	1879	3 administration session; and
1880	1880	4 (5) holding and verifying the completion of an
1881	1881	5 integration session.
1882	1882	6 Section 125. Preparation session.
1883	1883	7 (a) Before a client participates in an administration
1884	1884	8 session, the client must attend a preparation session with a
1885	1885	9 facilitator. A preparation session is intended to provide
1886	1886	10 individuals with comprehensive information about the potential
1887	1887	11 risks and benefits of the use of psilocybin.
1888	1888	12 (b) A preparation session may be, but need not be, held at
1889	1889	13 a service center. During the preparation session, the client
1890	1890	14 must complete a client intake form, develop a transportation
1891	1891	15 plan, and a safety and support plan.
1892	1892	16 (c) If a preparation session is completed in accordance
1893	1893	17 with all applicable requirements, specifications, and
1894	1894	18 guidelines, as determined by the Department, the facilitator
1895	1895	19 must certify, in a form and manner prescribed by the
1896	1896	20 Department, that the client completed the preparation session.
1897	1897	21 This certification shall be collected for the limited purpose
1898	1898	22 of ensuring the facilitator adheres to all applicable
1899	1899	23 requirements, specifications, and guidelines. The Department,
1900	1900	24 facilitator, and service center operator shall maintain such
1901	1901	25 certifications in a manner that ensures confidentiality in
1902	1902
1903	1903
1904	1904
1905	1905
1906	1906
1907	1907	SB2184 - 53 - LRB104 11945 RLC 22038 b
1908	1908
1909	1909
1910	1910	SB2184- 54 -LRB104 11945 RLC 22038 b SB2184 - 54 - LRB104 11945 RLC 22038 b
1911	1911	SB2184 - 54 - LRB104 11945 RLC 22038 b
1912	1912	1 accordance with Section 265 and shall not sell, disclose, or
1913	1913	2 otherwise transfer any personally identifiable information of
1914	1914	3 the client without the client's express written consent. The
1915	1915	4 Department, facilitator, and service center shall only
1916	1916	5 maintain personally identifiable information of the client to
1917	1917	6 the extent necessary to transact business and ensure
1918	1918	7 compliance with all laws and rules.
1919	1919	8 Section 130. Client information form.
1920	1920	9 (a) Before a client participates in an administration
1921	1921	10 session, the following must occur:
1922	1922	11 (1) The client must complete and sign a client
1923	1923	12 information form in a form and manner prescribed by the
1924	1924	13 Department.
1925	1925	14 (2) A copy of the completed and signed client
1926	1926	15 information form must be delivered to the service center
1927	1927	16 operator that operates the service center at which the
1928	1928	17 administration session is to be held and to the
1929	1929	18 facilitator that will supervise the administration
1930	1930	19 session.
1931	1931	20 (3) Enable the service center operator to confirm the
1932	1932	21 client has obtained a referral from a licensed physician,
1933	1933	22 psychiatrist, professional counselor, clinical
1934	1934	23 professional counselor, prescribing psychologist, or
1935	1935	24 clinical psychologist for psilocybin service.
1936	1936	25 (b) The client information form must comply with the
1937	1937
1938	1938
1939	1939
1940	1940
1941	1941
1942	1942	SB2184 - 54 - LRB104 11945 RLC 22038 b
1943	1943
1944	1944
1945	1945	SB2184- 55 -LRB104 11945 RLC 22038 b SB2184 - 55 - LRB104 11945 RLC 22038 b
1946	1946	SB2184 - 55 - LRB104 11945 RLC 22038 b
1947	1947	1 following:
1948	1948	2 (1) Solicit from the client such information as may be
1949	1949	3 necessary: (i) to enable a service center operator and a
1950	1950	4 facilitator to determine whether the client should
1951	1951	5 participate in an administration session, including
1952	1952	6 information that may identify risk factors and
1953	1953	7 contraindications, and (ii) to assist the service center
1954	1954	8 operator and the facilitator in meeting any public health
1955	1955	9 and safety standards and industry best practices during
1956	1956	10 the administration session.
1957	1957	11 (2) Contain such health and safety warnings and other
1958	1958	12 disclosures to the client as the Department may require.
1959	1959	13 (3) Contain the Client Bill of Rights subject to
1960	1960	14 Section 131.
1961	1961	15 (c) The service center operator shall maintain the client
1962	1962	16 information form in a manner that ensures confidentiality in
1963	1963	17 accordance with Section 265 and shall not sell, disclose, or
1964	1964	18 otherwise transfer any personally identifiable information of
1965	1965	19 the client without the client's express written consent.
1966	1966	20 (d) The service center operator shall require proof of a
1967	1967	21 referral for psilocybin service prior to the preparation
1968	1968	22 session.
1969	1969	23 Section 131. Client Bill of Rights.
1970	1970	24 (a) A service center must post the following "Client Bill
1971	1971	25 of Rights" in a prominent location within the licensed
1972	1972
1973	1973
1974	1974
1975	1975
1976	1976
1977	1977	SB2184 - 55 - LRB104 11945 RLC 22038 b
1978	1978
1979	1979
1980	1980	SB2184- 56 -LRB104 11945 RLC 22038 b SB2184 - 56 - LRB104 11945 RLC 22038 b
1981	1981	SB2184 - 56 - LRB104 11945 RLC 22038 b
1982	1982	1 premises and must provide every client with a copy during
1983	1983	2 their preparation session:
1984	1984	3 "Clients receiving psilocybin services in this State
1985	1985	4 have the following rights:
1986	1986	5 To be treated with dignity and respect while receiving
1987	1987	6 psilocybin services.
1988	1988	7 To receive competent and equitable care consistent
1989	1989	8 with values, policies, and practices that ensure all
1990	1990	9 people, especially those who have been historically
1991	1991	10 marginalized based on race, ethnicity, religion, language,
1992	1992	11 disability, age, gender, gender identity, sexual
1993	1993	12 orientation, social class, intersections among these
1994	1994	13 communities or identities, or other socially determined
1995	1995	14 circumstances are considered in the development of social
1996	1996	15 pathways to health equity.
1997	1997	16 To be free from physical, sexual, psychological, and
1998	1998	17 financial abuse before, during, and after receiving
1999	1999	18 psilocybin services.
2000	2000	19 To make decisions without coercion or undue influence.
2001	2001	20 To be informed of the known benefits and risks associated
2002	2002	21 with psilocybin services.
2003	2003	22 To refuse psilocybin services prior to beginning an
2004	2004	23 administration session.
2005	2005	24 To privacy and confidentiality regarding participation
2006	2006	25 in psilocybin services.
2007	2007	26 To refuse to release any information to third parties,
2008	2008
2009	2009
2010	2010
2011	2011
2012	2012
2013	2013	SB2184 - 56 - LRB104 11945 RLC 22038 b
2014	2014
2015	2015
2016	2016	SB2184- 57 -LRB104 11945 RLC 22038 b SB2184 - 57 - LRB104 11945 RLC 22038 b
2017	2017	SB2184 - 57 - LRB104 11945 RLC 22038 b
2018	2018	1 except as required by law. Information may be required to
2019	2019	2 be released by law when a client initiates a complaint,
2020	2020	3 when communications reveal an intent to cause harm to
2021	2021	4 others or disclose that a minor may have been a victim of
2022	2022	5 abuse, or when responding to an investigation by the
2023	2023	6 Department of Financial and Professional Regulation.
2024	2024	7 To full disclosure of any facilitator conflicts of
2025	2025	8 interest.
2026	2026	9 To a full and accurate explanation of the costs
2027	2027	10 associated with receiving psilocybin services before
2028	2028	11 receiving those services.
2029	2029	12 To store personal belongings securely while receiving
2030	2030	13 psilocybin services.
2031	2031	14 To access their client records after providing
2032	2032	15 reasonable notice to a facilitator or service center and
2033	2033	16 to correct information that is inaccurate.
2034	2034	17 To request a private space in which to receive
2035	2035	18 psilocybin services.
2036	2036	19 To be monitored and supported by a licensed
2037	2037	20 facilitator for the duration of psilocybin services until
2038	2038	21 it is safe for the client to leave the service center.
2039	2039	22 To receive psilocybin services from a licensed
2040	2040	23 facilitator for the duration of those services, except in
2041	2041	24 cases of emergency.
2042	2042	25 To access service centers and psilocybin services that
2043	2043	26 are welcoming and accessible to people with disabilities.
2044	2044
2045	2045
2046	2046
2047	2047
2048	2048
2049	2049	SB2184 - 57 - LRB104 11945 RLC 22038 b
2050	2050
2051	2051
2052	2052	SB2184- 58 -LRB104 11945 RLC 22038 b SB2184 - 58 - LRB104 11945 RLC 22038 b
2053	2053	SB2184 - 58 - LRB104 11945 RLC 22038 b
2054	2054	1 To discuss this Bill of Rights with licensed
2055	2055	2 facilitators and service center operators without facing
2056	2056	3 discrimination or retaliation.
2057	2057	4 To report violations of this Bill of Rights to the
2058	2058	5 Department of Financial and Professional Regulation, or
2059	2059	6 other appropriate governing body, without facing
2060	2060	7 discrimination or retaliation.
2061	2061	8 To withdraw or alter my consent to receive psilocybin
2062	2062	9 services at any time prior to beginning an administration
2063	2063	10 session.
2064	2064	11 To withdraw or alter my consent to release
2065	2065	12 information.
2066	2066	13 To receive services in a manner that considers my
2067	2067	14 individual conditions, sensitivities and health concerns.
2068	2068	15 To be fully informed of a service center's policies on
2069	2069	16 possession of firearms and other weapons on the licensed
2070	2070	17 premises.
2071	2071	18 To make complaints to the Department of Financial and
2072	2072	19 Professional Regulation or Department of Agriculture
2073	2073	20 regarding psilocybin products and services.
2074	2074	21 To receive prior notice of any service center licensee
2075	2075	22 representatives who may be present in the client
2076	2076	23 administration area to assist with operations.
2077	2077	24 To choose their facilitator and request an opportunity
2078	2078	25 to receive psilocybin services from an alternate
2079	2079	26 facilitator. Facilitators and service centers may decline
2080	2080
2081	2081
2082	2082
2083	2083
2084	2084
2085	2085	SB2184 - 58 - LRB104 11945 RLC 22038 b
2086	2086
2087	2087
2088	2088	SB2184- 59 -LRB104 11945 RLC 22038 b SB2184 - 59 - LRB104 11945 RLC 22038 b
2089	2089	SB2184 - 59 - LRB104 11945 RLC 22038 b
2090	2090	1 services to a client for any reason.
2091	2091	2 (b) The text of the Client Bill of Rights may not be
2092	2092	3 altered and must be printed in an easily legible font.
2093	2093	4 (c) A facilitator or service center must provide the
2094	2094	5 Client Bill of Rights in other accessible formats upon a
2095	2095	6 client's request.
2096	2096	7 (d) A facilitator or service center must provide the
2097	2097	8 Client Bill of Rights to a client at any time upon the client's
2098	2098	9 request.
2099	2099	10 Section 132. Safety and support plans.
2100	2100	11 (a) A facilitator must work with every client who will
2101	2101	12 participate in an administration session to draft a safety and
2102	2102	13 support plan that identifies risks and challenges specific to
2103	2103	14 the client's circumstances and resources available to mitigate
2104	2104	15 those risks and challenges, including the client's existing
2105	2105	16 support network and appropriate external resources.
2106	2106	17 (b) Safety and support plans must include contact
2107	2107	18 information for a person to be contacted if the client
2108	2108	19 experiences a medical or other emergency.
2109	2109	20 (c) Safety and support plans may not be changed during an
2110	2110	21 administration session.
2111	2111	22 (d) Client records described by this Act must be available
2112	2112	23 to the facilitator at the service center where the client
2113	2113	24 participates or intends to participate in an administration
2114	2114	25 session.
2115	2115
2116	2116
2117	2117
2118	2118
2119	2119
2120	2120	SB2184 - 59 - LRB104 11945 RLC 22038 b
2121	2121
2122	2122
2123	2123	SB2184- 60 -LRB104 11945 RLC 22038 b SB2184 - 60 - LRB104 11945 RLC 22038 b
2124	2124	SB2184 - 60 - LRB104 11945 RLC 22038 b
2125	2125	1 Section 133. Transportation plans.
2126	2126	2 (a) A facilitator must create and record a transportation
2127	2127	3 plan for every client that receives psilocybin services.
2128	2128	4 (b) Transportation plans must be signed by the client and
2129	2129	5 describe how the client will access safe transportation away
2130	2130	6 from the service center at the conclusion of an administration
2131	2131	7 session.
2132	2132	8 (c) Transportation plans shall advise a client not to
2133	2133	9 operate a motor vehicle directly following an administration
2134	2134	10 session. Facilitators shall make reasonable efforts to prevent
2135	2135	11 clients from operating a motor vehicle at the conclusion of an
2136	2136	12 administration session. If a client's failure to follow the
2137	2137	13 client's transportation plan creates a danger to the client's
2138	2138	14 safety or the safety of others, a facilitator must make
2139	2139	15 reasonable efforts to resolve the safety issue.
2140	2140	16 (d) If a facilitator is unable to resolve safety issues
2141	2141	17 caused by a client's failure to follow the client's
2142	2142	18 transportation plan after making reasonable efforts required
2143	2143	19 by subsection (c), a facilitator must contact appropriate
2144	2144	20 emergency services.
2145	2145	21 (e) If a client is unable to follow the client's
2146	2146	22 transportation plan, a facilitator must make reasonable
2147	2147	23 efforts to arrange for alternative transportation.
2148	2148	24 (f) A facilitator must document in writing and retain
2149	2149	25 documentation for all instances in which a client does not
2150	2150
2151	2151
2152	2152
2153	2153
2154	2154
2155	2155	SB2184 - 60 - LRB104 11945 RLC 22038 b
2156	2156
2157	2157
2158	2158	SB2184- 61 -LRB104 11945 RLC 22038 b SB2184 - 61 - LRB104 11945 RLC 22038 b
2159	2159	SB2184 - 61 - LRB104 11945 RLC 22038 b
2160	2160	1 follow the client's transportation plan.
2161	2161	2 (g) All client records, including any copies of client
2162	2162	3 records, described by this Act must be available to the
2163	2163	4 facilitator at the service center where the client
2164	2164	5 participates or intends to participate in an administration
2165	2165	6 session.
2166	2166	7 Section 134. Client information form.
2167	2167	8 (a) Before a client participates in an administration
2168	2168	9 session, the client shall complete and sign a client
2169	2169	10 information form, in a form and manner prescribed by the
2170	2170	11 Department of Financial and Professional Regulation, and shall
2171	2171	12 deliver a copy of the completed and signed client information
2172	2172	13 form to:
2173	2173	14 (1) the service center operator of the service center
2174	2174	15 at which the administration session is to be held; and
2175	2175	16 (2) the facilitator of the administration session.
2176	2176	17 (b) The client information form shall contain the
2177	2177	18 following information:
2178	2178	19 (1) the race, ethnicity, preferred spoken and written
2179	2179	20 languages, disability status, sexual orientation, gender
2180	2180	21 identity, income, age and county of residence of each
2181	2181	22 client; and
2182	2182	23 (2) the reason for which the client requested
2183	2183	24 psilocybin services.
2184	2184	25 (c) In addition to the information required in subsection
2185	2185
2186	2186
2187	2187
2188	2188
2189	2189
2190	2190	SB2184 - 61 - LRB104 11945 RLC 22038 b
2191	2191
2192	2192
2193	2193	SB2184- 62 -LRB104 11945 RLC 22038 b SB2184 - 62 - LRB104 11945 RLC 22038 b
2194	2194	SB2184 - 62 - LRB104 11945 RLC 22038 b
2195	2195	1 (b), the client information form may contain any information
2196	2196	2 deemed necessary by the Department of Financial and
2197	2197	3 Professional Regulation, including, but not limited to:
2198	2198	4 (1) information that may enable a service center
2199	2199	5 operator or facilitator to determine whether the client
2200	2200	6 should participate in an administration session;
2201	2201	7 (2) information that may assist a service center
2202	2202	8 operator or facilitator in meeting any public health and
2203	2203	9 safety standards and industry best practices during the
2204	2204	10 administration session; and
2205	2205	11 (3) health and safety warnings and other disclosures
2206	2206	12 to the client.
2207	2207	13 (d) Subject to paragraph (1) of subsection (b), a service
2208	2208	14 center operator shall aggregate and submit a copy of each
2209	2209	15 client information form received by the service center
2210	2210	16 operator to the Department of Financial and Professional
2211	2211	17 Regulation, in a form and manner prescribed by the Department,
2212	2212	18 that protects the personally identifiable information of the
2213	2213	19 client, on a quarterly basis.
2214	2214	20 Each client information form shall request the client's
2215	2215	21 consent in writing to share their client information form with
2216	2216	22 the Department of Financial and Professional Regulation. No
2217	2217	23 client information form may be submitted to the Department
2218	2218	24 without obtaining the client's written consent.
2219	2219	25 (e) The Department of Financial and Professional
2220	2220	26 Regulation shall compile and deidentify all client information
2221	2221
2222	2222
2223	2223
2224	2224
2225	2225
2226	2226	SB2184 - 62 - LRB104 11945 RLC 22038 b
2227	2227
2228	2228
2229	2229	SB2184- 63 -LRB104 11945 RLC 22038 b SB2184 - 63 - LRB104 11945 RLC 22038 b
2230	2230	SB2184 - 63 - LRB104 11945 RLC 22038 b
2231	2231	1 forms collected pursuant to this Section.
2232	2232	2 (f) All data and information collected under this Section
2233	2233	3 shall be collected in a manner that protects client
2234	2234	4 confidentiality as required in Section 265.
2235	2235	5 Section 135. Reliance on client information form.
2236	2236	6 (a) If a client information form is offered as evidence in
2237	2237	7 3 any administrative or criminal prosecution of a licensee or
2238	2238	8 licensee representative for sale or service of a psilocybin
2239	2239	9 product to a client, the licensee or licensee representative
2240	2240	10 is not guilty of any offense prohibiting a person from selling
2241	2241	11 or serving a psilocybin product to a client unless it is
2242	2242	12 demonstrated that a reasonable person would have determined
2243	2243	13 that the responses provided by the client on the client0
2244	2244	14 information form were incorrect or altered.
2245	2245	15 (b) A licensee or licensee representative shall be
2246	2246	16 entitled to rely upon all statements, declarations, and
2247	2247	17 representations made by a client in a client information form
2248	2248	18 unless it is demonstrated that either:
2249	2249	19 (1) a reasonable person would have determined that one
2250	2250	20 or more of the statements, declarations, or
2251	2251	21 representations made by the client in the client
2252	2252	22 information form were incorrect or altered; or
2253	2253	23 (2) the licensee or licensee representative violated a
2254	2254	24 provision of this Act or a rule adopted under this Act
2255	2255	25 relative to the client information form.
2256	2256
2257	2257
2258	2258
2259	2259
2260	2260
2261	2261	SB2184 - 63 - LRB104 11945 RLC 22038 b
2262	2262
2263	2263
2264	2264	SB2184- 64 -LRB104 11945 RLC 22038 b SB2184 - 64 - LRB104 11945 RLC 22038 b
2265	2265	SB2184 - 64 - LRB104 11945 RLC 22038 b
2266	2266	1 (c) Except as provided in subsection (b), no licensee or
2267	2267	2 licensee representative shall incur legal liability by virtue
2268	2268	3 of any untrue statement, declaration, or representation so
2269	2269	4 relied upon in good faith by the licensee or licensee
2270	2270	5 representative.
2271	2271	6 (d) The Department of Financial and Professional
2272	2272	7 Regulation shall adopt rules for recordkeeping, privacy, and
2273	2273	8 confidentiality requirements in accordance with Section 265 of
2274	2274	9 service centers. However, the recordkeeping shall not result
2275	2275	10 in disclosure to the public or any governmental agency of any
2276	2276	11 participant's personally identifiable information.
2277	2277	12 Section 136. Administration session.
2278	2278	13 (a) After a client completes a preparation session and
2279	2279	14 completes and signs a client information form, the client may
2280	2280	15 participate in an administration session.
2281	2281	16 (b) An administration session must be held under the
2282	2282	17 supervision of a licensed facilitator at a service center. A
2283	2283	18 facilitator or service center shall not permit a client to
2284	2284	19 consume psilocybin at any time other than during an
2285	2285	20 administration session at the service center.
2286	2286	21 (c) If an administration session is completed in
2287	2287	22 accordance with all applicable requirements, specifications,
2288	2288	23 and guidelines, as determined by the Department, the
2289	2289	24 facilitator must certify, in a form and manner prescribed by
2290	2290	25 the Department, that the client completed the administration
2291	2291
2292	2292
2293	2293
2294	2294
2295	2295
2296	2296	SB2184 - 64 - LRB104 11945 RLC 22038 b
2297	2297
2298	2298
2299	2299	SB2184- 65 -LRB104 11945 RLC 22038 b SB2184 - 65 - LRB104 11945 RLC 22038 b
2300	2300	SB2184 - 65 - LRB104 11945 RLC 22038 b
2301	2301	1 session. This certification shall be collected for the limited
2302	2302	2 purpose of ensuring the facilitator adheres to all applicable
2303	2303	3 requirements, specifications, and guidelines. The Department,
2304	2304	4 facilitator, and service center operator shall maintain such
2305	2305	5 certifications in a manner that ensures confidentiality in
2306	2306	6 accordance with Section 265 and shall not sell, disclose, or
2307	2307	7 otherwise transfer any personally identifiable information of
2308	2308	8 the client without the client's express written consent. The
2309	2309	9 Department, facilitator, and service center shall only
2310	2310	10 maintain personally identifiable information of the client to
2311	2311	11 the extent necessary to transact business and ensure
2312	2312	12 compliance with all laws and rules.
2313	2313	13 Section 137. Post-administration evaluation session. All
2314	2314	14 clients are required to participate in a post-administration
2315	2315	15 evaluation session prior to leaving a service center after
2316	2316	16 completing an administration session. After a client completes
2317	2317	17 an administration session, the facilitator must conduct a
2318	2318	18 post-administration evaluation session. During the session,
2319	2319	19 the facilitator will engage with the client to ensure there
2320	2320	20 are no medical emergencies that arose from the administration
2321	2321	21 session and also ensure that the client is no longer under the
2322	2322	22 hallucinogenic effects of psilocybin prior to releasing the
2323	2323	23 client from the service center. The facilitator shall consider
2324	2324	24 the client's physical attributes as well as the quantity
2325	2325	25 psilocybin administered in conducting the post-administration
2326	2326
2327	2327
2328	2328
2329	2329
2330	2330
2331	2331	SB2184 - 65 - LRB104 11945 RLC 22038 b
2332	2332
2333	2333
2334	2334	SB2184- 66 -LRB104 11945 RLC 22038 b SB2184 - 66 - LRB104 11945 RLC 22038 b
2335	2335	SB2184 - 66 - LRB104 11945 RLC 22038 b
2336	2336	1 evaluation.
2337	2337	2 Section 140. Integration session.
2338	2338	3 (a) After a client completes an administration session and
2339	2339	4 a post-administration evaluation session, a facilitator must
2340	2340	5 conduct an integration session with the client. However, the
2341	2341	6 integration session requirement may be waived if the client
2342	2342	7 has produced a written letter from the client's referring
2343	2343	8 licensed professional that states the licensed professional
2344	2344	9 will discuss the psilocybin service at a future appointment.
2345	2345	10 Integration sessions are intended to promote psychological
2346	2346	11 well-being and reduce the risk of adverse reactions by
2347	2347	12 ensuring individuals are not left to process potentially
2348	2348	13 overwhelming experiences alone.
2349	2349	14 (b) An integration session shall be held at a service
2350	2350	15 center.
2351	2351	16 (c) If an integration session is completed in accordance
2352	2352	17 with all applicable requirements, specifications, and
2353	2353	18 guidelines, as determined by the Department, the facilitator
2354	2354	19 shall certify in a form and manner prescribed by the
2355	2355	20 Department that the client completed the integration session
2356	2356	21 or otherwise provided the appropriate waiver materials. This
2357	2357	22 certification shall be collected for the limited purpose of
2358	2358	23 ensuring the facilitator adheres to all applicable
2359	2359	24 requirements, specifications, and guidelines. The Department,
2360	2360	25 facilitator, and service center operator shall maintain such
2361	2361
2362	2362
2363	2363
2364	2364
2365	2365
2366	2366	SB2184 - 66 - LRB104 11945 RLC 22038 b
2367	2367
2368	2368
2369	2369	SB2184- 67 -LRB104 11945 RLC 22038 b SB2184 - 67 - LRB104 11945 RLC 22038 b
2370	2370	SB2184 - 67 - LRB104 11945 RLC 22038 b
2371	2371	1 certifications in a manner that ensures confidentiality in
2372	2372	2 accordance with Section 265 and shall not sell, disclose, or
2373	2373	3 otherwise transfer any personally identifiable information of
2374	2374	4 the client without the client's express written consent. The
2375	2375	5 Department, facilitator, and service center shall only
2376	2376	6 maintain personally identifiable information of the client to
2377	2377	7 the extent necessary to transact business and ensure
2378	2378	8 compliance with all laws and rules.
2379	2379	9 Section 150. Refusal to provide psilocybin services to a
2380	2380	10 client.
2381	2381	11 (a) Subject to applicable State law, a licensee or
2382	2382	12 licensee representative may refuse to provide psilocybin
2383	2383	13 services to a potential client for any or no reason.
2384	2384	14 (b) Except as provided in subsection (c), and subject to
2385	2385	15 applicable State law, a licensee or licensee representative
2386	2386	16 may cease providing psilocybin services to a client for any or
2387	2387	17 no reason.
2388	2388	18 (c) A service center operator and a facilitator may not
2389	2389	19 cease providing psilocybin services to a client during an
2390	2390	20 administration session after the client has consumed a
2391	2391	21 psilocybin product, except as authorized by the Department of
2392	2392	22 Financial and Professional Regulation by rule or as necessary
2393	2393	23 in an emergency.
2394	2394	24 (d) A service center operator and a facilitator must
2395	2395	25 refuse to provide psilocybin service to a potential client
2396	2396
2397	2397
2398	2398
2399	2399
2400	2400
2401	2401	SB2184 - 67 - LRB104 11945 RLC 22038 b
2402	2402
2403	2403
2404	2404	SB2184- 68 -LRB104 11945 RLC 22038 b SB2184 - 68 - LRB104 11945 RLC 22038 b
2405	2405	SB2184 - 68 - LRB104 11945 RLC 22038 b
2406	2406	1 who:
2407	2407	2 (1) does not provide a referral for psilocybin
2408	2408	3 service;
2409	2409	4 (2) voluntarily discloses that the potential client
2410	2410	5 possesses certain risk factors indicating psilocybin
2411	2411	6 service is inappropriate or harmful as determined by the
2412	2412	7 Advisory Board under subsection (a) of Section 30 or by
2413	2413	8 rules adopted by the Department; or
2414	2414	9 (3) a reasonable person would believe, based on the
2415	2415	10 statements, conduct, or other behavior of the potential
2416	2416	11 client, that the potential client possesses certain risk
2417	2417	12 factors indicating psilocybin service is inappropriate or
2418	2418	13 harmful as determined by the Advisory Board under
2419	2419	14 subsection (a) of Section 30 or by rules adopted by the
2420	2420	15 Department.
2421	2421	16 Section 155. Department powers and duties relating to
2422	2422	17 facilitators.
2423	2423	18 (a) The Department of Financial and Professional
2424	2424	19 Regulation shall perform the following:
2425	2425	20 (1) Determine the qualifications, training, education,
2426	2426	21 and fitness of applicants for licenses to facilitate
2427	2427	22 psilocybin services, giving particular consideration to
2428	2428	23 the following:
2429	2429	24 (A) facilitation skills that are affirming,
2430	2430	25 nonjudgmental, culturally competent, trauma-informed,
2431	2431
2432	2432
2433	2433
2434	2434
2435	2435
2436	2436	SB2184 - 68 - LRB104 11945 RLC 22038 b
2437	2437
2438	2438
2439	2439	SB2184- 69 -LRB104 11945 RLC 22038 b SB2184 - 69 - LRB104 11945 RLC 22038 b
2440	2440	SB2184 - 69 - LRB104 11945 RLC 22038 b
2441	2441	1 rooted in informed consent, and nondirective;
2442	2442	2 (B) support skills for clients during an
2443	2443	3 administration session, including specialized skills
2444	2444	4 for the following:
2445	2445	5 (i) client safety; and
2446	2446	6 (ii) clients who may have a mental health
2447	2447	7 condition;
2448	2448	8 (C) the environment in which psilocybin services
2449	2449	9 should occur; and
2450	2450	10 (D) social and cultural considerations.
2451	2451	11 (2) Formulate a code of professional conduct for
2452	2452	12 facilitators, giving particular consideration to a code of
2453	2453	13 ethics.
2454	2454	14 (3) Establish standards of practice and professional
2455	2455	15 responsibility for individuals licensed by the Department
2456	2456	16 to facilitate psilocybin services.
2457	2457	17 (4) Establish minimum training requirements for
2458	2458	18 facilitators, including psilocybin facilitator practicum
2459	2459	19 requirements and training on culturally and linguistically
2460	2460	20 responsive services.
2461	2461	21 (5) Select licensing examinations for licenses to
2462	2462	22 facilitate psilocybin services.
2463	2463	23 (6) Provide for waivers of examinations, as
2464	2464	24 appropriate.
2465	2465	25 (7) Award credit hours based on an applicant's
2466	2466	26 professional credentialing, prior training and education,
2467	2467
2468	2468
2469	2469
2470	2470
2471	2471
2472	2472	SB2184 - 69 - LRB104 11945 RLC 22038 b
2473	2473
2474	2474
2475	2475	SB2184- 70 -LRB104 11945 RLC 22038 b SB2184 - 70 - LRB104 11945 RLC 22038 b
2476	2476	SB2184 - 70 - LRB104 11945 RLC 22038 b
2477	2477	1 or relevant experiences such as practicing or
2478	2478	2 participating in established plant or fungi-based healing
2479	2479	3 traditions.
2480	2480	4 (8) Appoint representatives to conduct or supervise
2481	2481	5 examinations of applicants for licenses to facilitate
2482	2482	6 psilocybin services.
2483	2483	7 (b) The Department of Financial and Professional
2484	2484	8 Regulation shall adopt by rule minimum standards of education
2485	2485	9 and training requirements for facilitators. These rules must
2486	2486	10 establish minimum standards for first-aid treatment and
2487	2487	11 training on CPR/AED and any other emergency medical response
2488	2488	12 training the Department deems appropriate for the safe
2489	2489	13 administration of psilocybin services.
2490	2490	14 (c) The Department of Financial and Professional
2491	2491	15 Regulation shall approve courses for facilitators. To obtain
2492	2492	16 approval of a course, the provider of a course must submit an
2493	2493	17 outline of instruction to the Department. The outline must
2494	2494	18 include the proposed courses, total hours of instruction,
2495	2495	19 hours of lectures in theory, and the hours of instruction in
2496	2496	20 application of practical skills.
2497	2497	21 (d) The Department of Financial and Professional
2498	2498	22 Regulation may, after 72 hours' notice, make an examination of
2499	2499	23 the books of a licensee for the purpose of determining
2500	2500	24 compliance with this Act and rules adopted under this Act.
2501	2501	25 (e) The Department of Financial and Professional
2502	2502	26 Regulation or the Department of Agriculture may at any time
2503	2503
2504	2504
2505	2505
2506	2506
2507	2507
2508	2508	SB2184 - 70 - LRB104 11945 RLC 22038 b
2509	2509
2510	2510
2511	2511	SB2184- 71 -LRB104 11945 RLC 22038 b SB2184 - 71 - LRB104 11945 RLC 22038 b
2512	2512	SB2184 - 71 - LRB104 11945 RLC 22038 b
2513	2513	1 make an examination of premises for which a license has been
2514	2514	2 issued under this Act for the purpose of determining
2515	2515	3 compliance with this Act and rules adopted under this Act.
2516	2516	4 (f) The Department of Financial and Professional
2517	2517	5 Regulation may not require the books of a licensee to be
2518	2518	6 maintained on the premises of the licensee.
2519	2519	7 (g) If a licensee holds more than one license issued under
2520	2520	8 this Act for the same premises, the Department of Financial
2521	2521	9 and Professional Regulation or the Department of Agriculture
2522	2522	10 may require the premises to be segregated into separate areas
2523	2523	11 for conducting the activities permitted under each license as
2524	2524	12 is necessary to protect the public health and safety.
2525	2525	13 (h) The Department of Financial and Professional
2526	2526	14 Regulation and the Department of Agriculture shall develop and
2527	2527	15 maintain a system for tracking the transfer of psilocybin
2528	2528	16 products between premises for which licenses have been issued
2529	2529	17 under this Act. The purposes of the system include, but are not
2530	2530	18 limited to, the following:
2531	2531	19 (1) preventing the diversion of psilocybin products to
2532	2532	20 other states;
2533	2533	21 (2) preventing persons from substituting or tampering
2534	2534	22 with psilocybin products;
2535	2535	23 (3) ensuring an accurate accounting of the production,
2536	2536	24 processing, and sale of psilocybin products;
2537	2537	25 (4) ensuring that laboratory testing results are
2538	2538	26 accurately reported; and
2539	2539
2540	2540
2541	2541
2542	2542
2543	2543
2544	2544	SB2184 - 71 - LRB104 11945 RLC 22038 b
2545	2545
2546	2546
2547	2547	SB2184- 72 -LRB104 11945 RLC 22038 b SB2184 - 72 - LRB104 11945 RLC 22038 b
2548	2548	SB2184 - 72 - LRB104 11945 RLC 22038 b
2549	2549	1 (5) ensuring compliance with this Act, rules adopted
2550	2550	2 under this Act, and any other law of this State that
2551	2551	3 charges the Department with a duty, function, or power
2552	2552	4 related to psilocybin.
2553	2553	5 (i) The system developed under subsection (h) must be
2554	2554	6 capable of tracking, at a minimum, the following:
2555	2555	7 (1) the manufacturing of psilocybin products;
2556	2556	8 (2) the sale of psilocybin products by a service
2557	2557	9 center operator to a client;
2558	2558	10 (3) the sale and purchase of psilocybin products
2559	2559	11 between licensees, as permitted by this Act;
2560	2560	12 (4) the transfer of psilocybin products between
2561	2561	13 premises for which licenses have been issued under this
2562	2562	14 Act; and
2563	2563	15 (5) any other information that the Department
2564	2564	16 determines is reasonably necessary to accomplish the
2565	2565	17 duties, functions, and powers of the Department under this
2566	2566	18 Act.
2567	2567	19 (j) Except as otherwise provided by law, the Department of
2568	2568	20 Financial and Professional Regulation and the Department of
2569	2569	21 Agriculture have any power, and may perform any function,
2570	2570	22 necessary for the Departments to prevent the diversion of
2571	2571	23 psilocybin products from licensees to a source that is not
2572	2572	24 operating legally under the laws of this State.
2573	2573	25 (k) In addition to any other disciplinary action available
2574	2574	26 to the Department of Financial and Professional Regulation and
2575	2575
2576	2576
2577	2577
2578	2578
2579	2579
2580	2580	SB2184 - 72 - LRB104 11945 RLC 22038 b
2581	2581
2582	2582
2583	2583	SB2184- 73 -LRB104 11945 RLC 22038 b SB2184 - 73 - LRB104 11945 RLC 22038 b
2584	2584	SB2184 - 73 - LRB104 11945 RLC 22038 b
2585	2585	1 the Department of Agriculture under this Act, either
2586	2586	2 Department may immediately restrict, suspend, or refuse to
2587	2587	3 renew a license issued under this Act if circumstances create
2588	2588	4 probable cause for the Department to conclude that a licensee
2589	2589	5 has purchased or received a psilocybin product from an
2590	2590	6 unlicensed source or that a licensee has sold, stored, or
2591	2591	7 transferred a psilocybin product in a manner that is not
2592	2592	8 permitted by the licensee's license.
2593	2593	9 (l) The Department of Financial and Professional
2594	2594	10 Regulation or the Department of Agriculture may require a
2595	2595	11 licensee or applicant for a license under this Act to submit,
2596	2596	12 in a form and manner prescribed by the Department, to the
2597	2597	13 Department a sworn statement showing the following:
2598	2598	14 (1) The name and address of each person who has a
2599	2599	15 financial interest in the business operating or to be
2600	2600	16 operated under the license.
2601	2601	17 (2) The nature and extent of the financial interest of
2602	2602	18 each person who has a financial interest in the business
2603	2603	19 operating or to be operated under the license.
2604	2604	20 (3) The Department of Financial and Professional
2605	2605	21 Regulation or the Department of Agriculture may refuse to
2606	2606	22 issue, or may suspend, revoke, or refuse to renew, a
2607	2607	23 license issued under this Act if the Department determines
2608	2608	24 that a person who has a financial interest in the business
2609	2609	25 operating or to be operated under the license committed or
2610	2610	26 failed to commit an act that would constitute grounds for
2611	2611
2612	2612
2613	2613
2614	2614
2615	2615
2616	2616	SB2184 - 73 - LRB104 11945 RLC 22038 b
2617	2617
2618	2618
2619	2619	SB2184- 74 -LRB104 11945 RLC 22038 b SB2184 - 74 - LRB104 11945 RLC 22038 b
2620	2620	SB2184 - 74 - LRB104 11945 RLC 22038 b
2621	2621	1 the Department to refuse to issue, or to suspend, revoke,
2622	2622	2 or refuse to renew, the license if the person is the
2623	2623	3 licensee or applicant for the license.
2624	2624	4 (m) Notwithstanding the lapse, suspension, or revocation
2625	2625	5 of a license issued under this Act, the Department of
2626	2626	6 Financial and Professional Regulation and the Department of
2627	2627	7 Agriculture may perform the following:
2628	2628	8 (1) proceed with any investigation of, or any action
2629	2629	9 or disciplinary proceeding against, the person who held
2630	2630	10 the license;
2631	2631	11 (2) revise or render void an order suspending or
2632	2632	12 revoking the license; and
2633	2633	13 (3) in cases involving the proposed denial of a
2634	2634	14 license applied for under this Act, the applicant for
2635	2635	15 licensure may not withdraw the applicant's application.
2636	2636	16 (n) Notwithstanding the lapse, suspension, or revocation
2637	2637	17 of a permit issued under Section 180, the Department of
2638	2638	18 Financial and Professional Regulation and the Department of
2639	2639	19 Agriculture may perform the following:
2640	2640	20 (1) proceed with any investigation of, or any action
2641	2641	21 or disciplinary proceeding against, the person who held
2642	2642	22 the permit;
2643	2643	23 (2) revise or render void an order suspending or
2644	2644	24 revoking the permit; and
2645	2645	25 (3) in cases involving the proposed denial of a permit
2646	2646	26 applied for under Section 180, the applicant may not
2647	2647
2648	2648
2649	2649
2650	2650
2651	2651
2652	2652	SB2184 - 74 - LRB104 11945 RLC 22038 b
2653	2653
2654	2654
2655	2655	SB2184- 75 -LRB104 11945 RLC 22038 b SB2184 - 75 - LRB104 11945 RLC 22038 b
2656	2656	SB2184 - 75 - LRB104 11945 RLC 22038 b
2657	2657	1 withdraw the applicant's application.
2658	2658	2 (o) The Department of Financial and Professional
2659	2659	3 Regulation and the Department of Agriculture may, by rule or
2660	2660	4 order, provide for the manner and conditions under which the
2661	2661	5 following occur:
2662	2662	6 (1) psilocybin products left by a deceased, insolvent,
2663	2663	7 or bankrupt person or licensee, or subject to a security
2664	2664	8 interest, may be foreclosed, sold under execution, or
2665	2665	9 otherwise disposed of;
2666	2666	10 (2) the business of a deceased, insolvent, or bankrupt
2667	2667	11 licensee may be operated for a reasonable period following
2668	2668	12 the death, insolvency, or bankruptcy; and
2669	2669	13 (3) a secured party may continue to operate at the
2670	2670	14 premises for which a license has been issued under this
2671	2671	15 Act for a reasonable period after default on the
2672	2672	16 indebtedness by the debtor.
2673	2673	17 Section 160. Conduct of licensees; prohibitions.
2674	2674	18 (a) A psilocybin product manufacturer that holds a license
2675	2675	19 under Section 80 may not manufacture psilocybin products
2676	2676	20 outdoors.
2677	2677	21 (b) A psilocybin product manufacturer that holds a license
2678	2678	22 under Section 80 may deliver psilocybin products only to or on
2679	2679	23 premises for which a license has been issued under Section 80
2680	2680	24 or Section 95 and may receive psilocybin products only from a
2681	2681	25 psilocybin product manufacturer that holds a license under
2682	2682
2683	2683
2684	2684
2685	2685
2686	2686
2687	2687	SB2184 - 75 - LRB104 11945 RLC 22038 b
2688	2688
2689	2689
2690	2690	SB2184- 76 -LRB104 11945 RLC 22038 b SB2184 - 76 - LRB104 11945 RLC 22038 b
2691	2691	SB2184 - 76 - LRB104 11945 RLC 22038 b
2692	2692	1 Section 80.
2693	2693	2 (c) A service center operator that holds a license under
2694	2694	3 Section 95 may deliver psilocybin products only to or on
2695	2695	4 premises for which a license has been issued under Section 95
2696	2696	5 and may receive psilocybin products only from a psilocybin
2697	2697	6 product manufacturer that holds a license under Section 80 or
2698	2698	7 a service center operator that holds a license under Section
2699	2699	8 95.
2700	2700	9 (d) The sale and administration of psilocybin products to
2701	2701	10 a client by a service center operator that holds a license
2702	2702	11 issued under Section 95 must be restricted to the premises for
2703	2703	12 which the license has been issued.
2704	2704	13 (e) The Department of Financial and Professional
2705	2705	14 Regulation or the Department of Agriculture may by order waive
2706	2706	15 the requirements of subsections (b) and (c) to ensure
2707	2707	16 compliance with this Act or a rule adopted under this Act. An
2708	2708	17 order issued under this subsection does not constitute a
2709	2709	18 waiver of any other requirement of this Act or any other rule
2710	2710	19 adopted under this Act.
2711	2711	20 (f) A licensee or licensee representative may not sell or
2712	2712	21 deliver a psilocybin product to a person under 21 years of age.
2713	2713	22 (g) Subject to subsection (h), a licensee or licensee
2714	2714	23 representative, before selling or providing a psilocybin
2715	2715	24 product to another person, must require the person to produce
2716	2716	25 one of the following pieces of identification:
2717	2717	26 (1) The person's passport.
2718	2718
2719	2719
2720	2720
2721	2721
2722	2722
2723	2723	SB2184 - 76 - LRB104 11945 RLC 22038 b
2724	2724
2725	2725
2726	2726	SB2184- 77 -LRB104 11945 RLC 22038 b SB2184 - 77 - LRB104 11945 RLC 22038 b
2727	2727	SB2184 - 77 - LRB104 11945 RLC 22038 b
2728	2728	1 (2) The person's driver's license, issued by the State
2729	2729	2 or another state of the United States.
2730	2730	3 (3) An identification card issued by the State.
2731	2731	4 (4) A United States military identification card.
2732	2732	5 (5) An identification card issued by a federally
2733	2733	6 recognized Indian tribe.
2734	2734	7 (6) Any other identification card issued by a state or
2735	2735	8 territory of the United States that bears a picture of the
2736	2736	9 person, the name of the person, the person's date of
2737	2737	10 birth, and a physical description of the person.
2738	2738	11 (h) The Department may adopt rules exempting a licensee or
2739	2739	12 licensee representative from the provisions of subsection (g).
2740	2740	13 (i) A client may not be required to procure for the purpose
2741	2741	14 of acquiring or purchasing a psilocybin product a piece of
2742	2742	15 identification other than a piece of identification described
2743	2743	16 in subsection (g).
2744	2744	17 (j) A service center operator, a facilitator, or any
2745	2745	18 employee of a service center operator or facilitator may not
2746	2746	19 disclose any information that may be used to identify a client
2747	2747	20 or any communication made by a client during the course of
2748	2748	21 providing psilocybin services or selling psilocybin products
2749	2749	22 to the client, except for the following:
2750	2750	23 (1) When the client or a person authorized to act on
2751	2751	24 behalf of the client gives consent to the disclosure.
2752	2752	25 (2) When the client initiates legal action or makes a
2753	2753	26 complaint against the service center operator, the
2754	2754
2755	2755
2756	2756
2757	2757
2758	2758
2759	2759	SB2184 - 77 - LRB104 11945 RLC 22038 b
2760	2760
2761	2761
2762	2762	SB2184- 78 -LRB104 11945 RLC 22038 b SB2184 - 78 - LRB104 11945 RLC 22038 b
2763	2763	SB2184 - 78 - LRB104 11945 RLC 22038 b
2764	2764	1 facilitator, or the employee.
2765	2765	2 (3) When the communication reveals the intent to
2766	2766	3 commit a crime harmful to the client or others.
2767	2767	4 (4) When the communication reveals that a minor may
2768	2768	5 have been a victim of a crime or physical, sexual, or
2769	2769	6 emotional abuse or neglect.
2770	2770	7 (5) When responding to an inquiry by the Department
2771	2771	8 made during the course of an investigation into the
2772	2772	9 conduct of the service center operator, the facilitator,
2773	2773	10 or the employee under this Act.
2774	2774	11 (k) A client may only purchase a psilocybin product at a
2775	2775	12 service center and may only consume such product during an
2776	2776	13 administration session on the premises of a service center.
2777	2777	14 (l) A licensee may not employ a person under 21 years of
2778	2778	15 age at premises for which a license has been issued under this
2779	2779	16 Act.
2780	2780	17 (m) During an inspection of premises for which a license
2781	2781	18 has been issued under this Act, the Department of Financial
2782	2782	19 and Professional Regulation or the Department of Agriculture
2783	2783	20 may require proof that a person performing work at the
2784	2784	21 premises is 21 years of age or older. If the person does not
2785	2785	22 provide the Department with acceptable proof of age upon
2786	2786	23 request, the Department may require the person to immediately
2787	2787	24 cease any activity and leave the premises until the Department
2788	2788	25 receives acceptable proof of age. This subsection does not
2789	2789	26 apply to a person temporarily at the premises to make a
2790	2790
2791	2791
2792	2792
2793	2793
2794	2794
2795	2795	SB2184 - 78 - LRB104 11945 RLC 22038 b
2796	2796
2797	2797
2798	2798	SB2184- 79 -LRB104 11945 RLC 22038 b SB2184 - 79 - LRB104 11945 RLC 22038 b
2799	2799	SB2184 - 79 - LRB104 11945 RLC 22038 b
2800	2800	1 service, maintenance, or repair call or for other purposes
2801	2801	2 independent of the premises operations.
2802	2802	3 (n) If a person performing work has not provided proof of
2803	2803	4 age requested by the Department of Financial and Professional
2804	2804	5 Regulation or the Department of Agriculture under subsection
2805	2805	6 (m), the Department may request that the licensee provide
2806	2806	7 proof that the person is 21 years of age or older. Failure of
2807	2807	8 the licensee to respond to a request made under this
2808	2808	9 subsection by providing acceptable proof of age for a person
2809	2809	10 is prima facie evidence that the licensee has allowed the
2810	2810	11 person to perform work at the premises for which a license has
2811	2811	12 been issued under this Act in violation of the minimum age
2812	2812	13 requirement.
2813	2813	14 (o) A licensee may not use or allow the use of a mark or
2814	2814	15 label on the container of a psilocybin product that is kept for
2815	2815	16 sale if the mark or label does not precisely and clearly
2816	2816	17 indicate the nature of the container's contents or if the mark
2817	2817	18 or label in any way might deceive a person about the nature,
2818	2818	19 composition, quantity, age, or quality of the container's
2819	2819	20 contents.
2820	2820	21 (p) The Department of Financial and Professional
2821	2821	22 Regulation or the Department of Agriculture may prohibit a
2822	2822	23 licensee from selling any psilocybin product that, in the
2823	2823	24 Department's judgment, is deceptively labeled or contains
2824	2824	25 injurious or adulterated ingredients.
2825	2825
2826	2826
2827	2827
2828	2828
2829	2829
2830	2830	SB2184 - 79 - LRB104 11945 RLC 22038 b
2831	2831
2832	2832
2833	2833	SB2184- 80 -LRB104 11945 RLC 22038 b SB2184 - 80 - LRB104 11945 RLC 22038 b
2834	2834	SB2184 - 80 - LRB104 11945 RLC 22038 b
2835	2835	1 Section 165. Psilocybin product prohibitions.
2836	2836	2 (a) A psilocybin product may not be sold or offered for
2837	2837	3 sale within this State unless the psilocybin product complies
2838	2838	4 with the minimum standards under the laws of this State.
2839	2839	5 (b) The Department of Financial and Professional
2840	2840	6 Regulation or the Department of Agriculture may prohibit the
2841	2841	7 sale of a psilocybin product by a service center operator for a
2842	2842	8 reasonable period of time, not exceeding 90 days, for the
2843	2843	9 purpose of determining whether the psilocybin product complies
2844	2844	10 with the minimum standards prescribed by the laws of this
2845	2845	11 State.
2846	2846	12 (c) A person may not make false representations or
2847	2847	13 statements to the Department of Financial and Professional
2848	2848	14 Regulation or the Department of Agriculture in order to induce
2849	2849	15 or prevent action by the Department.
2850	2850	16 (d) A licensee may not maintain a noisy, lewd, unsafe, or
2851	2851	17 unsanitary establishment or supply impure or otherwise
2852	2852	18 deleterious psilocybin products.
2853	2853	19 (e) A licensee may not misrepresent to a person or to the
2854	2854	20 public any psilocybin products.
2855	2855	21 Section 170. Purpose of licenses issued under this Act. A
2856	2856	22 license issued under this Act serves the purpose of exempting
2857	2857	23 the person who holds the license from the criminal laws of this
2858	2858	24 State for possession, delivery, or manufacture of psilocybin
2859	2859	25 products if the person complies with all State laws and rules
2860	2860
2861	2861
2862	2862
2863	2863
2864	2864
2865	2865	SB2184 - 80 - LRB104 11945 RLC 22038 b
2866	2866
2867	2867
2868	2868	SB2184- 81 -LRB104 11945 RLC 22038 b SB2184 - 81 - LRB104 11945 RLC 22038 b
2869	2869	SB2184 - 81 - LRB104 11945 RLC 22038 b
2870	2870	1 applicable to the licensee.
2871	2871	2 Section 171. Investigations.
2872	2872	3 (a) Manufacturers, service centers, and laboratories that
2873	2873	4 conduct testing of psilocybin products are subject to random
2874	2874	5 and unannounced dispensary inspections and psilocybin testing
2875	2875	6 by the Department of Financial and Professional Regulation,
2876	2876	7 the Department of Agriculture, the Illinois State Police,
2877	2877	8 local law enforcement, or as provided by rule.
2878	2878	9 (b) The Department of Financial and Professional
2879	2879	10 Regulation, the Department of Agriculture, and their
2880	2880	11 authorized representatives may enter any place, including a
2881	2881	12 vehicle, in which psilocybin is held, stored, dispensed, sold,
2882	2882	13 produced, delivered, transported, manufactured, or disposed of
2883	2883	14 and inspect, in a reasonable manner, the place and all
2884	2884	15 pertinent equipment, containers and labeling, and all things
2885	2885	16 including records, files, financial data, sales data, shipping
2886	2886	17 data, pricing data, personnel data, research, papers,
2887	2887	18 processes, controls, and facility, and inventory any stock of
2888	2888	19 psilocybin and obtain samples of any psilocybin or
2889	2889	20 psilocybin-infused product, any labels or containers for
2890	2890	21 psilocybin, or paraphernalia.
2891	2891	22 (c) The Department of Financial and Professional
2892	2892	23 Regulation or the Department of Agriculture may conduct an
2893	2893	24 investigation of an applicant, application, service center,
2894	2894	25 manufacturer, manufacturer agent, licensed laboratory that
2895	2895
2896	2896
2897	2897
2898	2898
2899	2899
2900	2900	SB2184 - 81 - LRB104 11945 RLC 22038 b
2901	2901
2902	2902
2903	2903	SB2184- 82 -LRB104 11945 RLC 22038 b SB2184 - 82 - LRB104 11945 RLC 22038 b
2904	2904	SB2184 - 82 - LRB104 11945 RLC 22038 b
2905	2905	1 conducts testing of a psilocybin product, principal officer,
2906	2906	2 facilitator, service center agent, third party vendor, or any
2907	2907	3 other party associated with a service center, facilitator,
2908	2908	4 manufacturer, or laboratory that conducts testing of
2909	2909	5 psilocybin for an alleged violation of this Act or rules or to
2910	2910	6 determine qualifications to be granted a registration by the
2911	2911	7 Department of Financial and Professional Regulation or the
2912	2912	8 Department of Agriculture.
2913	2913	9 (d) The Department of Financial or Professional Regulation
2914	2914	10 or the Department of Agriculture may require an applicant or
2915	2915	11 holder of any license issued pursuant to this Act to produce
2916	2916	12 documents, records, or any other material pertinent to the
2917	2917	13 investigation of an application or alleged violations of this
2918	2918	14 Act or rules. Failure to provide the required material may be
2919	2919	15 grounds for denial or discipline.
2920	2920	16 (e) Every person charged with preparation, obtaining, or
2921	2921	17 keeping records, logs, reports, or other documents in
2922	2922	18 connection with this Act and rules and every person in charge,
2923	2923	19 or having custody, of those documents shall, upon request by
2924	2924	20 the Department of Financial and Professional Regulation or the
2925	2925	21 Department of Agriculture, make the documents immediately
2926	2926	22 available for inspection and copying by either Department,
2927	2927	23 either Department's authorized representative, or others
2928	2928	24 authorized by law to review the documents.
2929	2929	25 Section 172. Citations. The Department of Financial or
2930	2930
2931	2931
2932	2932
2933	2933
2934	2934
2935	2935	SB2184 - 82 - LRB104 11945 RLC 22038 b
2936	2936
2937	2937
2938	2938	SB2184- 83 -LRB104 11945 RLC 22038 b SB2184 - 83 - LRB104 11945 RLC 22038 b
2939	2939	SB2184 - 83 - LRB104 11945 RLC 22038 b
2940	2940	1 Professional Regulation or the Department of Agriculture may
2941	2941	2 issue nondisciplinary citations for minor violations. Any such
2942	2942	3 citation issued by the Department of Financial or Professional
2943	2943	4 Regulation or the Department of Agriculture may be accompanied
2944	2944	5 by a fee. The fee shall not exceed $20,000 per violation. The
2945	2945	6 citation shall be issued to the licensee and shall contain the
2946	2946	7 licensee's name and address, the licensee's license number, a
2947	2947	8 brief factual statement, the Sections of the law allegedly
2948	2948	9 violated, and the fee, if any, imposed. The citation must
2949	2949	10 clearly state that the licensee may choose, in lieu of
2950	2950	11 accepting the citation, to request a hearing. If the licensee
2951	2951	12 does not dispute the matter in the citation with the
2952	2952	13 Department of Financial or Professional Regulation or the
2953	2953	14 Department of Agriculture within 30 days after the citation is
2954	2954	15 served, then the citation shall become final and not subject
2955	2955	16 to appeal. The penalty shall be a fee or other conditions as
2956	2956	17 established by rule.
2957	2957	18 Section 173. Grounds for discipline.
2958	2958	19 (a) The Department of Financial or Professional Regulation
2959	2959	20 or the Department of Agriculture may deny issuance, refuse to
2960	2960	21 renew or restore, or may reprimand, place on probation,
2961	2961	22 suspend, revoke, or take other disciplinary or nondisciplinary
2962	2962	23 action against any license or may impose a fine for any of the
2963	2963	24 following:
2964	2964	25 (1) material misstatement in furnishing information to
2965	2965
2966	2966
2967	2967
2968	2968
2969	2969
2970	2970	SB2184 - 83 - LRB104 11945 RLC 22038 b
2971	2971
2972	2972
2973	2973	SB2184- 84 -LRB104 11945 RLC 22038 b SB2184 - 84 - LRB104 11945 RLC 22038 b
2974	2974	SB2184 - 84 - LRB104 11945 RLC 22038 b
2975	2975	1 the Department;
2976	2976	2 (2) violations of this Act or rules;
2977	2977	3 (3) obtaining an authorization or license by fraud or
2978	2978	4 misrepresentation;
2979	2979	5 (4) a pattern of conduct that demonstrates
2980	2980	6 incompetence or that the applicant has engaged in conduct
2981	2981	7 or actions that would constitute grounds for discipline
2982	2982	8 under this Act;
2983	2983	9 (5) aiding or assisting another person in violating
2984	2984	10 any provision of this Act or rules;
2985	2985	11 (6) failing to respond to a written request for
2986	2986	12 information by the Department within 30 days;
2987	2987	13 (7) engaging in unprofessional, dishonorable, or
2988	2988	14 unethical conduct of a character likely to deceive,
2989	2989	15 defraud, or harm the public;
2990	2990	16 (8) adverse action by another United States
2991	2991	17 jurisdiction or foreign nation;
2992	2992	18 (9) a finding by the Department that the licensee,
2993	2993	19 after having his or her license placed on suspended or
2994	2994	20 probationary status, has violated the terms of the
2995	2995	21 suspension or probation;
2996	2996	22 (10) conviction, entry of a plea of guilty, nolo
2997	2997	23 contendere, or the equivalent in a State or federal court
2998	2998	24 of a principal officer or agent-in-charge of a felony
2999	2999	25 offense in accordance with Sections 2105-131, 2105-135,
3000	3000	26 and 2105-205 of the Department of Professional Regulation
3001	3001
3002	3002
3003	3003
3004	3004
3005	3005
3006	3006	SB2184 - 84 - LRB104 11945 RLC 22038 b
3007	3007
3008	3008
3009	3009	SB2184- 85 -LRB104 11945 RLC 22038 b SB2184 - 85 - LRB104 11945 RLC 22038 b
3010	3010	SB2184 - 85 - LRB104 11945 RLC 22038 b
3011	3011	1 Law of the Civil Administrative Code of Illinois;
3012	3012	2 (11) excessive use of or addiction to alcohol,
3013	3013	3 narcotics, stimulants, or any other chemical agent or
3014	3014	4 drug;
3015	3015	5 (12) a finding by the Department of a discrepancy in a
3016	3016	6 Department audit of psilocybin;
3017	3017	7 (13) a finding by the Department of a discrepancy in a
3018	3018	8 Department audit of capital or funds;
3019	3019	9 (14) a finding by the Department of acceptance of
3020	3020	10 psilocybin from a source other than a manufacturer
3021	3021	11 licensed by the Department of Agriculture, or a service
3022	3022	12 center licensed by the Department;
3023	3023	13 (15) an inability to operate using reasonable
3024	3024	14 judgment, skill, or safety due to physical or mental
3025	3025	15 illness or other impairment or disability, including,
3026	3026	16 without limitation, deterioration through the aging
3027	3027	17 process or loss of motor skills or mental incompetence;
3028	3028	18 (16) failing to report to the Department within the
3029	3029	19 time frames established, or if not identified, no later
3030	3030	20 than 14 days after an adverse action, of any adverse
3031	3031	21 action taken against the dispensing organization or an
3032	3032	22 agent by a licensing jurisdiction in any state or any
3033	3033	23 territory of the United States or any foreign
3034	3034	24 jurisdiction, any governmental agency, any law enforcement
3035	3035	25 agency or any court defined in this Section;
3036	3036	26 (17) any violation of the dispensing organization's
3037	3037
3038	3038
3039	3039
3040	3040
3041	3041
3042	3042	SB2184 - 85 - LRB104 11945 RLC 22038 b
3043	3043
3044	3044
3045	3045	SB2184- 86 -LRB104 11945 RLC 22038 b SB2184 - 86 - LRB104 11945 RLC 22038 b
3046	3046	SB2184 - 86 - LRB104 11945 RLC 22038 b
3047	3047	1 policies and procedures submitted to the Department
3048	3048	2 annually as a condition for licensure;
3049	3049	3 (18) failure to inform the Department of any change of
3050	3050	4 address no later than 10 business days after the change of
3051	3051	5 address occurs;
3052	3052	6 (19) disclosing customer names, personal information,
3053	3053	7 or protected health information in violation of any State
3054	3054	8 or federal law;
3055	3055	9 (20) operating a service center or manufacturing
3056	3056	10 psilocybin before obtaining a license from the appropriate
3057	3057	11 Department;
3058	3058	12 (21) performing duties authorized by this Act prior to
3059	3059	13 receiving a license to perform such duties;
3060	3060	14 (22) dispensing psilocybin when prohibited by this Act
3061	3061	15 or rules;
3062	3062	16 (23) any fact or condition that, if it had existed at
3063	3063	17 the time of the original application for the license,
3064	3064	18 would have warranted the denial of the license;
3065	3065	19 (24) permitting a person without a valid license to
3066	3066	20 perform licensed activities under this Act;
3067	3067	21 (25) failure to assign an agent-in-charge as required
3068	3068	22 by this Act;
3069	3069	23 (26) failure to provide any training required by the
3070	3070	24 Department within the provided timeframe;
3071	3071	25 (27) personnel insufficient in number or unqualified
3072	3072	26 in training or experience to properly operate the service
3073	3073
3074	3074
3075	3075
3076	3076
3077	3077
3078	3078	SB2184 - 86 - LRB104 11945 RLC 22038 b
3079	3079
3080	3080
3081	3081	SB2184- 87 -LRB104 11945 RLC 22038 b SB2184 - 87 - LRB104 11945 RLC 22038 b
3082	3082	SB2184 - 87 - LRB104 11945 RLC 22038 b
3083	3083	1 center or manufacturer;
3084	3084	2 (28) any pattern of activity that causes a harmful
3085	3085	3 impact on the community; and
3086	3086	4 (29) failing to prevent diversion, theft, or loss of
3087	3087	5 psilocybin.
3088	3088	6 (b) All fines and fees imposed under this Section shall be
3089	3089	7 paid no later than 60 days after the effective date of the
3090	3090	8 order imposing the fine or as otherwise specified in the
3091	3091	9 order.
3092	3092	10 (c) A circuit court order establishing that facilitator,
3093	3093	11 service center operator, or principal officer of a service
3094	3094	12 center, manufacturer, or laboratory conducting psilocybin
3095	3095	13 testing is subject to involuntary admission as that term is
3096	3096	14 defined in Section 1-119 or 1-119.1 of the Mental Health and
3097	3097	15 Developmental Disabilities Code shall operate as a suspension
3098	3098	16 of that license.
3099	3099	17 Section 174. Temporary suspension, service center, and
3100	3100	18 facilitators.
3101	3101	19 (a) The Director of Financial and Professional Regulation
3102	3102	20 may temporarily suspend a service center or facilitator
3103	3103	21 license without a hearing if the Director finds that a
3104	3104	22 licensee has violated Section 206 public safety or welfare
3105	3105	23 requires emergency action. The Director shall cause the
3106	3106	24 temporary suspension by issuing a suspension notice in
3107	3107	25 connection with the institution of proceedings for a hearing.
3108	3108
3109	3109
3110	3110
3111	3111
3112	3112
3113	3113	SB2184 - 87 - LRB104 11945 RLC 22038 b
3114	3114
3115	3115
3116	3116	SB2184- 88 -LRB104 11945 RLC 22038 b SB2184 - 88 - LRB104 11945 RLC 22038 b
3117	3117	SB2184 - 88 - LRB104 11945 RLC 22038 b
3118	3118	1 (b) If the Director temporarily suspends a license without
3119	3119	2 a hearing, the licensee or its agent is entitled to a hearing
3120	3120	3 within 45 days after the suspension notice has been issued.
3121	3121	4 The hearing shall be limited to the issues cited in the
3122	3122	5 suspension notice, unless all parties agree otherwise.
3123	3123	6 (c) If the Department does not hold a hearing within 60
3124	3124	7 days after the date the suspension notice was issued, then the
3125	3125	8 suspended license shall be automatically reinstated and the
3126	3126	9 suspension vacated.
3127	3127	10 (d) The suspended licensee or its agent may seek a
3128	3128	11 continuance of the hearing date, during which time the
3129	3129	12 suspension remains in effect and the license shall not be
3130	3130	13 automatically reinstated.
3131	3131	14 (e) Subsequently discovered causes of action by the
3132	3132	15 Department after the issuance of the suspension notice may be
3133	3133	16 filed as a separate notice of violation. The Department is not
3134	3134	17 precluded from filing a separate action against the suspended
3135	3135	18 licensee or its agent.
3136	3136	19 (f) If the Department determines a licensee has violated
3137	3137	20 Section 206, the Director shall suspend the licensee for a
3138	3138	21 period of no less than 6 months and may enact whatever
3139	3139	22 additional penalties the Director may deem necessary and
3140	3140	23 appropriate in accordance with the provisions of this Act or
3141	3141	24 adopted rules.
3142	3142	25 Section 175. Temporary suspension; manufacturer or
3143	3143
3144	3144
3145	3145
3146	3146
3147	3147
3148	3148	SB2184 - 88 - LRB104 11945 RLC 22038 b
3149	3149
3150	3150
3151	3151	SB2184- 89 -LRB104 11945 RLC 22038 b SB2184 - 89 - LRB104 11945 RLC 22038 b
3152	3152	SB2184 - 89 - LRB104 11945 RLC 22038 b
3153	3153	1 laboratory.
3154	3154	2 (a) The Director of Agriculture may temporarily suspend a
3155	3155	3 manufacturing or laboratory testing license without a hearing
3156	3156	4 if the Director finds that public safety or welfare requires
3157	3157	5 emergency action. The Director shall cause the temporary
3158	3158	6 suspension by issuing a suspension notice in connection with
3159	3159	7 the institution of proceedings for a hearing.
3160	3160	8 (b) If the Director temporarily suspends a license without
3161	3161	9 a hearing, the licensee or its agent is entitled to a hearing
3162	3162	10 within 45 days after the suspension notice has been issued.
3163	3163	11 The hearing shall be limited to the issues cited in the
3164	3164	12 suspension notice, unless all parties agree otherwise.
3165	3165	13 (c) If the Department does not hold a hearing within 45
3166	3166	14 days after the date the suspension notice was issued, then the
3167	3167	15 suspended license shall be automatically reinstated and the
3168	3168	16 suspension vacated.
3169	3169	17 (d) The suspended licensee or its agent may seek a
3170	3170	18 continuance of the hearing date, during which time the
3171	3171	19 suspension remains in effect and the license shall not be
3172	3172	20 automatically reinstated.
3173	3173	21 (e) Subsequently discovered causes of action by the
3174	3174	22 Department after the issuance of the suspension notice may be
3175	3175	23 filed as a separate notice of violation. The Department is not
3176	3176	24 precluded from filing a separate action against the suspended
3177	3177	25 licensee or agent.
3178	3178
3179	3179
3180	3180
3181	3181
3182	3182
3183	3183	SB2184 - 89 - LRB104 11945 RLC 22038 b
3184	3184
3185	3185
3186	3186	SB2184- 90 -LRB104 11945 RLC 22038 b SB2184 - 90 - LRB104 11945 RLC 22038 b
3187	3187	SB2184 - 90 - LRB104 11945 RLC 22038 b
3188	3188	1 Section 176. Unlicensed practice; violation; civil
3189	3189	2 penalty.
3190	3190	3 (a) In addition to any other penalty provided by law, any
3191	3191	4 person who practices, offers to practice, attempts to
3192	3192	5 practice, or holds oneself out to practice as a licensed
3193	3193	6 service center, facilitator, manufacturer, or laboratory
3194	3194	7 licensed to test psilocybin without being licensed under this
3195	3195	8 Act shall, in addition to any other penalty provided by law,
3196	3196	9 pay a civil penalty to the appropriate Department authorized
3197	3197	10 to issue such license in an amount not to exceed $10,000 for
3198	3198	11 each offense as determined by that Department. The civil
3199	3199	12 penalty shall be assessed by the appropriate Department after
3200	3200	13 a hearing is held in accordance with the provisions set forth
3201	3201	14 in this Act regarding the provision of a hearing for the
3202	3202	15 discipline of a licensee.
3203	3203	16 (b) The Department of Financial and Professional
3204	3204	17 Regulation and the Department of Agriculture have the
3205	3205	18 authority and power to investigate any and all unlicensed
3206	3206	19 activity.
3207	3207	20 (c) The civil penalty shall be paid within 60 days after
3208	3208	21 the effective date of the order imposing the civil penalty or
3209	3209	22 in accordance with the order imposing the civil penalty. The
3210	3210	23 order shall constitute a judgment and may be filed and
3211	3211	24 execution had thereon in the same manner as any judgment from
3212	3212	25 any court of this State.
3213	3213
3214	3214
3215	3215
3216	3216
3217	3217
3218	3218	SB2184 - 90 - LRB104 11945 RLC 22038 b
3219	3219
3220	3220
3221	3221	SB2184- 91 -LRB104 11945 RLC 22038 b SB2184 - 91 - LRB104 11945 RLC 22038 b
3222	3222	SB2184 - 91 - LRB104 11945 RLC 22038 b
3223	3223	1 Section 177. Notice; hearing.
3224	3224	2 (a) The Department conducting the disciplinary action
3225	3225	3 shall, before disciplining an applicant or licensee, at least
3226	3226	4 30 days before the date set for the hearing: (i) notify the
3227	3227	5 accused in writing of the charges made and the time and place
3228	3228	6 for the hearing on the charges; (ii) direct him or her to file
3229	3229	7 a written answer to the charges under oath no later than 20
3230	3230	8 days after service; and (iii) inform the applicant or licensee
3231	3231	9 that failure to answer will result in a default being entered
3232	3232	10 against the applicant or licensee.
3233	3233	11 (b) At the time and place fixed in the notice, the hearing
3234	3234	12 officer appointed by the Director of such Department shall
3235	3235	13 proceed to hear the charges, and the parties or their counsel
3236	3236	14 shall be accorded ample opportunity to present any pertinent
3237	3237	15 statements, testimony, evidence, and arguments. The hearing
3238	3238	16 officer may continue the hearing from time to time. In case the
3239	3239	17 person, after receiving the notice, fails to file an answer,
3240	3240	18 the person's license may, in the discretion of the Director,
3241	3241	19 having first received the recommendation of the hearing
3242	3242	20 officer, be suspended, revoked, or placed on probationary
3243	3243	21 status, or be subject to whatever disciplinary action the
3244	3244	22 Secretary considers proper, including a fine, without hearing,
3245	3245	23 if that act or acts charged constitute sufficient grounds for
3246	3246	24 that action under this Act.
3247	3247	25 (c) The written notice and any notice in the subsequent
3248	3248	26 proceeding may be served by regular mail or email to the
3249	3249
3250	3250
3251	3251
3252	3252
3253	3253
3254	3254	SB2184 - 91 - LRB104 11945 RLC 22038 b
3255	3255
3256	3256
3257	3257	SB2184- 92 -LRB104 11945 RLC 22038 b SB2184 - 92 - LRB104 11945 RLC 22038 b
3258	3258	SB2184 - 92 - LRB104 11945 RLC 22038 b
3259	3259	1 licensee's or applicant's address of record.
3260	3260	2 Section 178. Subpoenas; oaths. The Department of Financial
3261	3261	3 and Professional Regulation and the Department of Agriculture
3262	3262	4 shall have the power to subpoena and bring before it any person
3263	3263	5 and to take testimony either orally or by deposition, or both,
3264	3264	6 with the same fees and mileage and in the same manner as
3265	3265	7 prescribed by law in judicial proceedings in civil cases in
3266	3266	8 courts in this State. The Secretary, Director, or the hearing
3267	3267	9 officer shall each have the power to administer oaths to
3268	3268	10 witnesses at any hearings that the Departments are authorized
3269	3269	11 to conduct.
3270	3270	12 Section 179. Hearing; motion for rehearing.
3271	3271	13 (a) The hearing officer shall hear evidence in support of
3272	3272	14 the formal charges and evidence produced by the licensee. At
3273	3273	15 the conclusion of the hearing, the hearing officer shall
3274	3274	16 present to the Secretary a written report of the hearing
3275	3275	17 officer's findings of fact, conclusions of law, and
3276	3276	18 recommendations.
3277	3277	19 (b) At the conclusion of the hearing, a copy of the hearing
3278	3278	20 officer's report shall be served upon the applicant or
3279	3279	21 licensee by the Department of Financial and Professional
3280	3280	22 Regulation or the Department of Agriculture, either personally
3281	3281	23 or as provided in this Act for the service of a notice of
3282	3282	24 hearing. No later than 20 calendar days after service, the
3283	3283
3284	3284
3285	3285
3286	3286
3287	3287
3288	3288	SB2184 - 92 - LRB104 11945 RLC 22038 b
3289	3289
3290	3290
3291	3291	SB2184- 93 -LRB104 11945 RLC 22038 b SB2184 - 93 - LRB104 11945 RLC 22038 b
3292	3292	SB2184 - 93 - LRB104 11945 RLC 22038 b
3293	3293	1 applicant or licensee may present to the applicable Department
3294	3294	2 a motion in writing for rehearing, which shall specify the
3295	3295	3 particular grounds for rehearing. The applicable Department
3296	3296	4 may respond to the motion for rehearing within 20 calendar
3297	3297	5 days after its service on such Department. If no motion for
3298	3298	6 rehearing is filed, then, upon the expiration of the time
3299	3299	7 specified for filing such motion or upon denial of a motion for
3300	3300	8 rehearing, the Director may enter an order in accordance with
3301	3301	9 the recommendation of the hearing officer. If the applicant or
3302	3302	10 licensee orders from the reporting service and pays for a
3303	3303	11 transcript of the record within the time for filing a motion
3304	3304	12 for rehearing, the 20-day period within which a motion may be
3305	3305	13 filed shall commence upon the delivery of the transcript to
3306	3306	14 the applicant or licensee.
3307	3307	15 (c) If the Director disagrees in any regard with the
3308	3308	16 report of the hearing officer, the Director may issue an order
3309	3309	17 contrary to the report.
3310	3310	18 (d) Whenever the Director is not satisfied that
3311	3311	19 substantial justice has been done, the or Director may order a
3312	3312	20 rehearing by the same or another hearing officer.
3313	3313	21 (e) At any point in any investigation or disciplinary
3314	3314	22 proceeding under this Act, both parties may agree to a
3315	3315	23 negotiated consent order. The consent order shall be final
3316	3316	24 upon signature of the Director, as applicable.
3317	3317	25 Section 180. Issuing and renewing permits; fees; rules.
3318	3318
3319	3319
3320	3320
3321	3321
3322	3322
3323	3323	SB2184 - 93 - LRB104 11945 RLC 22038 b
3324	3324
3325	3325
3326	3326	SB2184- 94 -LRB104 11945 RLC 22038 b SB2184 - 94 - LRB104 11945 RLC 22038 b
3327	3327	SB2184 - 94 - LRB104 11945 RLC 22038 b
3328	3328	1 (a) The Department shall issue permits to qualified
3329	3329	2 applicants to perform work described in Section 175. The
3330	3330	3 Department shall adopt rules establishing the following:
3331	3331	4 (1) The qualifications for performing work described
3332	3332	5 in Section 175.
3333	3333	6 (2) The term of a permit issued under this Section.
3334	3334	7 (3) Procedures for applying for and renewing a permit
3335	3335	8 issued under this Section.
3336	3336	9 (4) Reasonable application, issuance, and renewal fees
3337	3337	10 for a permit issued under this Section.
3338	3338	11 (b) The Department of Financial and Professional
3339	3339	12 Regulation or the Department of Agriculture may require an
3340	3340	13 individual applying for a permit under this Section to
3341	3341	14 successfully complete a course, made available by or through
3342	3342	15 that Department, through which the individual receives
3343	3343	16 training on the following:
3344	3344	17 (1) checking identification;
3345	3345	18 (2) detecting intoxication;
3346	3346	19 (3) handling psilocybin products;
3347	3347	20 (4) if applicable, the manufacturing of psilocybin
3348	3348	21 products;
3349	3349	22 (5) the content of this Act and rules adopted under
3350	3350	23 this Act; and
3351	3351	24 (6) any matter deemed necessary by the Department to
3352	3352	25 protect the public health and safety.
3353	3353	26 (c) A Department or other provider of a course may charge a
3354	3354
3355	3355
3356	3356
3357	3357
3358	3358
3359	3359	SB2184 - 94 - LRB104 11945 RLC 22038 b
3360	3360
3361	3361
3362	3362	SB2184- 95 -LRB104 11945 RLC 22038 b SB2184 - 95 - LRB104 11945 RLC 22038 b
3363	3363	SB2184 - 95 - LRB104 11945 RLC 22038 b
3364	3364	1 reasonable fee for the course described under subsection (b).
3365	3365	2 (d) The Department of Financial and Professional
3366	3366	3 Regulation or the Department of Agriculture may not require an
3367	3367	4 individual to successfully complete a course described under
3368	3368	5 subsection (b) more than once, except for the following:
3369	3369	6 (1) As part of a final order suspending a permit
3370	3370	7 issued under this Section, the Department may require a
3371	3371	8 permit holder to successfully complete the course as a
3372	3372	9 condition of lifting the suspension.
3373	3373	10 (2) As part of a final order revoking a permit issued
3374	3374	11 under this Section, the Department shall require an
3375	3375	12 individual to successfully complete the course prior to
3376	3376	13 applying for a new permit.
3377	3377	14 (e) The Department shall conduct a criminal records check
3378	3378	15 on an individual applying for a permit under this Section.
3379	3379	16 (f) Subject to applicable provisions of State law, the
3380	3380	17 Department of Financial and Professional Regulation or the
3381	3381	18 Department of Agriculture may suspend, revoke, or refuse to
3382	3382	19 issue or renew a permit if the individual who is applying for
3383	3383	20 or who holds the permit meets any of the following:
3384	3384	21 (1) Is convicted of a felony, or is convicted of an
3385	3385	22 offense under this Act, except that the Department may not
3386	3386	23 consider a conviction for an offense under this Act if the
3387	3387	24 date of the conviction is 2 or more years before the date
3388	3388	25 of the application or renewal.
3389	3389	26 (2) Violates any provision of this Act or any rule
3390	3390
3391	3391
3392	3392
3393	3393
3394	3394
3395	3395	SB2184 - 95 - LRB104 11945 RLC 22038 b
3396	3396
3397	3397
3398	3398	SB2184- 96 -LRB104 11945 RLC 22038 b SB2184 - 96 - LRB104 11945 RLC 22038 b
3399	3399	SB2184 - 96 - LRB104 11945 RLC 22038 b
3400	3400	1 adopted under this Act.
3401	3401	2 (3) Makes a false statement to the Department.
3402	3402	3 (g) A permit issued under this Section is a personal
3403	3403	4 privilege and permits work described under Section 175 only
3404	3404	5 for the individual who holds the permit.
3405	3405	6 Section 185. Authority to require fingerprints. The
3406	3406	7 Department of Agriculture or the Department of Financial and
3407	3407	8 Professional Regulation, through the Illinois State Police,
3408	3408	9 may require the fingerprints of any individual listed on an
3409	3409	10 application submitted under Section 180 for purposes of
3410	3410	11 conducting a background check. The Department of Agriculture
3411	3411	12 or the Department of Financial Professional Regulation may
3412	3412	13 require fingerprints to be submitted for a background check
3413	3413	14 prior to or after the submission of an application. The
3414	3414	15 Illinois State Police shall charge a fee for conducting the
3415	3415	16 criminal history record check, which shall be deposited into
3416	3416	17 the State Police Services Fund and shall not exceed the actual
3417	3417	18 cost of the record check. In order to carry out this provision,
3418	3418	19 an individual listed on an application submitted under Section
3419	3419	20 180 may be required to submit a full set of fingerprints to the
3420	3420	21 Illinois State Police for the purpose of obtaining a State and
3421	3421	22 federal criminal records check. These fingerprints shall be
3422	3422	23 checked against the fingerprint records now and hereafter, to
3423	3423	24 the extent allowed by law, filed in the Illinois State Police
3424	3424	25 and Federal Bureau of Investigation criminal history records
3425	3425
3426	3426
3427	3427
3428	3428
3429	3429
3430	3430	SB2184 - 96 - LRB104 11945 RLC 22038 b
3431	3431
3432	3432
3433	3433	SB2184- 97 -LRB104 11945 RLC 22038 b SB2184 - 97 - LRB104 11945 RLC 22038 b
3434	3434	SB2184 - 97 - LRB104 11945 RLC 22038 b
3435	3435	1 databases. The Illinois State Police shall furnish, following
3436	3436	2 positive identification, all State conviction information to
3437	3437	3 the Department of Agriculture or the Department of Financial
3438	3438	4 and Professional Regulation.
3439	3439	5 Section 190. Psilocybin Control and Regulation Fund. The
3440	3440	6 Psilocybin Control and Regulation Fund is established as a
3441	3441	7 special fund in the State treasury. Interest earned by the
3442	3442	8 Psilocybin Control and Regulation Fund shall be credited to
3443	3443	9 the Fund.
3444	3444	10 Section 195. Prohibited conduct.
3445	3445	11 (a) Except as authorized by rule, or as necessary in an
3446	3446	12 emergency, a person under 21 years of age may not enter or
3447	3447	13 attempt to enter any portion of premises posted or otherwise
3448	3448	14 identified as being prohibited to the use of persons under 21
3449	3449	15 years of age.
3450	3450	16 (b) A person who violates subsection (a) commits a Class B
3451	3451	17 misdemeanor.
3452	3452	18 (c) The prohibitions of this Section do not apply to a
3453	3453	19 person under 21 years of age who is acting under the direction
3454	3454	20 of the Department of Financial and Professional Regulation or
3455	3455	21 the Department of Agriculture or under the direction of a
3456	3456	22 State or local law enforcement agency for the purpose of
3457	3457	23 investigating the possible violation of a law prohibiting the
3458	3458	24 sale of a psilocybin product to a person who is under 18 years
3459	3459
3460	3460
3461	3461
3462	3462
3463	3463
3464	3464	SB2184 - 97 - LRB104 11945 RLC 22038 b
3465	3465
3466	3466
3467	3467	SB2184- 98 -LRB104 11945 RLC 22038 b SB2184 - 98 - LRB104 11945 RLC 22038 b
3468	3468	SB2184 - 98 - LRB104 11945 RLC 22038 b
3469	3469	1 of age.
3470	3470	2 (d) The prohibitions of this Section do not apply to a
3471	3471	3 person under 21 years of age who is acting under the direction
3472	3472	4 of a licensee for the purpose of investigating possible
3473	3473	5 violations by employees of the licensee of laws prohibiting
3474	3474	6 sales of psilocybin products to persons who are under 18 years
3475	3475	7 of age.
3476	3476	8 (e) A person under 21 years of age is not in violation of,
3477	3477	9 and is immune from prosecution under, this Section if either
3478	3478	10 of the following occurred:
3479	3479	11 (1) The person contacted emergency medical services or
3480	3480	12 a law enforcement agency in order to obtain medical
3481	3481	13 assistance for another person who was in need of medical
3482	3482	14 assistance because that person consumed a psilocybin
3483	3483	15 product and the evidence of the violation was obtained as
3484	3484	16 a result of the person having contacted emergency medical
3485	3485	17 services or a law enforcement agency.
3486	3486	18 (2) The person was in need of medical assistance
3487	3487	19 because the person consumed a psilocybin product and the
3488	3488	20 evidence of the violation was obtained as a result of the
3489	3489	21 person having sought or obtained the medical assistance.
3490	3490	22 (f) Subsection (e) does not exclude the use of evidence
3491	3491	23 obtained as a result of a person having sought medical
3492	3492	24 assistance in proceedings for crimes or offenses other than a
3493	3493	25 violation of this Section.
3494	3494
3495	3495
3496	3496
3497	3497
3498	3498
3499	3499	SB2184 - 98 - LRB104 11945 RLC 22038 b
3500	3500
3501	3501
3502	3502	SB2184- 99 -LRB104 11945 RLC 22038 b SB2184 - 99 - LRB104 11945 RLC 22038 b
3503	3503	SB2184 - 99 - LRB104 11945 RLC 22038 b
3504	3504	1 Section 200. Prohibition against giving psilocybin
3505	3505	2 products to a person who is visibly intoxicated; penalty.
3506	3506	3 (a) A person may not sell, give, or otherwise make
3507	3507	4 available a psilocybin product to a person who is visibly
3508	3508	5 intoxicated.
3509	3509	6 (b) Violation of this Section is a Class A misdemeanor.
3510	3510	7 Section 205. Prohibition against giving psilocybin product
3511	3511	8 as prize; penalty.
3512	3512	9 (a) A psilocybin product may not be given as a prize,
3513	3513	10 premium, or consideration for a lottery, contest, game of
3514	3514	11 chance, game of skill, or competition of any kind.
3515	3515	12 (b) Violation of this Section is a Class A misdemeanor.
3516	3516	13 Section 206. Prohibition against giving psilocybin
3517	3517	14 products to a person for off-site consumption.
3518	3518	15 (a) A person may not sell, give, or otherwise make
3519	3519	16 available a psilocybin product to a person to be consumed
3520	3520	17 outside of the premises of a service center or otherwise
3521	3521	18 outside of an administration session.
3522	3522	19 (b) Violation of this Section will result in the loss of
3523	3523	20 license of a facilitator or service center operator as well as
3524	3524	21 any applicable criminal penalties for tax fraud or tax
3525	3525	22 evasion.
3526	3526	23 Section 210. Civil enforcement. In addition to any other
3527	3527
3528	3528
3529	3529
3530	3530
3531	3531
3532	3532	SB2184 - 99 - LRB104 11945 RLC 22038 b
3533	3533
3534	3534
3535	3535	SB2184- 100 -LRB104 11945 RLC 22038 b SB2184 - 100 - LRB104 11945 RLC 22038 b
3536	3536	SB2184 - 100 - LRB104 11945 RLC 22038 b
3537	3537	1 liability or penalty provided by law, the Department of
3538	3538	2 Financial and Professional Regulation or the Department of
3539	3539	3 Agriculture may impose for each violation of a provision of
3540	3540	4 this Act or a rule adopted under this Act a civil penalty that
3541	3541	5 does not exceed $5,000 for each violation. Moneys collected
3542	3542	6 under this Section shall be deposited into the Psilocybin
3543	3543	7 Control and Regulation Fund.
3544	3544	8 Section 215. Criminal enforcement.
3545	3545	9 (a) The law enforcement officers of this State may enforce
3546	3546	10 this Act and assist the Department of Financial and
3547	3547	11 Professional Regulation or the Department of Agriculture in
3548	3548	12 detecting violations of this Act and apprehending offenders. A
3549	3549	13 law enforcement officer who has notice, knowledge, or
3550	3550	14 reasonable grounds for suspicion of a violation of this Act
3551	3551	15 shall immediately notify the State's Attorney who has
3552	3552	16 jurisdiction over the violation and furnish the State's
3553	3553	17 Attorney who has jurisdiction over the violation with the name
3554	3554	18 and address of any witnesses to the violation or other
3555	3555	19 information related to the violation.
3556	3556	20 (b) A county court, State's Attorney, or municipal
3557	3557	21 authority, immediately upon the conviction of a licensee of a
3558	3558	22 violation of this Act or of a violation of any other law of
3559	3559	23 this State or ordinance of a city or county located in this
3560	3560	24 State, an element of which is the possession, delivery, or
3561	3561	25 manufacture of a psilocybin product, shall notify the
3562	3562
3563	3563
3564	3564
3565	3565
3566	3566
3567	3567	SB2184 - 100 - LRB104 11945 RLC 22038 b
3568	3568
3569	3569
3570	3570	SB2184- 101 -LRB104 11945 RLC 22038 b SB2184 - 101 - LRB104 11945 RLC 22038 b
3571	3571	SB2184 - 101 - LRB104 11945 RLC 22038 b
3572	3572	1 Department of the conviction.
3573	3573	2 (c) Violation of a rule adopted under paragraph (3) of
3574	3574	3 subsection (b) of Section 35 is a Class C misdemeanor.
3575	3575	4 Section 220. Home rule; licensure. The authority to
3576	3576	5 require a license for the manufacturing or sale of psilocybin
3577	3577	6 products in this State or for the provision of psilocybin
3578	3578	7 services in this State is an exclusive power and function of
3579	3579	8 the State. No unit of local government, including a home rule
3580	3580	9 unit or any non-home rule county within the unincorporated
3581	3581	10 territory of the county, may license the manufacture, sale, or
3582	3582	11 provision of psilocybin products. This Section is a denial and
3583	3583	12 limitation of home rule powers and functions under subsection
3584	3584	13 (h) of Section 6 of Article VII of the Illinois Constitution. A
3585	3585	14 unit of local government, including a home rule unit or any
3586	3586	15 non-home rule county within the unincorporated territory of
3587	3587	16 the county, may enact reasonable zoning ordinances or
3588	3588	17 resolutions, not in conflict with this Act or with Department
3589	3589	18 of Agriculture or Department of Financial and Professional
3590	3590	19 Regulation rules, regulating service centers or psilocybin
3591	3591	20 product manufacturers.
3592	3592	21 Section 225. Local tax or fee prohibited.
3593	3593	22 (a) The authority to impose a tax or fee on the
3594	3594	23 manufacturing, sale, or provision of psilocybin products in
3595	3595	24 this State or on the provision of psilocybin services in this
3596	3596
3597	3597
3598	3598
3599	3599
3600	3600
3601	3601	SB2184 - 101 - LRB104 11945 RLC 22038 b
3602	3602
3603	3603
3604	3604	SB2184- 102 -LRB104 11945 RLC 22038 b SB2184 - 102 - LRB104 11945 RLC 22038 b
3605	3605	SB2184 - 102 - LRB104 11945 RLC 22038 b
3606	3606	1 State is an exclusive power and function of the State. A home
3607	3607	2 rule unit may not impose a tax or fee on the manufacture, sale,
3608	3608	3 or provision of psilocybin products. This Section is a denial
3609	3609	4 and limitation of home rule powers and functions under
3610	3610	5 subsection (g) of Section 6 of Article VII of the Illinois
3611	3611	6 Constitution.
3612	3612	7 (b) A county, municipality, or unit of local government
3613	3613	8 may not adopt or enact ordinances imposing a tax or fee on the
3614	3614	9 manufacturing or sale of psilocybin products in this State or
3615	3615	10 on the provision of psilocybin services in this State.
3616	3616	11 Section 230. Prohibition against refusing to perform
3617	3617	12 certain duties.
3618	3618	13 (a) The Department of Agriculture, the Department of
3619	3619	14 Financial and Professional Regulation, the Illinois State
3620	3620	15 Police, and the Department of Revenue may not refuse to
3621	3621	16 perform any duty under this Act on the basis that
3622	3622	17 manufacturing, distributing, dispensing, possessing, or using
3623	3623	18 psilocybin products is prohibited by federal law.
3624	3624	19 (b) The Department of Financial and Professional
3625	3625	20 Regulation or the Department of Agriculture may not revoke,
3626	3626	21 refuse to issue, or renew a license or permit under this Act on
3627	3627	22 the basis that manufacturing, distributing, dispensing,
3628	3628	23 possessing, or using psilocybin products is prohibited by
3629	3629	24 federal law.
3630	3630
3631	3631
3632	3632
3633	3633
3634	3634
3635	3635	SB2184 - 102 - LRB104 11945 RLC 22038 b
3636	3636
3637	3637
3638	3638	SB2184- 103 -LRB104 11945 RLC 22038 b SB2184 - 103 - LRB104 11945 RLC 22038 b
3639	3639	SB2184 - 103 - LRB104 11945 RLC 22038 b
3640	3640	1 Section 235. Authority to purchase, possess, seize, or
3641	3641	2 dispose of psilocybin products. Subject to any applicable
3642	3642	3 provision of State law, any State officer, board, commission,
3643	3643	4 corporation, institution, department, or other State body, and
3644	3644	5 any local officer, board, commission, institution, department,
3645	3645	6 or other local government body, that is authorized by the laws
3646	3646	7 of this State to perform a duty, function, or power with
3647	3647	8 respect to a psilocybin product may purchase, possess, seize,
3648	3648	9 or dispose of the psilocybin product as the State officer,
3649	3649	10 board, commission, corporation, institution, department, or
3650	3650	11 other State body or the local officer, board, commission,
3651	3651	12 institution, department, or other local government body
3652	3652	13 considers necessary to ensure compliance with and enforce the
3653	3653	14 applicable State law or any rule adopted under the applicable
3654	3654	15 State law.
3655	3655	16 Section 240. Suspension of a license or permit without
3656	3656	17 notice. In the case of an invasion, disaster, insurrection,
3657	3657	18 riot, or imminent danger of invasion, disaster, insurrection,
3658	3658	19 or riot, the Governor may, for the duration of the invasion,
3659	3659	20 disaster, insurrection, riot, or imminent danger, immediately
3660	3660	21 and without notice, suspend, in the area involved, any license
3661	3661	22 or permit issued under this Act.
3662	3662	23 Section 245. Psilocybin-producing fungi as a crop.
3663	3663	24 (a) In this Section, "psilocybin-producing fungi" means:
3664	3664
3665	3665
3666	3666
3667	3667
3668	3668
3669	3669	SB2184 - 103 - LRB104 11945 RLC 22038 b
3670	3670
3671	3671
3672	3672	SB2184- 104 -LRB104 11945 RLC 22038 b SB2184 - 104 - LRB104 11945 RLC 22038 b
3673	3673	SB2184 - 104 - LRB104 11945 RLC 22038 b
3674	3674	1 (1) a crop for the purposes of agricultural use;
3675	3675	2 (2) a crop for purposes of a farm or agricultural
3676	3676	3 practice;
3677	3677	4 (3) a product of farm use; and
3678	3678	5 (4) the product of an agricultural activity.
3679	3679	6 (b) Notwithstanding the provisions of any law to the
3680	3680	7 contrary, the following are not permitted uses on land
3681	3681	8 designated for exclusive agriculture use:
3682	3682	9 (1) a new dwelling used in conjunction with a
3683	3683	10 psilocybin-producing fungi crop; and
3684	3684	11 (2) a produce stand used in conjunction with a
3685	3685	12 psilocybin-producing fungi crop.
3686	3686	13 (c) The operation of a service center may be carried on in
3687	3687	14 conjunction with a psilocybin-producing fungi crop.
3688	3688	15 (d) A county may allow the manufacture of psilocybin
3689	3689	16 products as an agricultural use on land zoned for agricultural
3690	3690	17 and rural land use in the same manner as the manufacture of
3691	3691	18 psilocybin products is allowed in exclusive agricultural use
3692	3692	19 zones under this Section or any other applicable State law.
3693	3693	20 (e) This Section applies to psilocybin product
3694	3694	21 manufacturers that hold a license under Section 80.
3695	3695	22 Section 250. Regulation of psilocybin products as food or
3696	3696	23 other commodity.
3697	3697	24 (a) Notwithstanding the authority granted to the
3698	3698	25 Department of Agriculture under the provisions of any law to
3699	3699
3700	3700
3701	3701
3702	3702
3703	3703
3704	3704	SB2184 - 104 - LRB104 11945 RLC 22038 b
3705	3705
3706	3706
3707	3707	SB2184- 105 -LRB104 11945 RLC 22038 b SB2184 - 105 - LRB104 11945 RLC 22038 b
3708	3708	SB2184 - 105 - LRB104 11945 RLC 22038 b
3709	3709	1 the contrary, the Department of Agriculture may not exercise
3710	3710	2 authority over a psilocybin product or a licensee except as
3711	3711	3 provided in this Act.
3712	3712	4 (b) In exercising its authority under this Act, the
3713	3713	5 Department of Agriculture may not:
3714	3714	6 (1) establish standards for psilocybin products as a
3715	3715	7 food additive; or
3716	3716	8 (2) consider psilocybin products to be an adulterant
3717	3717	9 unless the concentration of a psilocybin product exceeds
3718	3718	10 acceptable levels established by the Department by rule.
3719	3719	11 Section 255. Enforceability of contracts. A contract is
3720	3720	12 not unenforceable on the basis that manufacturing,
3721	3721	13 distributing, dispensing, possessing, or using psilocybin
3722	3722	14 products is prohibited by federal law.
3723	3723	15 Section 260. Department database for verification of
3724	3724	16 license. The Department of Financial and Professional
3725	3725	17 Regulation and the Department of Agriculture shall maintain an
3726	3726	18 online database for people to inquire if an address is the
3727	3727	19 location of a premises for which a license has been issued
3728	3728	20 under this Act or is the location of a premises for which an
3729	3729	21 application for licensure has been submitted under Section 50.
3730	3730	22 Section 265. Confidentiality; Information related to
3731	3731	23 licensure that is exempt from disclosure.
3732	3732
3733	3733
3734	3734
3735	3735
3736	3736
3737	3737	SB2184 - 105 - LRB104 11945 RLC 22038 b
3738	3738
3739	3739
3740	3740	SB2184- 106 -LRB104 11945 RLC 22038 b SB2184 - 106 - LRB104 11945 RLC 22038 b
3741	3741	SB2184 - 106 - LRB104 11945 RLC 22038 b
3742	3742	1 (a) The following information received and records kept by
3743	3743	2 the Department of Financial and Professional Regulation,
3744	3744	3 Department of Agriculture, or Illinois State Police for
3745	3745	4 purposes of administering this Act are subject to all
3746	3746	5 applicable federal privacy laws, confidential, and exempt from
3747	3747	6 the Freedom of Information Act, and not subject to disclosure
3748	3748	7 to any individual or public or private entity, except as
3749	3749	8 necessary for authorized employees of those authorized
3750	3750	9 agencies to perform official duties under this Act and the
3751	3751	10 following information received and records kept by the
3752	3752	11 Department of Agriculture, Department of Financial and
3753	3753	12 Professional Regulation, and Illinois State Police, excluding
3754	3754	13 any existing or non-existing Illinois or national criminal
3755	3755	14 history record information as defined in subsection (d), may
3756	3756	15 be disclosed to each other upon request:
3757	3757	16 (1) Referrals, their contents, and supporting
3758	3758	17 information submitted by clients, including information
3759	3759	18 regarding their referring health care professionals.
3760	3760	19 (2) Applications and renewals, their contents, and
3761	3761	20 supporting information submitted by or on behalf of
3762	3762	21 service centers and service center operators in compliance
3763	3763	22 with this Act, including their physical addresses. This
3764	3764	23 does not preclude the release of ownership information of
3765	3765	24 service center business establishment licenses.
3766	3766	25 (3) Applications and renewals, their contents, and
3767	3767	26 supporting information submitted by or on behalf of
3768	3768
3769	3769
3770	3770
3771	3771
3772	3772
3773	3773	SB2184 - 106 - LRB104 11945 RLC 22038 b
3774	3774
3775	3775
3776	3776	SB2184- 107 -LRB104 11945 RLC 22038 b SB2184 - 107 - LRB104 11945 RLC 22038 b
3777	3777	SB2184 - 107 - LRB104 11945 RLC 22038 b
3778	3778	1 facilitators in compliance with this Act.
3779	3779	2 (4) Applications and renewals, their contents, and
3780	3780	3 supporting information submitted by or on behalf of
3781	3781	4 psilocybin product manufacturers in compliance with this
3782	3782	5 Act, including their physical addresses.
3783	3783	6 (a-5) The following information received and records kept
3784	3784	7 by service centers and their licensees, facilitators, or
3785	3785	8 psilocybin product manufacturers for purposes of administering
3786	3786	9 this Act are subject to all applicable federal privacy laws,
3787	3787	10 confidential, and exempt from the Freedom of Information Act,
3788	3788	11 and not subject to disclosure to any individual or public or
3789	3789	12 private entity, except as necessary for authorized employees
3790	3790	13 of those by service centers and their licensees, facilitators,
3791	3791	14 or psilocybin product manufacturers to perform official duties
3792	3792	15 under this Act:
3793	3793	16 (1) Referrals, their contents, and supporting
3794	3794	17 information submitted by clients, including information
3795	3795	18 regarding their referring health care professionals.
3796	3796	19 (2) Any records or information related to a
3797	3797	20 preparation session. This does not preclude the release of
3798	3798	21 records or information related to a preparation session
3799	3799	22 for the purposes of compliance with a criminal or
3800	3800	23 administrative investigation.
3801	3801	24 (3) Any records or information related to an
3802	3802	25 administration session. This does not preclude the release
3803	3803	26 of records or information related to an administration
3804	3804
3805	3805
3806	3806
3807	3807
3808	3808
3809	3809	SB2184 - 107 - LRB104 11945 RLC 22038 b
3810	3810
3811	3811
3812	3812	SB2184- 108 -LRB104 11945 RLC 22038 b SB2184 - 108 - LRB104 11945 RLC 22038 b
3813	3813	SB2184 - 108 - LRB104 11945 RLC 22038 b
3814	3814	1 session for the purposes of compliance with a criminal or
3815	3815	2 administrative investigation.
3816	3816	3 (4) Any records or information related to an
3817	3817	4 integration session. This does not preclude the release of
3818	3818	5 records or information related to an integration session
3819	3819	6 for the purposes of compliance with a criminal or
3820	3820	7 administrative investigation.
3821	3821	8 (5) Any records or information related to a
3822	3822	9 post-administrative evaluation session. This does not
3823	3823	10 preclude the release of records or information related to
3824	3824	11 a post-administrative evaluation session for the purposes
3825	3825	12 of compliance with a criminal or administrative
3826	3826	13 investigation.
3827	3827	14 (b) Nothing in this Section precludes the following:
3828	3828	15 (1) The Department of Agriculture or the Department of
3829	3829	16 Financial and Professional Regulation employees may notify
3830	3830	17 law enforcement about falsified or fraudulent information
3831	3831	18 submitted to the Departments if the employee who suspects
3832	3832	19 that falsified or fraudulent information has been
3833	3833	20 submitted conferred with his or her supervisor and both
3834	3834	21 agree that circumstances exist that warrant reporting.
3835	3835	22 (2) If the employee conferred with his or her
3836	3836	23 supervisor and both agree that circumstances exist that
3837	3837	24 warrant reporting, the Department of Financial and
3838	3838	25 Professional Regulation employees may notify the
3839	3839	26 Department of Financial and Professional Regulation if
3840	3840
3841	3841
3842	3842
3843	3843
3844	3844
3845	3845	SB2184 - 108 - LRB104 11945 RLC 22038 b
3846	3846
3847	3847
3848	3848	SB2184- 109 -LRB104 11945 RLC 22038 b SB2184 - 109 - LRB104 11945 RLC 22038 b
3849	3849	SB2184 - 109 - LRB104 11945 RLC 22038 b
3850	3850	1 there is reasonable cause to believe a certifying health
3851	3851	2 care professional:
3852	3852	3 (A) issued a written referral without a bona fide
3853	3853	4 health care professional-patient relationship under
3854	3854	5 this Act;
3855	3855	6 (B) issued a written referral to a person who was
3856	3856	7 not under the referring health care professional's
3857	3857	8 care; or
3858	3858	9 (C) failed to abide by the acceptable and
3859	3859	10 prevailing standard of care when evaluating a
3860	3860	11 patient's medical condition.
3861	3861	12 (3) The Department of Agriculture and the Department
3862	3862	13 of Financial and Professional Regulation may notify State
3863	3863	14 or local law enforcement about apparent criminal
3864	3864	15 violations of this Act if the employee who suspects the
3865	3865	16 offense has conferred with his or her supervisor and both
3866	3866	17 agree that circumstances exist that warrant reporting.
3867	3867	18 (4) Service centers and psilocybin product
3868	3868	19 manufacturers may notify the Department of Financial and
3869	3869	20 Professional Regulation or the Department of Agriculture
3870	3870	21 of a suspected violation or attempted violation of this
3871	3871	22 Act or the rules issued under it.
3872	3872	23 (5) The publication of the Illinois Psilocybin
3873	3873	24 Advisory Board's annual report under Section 30.
3874	3874	25 (b-5) The Department of Financial and Professional
3875	3875	26 Regulation shall publish on the Department's website a list of
3876	3876
3877	3877
3878	3878
3879	3879
3880	3880
3881	3881	SB2184 - 109 - LRB104 11945 RLC 22038 b
3882	3882
3883	3883
3884	3884	SB2184- 110 -LRB104 11945 RLC 22038 b SB2184 - 110 - LRB104 11945 RLC 22038 b
3885	3885	SB2184 - 110 - LRB104 11945 RLC 22038 b
3886	3886	1 the ownership information of service center licensees under
3887	3887	2 the Department's jurisdiction. The list shall include, but
3888	3888	3 shall not be limited to, the name of the person or entity
3889	3889	4 holding each service center license and the address at which
3890	3890	5 the entity is operating under this Act. This list shall be
3891	3891	6 published and updated monthly.
3892	3892	7 (c) Except for any ownership information released pursuant
3893	3893	8 to subsection (b-5) or as otherwise authorized or required by
3894	3894	9 law, it is a Class B misdemeanor with a $1,000 fine for any
3895	3895	10 person, including an employee or official of the Department of
3896	3896	11 Financial and Professional Regulation or the Department of
3897	3897	12 Agriculture or another State agency or local government, to
3898	3898	13 breach the confidentiality of information obtained under this
3899	3899	14 Act.
3900	3900	15 (d) The Department of Agriculture, the Illinois State
3901	3901	16 Police, and the Department of Financial and Professional
3902	3902	17 Regulation shall not share or disclose any existing or
3903	3903	18 non-existing State or national criminal history record
3904	3904	19 information. For the purposes of this Section, "any existing
3905	3905	20 or non-existing State or national criminal history record
3906	3906	21 information" means any State or national criminal history
3907	3907	22 record information, including, but not limited to, the lack of
3908	3908	23 or non-existence of these records.
3909	3909	24 (e) Subject to subsection (f), information is exempt from
3910	3910	25 public disclosure under the Freedom of Information Act if the
3911	3911	26 information is any of the following:
3912	3912
3913	3913
3914	3914
3915	3915
3916	3916
3917	3917	SB2184 - 110 - LRB104 11945 RLC 22038 b
3918	3918
3919	3919
3920	3920	SB2184- 111 -LRB104 11945 RLC 22038 b SB2184 - 111 - LRB104 11945 RLC 22038 b
3921	3921	SB2184 - 111 - LRB104 11945 RLC 22038 b
3922	3922	1 (1) Personally identifiable information.
3923	3923	2 (2) The address of premises for which a license has
3924	3924	3 been issued or for which an applicant has proposed
3925	3925	4 licensure under Section 275.
3926	3926	5 (3) Related to the security plan or the operational
3927	3927	6 plan for premises for which a license has been issued or
3928	3928	7 for which an applicant has proposed licensure under
3929	3929	8 Section 80, 95, or 275.
3930	3930	9 (4) Related to any record that the Department of
3931	3931	10 Financial and Professional Regulation or the Department of
3932	3932	11 Agriculture determines contains proprietary information of
3933	3933	12 a licensee.
3934	3934	13 (f) The exemption from public disclosure as provided by
3935	3935	14 this Section does not apply to the following:
3936	3936	15 (1) the name of an individual listed on an application
3937	3937	16 if the individual is a direct owner of the business
3938	3938	17 operating or to be operated under the license; or
3939	3939	18 (2) a request for information if the request is made
3940	3940	19 by a law enforcement agency.
3941	3941	20 (g) For purposes of paragraph (1) of subsection (f), an
3942	3942	21 individual is not a direct owner of the business operating or
3943	3943	22 to be operated under the license if the individual is either of
3944	3944	23 the following:
3945	3945	24 (1) the direct owner of the business operating or to
3946	3946	25 be operated under the license is a legal entity; or
3947	3947	26 (2) merely a general partner, limited partner, member,
3948	3948
3949	3949
3950	3950
3951	3951
3952	3952
3953	3953	SB2184 - 111 - LRB104 11945 RLC 22038 b
3954	3954
3955	3955
3956	3956	SB2184- 112 -LRB104 11945 RLC 22038 b SB2184 - 112 - LRB104 11945 RLC 22038 b
3957	3957	SB2184 - 112 - LRB104 11945 RLC 22038 b
3958	3958	1 shareholder, or other direct or indirect owner of the
3959	3959	2 legal entity.
3960	3960	3 Section 270. Testing standards and processes; rules.
3961	3961	4 (a) As is necessary to protect the public health and
3962	3962	5 safety, the Department of Agriculture shall adopt rules that
3963	3963	6 achieve the following:
3964	3964	7 (1) Establish standards for testing psilocybin
3965	3965	8 products.
3966	3966	9 (2) Identify appropriate tests for psilocybin
3967	3967	10 products, depending on the type of psilocybin product and
3968	3968	11 the manner in which the psilocybin product was
3969	3969	12 manufactured, that are necessary to protect the public
3970	3970	13 health and safety, which may include, but are not limited
3971	3971	14 to, tests for the following:
3972	3972	15 (A) microbiological contaminants;
3973	3973	16 (B) pesticides;
3974	3974	17 (C) other contaminants;
3975	3975	18 (D) solvents or residual solvents;
3976	3976	19 (E) psilocybin concentration;
3977	3977	20 (F) psilocin concentration; and
3978	3978	21 (G) total tryptamine concentration.
3979	3979	22 (3) Establish procedures for determining batch sizes
3980	3980	23 and for sampling psilocybin products.
3981	3981	24 (4) Establish different minimum standards for
3982	3982	25 different varieties of psilocybin products.
3983	3983
3984	3984
3985	3985
3986	3986
3987	3987
3988	3988	SB2184 - 112 - LRB104 11945 RLC 22038 b
3989	3989
3990	3990
3991	3991	SB2184- 113 -LRB104 11945 RLC 22038 b SB2184 - 113 - LRB104 11945 RLC 22038 b
3992	3992	SB2184 - 113 - LRB104 11945 RLC 22038 b
3993	3993	1 (b) In addition to the testing requirements established
3994	3994	2 under subsection (a), the Department may require psilocybin
3995	3995	3 products to be tested in accordance with any applicable law of
3996	3996	4 this State, or any applicable rule adopted under a law of this
3997	3997	5 State, related to the production and processing of food
3998	3998	6 products or commodities.
3999	3999	7 (c) In adopting rules under this Act, the Department may
4000	4000	8 require a psilocybin product manufacturer that holds a license
4001	4001	9 under Section 80 to test psilocybin products before selling or
4002	4002	10 transferring the psilocybin products.
4003	4003	11 (d) The Department may conduct random testing of
4004	4004	12 psilocybin products for the purpose of determining whether a
4005	4005	13 licensee subject to testing under subsection (c) is in
4006	4006	14 compliance with this Section.
4007	4007	15 (e) In adopting rules to implement this Section, the
4008	4008	16 Department may not require a psilocybin product to undergo the
4009	4009	17 same test more than once unless the psilocybin product is
4010	4010	18 processed into a different type of psilocybin product or the
4011	4011	19 condition of the psilocybin product has fundamentally changed.
4012	4012	20 (f) The testing of psilocybin products as required by this
4013	4013	21 Section must be conducted by a laboratory licensed by the
4014	4014	22 Department under Section 275 and accredited by the Department
4015	4015	23 under Section 290.
4016	4016	24 (g) In adopting rules under subsection (a), the Department
4017	4017	25 shall consider the cost of a potential testing procedure and
4018	4018	26 how that cost will affect the cost to the ultimate client and
4019	4019
4020	4020
4021	4021
4022	4022
4023	4023
4024	4024	SB2184 - 113 - LRB104 11945 RLC 22038 b
4025	4025
4026	4026
4027	4027	SB2184- 114 -LRB104 11945 RLC 22038 b SB2184 - 114 - LRB104 11945 RLC 22038 b
4028	4028	SB2184 - 114 - LRB104 11945 RLC 22038 b
4029	4029	1 may not adopt rules that are more restrictive than is
4030	4030	2 reasonably necessary to protect the public health and safety.
4031	4031	3 Section 275. Laboratory licensure; qualifications; fees;
4032	4032	4 rules.
4033	4033	5 (a) A laboratory that conducts testing of psilocybin
4034	4034	6 products as required by Section 270 must have a license to
4035	4035	7 operate at the premises at which the psilocybin products are
4036	4036	8 tested.
4037	4037	9 (b) For purposes of this Section, the Department of
4038	4038	10 Agriculture shall adopt rules establishing the following:
4039	4039	11 (1) Qualifications to be licensed under this Section,
4040	4040	12 including that an applicant for licensure under this
4041	4041	13 Section must be accredited by the Department as described
4042	4042	14 in Section 290.
4043	4043	15 (2) Processes for applying for and renewing a license
4044	4044	16 under this Section.
4045	4045	17 (3) Fees for applying for, receiving, and renewing a
4046	4046	18 license under this Section.
4047	4047	19 (4) Procedures for the following:
4048	4048	20 (A) tracking psilocybin products to be tested;
4049	4049	21 (B) documenting and reporting test results; and
4050	4050	22 (C) disposing of samples of psilocybin products
4051	4051	23 that have been tested.
4052	4052	24 (c) A license issued under this Section must be renewed
4053	4053	25 annually.
4054	4054
4055	4055
4056	4056
4057	4057
4058	4058
4059	4059	SB2184 - 114 - LRB104 11945 RLC 22038 b
4060	4060
4061	4061
4062	4062	SB2184- 115 -LRB104 11945 RLC 22038 b SB2184 - 115 - LRB104 11945 RLC 22038 b
4063	4063	SB2184 - 115 - LRB104 11945 RLC 22038 b
4064	4064	1 (d) The Department may inspect premises licensed under
4065	4065	2 this Section to ensure compliance with Sections 270 through
4066	4066	3 310 and rules adopted under those Sections.
4067	4067	4 (e) Subject to applicable provisions of State law, the
4068	4068	5 Department may refuse to issue or renew, or may suspend or
4069	4069	6 revoke, a license issued under this Section for violation of a
4070	4070	7 provision of this Act or a rule adopted under a provision of
4071	4071	8 this Act.
4072	4072	9 (f) Fees adopted under paragraph (3) of subsection (b)
4073	4073	10 must be reasonably calculated to pay the expenses incurred by
4074	4074	11 the Department under this Act.
4075	4075	12 (g) Fees collected under this Section shall be deposited
4076	4076	13 into the Psilocybin Control and Regulation Fund and are
4077	4077	14 continuously appropriated to the Department for the purpose of
4078	4078	15 carrying out the duties, functions, and powers of the
4079	4079	16 Department under this Act.
4080	4080	17 Section 280. Authority to require fingerprints. The
4081	4081	18 Department of Agriculture, through the Illinois State Police,
4082	4082	19 may require the fingerprints of any individual listed on an
4083	4083	20 application submitted under Section 275 for purposes of
4084	4084	21 conducting a background check. The Department of Agriculture
4085	4085	22 may require fingerprints to be submitted for a background
4086	4086	23 check prior to or after the submission of an application. The
4087	4087	24 Illinois State Police shall charge a fee for conducting the
4088	4088	25 criminal history record check, which shall be deposited into
4089	4089
4090	4090
4091	4091
4092	4092
4093	4093
4094	4094	SB2184 - 115 - LRB104 11945 RLC 22038 b
4095	4095
4096	4096
4097	4097	SB2184- 116 -LRB104 11945 RLC 22038 b SB2184 - 116 - LRB104 11945 RLC 22038 b
4098	4098	SB2184 - 116 - LRB104 11945 RLC 22038 b
4099	4099	1 the State Police Services Fund and shall not exceed the actual
4100	4100	2 cost of the record check. In order to carry out this provision,
4101	4101	3 an individual listed on an application submitted under Section
4102	4102	4 275 may be required to submit a full set of fingerprints to the
4103	4103	5 Illinois State Police for the purpose of obtaining a State and
4104	4104	6 federal criminal records check. These fingerprints shall be
4105	4105	7 checked against the fingerprint records now and hereafter, to
4106	4106	8 the extent allowed by law, filed in the Illinois State Police
4107	4107	9 and Federal Bureau of Investigation criminal history records
4108	4108	10 databases. The Illinois State Police shall furnish, following
4109	4109	11 positive identification, all State conviction information to
4110	4110	12 the Department of Agriculture. The powers conferred on the
4111	4111	13 Department under this Section include the power to require the
4112	4112	14 fingerprints of the following persons:
4113	4113	15 (1) If the applicant is a limited partnership, each
4114	4114	16 general partner of the limited partnership.
4115	4115	17 (2) If the applicant is a manager-managed limited
4116	4116	18 liability company, each manager of the limited liability
4117	4117	19 company.
4118	4118	20 (3) If the applicant is a member-managed limited
4119	4119	21 liability company, each voting member of the limited
4120	4120	22 liability company.
4121	4121	23 (4) If the applicant is a corporation, each director
4122	4122	24 and officer of the corporation.
4123	4123	25 (5) Any individual who holds a financial interest of
4124	4124	26 10% or more in the person applying for the license.
4125	4125
4126	4126
4127	4127
4128	4128
4129	4129
4130	4130	SB2184 - 116 - LRB104 11945 RLC 22038 b
4131	4131
4132	4132
4133	4133	SB2184- 117 -LRB104 11945 RLC 22038 b SB2184 - 117 - LRB104 11945 RLC 22038 b
4134	4134	SB2184 - 117 - LRB104 11945 RLC 22038 b
4135	4135	1 Section 285. Statement of applicant for laboratory
4136	4136	2 licensure. The Department of Agriculture may require a
4137	4137	3 licensee or applicant for a license under Section 275 to
4138	4138	4 submit, in a form and manner prescribed by the Department, to
4139	4139	5 the Department a sworn statement showing the following:
4140	4140	6 (1) The name and address of each person who has a
4141	4141	7 financial interest in the business operating or to be
4142	4142	8 operated under the license.
4143	4143	9 (2) The nature and extent of the financial interest of
4144	4144	10 each person who has a financial interest in the business
4145	4145	11 operating or to be operated under the license.
4146	4146	12 (3) The Department may refuse to issue, or may
4147	4147	13 suspend, revoke, or refuse to renew, a license issued
4148	4148	14 under Section 275 if the Department determines that a
4149	4149	15 person who has a financial interest in the business
4150	4150	16 operating or to be operated under the license committed or
4151	4151	17 failed to commit an act that would constitute grounds for
4152	4152	18 the Department to refuse to issue, or to suspend, revoke,
4153	4153	19 or refuse to renew, the license if the person were the
4154	4154	20 licensee or applicant for the license.
4155	4155	21 Section 290. Laboratory accreditation.
4156	4156	22 (a) A laboratory that conducts testing of a psilocybin
4157	4157	23 product as required by Section 275 must be accredited and meet
4158	4158	24 other qualifications as established by the Department of
4159	4159
4160	4160
4161	4161
4162	4162
4163	4163
4164	4164	SB2184 - 117 - LRB104 11945 RLC 22038 b
4165	4165
4166	4166
4167	4167	SB2184- 118 -LRB104 11945 RLC 22038 b SB2184 - 118 - LRB104 11945 RLC 22038 b
4168	4168	SB2184 - 118 - LRB104 11945 RLC 22038 b
4169	4169	1 Agriculture under this Section.
4170	4170	2 (b) In addition to other qualifications required pursuant
4171	4171	3 to applicable law, the Department shall require an applicant
4172	4172	4 for accreditation for purposes related to the testing of
4173	4173	5 psilocybin products to:
4174	4174	6 (1) complete an application;
4175	4175	7 (2) undergo an onsite inspection; and
4176	4176	8 (3) meet other applicable requirements,
4177	4177	9 specifications, and guidelines for testing psilocybin
4178	4178	10 products as determined to be appropriate by the Department
4179	4179	11 by rule.
4180	4180	12 (c) The Department may inspect premises licensed under
4181	4181	13 Section 275 to ensure compliance with Sections 270 through 310
4182	4182	14 and rules adopted under those Sections.
4183	4183	15 (d) Subject to applicable provisions of State law, the
4184	4184	16 Department may refuse to issue or renew, or may suspend or
4185	4185	17 revoke, a laboratory's accreditation granted under this
4186	4186	18 Section for violation of a provision of this Act or a rule
4187	4187	19 adopted under this Act.
4188	4188	20 (e) In establishing fees under this Section for
4189	4189	21 laboratories that test psilocybin products, the Department
4190	4190	22 shall establish fees that are reasonably calculated to pay the
4191	4191	23 expenses incurred by the Department under this Section in
4192	4192	24 accrediting laboratories that test psilocybin products.
4193	4193	25 Section 295. Authority to discipline licensees. Subject to
4194	4194
4195	4195
4196	4196
4197	4197
4198	4198
4199	4199	SB2184 - 118 - LRB104 11945 RLC 22038 b
4200	4200
4201	4201
4202	4202	SB2184- 119 -LRB104 11945 RLC 22038 b SB2184 - 119 - LRB104 11945 RLC 22038 b
4203	4203	SB2184 - 119 - LRB104 11945 RLC 22038 b
4204	4204	1 applicable provisions of State law, if an applicant or
4205	4205	2 licensee violates a provision of Sections 270 through 310 or a
4206	4206	3 rule adopted under those Sections, the Department of
4207	4207	4 Agriculture may refuse to issue or renew, or may suspend or
4208	4208	5 revoke, a license issued under Section 80, 95, 105, or 275.
4209	4209	6 Section 300. Authority of the Department of Agriculture
4210	4210	7 over certain persons; license actions.
4211	4211	8 (a) Notwithstanding the lapse, suspension, or revocation
4212	4212	9 of a license issued under Section 275, the Department of
4213	4213	10 Agriculture may do either of the following:
4214	4214	11 (1) Proceed with any investigation of, or any action
4215	4215	12 or disciplinary proceeding against, the person who held
4216	4216	13 the license.
4217	4217	14 (2) Revise or render void an order suspending or
4218	4218	15 revoking the license.
4219	4219	16 (b) In cases involving the proposed denial of a license
4220	4220	17 applied for under this Act, the applicant for licensure may
4221	4221	18 not withdraw the applicant's application.
4222	4222	19 Section 305. Civil penalty for certain violations.
4223	4223	20 (a) In addition to any other liability or penalty provided
4224	4224	21 by law, the Department of Agriculture may impose for each
4225	4225	22 violation of a provision of Sections 270 through 310 or a rule
4226	4226	23 adopted under those Sections a civil penalty that does not
4227	4227	24 exceed $500 for each day that the violation occurs.
4228	4228
4229	4229
4230	4230
4231	4231
4232	4232
4233	4233	SB2184 - 119 - LRB104 11945 RLC 22038 b
4234	4234
4235	4235
4236	4236	SB2184- 120 -LRB104 11945 RLC 22038 b SB2184 - 120 - LRB104 11945 RLC 22038 b
4237	4237	SB2184 - 120 - LRB104 11945 RLC 22038 b
4238	4238	1 (b) The Department of Agriculture shall impose civil
4239	4239	2 penalties under this Section in the manner provided by
4240	4240	3 applicable State law.
4241	4241	4 (c) Moneys collected under this Section shall be deposited
4242	4242	5 into the Psilocybin Control and Regulation Fund and are
4243	4243	6 continuously appropriated to the Department for the purpose of
4244	4244	7 carrying out the duties, functions, and powers of the
4245	4245	8 Department under this Act.
4246	4246	9 Section 310. Exemption from criminal liability. A person
4247	4247	10 who holds a license under Section 275, and an employee of or
4248	4248	11 other person who performs work for a person who holds a license
4249	4249	12 under Section 275, is exempt from the criminal laws of this
4250	4250	13 State for possession, delivery, or manufacture of psilocybin,
4251	4251	14 aiding and abetting another in the possession, delivery, or
4252	4252	15 manufacture of psilocybin, or any other criminal offense in
4253	4253	16 which possession, delivery, or manufacture of psilocybin is an
4254	4254	17 element, while performing activities related to testing as
4255	4255	18 described in Sections 270 through this Section.
4256	4256	19 Section 315. Labeling requirements; rules.
4257	4257	20 (a) As is necessary to protect the public health and
4258	4258	21 safety, the Department of Agriculture shall adopt rules
4259	4259	22 establishing standards for the labeling of psilocybin
4260	4260	23 products, including, but not limited to, the following:
4261	4261	24 (1) Ensuring that psilocybin products have labeling
4262	4262
4263	4263
4264	4264
4265	4265
4266	4266
4267	4267	SB2184 - 120 - LRB104 11945 RLC 22038 b
4268	4268
4269	4269
4270	4270	SB2184- 121 -LRB104 11945 RLC 22038 b SB2184 - 121 - LRB104 11945 RLC 22038 b
4271	4271	SB2184 - 121 - LRB104 11945 RLC 22038 b
4272	4272	1 that communicates the following:
4273	4273	2 (A) Health and safety warnings.
4274	4274	3 (B) If applicable, activation time.
4275	4275	4 (C) Potency.
4276	4276	5 (D) If applicable, serving size and the number of
4277	4277	6 servings included in a psilocybin product.
4278	4278	7 (E) Content of the psilocybin product.
4279	4279	8 (2) Labeling that is in accordance with applicable
4280	4280	9 State food labeling requirements for the same type of food
4281	4281	10 product or potable liquid when the food product or potable
4282	4282	11 liquid does not contain psilocybin.
4283	4283	12 (b) In adopting rules under this Act, the Department shall
4284	4284	13 require all psilocybin products sold or transferred by a
4285	4285	14 service center that holds a license issued under Section 95 to
4286	4286	15 be labeled in accordance with subsection (a) and rules adopted
4287	4287	16 under subsection (a).
4288	4288	17 (c) In adopting rules under subsection (a), the
4289	4289	18 Department:
4290	4290	19 (1) may establish different labeling standards for
4291	4291	20 different varieties and types of psilocybin products;
4292	4292	21 (2) shall consider the cost of a potential requirement
4293	4293	22 and how that cost will affect the cost to the ultimate
4294	4294	23 client; and
4295	4295	24 (3) may not adopt rules that are more restrictive than
4296	4296	25 is reasonably necessary to protect the public health and
4297	4297	26 safety.
4298	4298
4299	4299
4300	4300
4301	4301
4302	4302
4303	4303	SB2184 - 121 - LRB104 11945 RLC 22038 b
4304	4304
4305	4305
4306	4306	SB2184- 122 -LRB104 11945 RLC 22038 b SB2184 - 122 - LRB104 11945 RLC 22038 b
4307	4307	SB2184 - 122 - LRB104 11945 RLC 22038 b
4308	4308	1 Section 320. Preapproval of labels.
4309	4309	2 (a) The Department of Agriculture may by rule require a
4310	4310	3 licensee to submit a label intended for use on a psilocybin
4311	4311	4 product for preapproval by the Department before the licensee
4312	4312	5 may sell or transfer a psilocybin product bearing the label.
4313	4313	6 The Department shall determine whether a label submitted under
4314	4314	7 this Section complies with Section 315 and any rule adopted
4315	4315	8 under Section 315.
4316	4316	9 (b) The Department of Agriculture may impose a fee for
4317	4317	10 submitting a label for preapproval under this Section that is
4318	4318	11 reasonably calculated to not exceed the cost of administering
4319	4319	12 this Section.
4320	4320	13 Section 325. Packaging requirements; rules.
4321	4321	14 (a) As is necessary to protect the public health and
4322	4322	15 safety, the Department of Agriculture shall adopt rules
4323	4323	16 establishing standards for the packaging of psilocybin
4324	4324	17 products, including, but not limited to, ensuring that
4325	4325	18 psilocybin products are not marketed in a manner that is
4326	4326	19 either untruthful or misleading, or otherwise creates a
4327	4327	20 significant risk of harm to public health and safety.
4328	4328	21 (b) In adopting rules under this Act, the Department shall
4329	4329	22 require all psilocybin products sold or transferred by a
4330	4330	23 service center that holds a license issued under Section 95 to
4331	4331	24 be packaged in accordance with subsection (a) and rules
4332	4332
4333	4333
4334	4334
4335	4335
4336	4336
4337	4337	SB2184 - 122 - LRB104 11945 RLC 22038 b
4338	4338
4339	4339
4340	4340	SB2184- 123 -LRB104 11945 RLC 22038 b SB2184 - 123 - LRB104 11945 RLC 22038 b
4341	4341	SB2184 - 123 - LRB104 11945 RLC 22038 b
4342	4342	1 adopted under subsection (a).
4343	4343	2 (c) In adopting rules under subsection (a), the
4344	4344	3 Department:
4345	4345	4 (1) may establish different packaging standards for
4346	4346	5 different varieties and types of psilocybin products;
4347	4347	6 (2) may consider the effect on the environment of
4348	4348	7 requiring certain packaging;
4349	4349	8 (3) shall consider the cost of a potential requirement
4350	4350	9 and how that cost will affect the cost to the ultimate
4351	4351	10 client; and
4352	4352	11 (4) may not adopt rules that are more restrictive than
4353	4353	12 is reasonably necessary to protect the public health and
4354	4354	13 safety.
4355	4355	14 Section 330. Preapproval of packaging.
4356	4356	15 (a) The Department of Agriculture may by rule require a
4357	4357	16 licensee to submit packaging intended for a psilocybin product
4358	4358	17 for preapproval by the Department before the licensee may sell
4359	4359	18 or transfer a psilocybin product packaged in the packaging.
4360	4360	19 The Department shall determine whether packaging submitted
4361	4361	20 under this Section complies with Section 325 and any rule
4362	4362	21 adopted under Section 325.
4363	4363	22 (b) The Department of Agriculture may impose a fee for
4364	4364	23 submitting packaging for preapproval under this Section that
4365	4365	24 is reasonably calculated to not exceed the cost of
4366	4366	25 administering this Section.
4367	4367
4368	4368
4369	4369
4370	4370
4371	4371
4372	4372	SB2184 - 123 - LRB104 11945 RLC 22038 b
4373	4373
4374	4374
4375	4375	SB2184- 124 -LRB104 11945 RLC 22038 b SB2184 - 124 - LRB104 11945 RLC 22038 b
4376	4376	SB2184 - 124 - LRB104 11945 RLC 22038 b
4377	4377	1 Section 335. Dosage requirements; rules.
4378	4378	2 (a) The Department of Agriculture shall adopt rules
4379	4379	3 establishing the following:
4380	4380	4 (1) The maximum concentration of psilocybin that is
4381	4381	5 permitted in a single serving of a psilocybin product.
4382	4382	6 (2) The number of servings that are permitted in a
4383	4383	7 psilocybin product package.
4384	4384	8 (b) In adopting rules under this Act, the Department shall
4385	4385	9 require all psilocybin products sold or transferred by a
4386	4386	10 service center that holds a license under Section 95 to meet
4387	4387	11 the concentration standards and packaging standards adopted by
4388	4388	12 rule pursuant to this Section.
4389	4389	13 Section 340. Inspections. To ensure compliance with
4390	4390	14 Sections 315 through 350 and any rule adopted under those
4391	4391	15 Sections, the Department of Agriculture or the Department of
4392	4392	16 Financial and Professional Regulation may inspect the premises
4393	4393	17 of a person that holds a license under Section 80 or 95.
4394	4394	18 Section 341. Violation of tax Acts; refusal, revocation,
4395	4395	19 or suspension of license.
4396	4396	20 (a) In addition to other grounds specified in this Act,
4397	4397	21 the Department of Agriculture and Department of Financial and
4398	4398	22 Professional Regulation, upon notification by the Department
4399	4399	23 of Revenue, shall refuse the issuance or renewal of a license
4400	4400
4401	4401
4402	4402
4403	4403
4404	4404
4405	4405	SB2184 - 124 - LRB104 11945 RLC 22038 b
4406	4406
4407	4407
4408	4408	SB2184- 125 -LRB104 11945 RLC 22038 b SB2184 - 125 - LRB104 11945 RLC 22038 b
4409	4409	SB2184 - 125 - LRB104 11945 RLC 22038 b
4410	4410	1 or suspend or revoke the license of any person, for any of the
4411	4411	2 following violations of any tax Act administered by the
4412	4412	3 Department of Revenue:
4413	4413	4 (1) failure to file a tax return;
4414	4414	5 (2) the filing of a fraudulent return;
4415	4415	6 (3) failure to pay all or part of any tax or penalty
4416	4416	7 finally determined to be due;
4417	4417	8 (4) failure to keep books and records;
4418	4418	9 (5) failure to secure and display a certificate or
4419	4419	10 sub-certificate of registration, if required; or
4420	4420	11 (6) willful violation of any rule or regulation of the
4421	4421	12 Department relating to the administration and enforcement
4422	4422	13 of tax liability.
4423	4423	14 (b) After all violations of any of items (1) through (6) of
4424	4424	15 subsection (a) have been corrected or resolved, the Department
4425	4425	16 shall, upon request of the applicant or, if not requested, may
4426	4426	17 notify the entities listed in subsection (a) that the
4427	4427	18 violations have been corrected or resolved. Upon receiving
4428	4428	19 notice from the Department that a violation of any of items (1)
4429	4429	20 through (6) of subsection (a) have been corrected or otherwise
4430	4430	21 resolved to the Department of Revenue's satisfaction, the
4431	4431	22 Department of Agriculture and the Department of Financial and
4432	4432	23 Professional Regulation may issue or renew the license or
4433	4433	24 vacate an order of suspension or revocation.
4434	4434	25 Section 345. Discipline of licensees. Subject to
4435	4435
4436	4436
4437	4437
4438	4438
4439	4439
4440	4440	SB2184 - 125 - LRB104 11945 RLC 22038 b
4441	4441
4442	4442
4443	4443	SB2184- 126 -LRB104 11945 RLC 22038 b SB2184 - 126 - LRB104 11945 RLC 22038 b
4444	4444	SB2184 - 126 - LRB104 11945 RLC 22038 b
4445	4445	1 applicable provisions of law, if an applicant or licensee
4446	4446	2 violates a provision of Sections 315 through 350 or a rule
4447	4447	3 adopted under those Sections, the Department of Agriculture or
4448	4448	4 the Department of Financial and Professional Regulation may
4449	4449	5 refuse to issue or renew, or may suspend or revoke, a license
4450	4450	6 issued under Section 80, 95, or 105.
4451	4451	7 Section 350. Civil penalties.
4452	4452	8 (a) In addition to any other liability or penalty provided
4453	4453	9 by law, the Department of Agriculture may impose for each
4454	4454	10 violation of a provision of Sections 315 through 350 or a rule
4455	4455	11 adopted under those Sections, a civil penalty that does not
4456	4456	12 exceed $500 for each day that the violation occurs.
4457	4457	13 (b) The Department of Agriculture shall impose civil
4458	4458	14 penalties under this Section in the manner provided under
4459	4459	15 applicable State law.
4460	4460	16 (c) Moneys collected under this Section shall be deposited
4461	4461	17 into the Psilocybin Control and Regulation Fund and are
4462	4462	18 continuously appropriated to the Department for the purpose of
4463	4463	19 carrying out the duties, functions, and powers of the
4464	4464	20 Department under this Act.
4465	4465	21 Section 355. Definitions. In this Section through Section
4466	4466	22 425:
4467	4467	23 "Psilocybin retailer" means a service center operator that
4468	4468	24 sells psilocybin for use and not for resale.
4469	4469
4470	4470
4471	4471
4472	4472
4473	4473
4474	4474	SB2184 - 126 - LRB104 11945 RLC 22038 b
4475	4475
4476	4476
4477	4477	SB2184- 127 -LRB104 11945 RLC 22038 b SB2184 - 127 - LRB104 11945 RLC 22038 b
4478	4478	SB2184 - 127 - LRB104 11945 RLC 22038 b
4479	4479	1 "Retail sale" means any transfer or exchange of a
4480	4480	2 psilocybin product by any person to a client.
4481	4481	3 "Retail sales price" means the price paid for a psilocybin
4482	4482	4 product, excluding tax, to a service center operator by or on
4483	4483	5 behalf of a client.
4484	4484	6 Section 360. Tax imposed.
4485	4485	7 (a) Beginning January 1, 2026, a tax is imposed upon
4486	4486	8 purchasers for the privilege of using psilocybin at a rate of
4487	4487	9 15% of the purchase price.
4488	4488	10 (b) The purchase of any product that contains any amount
4489	4489	11 of psilocybin or any derivative thereof is subject to the tax
4490	4490	12 under subsection (a) on the full purchase price of the
4491	4491	13 product.
4492	4492	14 (c) The tax imposed by this Section is not imposed with
4493	4493	15 respect to any transaction in interstate commerce, to the
4494	4494	16 extent the transaction may not, under the Constitution and
4495	4495	17 statutes of the United States, be made the subject of taxation
4496	4496	18 by this State.
4497	4497	19 (d) The tax imposed under this Act shall be in addition to
4498	4498	20 all other occupation, privilege, or excise taxes imposed by
4499	4499	21 the State or by any municipal corporation or political
4500	4500	22 subdivision thereof.
4501	4501	23 (e) The tax imposed under this Act shall not be imposed on
4502	4502	24 any purchase by a purchaser if the psilocybin retailer is
4503	4503	25 prohibited by federal or State Constitution, treaty,
4504	4504
4505	4505
4506	4506
4507	4507
4508	4508
4509	4509	SB2184 - 127 - LRB104 11945 RLC 22038 b
4510	4510
4511	4511
4512	4512	SB2184- 128 -LRB104 11945 RLC 22038 b SB2184 - 128 - LRB104 11945 RLC 22038 b
4513	4513	SB2184 - 128 - LRB104 11945 RLC 22038 b
4514	4514	1 convention, statute, or court decision from collecting the tax
4515	4515	2 from the purchaser.
4516	4516	3 Section 365. Bundling of taxable and nontaxable items;
4517	4517	4 prohibition; taxation. If a psilocybin retailer sells
4518	4518	5 psilocybin or psilocybin-infused products in combination or
4519	4519	6 bundled with items that are not subject to tax under this Act
4520	4520	7 for one price, then the tax under this Act is imposed on the
4521	4521	8 purchase price of the entire bundled product.
4522	4522	9 Section 370. Collection of tax.
4523	4523	10 (a) The tax imposed by this Act shall be collected from the
4524	4524	11 purchaser by the psilocybin retailer at the rate stated in
4525	4525	12 Section 360 with respect to psilocybin sold by the psilocybin
4526	4526	13 retailer to the purchaser, and shall be remitted to the
4527	4527	14 Department as provided in Section 385. Psilocybin retailers
4528	4528	15 shall collect the tax from purchasers by adding the tax to the
4529	4529	16 amount of the purchase price received from the purchaser for
4530	4530	17 selling psilocybin to the purchaser. The tax imposed by this
4531	4531	18 Act shall, when collected, be stated as a distinct item
4532	4532	19 separate and apart from the purchase price of the psilocybin.
4533	4533	20 (b) If a psilocybin retailer collects the tax imposed
4534	4534	21 pursuant to Section 360 measured by a purchase price that is
4535	4535	22 not subject to Section 360, or if a psilocybin retailer, in
4536	4536	23 collecting the tax pursuant to Section 360 measured by a
4537	4537	24 purchase price that is subject to tax under this Act, collects
4538	4538
4539	4539
4540	4540
4541	4541
4542	4542
4543	4543	SB2184 - 128 - LRB104 11945 RLC 22038 b
4544	4544
4545	4545
4546	4546	SB2184- 129 -LRB104 11945 RLC 22038 b SB2184 - 129 - LRB104 11945 RLC 22038 b
4547	4547	SB2184 - 129 - LRB104 11945 RLC 22038 b
4548	4548	1 more from the purchaser than the required amount on the
4549	4549	2 transaction, the purchaser shall have a legal right to claim a
4550	4550	3 refund of that amount from the psilocybin retailer. If,
4551	4551	4 however, that amount is not refunded to the purchaser for any
4552	4552	5 reason, the psilocybin retailer is liable to pay that amount
4553	4553	6 to the Department.
4554	4554	7 (c) Any person purchasing psilocybin subject to tax under
4555	4555	8 this Act as to which there has been no charge made to the
4556	4556	9 purchaser of the tax imposed by Section 360 shall make payment
4557	4557	10 of the tax imposed by Section 360 in the form and manner
4558	4558	11 provided by the Department not later than the 20th day of the
4559	4559	12 month following the month of purchase of the psilocybin.
4560	4560	13 Section 375. Registration of psilocybin retailers. Every
4561	4561	14 psilocybin retailer required to collect the tax under this Act
4562	4562	15 shall apply to the Department for a certificate of
4563	4563	16 registration under this Act. All applications for registration
4564	4564	17 under this Act shall be made by electronic means in the form
4565	4565	18 and manner required by the Department. For that purpose, the
4566	4566	19 provisions of Section 2a of the Retailers' Occupation Tax Act
4567	4567	20 are incorporated into this Act to the extent not inconsistent
4568	4568	21 with this Act. In addition, no certificate of registration
4569	4569	22 shall be issued under this Act unless the applicant is
4570	4570	23 licensed under this Act.
4571	4571	24 Section 380. Tax collected as debt owed to the State. Any
4572	4572
4573	4573
4574	4574
4575	4575
4576	4576
4577	4577	SB2184 - 129 - LRB104 11945 RLC 22038 b
4578	4578
4579	4579
4580	4580	SB2184- 130 -LRB104 11945 RLC 22038 b SB2184 - 130 - LRB104 11945 RLC 22038 b
4581	4581	SB2184 - 130 - LRB104 11945 RLC 22038 b
4582	4582	1 psilocybin retailer required to collect the tax imposed by
4583	4583	2 this Act shall be liable to the Department for the tax, whether
4584	4584	3 or not the tax has been collected by the psilocybin retailer,
4585	4585	4 and any such tax shall constitute a debt owed by the psilocybin
4586	4586	5 retailer to this State. To the extent that a psilocybin
4587	4587	6 retailer required to collect the tax imposed by this Act has
4588	4588	7 actually collected that tax, the tax is held in trust for the
4589	4589	8 benefit of the Department.
4590	4590	9 Section 385. Return and payment of tax by the psilocybin
4591	4591	10 retailer. Each psilocybin retailer that is required or
4592	4592	11 authorized to collect the tax imposed by this Act shall make a
4593	4593	12 return to the Department, by electronic means, on or before
4594	4594	13 the 20th day of each month for the preceding calendar month
4595	4595	14 stating the following:
4596	4596	15 (1) the psilocybin retailer's name;
4597	4597	16 (2) the address of the psilocybin retailer's principal
4598	4598	17 place of business and the address of the principal place
4599	4599	18 of business (if that is a different address) from which
4600	4600	19 the psilocybin retailer engaged in the business of selling
4601	4601	20 psilocybin subject to tax under this Act;
4602	4602	21 (3) the total purchase price received by the
4603	4603	22 psilocybin retailer for psilocybin subject to tax under
4604	4604	23 this Act;
4605	4605	24 (4) the amount of tax due at each rate;
4606	4606	25 (5) the signature of the psilocybin retailer; and
4607	4607
4608	4608
4609	4609
4610	4610
4611	4611
4612	4612	SB2184 - 130 - LRB104 11945 RLC 22038 b
4613	4613
4614	4614
4615	4615	SB2184- 131 -LRB104 11945 RLC 22038 b SB2184 - 131 - LRB104 11945 RLC 22038 b
4616	4616	SB2184 - 131 - LRB104 11945 RLC 22038 b
4617	4617	1 (6) any other information as the Department may
4618	4618	2 reasonably require.
4619	4619	3 All returns required to be filed and payments required to
4620	4620	4 be made under this Act shall be by electronic means.
4621	4621	5 Psilocybin retailers who demonstrate hardship in paying
4622	4622	6 electronically may petition the Department to waive the
4623	4623	7 electronic payment requirement.
4624	4624	8 Any amount that is required to be shown or reported on any
4625	4625	9 return or other document under this Act shall, if the amount is
4626	4626	10 not a whole-dollar amount, be increased to the nearest
4627	4627	11 whole-dollar amount if the fractional part of a dollar is
4628	4628	12 $0.50 or more and decreased to the nearest whole-dollar amount
4629	4629	13 if the fractional part of a dollar is less than $0.50. If a
4630	4630	14 total amount of less than $1 is payable, refundable, or
4631	4631	15 creditable, the amount shall be disregarded if it is less than
4632	4632	16 $0.50 and shall be increased to $1 if it is $0.50 or more.
4633	4633	17 The psilocybin retailer making the return provided for in
4634	4634	18 this Section shall also pay to the Department, in accordance
4635	4635	19 with this Section, the amount of tax imposed by this Act, less
4636	4636	20 a discount of 2% per return period, which is allowed to
4637	4637	21 reimburse the psilocybin retailer for the expenses incurred in
4638	4638	22 keeping records, collecting tax, preparing and filing returns,
4639	4639	23 remitting the tax, and supplying data to the Department upon
4640	4640	24 request. No discount may be claimed by a psilocybin retailer
4641	4641	25 on returns not timely filed and for taxes not timely remitted.
4642	4642	26 No discount may be claimed by a taxpayer for any return that is
4643	4643
4644	4644
4645	4645
4646	4646
4647	4647
4648	4648	SB2184 - 131 - LRB104 11945 RLC 22038 b
4649	4649
4650	4650
4651	4651	SB2184- 132 -LRB104 11945 RLC 22038 b SB2184 - 132 - LRB104 11945 RLC 22038 b
4652	4652	SB2184 - 132 - LRB104 11945 RLC 22038 b
4653	4653	1 not filed electronically. No discount may be claimed by a
4654	4654	2 taxpayer for any payment that is not made electronically,
4655	4655	3 unless a waiver has been granted under this Section.
4656	4656	4 Notwithstanding any other provision of this Act concerning
4657	4657	5 the time within which a psilocybin retailer may file a return,
4658	4658	6 any such psilocybin retailer who ceases to engage in the kind
4659	4659	7 of business that makes the person responsible for filing
4660	4660	8 returns under this Act shall file a final return under this Act
4661	4661	9 with the Department within one month after discontinuing the
4662	4662	10 business.
4663	4663	11 Each psilocybin retailer shall make estimated payments to
4664	4664	12 the Department on or before the 7th, 15th, 22nd, and last day
4665	4665	13 of the month during which tax liability to the Department is
4666	4666	14 incurred. The payments shall be in an amount not less than the
4667	4667	15 lower of either 22.5% of the psilocybin retailer's actual tax
4668	4668	16 liability for the month or 25% of the psilocybin retailer's
4669	4669	17 actual tax liability for the same calendar month of the
4670	4670	18 preceding year. The amount of the quarter-monthly payments
4671	4671	19 shall be credited against the final tax liability of the
4672	4672	20 psilocybin retailer's return for that month. If any such
4673	4673	21 quarter-monthly payment is not paid at the time or in the
4674	4674	22 amount required by this Section, then the psilocybin retailer
4675	4675	23 shall be liable for penalties and interest on the difference
4676	4676	24 between the minimum amount due as a payment and the amount of
4677	4677	25 the quarter-monthly payment actually and timely paid, except
4678	4678	26 insofar as the psilocybin retailer has previously made
4679	4679
4680	4680
4681	4681
4682	4682
4683	4683
4684	4684	SB2184 - 132 - LRB104 11945 RLC 22038 b
4685	4685
4686	4686
4687	4687	SB2184- 133 -LRB104 11945 RLC 22038 b SB2184 - 133 - LRB104 11945 RLC 22038 b
4688	4688	SB2184 - 133 - LRB104 11945 RLC 22038 b
4689	4689	1 payments for that month to the Department in excess of the
4690	4690	2 minimum payments previously due as provided in this Section.
4691	4691	3 If any payment provided for in this Section exceeds the
4692	4692	4 taxpayer's liabilities under this Act, as shown on an original
4693	4693	5 monthly return, the Department shall, if requested by the
4694	4694	6 taxpayer, issue to the taxpayer a credit memorandum no later
4695	4695	7 than 30 days after the date of payment. The credit evidenced by
4696	4696	8 the credit memorandum may be assigned by the taxpayer to a
4697	4697	9 similar taxpayer under this Act, in accordance with reasonable
4698	4698	10 rules to be prescribed by the Department. If no such request is
4699	4699	11 made, the taxpayer may credit the excess payment against tax
4700	4700	12 liability subsequently to be remitted to the Department under
4701	4701	13 this Act, in accordance with reasonable rules prescribed by
4702	4702	14 the Department. If the Department subsequently determines that
4703	4703	15 all or any part of the credit taken was not actually due to the
4704	4704	16 taxpayer, the taxpayer's discount shall be reduced, if
4705	4705	17 necessary, to reflect the difference between the credit taken
4706	4706	18 and that actually due, and that taxpayer shall be liable for
4707	4707	19 penalties and interest on the difference. If a psilocybin
4708	4708	20 retailer fails to sign a return within 30 days after the proper
4709	4709	21 notice and demand for signature by the Department is received
4710	4710	22 by the psilocybin retailer, the return shall be considered
4711	4711	23 valid and any amount shown to be due on the return shall be
4712	4712	24 deemed assessed.
4713	4713	25 Section 390. Deposit of proceeds. All moneys received by
4714	4714
4715	4715
4716	4716
4717	4717
4718	4718
4719	4719	SB2184 - 133 - LRB104 11945 RLC 22038 b
4720	4720
4721	4721
4722	4722	SB2184- 134 -LRB104 11945 RLC 22038 b SB2184 - 134 - LRB104 11945 RLC 22038 b
4723	4723	SB2184 - 134 - LRB104 11945 RLC 22038 b
4724	4724	1 the Department under this Act shall be paid into the Illinois
4725	4725	2 Psilocybin Fund.
4726	4726	3 Section 395. Recordkeeping; books and records.
4727	4727	4 (a) Every retailer of psilocybin, whether or not the
4728	4728	5 retailer has obtained a certificate of registration under
4729	4729	6 Section 375, shall keep complete and accurate records of
4730	4730	7 psilocybin held, purchased, sold, or otherwise disposed of,
4731	4731	8 and shall preserve and keep all invoices, bills of lading,
4732	4732	9 sales records, and copies of bills of sale, returns, and other
4733	4733	10 pertinent papers and documents relating to the purchase, sale,
4734	4734	11 or disposition of psilocybin. Such records need not be
4735	4735	12 maintained on the licensed premises but must be maintained in
4736	4736	13 the State. However, all original invoices or copies thereof
4737	4737	14 covering purchases of psilocybin must be retained on the
4738	4738	15 licensed premises for a period of 90 days after such purchase,
4739	4739	16 unless the Department has granted a waiver in response to a
4740	4740	17 written request in cases where records are kept at a central
4741	4741	18 business location within the State. The Department shall adopt
4742	4742	19 rules regarding the eligibility for a waiver, revocation of a
4743	4743	20 waiver, and requirements and standards for maintenance and
4744	4744	21 accessibility of records located at a central location under a
4745	4745	22 waiver provided under this Section.
4746	4746	23 (b) Books, records, papers, and documents that are
4747	4747	24 required by this Act to be kept shall, at all times during the
4748	4748	25 usual business hours of the day, be subject to inspection by
4749	4749
4750	4750
4751	4751
4752	4752
4753	4753
4754	4754	SB2184 - 134 - LRB104 11945 RLC 22038 b
4755	4755
4756	4756
4757	4757	SB2184- 135 -LRB104 11945 RLC 22038 b SB2184 - 135 - LRB104 11945 RLC 22038 b
4758	4758	SB2184 - 135 - LRB104 11945 RLC 22038 b
4759	4759	1 the Department or its duly authorized agents and employees.
4760	4760	2 The books, records, papers, and documents for any period with
4761	4761	3 respect to which the Department is authorized to issue a
4762	4762	4 notice of tax liability shall be preserved until the
4763	4763	5 expiration of that period.
4764	4764	6 Section 400. Violations and penalties.
4765	4765	7 (a) When the amount due is under $300, any retailer of
4766	4766	8 psilocybin who fails to file a return, willfully fails or
4767	4767	9 refuses to make any payment to the Department of the tax
4768	4768	10 imposed by this Act, or files a fraudulent return, or any
4769	4769	11 officer or agent of a corporation engaged in the business of
4770	4770	12 selling psilocybin to purchasers located in this State who
4771	4771	13 signs a fraudulent return filed on behalf of the corporation,
4772	4772	14 or any accountant or other agent who knowingly enters false
4773	4773	15 information on the return of any taxpayer under this Act is
4774	4774	16 guilty of a Class 4 felony.
4775	4775	17 (b) When the amount due is $300 or more, any retailer of
4776	4776	18 psilocybin who files, or causes to be filed, a fraudulent
4777	4777	19 return, or any officer or agent of a corporation engaged in the
4778	4778	20 business of selling psilocybin to purchasers located in this
4779	4779	21 State who files or causes to be filed or signs or causes to be
4780	4780	22 signed a fraudulent return filed on behalf of the corporation,
4781	4781	23 or any accountant or other agent who knowingly enters false
4782	4782	24 information on the return of any taxpayer under this Act is
4783	4783	25 guilty of a Class 3 felony.
4784	4784
4785	4785
4786	4786
4787	4787
4788	4788
4789	4789	SB2184 - 135 - LRB104 11945 RLC 22038 b
4790	4790
4791	4791
4792	4792	SB2184- 136 -LRB104 11945 RLC 22038 b SB2184 - 136 - LRB104 11945 RLC 22038 b
4793	4793	SB2184 - 136 - LRB104 11945 RLC 22038 b
4794	4794	1 (c) Any person who violates any provision of Section 375,
4795	4795	2 fails to keep books and records as required under this Act, or
4796	4796	3 willfully violates a rule of the Department for the
4797	4797	4 administration and enforcement of this Act is guilty of a
4798	4798	5 Class 4 felony. A person commits a separate offense on each day
4799	4799	6 that he or she engages in business in violation of Section 375
4800	4800	7 or a rule of the Department for the administration and
4801	4801	8 enforcement of this Article. If a person fails to produce the
4802	4802	9 books and records for inspection by the Department upon
4803	4803	10 request, a prima facie presumption shall arise that the person
4804	4804	11 has failed to keep books and records as required under this
4805	4805	12 Act. A person who is unable to rebut this presumption is in
4806	4806	13 violation of this Act and is subject to the penalties provided
4807	4807	14 in this Section.
4808	4808	15 (d) Any person who violates any provision of Sections 375,
4809	4809	16 fails to keep books and records as required under this Act, or
4810	4810	17 willfully violates a rule of the Department for the
4811	4811	18 administration and enforcement of this Act, is guilty of a
4812	4812	19 business offense and may be fined up to $5,000. If a person
4813	4813	20 fails to produce books and records for inspection by the
4814	4814	21 Department upon request, a prima facie presumption shall arise
4815	4815	22 that the person has failed to keep books and records as
4816	4816	23 required under this Act. A person who is unable to rebut this
4817	4817	24 presumption is in violation of this Act and is subject to the
4818	4818	25 penalties provided in this Section. A person commits a
4819	4819	26 separate offense on each day that he or she engages in business
4820	4820
4821	4821
4822	4822
4823	4823
4824	4824
4825	4825	SB2184 - 136 - LRB104 11945 RLC 22038 b
4826	4826
4827	4827
4828	4828	SB2184- 137 -LRB104 11945 RLC 22038 b SB2184 - 137 - LRB104 11945 RLC 22038 b
4829	4829	SB2184 - 137 - LRB104 11945 RLC 22038 b
4830	4830	1 in violation of Section 375.
4831	4831	2 (e) Any taxpayer or agent of a taxpayer who with the intent
4832	4832	3 to defraud purports to make a payment due to the Department by
4833	4833	4 issuing or delivering a check or other order upon a real or
4834	4834	5 fictitious depository for the payment of money, knowing that
4835	4835	6 it will not be paid by the depository, is guilty of a deceptive
4836	4836	7 practice in violation of Section 17-1 of the Criminal Code of
4837	4837	8 2012.
4838	4838	9 (f) Any person who fails to keep books and records or fails
4839	4839	10 to produce books and records for inspection, as required by
4840	4840	11 Section 65-36, is liable to pay to the Department, for deposit
4841	4841	12 in the Tax Compliance and Administration Fund, a penalty of
4842	4842	13 $1,000 for the first failure to keep books and records or
4843	4843	14 failure to produce books and records for inspection, as
4844	4844	15 required by Section 65-36, and $3,000 for each subsequent
4845	4845	16 failure to keep books and records or failure to produce books
4846	4846	17 and records for inspection, as required by Section 395.
4847	4847	18 (g) Any person who knowingly acts as a retailer of
4848	4848	19 psilocybin in this State without first having obtained a
4849	4849	20 certificate of registration to do so in compliance with this
4850	4850	21 Act shall be guilty of a Class 4 felony.
4851	4851	22 (h) A person commits the offense of tax evasion under this
4852	4852	23 Act when the person knowingly attempts in any manner to evade
4853	4853	24 or defeat the tax imposed on the person or on any other person,
4854	4854	25 or the payment thereof, and the person commits an affirmative
4855	4855	26 act in furtherance of the evasion. As used in this Section,
4856	4856
4857	4857
4858	4858
4859	4859
4860	4860
4861	4861	SB2184 - 137 - LRB104 11945 RLC 22038 b
4862	4862
4863	4863
4864	4864	SB2184- 138 -LRB104 11945 RLC 22038 b SB2184 - 138 - LRB104 11945 RLC 22038 b
4865	4865	SB2184 - 138 - LRB104 11945 RLC 22038 b
4866	4866	1 "affirmative act in furtherance of the evasion" means an act
4867	4867	2 designed in whole or in part to (i) conceal, misrepresent,
4868	4868	3 falsify, or manipulate any material fact or (ii) tamper with
4869	4869	4 or destroy documents or materials related to a person's tax
4870	4870	5 liability under this Act. Two or more acts of sales tax evasion
4871	4871	6 may be charged as a single count in any indictment,
4872	4872	7 information, or complaint and the amount of tax deficiency may
4873	4873	8 be aggregated for purposes of determining the amount of tax
4874	4874	9 that is attempted to be or is evaded and the period between the
4875	4875	10 first and last acts may be alleged as the date of the offense.
4876	4876	11 (1) When the amount of tax, the assessment or payment
4877	4877	12 of which is attempted to be or is evaded is less than $500,
4878	4878	13 a person is guilty of a Class 4 felony.
4879	4879	14 (2) When the amount of tax, the assessment or payment
4880	4880	15 of which is attempted to be or is evaded is $500 or more
4881	4881	16 but less than $10,000, a person is guilty of a Class 3
4882	4882	17 felony.
4883	4883	18 (3) When the amount of tax, the assessment or payment
4884	4884	19 of which is attempted to be or is evaded is $10,000 or more
4885	4885	20 but less than $100,000, a person is guilty of a Class 2
4886	4886	21 felony.
4887	4887	22 (4) When the amount of tax, the assessment or payment
4888	4888	23 of which is attempted to be or is evaded is $100,000 or
4889	4889	24 more, a person is guilty of a Class 1 felony.
4890	4890	25 Any person who knowingly sells, purchases, installs,
4891	4891	26 transfers, possesses, uses, or accesses any automated sales
4892	4892
4893	4893
4894	4894
4895	4895
4896	4896
4897	4897	SB2184 - 138 - LRB104 11945 RLC 22038 b
4898	4898
4899	4899
4900	4900	SB2184- 139 -LRB104 11945 RLC 22038 b SB2184 - 139 - LRB104 11945 RLC 22038 b
4901	4901	SB2184 - 139 - LRB104 11945 RLC 22038 b
4902	4902	1 suppression device, zapper, or phantom-ware in this State is
4903	4903	2 guilty of a Class 3 felony.
4904	4904	3 As used in this Section:
4905	4905	4 "Automated sales suppression device" or "zapper" means a
4906	4906	5 software program that falsifies the electronic records of an
4907	4907	6 electronic cash register or other point-of-sale system,
4908	4908	7 including, but not limited to, transaction data and
4909	4909	8 transaction reports. "Automated sales suppression device" or
4910	4910	9 "zapper" includes the software program, any device that
4911	4911	10 carries the software program, or an Internet link to the
4912	4912	11 software program.
4913	4913	12 "Electronic cash register" means a device that keeps a
4914	4914	13 register or supporting documents through the use of an
4915	4915	14 electronic device or computer system designed to record
4916	4916	15 transaction data for the purpose of computing, compiling, or
4917	4917	16 processing retail sales transaction data in any manner.
4918	4918	17 "Phantom-ware" means a hidden programming option embedded
4919	4919	18 in the operating system of an electronic cash register or
4920	4920	19 hardwired into an electronic cash register that can be used to
4921	4921	20 create a second set of records or that can eliminate or
4922	4922	21 manipulate transaction records in an electronic cash register.
4923	4923	22 "Transaction data" includes: items purchased by a
4924	4924	23 purchaser; the price of each item; a taxability determination
4925	4925	24 for each item; a segregated tax amount for each taxed item; the
4926	4926	25 amount of cash or credit tendered; the net amount returned to
4927	4927	26 the customer in change; the date and time of the purchase; the
4928	4928
4929	4929
4930	4930
4931	4931
4932	4932
4933	4933	SB2184 - 139 - LRB104 11945 RLC 22038 b
4934	4934
4935	4935
4936	4936	SB2184- 140 -LRB104 11945 RLC 22038 b SB2184 - 140 - LRB104 11945 RLC 22038 b
4937	4937	SB2184 - 140 - LRB104 11945 RLC 22038 b
4938	4938	1 name, address, and identification number of the vendor; and
4939	4939	2 the receipt or invoice number of the transaction.
4940	4940	3 "Transaction report" means a report that documents,
4941	4941	4 without limitation, the sales, taxes, or fees collected, media
4942	4942	5 totals, and discount voids at an electronic cash register and
4943	4943	6 that is printed on a cash register tape at the end of a day or
4944	4944	7 shift, or a report that documents every action at an
4945	4945	8 electronic cash register and is stored electronically.
4946	4946	9 A prosecution for any act in violation of this Section may
4947	4947	10 be commenced at any time within 5 years of the commission of
4948	4948	11 that act.
4949	4949	12 (i) The Department may adopt rules to administer the
4950	4950	13 penalties under this Section.
4951	4951	14 (j) Any person whose principal place of business is in
4952	4952	15 this State and who is charged with a violation under this
4953	4953	16 Section shall be tried in the county where his or her principal
4954	4954	17 place of business is located unless he or she asserts a right
4955	4955	18 to be tried in another venue.
4956	4956	19 (k) Except as otherwise provided in subsection (h), a
4957	4957	20 prosecution for a violation described in this Section may be
4958	4958	21 commenced within 3 years after the commission of the act
4959	4959	22 constituting the violation.
4960	4960	23 Section 405. Arrest; search and seizure without warrant.
4961	4961	24 Any duly authorized employee of the Department: (i) may arrest
4962	4962	25 without warrant any person committing in the employee's
4963	4963
4964	4964
4965	4965
4966	4966
4967	4967
4968	4968	SB2184 - 140 - LRB104 11945 RLC 22038 b
4969	4969
4970	4970
4971	4971	SB2184- 141 -LRB104 11945 RLC 22038 b SB2184 - 141 - LRB104 11945 RLC 22038 b
4972	4972	SB2184 - 141 - LRB104 11945 RLC 22038 b
4973	4973	1 presence a violation of any of the provisions of this Act; (ii)
4974	4974	2 may without a search warrant inspect all psilocybin located in
4975	4975	3 any place of business; (iii) may seize any psilocybin in the
4976	4976	4 possession of the retailer in violation of this Act; and (iv)
4977	4977	5 may seize any psilocybin on which the tax imposed by this Act
4978	4978	6 has not been paid. The psilocybin seized is subject to
4979	4979	7 confiscation and forfeiture as provided in Sections 415 and
4980	4980	8 416.
4981	4981	9 Section 410. Seizure and forfeiture. After seizing any
4982	4982	10 psilocybin as provided in this Act, the Department must hold a
4983	4983	11 hearing and determine whether the retailer was properly
4984	4984	12 registered to sell the psilocybin at the time of its seizure by
4985	4985	13 the Department. The Department shall give not less than 20
4986	4986	14 days' notice of the time and place of the hearing to the owner
4987	4987	15 of the psilocybin, if the owner is known, and also to the
4988	4988	16 person in whose possession the psilocybin was found, if that
4989	4989	17 person is known and if the person in possession is not the
4990	4990	18 owner of the psilocybin. If neither the owner nor the person in
4991	4991	19 possession of the psilocybin is known, the Department must
4992	4992	20 cause publication of the time and place of the hearing to be
4993	4993	21 made at least once in each week for 3 weeks successively in a
4994	4994	22 newspaper of general circulation in the county where the
4995	4995	23 hearing is to be held.
4996	4996	24 If, as the result of the hearing, the Department
4997	4997	25 determines that the retailer was not properly registered at
4998	4998
4999	4999
5000	5000
5001	5001
5002	5002
5003	5003	SB2184 - 141 - LRB104 11945 RLC 22038 b
5004	5004
5005	5005
5006	5006	SB2184- 142 -LRB104 11945 RLC 22038 b SB2184 - 142 - LRB104 11945 RLC 22038 b
5007	5007	SB2184 - 142 - LRB104 11945 RLC 22038 b
5008	5008	1 the time the psilocybin was seized, the Department must enter
5009	5009	2 an order declaring the psilocybin confiscated and forfeited to
5010	5010	3 the State, to be held by the Department for disposal by it as
5011	5011	4 provided in Section 416. The Department must give notice of
5012	5012	5 the order to the owner of the psilocybin, if the owner is
5013	5013	6 known, and also to the person in whose possession the
5014	5014	7 psilocybin was found, if that person is known and if the person
5015	5015	8 in possession is not the owner of the psilocybin. If neither
5016	5016	9 the owner nor the person in possession of the psilocybin is
5017	5017	10 known, the Department must cause publication of the order to
5018	5018	11 be made at least once in each week for 3 weeks successively in
5019	5019	12 a newspaper of general circulation in the county where the
5020	5020	13 hearing was held.
5021	5021	14 Section 415. Search warrant; issuance and return; process;
5022	5022	15 confiscation of psilocybin; forfeitures.
5023	5023	16 (a) If a peace officer of this State or any duly authorized
5024	5024	17 officer or employee of the Department has reason to believe
5025	5025	18 that any violation of this Act or a rule of the Department for
5026	5026	19 the administration and enforcement of this Act has occurred
5027	5027	20 and that the person violating this Act or rule has in that
5028	5028	21 person's possession any psilocybin in violation of this Act or
5029	5029	22 a rule of the Department for the administration and
5030	5030	23 enforcement of this Act, that peace officer, or officer or
5031	5031	24 employee of the Department, may file or cause to be filed his
5032	5032	25 or her complaint in writing, verified by affidavit, with any
5033	5033
5034	5034
5035	5035
5036	5036
5037	5037
5038	5038	SB2184 - 142 - LRB104 11945 RLC 22038 b
5039	5039
5040	5040
5041	5041	SB2184- 143 -LRB104 11945 RLC 22038 b SB2184 - 143 - LRB104 11945 RLC 22038 b
5042	5042	SB2184 - 143 - LRB104 11945 RLC 22038 b
5043	5043	1 court within whose jurisdiction the premises to be searched
5044	5044	2 are situated, stating the facts upon which the belief is
5045	5045	3 founded, the premises to be searched, and the property to be
5046	5046	4 seized, and procure a search warrant and execute that warrant.
5047	5047	5 Upon the execution of the search warrant, the peace officer,
5048	5048	6 or officer or employee of the Department, executing the search
5049	5049	7 warrant shall make due return of the warrant to the court
5050	5050	8 issuing the warrant, together with an inventory of the
5051	5051	9 property taken under the warrant. The court must then issue
5052	5052	10 process against the owner of the property if the owner is
5053	5053	11 known; otherwise, process must be issued against the person in
5054	5054	12 whose possession the property is found, if that person is
5055	5055	13 known. In case of inability to serve process upon the owner or
5056	5056	14 the person in possession of the property at the time of its
5057	5057	15 seizure, notice of the proceedings before the court must be
5058	5058	16 given in the same manner as required by the law governing cases
5059	5059	17 of attachment. Upon the return of the process duly served or
5060	5060	18 upon the posting or publishing of notice made, as appropriate,
5061	5061	19 the court or jury, if a jury is demanded, shall proceed to
5062	5062	20 determine whether the property seized was held or possessed in
5063	5063	21 violation of this Act or a rule of the Department for the
5064	5064	22 administration and enforcement of this Act. If a violation is
5065	5065	23 found, judgment shall be entered confiscating the property and
5066	5066	24 forfeiting it to the State and ordering its delivery to the
5067	5067	25 Department. In addition, the court may tax and assess the
5068	5068	26 costs of the proceedings.
5069	5069
5070	5070
5071	5071
5072	5072
5073	5073
5074	5074	SB2184 - 143 - LRB104 11945 RLC 22038 b
5075	5075
5076	5076
5077	5077	SB2184- 144 -LRB104 11945 RLC 22038 b SB2184 - 144 - LRB104 11945 RLC 22038 b
5078	5078	SB2184 - 144 - LRB104 11945 RLC 22038 b
5079	5079	1 (b) When any psilocybin has been declared forfeited to the
5080	5080	2 State by the Department, as provided in Section III and this
5081	5081	3 Section, and when all proceedings for the judicial review of
5082	5082	4 the Department's decision have terminated, the Department
5083	5083	5 shall, to the extent that its decision is sustained on review,
5084	5084	6 destroy or maintain and use such psilocybin in an undercover
5085	5085	7 capacity.
5086	5086	8 (c) The Department may, before any destruction of
5087	5087	9 psilocybin, permit the true holder of trademark rights in the
5088	5088	10 psilocybin to inspect such psilocybin in order to assist the
5089	5089	11 Department in any investigation regarding such psilocybin.
5090	5090	12 Section 416. Psilocybin retailers; purchase and possession
5091	5091	13 of psilocybin. Psilocybin retailers shall purchase psilocybin
5092	5092	14 for resale only from manufacturers as authorized by this Act.
5093	5093	15 Section 417. Rulemaking. The Department may adopt rules in
5094	5094	16 accordance with the Illinois Administrative Procedure Act and
5095	5095	17 prescribe forms relating to the administration and enforcement
5096	5096	18 of this Act as it deems appropriate.
5097	5097	19 Section 420. Illinois Psilocybin Fund. The Illinois
5098	5098	20 Psilocybin Fund is created as a special fund in the State
5099	5099	21 treasury. The Fund shall consist of moneys transferred to the
5100	5100	22 Fund under Section 425. The Department of Revenue shall
5101	5101	23 certify quarterly the amount of moneys available in the
5102	5102
5103	5103
5104	5104
5105	5105
5106	5106
5107	5107	SB2184 - 144 - LRB104 11945 RLC 22038 b
5108	5108
5109	5109
5110	5110	SB2184- 145 -LRB104 11945 RLC 22038 b SB2184 - 145 - LRB104 11945 RLC 22038 b
5111	5111	SB2184 - 145 - LRB104 11945 RLC 22038 b
5112	5112	1 Illinois Psilocybin Fund. The Department of Revenue shall
5113	5113	2 transfer quarterly the moneys in the Illinois Psilocybin Fund
5114	5114	3 to the Psilocybin Control and Regulation Fund.
5115	5115	4 Section 425. Illinois Psilocybin Fund; payment of
5116	5116	5 expenses. All moneys received by the Department of Revenue
5117	5117	6 under Sections 355 through this Section shall be deposited
5118	5118	7 into the Illinois Psilocybin Fund. The Department of Revenue
5119	5119	8 may pay expenses for the administration and enforcement of
5120	5120	9 Sections 355 through this Section out of moneys received from
5121	5121	10 the tax imposed under Section 360. Amounts necessary to pay
5122	5122	11 administrative and enforcement expenses are continuously
5123	5123	12 appropriated to the Department of Revenue from the Illinois
5124	5124	13 Psilocybin Fund.
5125	5125	14 Section 430. Incorporation by reference. All of the
5126	5126	15 provisions of Sections 4, 5, 5a, 5b, 5c, 5d, 5e, 5f, 5g, 5h,
5127	5127	16 5i, 5j, 6, 6a, 6b, 6c, 8, 9, 10, 11, 11a, and 12 of the
5128	5128	17 Retailers' Occupation Tax Act, and all applicable provisions
5129	5129	18 of the Uniform Penalty and Interest Act that are not
5130	5130	19 inconsistent with this Act, apply to clients, legal entities,
5131	5131	20 licensees, licensee representatives, psilocybin product
5132	5132	21 manufacturers, service centers, service center operators, and
5133	5133	22 facilitators to the same extent as if those provisions were
5134	5134	23 included in this Act. References in the incorporated Sections
5135	5135	24 of the Retailers' Occupation Tax Act to retailers, to sellers,
5136	5136
5137	5137
5138	5138
5139	5139
5140	5140
5141	5141	SB2184 - 145 - LRB104 11945 RLC 22038 b
5142	5142
5143	5143
5144	5144	SB2184- 146 -LRB104 11945 RLC 22038 b SB2184 - 146 - LRB104 11945 RLC 22038 b
5145	5145	SB2184 - 146 - LRB104 11945 RLC 22038 b
5146	5146	1 or to persons engaged in the business of selling tangible
5147	5147	2 personal property mean distributors when used in this Act.
5148	5148	3 References in the incorporated Sections to sales of tangible
5149	5149	4 personal property mean sales of tobacco products when used in
5150	5150	5 this Act.
5151	5151	6 Section 435. Registration under the Retailers' Occupation
5152	5152	7 Tax Act. A retailer maintaining a place of business in this
5153	5153	8 State, if required to register under the Retailers' Occupation
5154	5154	9 Tax Act, need not obtain an additional certificate of
5155	5155	10 registration under this Act, but shall be deemed to be
5156	5156	11 sufficiently registered by virtue of his being registered
5157	5157	12 under the Retailers' Occupation Tax Act. Every retailer
5158	5158	13 maintaining a place of business in this State, if not required
5159	5159	14 to register under the Retailers' Occupation Tax Act, shall
5160	5160	15 apply to the Department of Revenue (upon a form prescribed and
5161	5161	16 furnished by the Department of Revenue) for a certificate of
5162	5162	17 registration under this Act. In completing such application,
5163	5163	18 the applicant shall furnish such information as the Department
5164	5164	19 of Revenue may reasonably require. Upon approval of an
5165	5165	20 application for certificate of registration, the Department of
5166	5166	21 Revenue shall issue, without charge, a certificate of
5167	5167	22 registration to the applicant. Such certificate of
5168	5168	23 registration shall be displayed at the address which the
5169	5169	24 applicant states in his or her application to be the principal
5170	5170	25 place of business or location from which he or she will act as
5171	5171
5172	5172
5173	5173
5174	5174
5175	5175
5176	5176	SB2184 - 146 - LRB104 11945 RLC 22038 b
5177	5177
5178	5178
5179	5179	SB2184- 147 -LRB104 11945 RLC 22038 b SB2184 - 147 - LRB104 11945 RLC 22038 b
5180	5180	SB2184 - 147 - LRB104 11945 RLC 22038 b
5181	5181	1 a retailer in this State. If the applicant will act as a
5182	5182	2 retailer in this State from other places of business or
5183	5183	3 locations, he or she shall list the addresses of such
5184	5184	4 additional places of business or locations in this application
5185	5185	5 for certificate of registration, and the Department of Revenue
5186	5186	6 shall issue a subcertificate of registration to the applicant
5187	5187	7 for each such additional place of business or location. Each
5188	5188	8 subcertificate of registration shall be conspicuously
5189	5189	9 displayed at the place for which it is issued. Such
5190	5190	10 sub-certificate of registration shall bear the same
5191	5191	11 registration number as that appearing upon the certificate of
5192	5192	12 registration to which such subcertificates of registration
5193	5193	13 relate. Where a retailer operates more than one place of
5194	5194	14 business which is subject to registration under this Section
5195	5195	15 and such businesses are substantially different in character
5196	5196	16 or are engaged in under different trade names or are engaged in
5197	5197	17 under other substantially dissimilar circumstances (so that it
5198	5198	18 is more practicable, from an accounting, auditing, or
5199	5199	19 bookkeeping standpoint, for such businesses to be separately
5200	5200	20 registered), the Department of Revenue may require or permit
5201	5201	21 such person to apply for and obtain a separate certificate of
5202	5202	22 registration for each such business or for any of such
5203	5203	23 businesses instead of registering such person, as to all such
5204	5204	24 businesses, under a single certificate of registration
5205	5205	25 supplemented by related subcertificates of registration. No
5206	5206	26 certificate of registration shall be issued to any person who
5207	5207
5208	5208
5209	5209
5210	5210
5211	5211
5212	5212	SB2184 - 147 - LRB104 11945 RLC 22038 b
5213	5213
5214	5214
5215	5215	SB2184- 148 -LRB104 11945 RLC 22038 b SB2184 - 148 - LRB104 11945 RLC 22038 b
5216	5216	SB2184 - 148 - LRB104 11945 RLC 22038 b
5217	5217	1 is in default to the State for moneys due hereunder.
5218	5218	2 The Department of Revenue may, in its discretion, upon
5219	5219	3 application, authorize the collection of the tax herein
5220	5220	4 imposed by any retailer not maintaining a place of business
5221	5221	5 within this State, who, to the satisfaction of the Department
5222	5222	6 of Revenue, furnishes adequate security to insure collection
5223	5223	7 and payment of the tax. Such retailer shall be issued, without
5224	5224	8 charge, a permit to collect such tax. When so authorized, it
5225	5225	9 shall be the duty of such retailer to collect the tax upon all
5226	5226	10 tangible personal property sold to his knowledge for use
5227	5227	11 within this State, in the same manner and subject to the same
5228	5228	12 requirements, including the furnishing of a receipt to the
5229	5229	13 purchaser (if demanded by the purchaser), as a retailer
5230	5230	14 maintaining a place of business within this State. The receipt
5231	5231	15 given to the purchaser shall be sufficient to relieve him or
5232	5232	16 her from further liability for the tax to which such receipt
5233	5233	17 may refer. Such permit may be revoked by the Department as
5234	5234	18 provided herein.
5235	5235	19 Section 440. Severability. The provisions of this Act are
5236	5236	20 severable under Section 1.31 of the Statute on Statutes.
5237	5237	21 Section 900. The Freedom of Information Act is amended by
5238	5238	22 changing Section 7 as follows:
5239	5239	23 (5 ILCS 140/7)
5240	5240
5241	5241
5242	5242
5243	5243
5244	5244
5245	5245	SB2184 - 148 - LRB104 11945 RLC 22038 b
5246	5246
5247	5247
5248	5248	SB2184- 149 -LRB104 11945 RLC 22038 b SB2184 - 149 - LRB104 11945 RLC 22038 b
5249	5249	SB2184 - 149 - LRB104 11945 RLC 22038 b
5250	5250	1 Sec. 7. Exemptions.
5251	5251	2 (1) When a request is made to inspect or copy a public
5252	5252	3 record that contains information that is exempt from
5253	5253	4 disclosure under this Section, but also contains information
5254	5254	5 that is not exempt from disclosure, the public body may elect
5255	5255	6 to redact the information that is exempt. The public body
5256	5256	7 shall make the remaining information available for inspection
5257	5257	8 and copying. Subject to this requirement, the following shall
5258	5258	9 be exempt from inspection and copying:
5259	5259	10 (a) Information specifically prohibited from
5260	5260	11 disclosure by federal or State law or rules and
5261	5261	12 regulations implementing federal or State law.
5262	5262	13 (b) Private information, unless disclosure is required
5263	5263	14 by another provision of this Act, a State or federal law,
5264	5264	15 or a court order.
5265	5265	16 (b-5) Files, documents, and other data or databases
5266	5266	17 maintained by one or more law enforcement agencies and
5267	5267	18 specifically designed to provide information to one or
5268	5268	19 more law enforcement agencies regarding the physical or
5269	5269	20 mental status of one or more individual subjects.
5270	5270	21 (c) Personal information contained within public
5271	5271	22 records, the disclosure of which would constitute a
5272	5272	23 clearly unwarranted invasion of personal privacy, unless
5273	5273	24 the disclosure is consented to in writing by the
5274	5274	25 individual subjects of the information. "Unwarranted
5275	5275	26 invasion of personal privacy" means the disclosure of
5276	5276
5277	5277
5278	5278
5279	5279
5280	5280
5281	5281	SB2184 - 149 - LRB104 11945 RLC 22038 b
5282	5282
5283	5283
5284	5284	SB2184- 150 -LRB104 11945 RLC 22038 b SB2184 - 150 - LRB104 11945 RLC 22038 b
5285	5285	SB2184 - 150 - LRB104 11945 RLC 22038 b
5286	5286	1 information that is highly personal or objectionable to a
5287	5287	2 reasonable person and in which the subject's right to
5288	5288	3 privacy outweighs any legitimate public interest in
5289	5289	4 obtaining the information. The disclosure of information
5290	5290	5 that bears on the public duties of public employees and
5291	5291	6 officials shall not be considered an invasion of personal
5292	5292	7 privacy.
5293	5293	8 (d) Records in the possession of any public body
5294	5294	9 created in the course of administrative enforcement
5295	5295	10 proceedings, and any law enforcement or correctional
5296	5296	11 agency for law enforcement purposes, but only to the
5297	5297	12 extent that disclosure would:
5298	5298	13 (i) interfere with pending or actually and
5299	5299	14 reasonably contemplated law enforcement proceedings
5300	5300	15 conducted by any law enforcement or correctional
5301	5301	16 agency that is the recipient of the request;
5302	5302	17 (ii) interfere with active administrative
5303	5303	18 enforcement proceedings conducted by the public body
5304	5304	19 that is the recipient of the request;
5305	5305	20 (iii) create a substantial likelihood that a
5306	5306	21 person will be deprived of a fair trial or an impartial
5307	5307	22 hearing;
5308	5308	23 (iv) unavoidably disclose the identity of a
5309	5309	24 confidential source, confidential information
5310	5310	25 furnished only by the confidential source, or persons
5311	5311	26 who file complaints with or provide information to
5312	5312
5313	5313
5314	5314
5315	5315
5316	5316
5317	5317	SB2184 - 150 - LRB104 11945 RLC 22038 b
5318	5318
5319	5319
5320	5320	SB2184- 151 -LRB104 11945 RLC 22038 b SB2184 - 151 - LRB104 11945 RLC 22038 b
5321	5321	SB2184 - 151 - LRB104 11945 RLC 22038 b
5322	5322	1 administrative, investigative, law enforcement, or
5323	5323	2 penal agencies; except that the identities of
5324	5324	3 witnesses to traffic crashes, traffic crash reports,
5325	5325	4 and rescue reports shall be provided by agencies of
5326	5326	5 local government, except when disclosure would
5327	5327	6 interfere with an active criminal investigation
5328	5328	7 conducted by the agency that is the recipient of the
5329	5329	8 request;
5330	5330	9 (v) disclose unique or specialized investigative
5331	5331	10 techniques other than those generally used and known
5332	5332	11 or disclose internal documents of correctional
5333	5333	12 agencies related to detection, observation, or
5334	5334	13 investigation of incidents of crime or misconduct, and
5335	5335	14 disclosure would result in demonstrable harm to the
5336	5336	15 agency or public body that is the recipient of the
5337	5337	16 request;
5338	5338	17 (vi) endanger the life or physical safety of law
5339	5339	18 enforcement personnel or any other person; or
5340	5340	19 (vii) obstruct an ongoing criminal investigation
5341	5341	20 by the agency that is the recipient of the request.
5342	5342	21 (d-5) A law enforcement record created for law
5343	5343	22 enforcement purposes and contained in a shared electronic
5344	5344	23 record management system if the law enforcement agency
5345	5345	24 that is the recipient of the request did not create the
5346	5346	25 record, did not participate in or have a role in any of the
5347	5347	26 events which are the subject of the record, and only has
5348	5348
5349	5349
5350	5350
5351	5351
5352	5352
5353	5353	SB2184 - 151 - LRB104 11945 RLC 22038 b
5354	5354
5355	5355
5356	5356	SB2184- 152 -LRB104 11945 RLC 22038 b SB2184 - 152 - LRB104 11945 RLC 22038 b
5357	5357	SB2184 - 152 - LRB104 11945 RLC 22038 b
5358	5358	1 access to the record through the shared electronic record
5359	5359	2 management system.
5360	5360	3 (d-6) Records contained in the Officer Professional
5361	5361	4 Conduct Database under Section 9.2 of the Illinois Police
5362	5362	5 Training Act, except to the extent authorized under that
5363	5363	6 Section. This includes the documents supplied to the
5364	5364	7 Illinois Law Enforcement Training Standards Board from the
5365	5365	8 Illinois State Police and Illinois State Police Merit
5366	5366	9 Board.
5367	5367	10 (d-7) Information gathered or records created from the
5368	5368	11 use of automatic license plate readers in connection with
5369	5369	12 Section 2-130 of the Illinois Vehicle Code.
5370	5370	13 (e) Records that relate to or affect the security of
5371	5371	14 correctional institutions and detention facilities.
5372	5372	15 (e-5) Records requested by persons committed to the
5373	5373	16 Department of Corrections, Department of Human Services
5374	5374	17 Division of Mental Health, or a county jail if those
5375	5375	18 materials are available in the library of the correctional
5376	5376	19 institution or facility or jail where the inmate is
5377	5377	20 confined.
5378	5378	21 (e-6) Records requested by persons committed to the
5379	5379	22 Department of Corrections, Department of Human Services
5380	5380	23 Division of Mental Health, or a county jail if those
5381	5381	24 materials include records from staff members' personnel
5382	5382	25 files, staff rosters, or other staffing assignment
5383	5383	26 information.
5384	5384
5385	5385
5386	5386
5387	5387
5388	5388
5389	5389	SB2184 - 152 - LRB104 11945 RLC 22038 b
5390	5390
5391	5391
5392	5392	SB2184- 153 -LRB104 11945 RLC 22038 b SB2184 - 153 - LRB104 11945 RLC 22038 b
5393	5393	SB2184 - 153 - LRB104 11945 RLC 22038 b
5394	5394	1 (e-7) Records requested by persons committed to the
5395	5395	2 Department of Corrections or Department of Human Services
5396	5396	3 Division of Mental Health if those materials are available
5397	5397	4 through an administrative request to the Department of
5398	5398	5 Corrections or Department of Human Services Division of
5399	5399	6 Mental Health.
5400	5400	7 (e-8) Records requested by a person committed to the
5401	5401	8 Department of Corrections, Department of Human Services
5402	5402	9 Division of Mental Health, or a county jail, the
5403	5403	10 disclosure of which would result in the risk of harm to any
5404	5404	11 person or the risk of an escape from a jail or correctional
5405	5405	12 institution or facility.
5406	5406	13 (e-9) Records requested by a person in a county jail
5407	5407	14 or committed to the Department of Corrections or
5408	5408	15 Department of Human Services Division of Mental Health,
5409	5409	16 containing personal information pertaining to the person's
5410	5410	17 victim or the victim's family, including, but not limited
5411	5411	18 to, a victim's home address, home telephone number, work
5412	5412	19 or school address, work telephone number, social security
5413	5413	20 number, or any other identifying information, except as
5414	5414	21 may be relevant to a requester's current or potential case
5415	5415	22 or claim.
5416	5416	23 (e-10) Law enforcement records of other persons
5417	5417	24 requested by a person committed to the Department of
5418	5418	25 Corrections, Department of Human Services Division of
5419	5419	26 Mental Health, or a county jail, including, but not
5420	5420
5421	5421
5422	5422
5423	5423
5424	5424
5425	5425	SB2184 - 153 - LRB104 11945 RLC 22038 b
5426	5426
5427	5427
5428	5428	SB2184- 154 -LRB104 11945 RLC 22038 b SB2184 - 154 - LRB104 11945 RLC 22038 b
5429	5429	SB2184 - 154 - LRB104 11945 RLC 22038 b
5430	5430	1 limited to, arrest and booking records, mug shots, and
5431	5431	2 crime scene photographs, except as these records may be
5432	5432	3 relevant to the requester's current or potential case or
5433	5433	4 claim.
5434	5434	5 (f) Preliminary drafts, notes, recommendations,
5435	5435	6 memoranda, and other records in which opinions are
5436	5436	7 expressed, or policies or actions are formulated, except
5437	5437	8 that a specific record or relevant portion of a record
5438	5438	9 shall not be exempt when the record is publicly cited and
5439	5439	10 identified by the head of the public body. The exemption
5440	5440	11 provided in this paragraph (f) extends to all those
5441	5441	12 records of officers and agencies of the General Assembly
5442	5442	13 that pertain to the preparation of legislative documents.
5443	5443	14 (g) Trade secrets and commercial or financial
5444	5444	15 information obtained from a person or business where the
5445	5445	16 trade secrets or commercial or financial information are
5446	5446	17 furnished under a claim that they are proprietary,
5447	5447	18 privileged, or confidential, and that disclosure of the
5448	5448	19 trade secrets or commercial or financial information would
5449	5449	20 cause competitive harm to the person or business, and only
5450	5450	21 insofar as the claim directly applies to the records
5451	5451	22 requested.
5452	5452	23 The information included under this exemption includes
5453	5453	24 all trade secrets and commercial or financial information
5454	5454	25 obtained by a public body, including a public pension
5455	5455	26 fund, from a private equity fund or a privately held
5456	5456
5457	5457
5458	5458
5459	5459
5460	5460
5461	5461	SB2184 - 154 - LRB104 11945 RLC 22038 b
5462	5462
5463	5463
5464	5464	SB2184- 155 -LRB104 11945 RLC 22038 b SB2184 - 155 - LRB104 11945 RLC 22038 b
5465	5465	SB2184 - 155 - LRB104 11945 RLC 22038 b
5466	5466	1 company within the investment portfolio of a private
5467	5467	2 equity fund as a result of either investing or evaluating
5468	5468	3 a potential investment of public funds in a private equity
5469	5469	4 fund. The exemption contained in this item does not apply
5470	5470	5 to the aggregate financial performance information of a
5471	5471	6 private equity fund, nor to the identity of the fund's
5472	5472	7 managers or general partners. The exemption contained in
5473	5473	8 this item does not apply to the identity of a privately
5474	5474	9 held company within the investment portfolio of a private
5475	5475	10 equity fund, unless the disclosure of the identity of a
5476	5476	11 privately held company may cause competitive harm.
5477	5477	12 Nothing contained in this paragraph (g) shall be
5478	5478	13 construed to prevent a person or business from consenting
5479	5479	14 to disclosure.
5480	5480	15 (h) Proposals and bids for any contract, grant, or
5481	5481	16 agreement, including information which if it were
5482	5482	17 disclosed would frustrate procurement or give an advantage
5483	5483	18 to any person proposing to enter into a contractor
5484	5484	19 agreement with the body, until an award or final selection
5485	5485	20 is made. Information prepared by or for the body in
5486	5486	21 preparation of a bid solicitation shall be exempt until an
5487	5487	22 award or final selection is made.
5488	5488	23 (i) Valuable formulae, computer geographic systems,
5489	5489	24 designs, drawings, and research data obtained or produced
5490	5490	25 by any public body when disclosure could reasonably be
5491	5491	26 expected to produce private gain or public loss. The
5492	5492
5493	5493
5494	5494
5495	5495
5496	5496
5497	5497	SB2184 - 155 - LRB104 11945 RLC 22038 b
5498	5498
5499	5499
5500	5500	SB2184- 156 -LRB104 11945 RLC 22038 b SB2184 - 156 - LRB104 11945 RLC 22038 b
5501	5501	SB2184 - 156 - LRB104 11945 RLC 22038 b
5502	5502	1 exemption for "computer geographic systems" provided in
5503	5503	2 this paragraph (i) does not extend to requests made by
5504	5504	3 news media as defined in Section 2 of this Act when the
5505	5505	4 requested information is not otherwise exempt and the only
5506	5506	5 purpose of the request is to access and disseminate
5507	5507	6 information regarding the health, safety, welfare, or
5508	5508	7 legal rights of the general public.
5509	5509	8 (j) The following information pertaining to
5510	5510	9 educational matters:
5511	5511	10 (i) test questions, scoring keys, and other
5512	5512	11 examination data used to administer an academic
5513	5513	12 examination;
5514	5514	13 (ii) information received by a primary or
5515	5515	14 secondary school, college, or university under its
5516	5516	15 procedures for the evaluation of faculty members by
5517	5517	16 their academic peers;
5518	5518	17 (iii) information concerning a school or
5519	5519	18 university's adjudication of student disciplinary
5520	5520	19 cases, but only to the extent that disclosure would
5521	5521	20 unavoidably reveal the identity of the student; and
5522	5522	21 (iv) course materials or research materials used
5523	5523	22 by faculty members.
5524	5524	23 (k) Architects' plans, engineers' technical
5525	5525	24 submissions, and other construction related technical
5526	5526	25 documents for projects not constructed or developed in
5527	5527	26 whole or in part with public funds and the same for
5528	5528
5529	5529
5530	5530
5531	5531
5532	5532
5533	5533	SB2184 - 156 - LRB104 11945 RLC 22038 b
5534	5534
5535	5535
5536	5536	SB2184- 157 -LRB104 11945 RLC 22038 b SB2184 - 157 - LRB104 11945 RLC 22038 b
5537	5537	SB2184 - 157 - LRB104 11945 RLC 22038 b
5538	5538	1 projects constructed or developed with public funds,
5539	5539	2 including, but not limited to, power generating and
5540	5540	3 distribution stations and other transmission and
5541	5541	4 distribution facilities, water treatment facilities,
5542	5542	5 airport facilities, sport stadiums, convention centers,
5543	5543	6 and all government owned, operated, or occupied buildings,
5544	5544	7 but only to the extent that disclosure would compromise
5545	5545	8 security.
5546	5546	9 (l) Minutes of meetings of public bodies closed to the
5547	5547	10 public as provided in the Open Meetings Act until the
5548	5548	11 public body makes the minutes available to the public
5549	5549	12 under Section 2.06 of the Open Meetings Act.
5550	5550	13 (m) Communications between a public body and an
5551	5551	14 attorney or auditor representing the public body that
5552	5552	15 would not be subject to discovery in litigation, and
5553	5553	16 materials prepared or compiled by or for a public body in
5554	5554	17 anticipation of a criminal, civil, or administrative
5555	5555	18 proceeding upon the request of an attorney advising the
5556	5556	19 public body, and materials prepared or compiled with
5557	5557	20 respect to internal audits of public bodies.
5558	5558	21 (n) Records relating to a public body's adjudication
5559	5559	22 of employee grievances or disciplinary cases; however,
5560	5560	23 this exemption shall not extend to the final outcome of
5561	5561	24 cases in which discipline is imposed.
5562	5562	25 (o) Administrative or technical information associated
5563	5563	26 with automated data processing operations, including, but
5564	5564
5565	5565
5566	5566
5567	5567
5568	5568
5569	5569	SB2184 - 157 - LRB104 11945 RLC 22038 b
5570	5570
5571	5571
5572	5572	SB2184- 158 -LRB104 11945 RLC 22038 b SB2184 - 158 - LRB104 11945 RLC 22038 b
5573	5573	SB2184 - 158 - LRB104 11945 RLC 22038 b
5574	5574	1 not limited to, software, operating protocols, computer
5575	5575	2 program abstracts, file layouts, source listings, object
5576	5576	3 modules, load modules, user guides, documentation
5577	5577	4 pertaining to all logical and physical design of
5578	5578	5 computerized systems, employee manuals, and any other
5579	5579	6 information that, if disclosed, would jeopardize the
5580	5580	7 security of the system or its data or the security of
5581	5581	8 materials exempt under this Section.
5582	5582	9 (p) Records relating to collective negotiating matters
5583	5583	10 between public bodies and their employees or
5584	5584	11 representatives, except that any final contract or
5585	5585	12 agreement shall be subject to inspection and copying.
5586	5586	13 (q) Test questions, scoring keys, and other
5587	5587	14 examination data used to determine the qualifications of
5588	5588	15 an applicant for a license or employment.
5589	5589	16 (r) The records, documents, and information relating
5590	5590	17 to real estate purchase negotiations until those
5591	5591	18 negotiations have been completed or otherwise terminated.
5592	5592	19 With regard to a parcel involved in a pending or actually
5593	5593	20 and reasonably contemplated eminent domain proceeding
5594	5594	21 under the Eminent Domain Act, records, documents, and
5595	5595	22 information relating to that parcel shall be exempt except
5596	5596	23 as may be allowed under discovery rules adopted by the
5597	5597	24 Illinois Supreme Court. The records, documents, and
5598	5598	25 information relating to a real estate sale shall be exempt
5599	5599	26 until a sale is consummated.
5600	5600
5601	5601
5602	5602
5603	5603
5604	5604
5605	5605	SB2184 - 158 - LRB104 11945 RLC 22038 b
5606	5606
5607	5607
5608	5608	SB2184- 159 -LRB104 11945 RLC 22038 b SB2184 - 159 - LRB104 11945 RLC 22038 b
5609	5609	SB2184 - 159 - LRB104 11945 RLC 22038 b
5610	5610	1 (s) Any and all proprietary information and records
5611	5611	2 related to the operation of an intergovernmental risk
5612	5612	3 management association or self-insurance pool or jointly
5613	5613	4 self-administered health and accident cooperative or pool.
5614	5614	5 Insurance or self-insurance (including any
5615	5615	6 intergovernmental risk management association or
5616	5616	7 self-insurance pool) claims, loss or risk management
5617	5617	8 information, records, data, advice, or communications.
5618	5618	9 (t) Information contained in or related to
5619	5619	10 examination, operating, or condition reports prepared by,
5620	5620	11 on behalf of, or for the use of a public body responsible
5621	5621	12 for the regulation or supervision of financial
5622	5622	13 institutions, insurance companies, or pharmacy benefit
5623	5623	14 managers, unless disclosure is otherwise required by State
5624	5624	15 law.
5625	5625	16 (u) Information that would disclose or might lead to
5626	5626	17 the disclosure of secret or confidential information,
5627	5627	18 codes, algorithms, programs, or private keys intended to
5628	5628	19 be used to create electronic signatures under the Uniform
5629	5629	20 Electronic Transactions Act.
5630	5630	21 (v) Vulnerability assessments, security measures, and
5631	5631	22 response policies or plans that are designed to identify,
5632	5632	23 prevent, or respond to potential attacks upon a
5633	5633	24 community's population or systems, facilities, or
5634	5634	25 installations, but only to the extent that disclosure
5635	5635	26 could reasonably be expected to expose the vulnerability
5636	5636
5637	5637
5638	5638
5639	5639
5640	5640
5641	5641	SB2184 - 159 - LRB104 11945 RLC 22038 b
5642	5642
5643	5643
5644	5644	SB2184- 160 -LRB104 11945 RLC 22038 b SB2184 - 160 - LRB104 11945 RLC 22038 b
5645	5645	SB2184 - 160 - LRB104 11945 RLC 22038 b
5646	5646	1 or jeopardize the effectiveness of the measures, policies,
5647	5647	2 or plans, or the safety of the personnel who implement
5648	5648	3 them or the public. Information exempt under this item may
5649	5649	4 include such things as details pertaining to the
5650	5650	5 mobilization or deployment of personnel or equipment, to
5651	5651	6 the operation of communication systems or protocols, to
5652	5652	7 cybersecurity vulnerabilities, or to tactical operations.
5653	5653	8 (w) (Blank).
5654	5654	9 (x) Maps and other records regarding the location or
5655	5655	10 security of generation, transmission, distribution,
5656	5656	11 storage, gathering, treatment, or switching facilities
5657	5657	12 owned by a utility, by a power generator, or by the
5658	5658	13 Illinois Power Agency.
5659	5659	14 (y) Information contained in or related to proposals,
5660	5660	15 bids, or negotiations related to electric power
5661	5661	16 procurement under Section 1-75 of the Illinois Power
5662	5662	17 Agency Act and Section 16-111.5 of the Public Utilities
5663	5663	18 Act that is determined to be confidential and proprietary
5664	5664	19 by the Illinois Power Agency or by the Illinois Commerce
5665	5665	20 Commission.
5666	5666	21 (z) Information about students exempted from
5667	5667	22 disclosure under Section 10-20.38 or 34-18.29 of the
5668	5668	23 School Code, and information about undergraduate students
5669	5669	24 enrolled at an institution of higher education exempted
5670	5670	25 from disclosure under Section 25 of the Illinois Credit
5671	5671	26 Card Marketing Act of 2009.
5672	5672
5673	5673
5674	5674
5675	5675
5676	5676
5677	5677	SB2184 - 160 - LRB104 11945 RLC 22038 b
5678	5678
5679	5679
5680	5680	SB2184- 161 -LRB104 11945 RLC 22038 b SB2184 - 161 - LRB104 11945 RLC 22038 b
5681	5681	SB2184 - 161 - LRB104 11945 RLC 22038 b
5682	5682	1 (aa) Information the disclosure of which is exempted
5683	5683	2 under the Viatical Settlements Act of 2009.
5684	5684	3 (bb) Records and information provided to a mortality
5685	5685	4 review team and records maintained by a mortality review
5686	5686	5 team appointed under the Department of Juvenile Justice
5687	5687	6 Mortality Review Team Act.
5688	5688	7 (cc) Information regarding interments, entombments, or
5689	5689	8 inurnments of human remains that are submitted to the
5690	5690	9 Cemetery Oversight Database under the Cemetery Care Act or
5691	5691	10 the Cemetery Oversight Act, whichever is applicable.
5692	5692	11 (dd) Correspondence and records (i) that may not be
5693	5693	12 disclosed under Section 11-9 of the Illinois Public Aid
5694	5694	13 Code or (ii) that pertain to appeals under Section 11-8 of
5695	5695	14 the Illinois Public Aid Code.
5696	5696	15 (ee) The names, addresses, or other personal
5697	5697	16 information of persons who are minors and are also
5698	5698	17 participants and registrants in programs of park
5699	5699	18 districts, forest preserve districts, conservation
5700	5700	19 districts, recreation agencies, and special recreation
5701	5701	20 associations.
5702	5702	21 (ff) The names, addresses, or other personal
5703	5703	22 information of participants and registrants in programs of
5704	5704	23 park districts, forest preserve districts, conservation
5705	5705	24 districts, recreation agencies, and special recreation
5706	5706	25 associations where such programs are targeted primarily to
5707	5707	26 minors.
5708	5708
5709	5709
5710	5710
5711	5711
5712	5712
5713	5713	SB2184 - 161 - LRB104 11945 RLC 22038 b
5714	5714
5715	5715
5716	5716	SB2184- 162 -LRB104 11945 RLC 22038 b SB2184 - 162 - LRB104 11945 RLC 22038 b
5717	5717	SB2184 - 162 - LRB104 11945 RLC 22038 b
5718	5718	1 (gg) Confidential information described in Section
5719	5719	2 1-100 of the Illinois Independent Tax Tribunal Act of
5720	5720	3 2012.
5721	5721	4 (hh) The report submitted to the State Board of
5722	5722	5 Education by the School Security and Standards Task Force
5723	5723	6 under item (8) of subsection (d) of Section 2-3.160 of the
5724	5724	7 School Code and any information contained in that report.
5725	5725	8 (ii) Records requested by persons committed to or
5726	5726	9 detained by the Department of Human Services under the
5727	5727	10 Sexually Violent Persons Commitment Act or committed to
5728	5728	11 the Department of Corrections under the Sexually Dangerous
5729	5729	12 Persons Act if those materials: (i) are available in the
5730	5730	13 library of the facility where the individual is confined;
5731	5731	14 (ii) include records from staff members' personnel files,
5732	5732	15 staff rosters, or other staffing assignment information;
5733	5733	16 or (iii) are available through an administrative request
5734	5734	17 to the Department of Human Services or the Department of
5735	5735	18 Corrections.
5736	5736	19 (jj) Confidential information described in Section
5737	5737	20 5-535 of the Civil Administrative Code of Illinois.
5738	5738	21 (kk) The public body's credit card numbers, debit card
5739	5739	22 numbers, bank account numbers, Federal Employer
5740	5740	23 Identification Number, security code numbers, passwords,
5741	5741	24 and similar account information, the disclosure of which
5742	5742	25 could result in identity theft or impression or defrauding
5743	5743	26 of a governmental entity or a person.
5744	5744
5745	5745
5746	5746
5747	5747
5748	5748
5749	5749	SB2184 - 162 - LRB104 11945 RLC 22038 b
5750	5750
5751	5751
5752	5752	SB2184- 163 -LRB104 11945 RLC 22038 b SB2184 - 163 - LRB104 11945 RLC 22038 b
5753	5753	SB2184 - 163 - LRB104 11945 RLC 22038 b
5754	5754	1 (ll) Records concerning the work of the threat
5755	5755	2 assessment team of a school district, including, but not
5756	5756	3 limited to, any threat assessment procedure under the
5757	5757	4 School Safety Drill Act and any information contained in
5758	5758	5 the procedure.
5759	5759	6 (mm) Information prohibited from being disclosed under
5760	5760	7 subsections (a) and (b) of Section 15 of the Student
5761	5761	8 Confidential Reporting Act.
5762	5762	9 (nn) Proprietary information submitted to the
5763	5763	10 Environmental Protection Agency under the Drug Take-Back
5764	5764	11 Act.
5765	5765	12 (oo) Records described in subsection (f) of Section
5766	5766	13 3-5-1 of the Unified Code of Corrections.
5767	5767	14 (pp) Any and all information regarding burials,
5768	5768	15 interments, or entombments of human remains as required to
5769	5769	16 be reported to the Department of Natural Resources
5770	5770	17 pursuant either to the Archaeological and Paleontological
5771	5771	18 Resources Protection Act or the Human Remains Protection
5772	5772	19 Act.
5773	5773	20 (qq) Reports described in subsection (e) of Section
5774	5774	21 16-15 of the Abortion Care Clinical Training Program Act.
5775	5775	22 (rr) Information obtained by a certified local health
5776	5776	23 department under the Access to Public Health Data Act.
5777	5777	24 (ss) For a request directed to a public body that is
5778	5778	25 also a HIPAA-covered entity, all information that is
5779	5779	26 protected health information, including demographic
5780	5780
5781	5781
5782	5782
5783	5783
5784	5784
5785	5785	SB2184 - 163 - LRB104 11945 RLC 22038 b
5786	5786
5787	5787
5788	5788	SB2184- 164 -LRB104 11945 RLC 22038 b SB2184 - 164 - LRB104 11945 RLC 22038 b
5789	5789	SB2184 - 164 - LRB104 11945 RLC 22038 b
5790	5790	1 information, that may be contained within or extracted
5791	5791	2 from any record held by the public body in compliance with
5792	5792	3 State and federal medical privacy laws and regulations,
5793	5793	4 including, but not limited to, the Health Insurance
5794	5794	5 Portability and Accountability Act and its regulations, 45
5795	5795	6 CFR Parts 160 and 164. As used in this paragraph,
5796	5796	7 "HIPAA-covered entity" has the meaning given to the term
5797	5797	8 "covered entity" in 45 CFR 160.103 and "protected health
5798	5798	9 information" has the meaning given to that term in 45 CFR
5799	5799	10 160.103.
5800	5800	11 (tt) Proposals or bids submitted by engineering
5801	5801	12 consultants in response to requests for proposal or other
5802	5802	13 competitive bidding requests by the Department of
5803	5803	14 Transportation or the Illinois Toll Highway Authority.
5804	5804	15 (uu) Correspondence and records that may not be
5805	5805	16 disclosed under Section 265 of the Compassionate Use and
5806	5806	17 Research of Entheogens Act.
5807	5807	18 (1.5) Any information exempt from disclosure under the
5808	5808	19 Judicial Privacy Act shall be redacted from public records
5809	5809	20 prior to disclosure under this Act.
5810	5810	21 (2) A public record that is not in the possession of a
5811	5811	22 public body but is in the possession of a party with whom the
5812	5812	23 agency has contracted to perform a governmental function on
5813	5813	24 behalf of the public body, and that directly relates to the
5814	5814	25 governmental function and is not otherwise exempt under this
5815	5815	26 Act, shall be considered a public record of the public body,
5816	5816
5817	5817
5818	5818
5819	5819
5820	5820
5821	5821	SB2184 - 164 - LRB104 11945 RLC 22038 b
5822	5822
5823	5823
5824	5824	SB2184- 165 -LRB104 11945 RLC 22038 b SB2184 - 165 - LRB104 11945 RLC 22038 b
5825	5825	SB2184 - 165 - LRB104 11945 RLC 22038 b
5826	5826	1 for purposes of this Act.
5827	5827	2 (3) This Section does not authorize withholding of
5828	5828	3 information or limit the availability of records to the
5829	5829	4 public, except as stated in this Section or otherwise provided
5830	5830	5 in this Act.
5831	5831	6 (Source: P.A. 102-38, eff. 6-25-21; 102-558, eff. 8-20-21;
5832	5832	7 102-694, eff. 1-7-22; 102-752, eff. 5-6-22; 102-753, eff.
5833	5833	8 1-1-23; 102-776, eff. 1-1-23; 102-791, eff. 5-13-22; 102-982,
5834	5834	9 eff. 7-1-23; 102-1055, eff. 6-10-22; 103-154, eff. 6-30-23;
5835	5835	10 103-423, eff. 1-1-24; 103-446, eff. 8-4-23; 103-462, eff.
5836	5836	11 8-4-23; 103-540, eff. 1-1-24; 103-554, eff. 1-1-24; 103-605,
5837	5837	12 eff. 7-1-24; 103-865, eff. 1-1-25.)
5838	5838	13 Section 905. The State Finance Act is amended by adding
5839	5839	14 Sections 5.1030 and 5.1031 as follows:
5840	5840	15 (30 ILCS 105/5.1030 new)
5841	5841	16 Sec. 5.1030. The Psilocybin Control and Regulation Fund.
5842	5842	17 (30 ILCS 105/5.1031 new)
5843	5843	18 Sec. 5.1031. The Illinois Psilocybin Fund.
5844	5844	19 Section 910. The Illinois Independent Tax Tribunal Act of
5845	5845	20 2012 is amended by changing Section 1-45 as follows:
5846	5846	21 (35 ILCS 1010/1-45)
5847	5847
5848	5848
5849	5849
5850	5850
5851	5851
5852	5852	SB2184 - 165 - LRB104 11945 RLC 22038 b
5853	5853
5854	5854
5855	5855	SB2184- 166 -LRB104 11945 RLC 22038 b SB2184 - 166 - LRB104 11945 RLC 22038 b
5856	5856	SB2184 - 166 - LRB104 11945 RLC 22038 b
5857	5857	1 Sec. 1-45. Jurisdiction of the Tax Tribunal.
5858	5858	2 (a) Except as provided by the Constitution of the United
5859	5859	3 States, the Constitution of the State of Illinois, or any
5860	5860	4 statutes of this State, including, but not limited to, the
5861	5861	5 State Officers and Employees Money Disposition Act, the Tax
5862	5862	6 Tribunal shall have original jurisdiction over all
5863	5863	7 determinations of the Department reflected on a Notice of
5864	5864	8 Deficiency, Notice of Tax Liability, Notice of Claim Denial,
5865	5865	9 or Notice of Penalty Liability issued under the Illinois
5866	5866	10 Income Tax Act, the Use Tax Act, the Service Use Tax Act, the
5867	5867	11 Service Occupation Tax Act, the Retailers' Occupation Tax Act,
5868	5868	12 the Cigarette Tax Act, the Cigarette Use Tax Act, the Tobacco
5869	5869	13 Products Tax Act of 1995, the Hotel Operators' Occupation Tax
5870	5870	14 Act, the Motor Fuel Tax Law, the Automobile Renting Occupation
5871	5871	15 and Use Tax Act, the Coin-Operated Amusement Device and
5872	5872	16 Redemption Machine Tax Act, the Gas Revenue Tax Act, the Water
5873	5873	17 Company Invested Capital Tax Act, the Telecommunications
5874	5874	18 Excise Tax Act, the Telecommunications Infrastructure
5875	5875	19 Maintenance Fee Act, the Public Utilities Revenue Act, the
5876	5876	20 Electricity Excise Tax Law, the Aircraft Use Tax Law, the
5877	5877	21 Watercraft Use Tax Law, the Gas Use Tax Law, or the Uniform
5878	5878	22 Penalty and Interest Act, or the Compassionate Use and
5879	5879	23 Research of Entheogens Act. Jurisdiction of the Tax Tribunal
5880	5880	24 is limited to Notices of Tax Liability, Notices of Deficiency,
5881	5881	25 Notices of Claim Denial, and Notices of Penalty Liability
5882	5882	26 where the amount at issue in a notice, or the aggregate amount
5883	5883
5884	5884
5885	5885
5886	5886
5887	5887
5888	5888	SB2184 - 166 - LRB104 11945 RLC 22038 b
5889	5889
5890	5890
5891	5891	SB2184- 167 -LRB104 11945 RLC 22038 b SB2184 - 167 - LRB104 11945 RLC 22038 b
5892	5892	SB2184 - 167 - LRB104 11945 RLC 22038 b
5893	5893	1 at issue in multiple notices issued for the same tax year or
5894	5894	2 audit period, exceeds $15,000, exclusive of penalties and
5895	5895	3 interest. In notices solely asserting either an interest or
5896	5896	4 penalty assessment, or both, the Tax Tribunal shall have
5897	5897	5 jurisdiction over cases where the combined total of all
5898	5898	6 penalties or interest assessed exceeds $15,000.
5899	5899	7 (b) Except as otherwise permitted by this Act and by the
5900	5900	8 Constitution of the State of Illinois or otherwise by State
5901	5901	9 law, including, but not limited to, the State Officers and
5902	5902	10 Employees Money Disposition Act, no person shall contest any
5903	5903	11 matter within the jurisdiction of the Tax Tribunal in any
5904	5904	12 action, suit, or proceeding in the circuit court or any other
5905	5905	13 court of the State. If a person attempts to do so, then such
5906	5906	14 action, suit, or proceeding shall be dismissed without
5907	5907	15 prejudice. The improper commencement of any action, suit, or
5908	5908	16 proceeding does not extend the time period for commencing a
5909	5909	17 proceeding in the Tax Tribunal.
5910	5910	18 (c) The Tax Tribunal may require the taxpayer to post a
5911	5911	19 bond equal to 25% of the liability at issue (1) upon motion of
5912	5912	20 the Department and a showing that (A) the taxpayer's action is
5913	5913	21 frivolous or legally insufficient or (B) the taxpayer is
5914	5914	22 acting primarily for the purpose of delaying the collection of
5915	5915	23 tax or prejudicing the ability ultimately to collect the tax,
5916	5916	24 or (2) if, at any time during the proceedings, it is determined
5917	5917	25 by the Tax Tribunal that the taxpayer is not pursuing the
5918	5918	26 resolution of the case with due diligence. If the Tax Tribunal
5919	5919
5920	5920
5921	5921
5922	5922
5923	5923
5924	5924	SB2184 - 167 - LRB104 11945 RLC 22038 b
5925	5925
5926	5926
5927	5927	SB2184- 168 -LRB104 11945 RLC 22038 b SB2184 - 168 - LRB104 11945 RLC 22038 b
5928	5928	SB2184 - 168 - LRB104 11945 RLC 22038 b
5929	5929	1 finds in a particular case that the taxpayer cannot procure
5930	5930	2 and furnish a satisfactory surety or sureties for the kind of
5931	5931	3 bond required herein, the Tax Tribunal may relieve the
5932	5932	4 taxpayer of the obligation of filing such bond, if, upon the
5933	5933	5 timely application for a lien in lieu thereof and accompanying
5934	5934	6 proof therein submitted, the Tax Tribunal is satisfied that
5935	5935	7 any such lien imposed would operate to secure the assessment
5936	5936	8 in the manner and to the degree as would a bond. The Tax
5937	5937	9 Tribunal shall adopt rules for the procedures to be used in
5938	5938	10 securing a bond or lien under this Section.
5939	5939	11 (d) If, with or after the filing of a timely petition, the
5940	5940	12 taxpayer pays all or part of the tax or other amount in issue
5941	5941	13 before the Tax Tribunal has rendered a decision, the Tax
5942	5942	14 Tribunal shall treat the taxpayer's petition as a protest of a
5943	5943	15 denial of claim for refund of the amount so paid upon a written
5944	5944	16 motion filed by the taxpayer.
5945	5945	17 (e) The Tax Tribunal shall not have jurisdiction to
5946	5946	18 review:
5947	5947	19 (1) any assessment made under the Property Tax Code;
5948	5948	20 (2) any decisions relating to the issuance or denial
5949	5949	21 of an exemption ruling for any entity claiming exemption
5950	5950	22 from any tax imposed under the Property Tax Code or any
5951	5951	23 State tax administered by the Department;
5952	5952	24 (3) a notice of proposed tax liability, notice of
5953	5953	25 proposed deficiency, or any other notice of proposed
5954	5954	26 assessment or notice of intent to take some action;
5955	5955
5956	5956
5957	5957
5958	5958
5959	5959
5960	5960	SB2184 - 168 - LRB104 11945 RLC 22038 b
5961	5961
5962	5962
5963	5963	SB2184- 169 -LRB104 11945 RLC 22038 b SB2184 - 169 - LRB104 11945 RLC 22038 b
5964	5964	SB2184 - 169 - LRB104 11945 RLC 22038 b
5965	5965	1 (4) any action or determination of the Department
5966	5966	2 regarding tax liabilities that have become finalized by
5967	5967	3 law, including but not limited to the issuance of liens,
5968	5968	4 levies, and revocations, suspensions, or denials of
5969	5969	5 licenses or certificates of registration or any other
5970	5970	6 collection activities;
5971	5971	7 (5) any proceedings of the Department's informal
5972	5972	8 administrative appeals function; and
5973	5973	9 (6) any challenge to an administrative subpoena issued
5974	5974	10 by the Department.
5975	5975	11 (f) The Tax Tribunal shall decide questions regarding the
5976	5976	12 constitutionality of statutes and rules adopted by the
5977	5977	13 Department as applied to the taxpayer, but shall not have the
5978	5978	14 power to declare a statute or rule unconstitutional or
5979	5979	15 otherwise invalid on its face. A taxpayer challenging the
5980	5980	16 constitutionality of a statute or rule on its face may present
5981	5981	17 such challenge to the Tax Tribunal for the sole purpose of
5982	5982	18 making a record for review by the Illinois Appellate Court.
5983	5983	19 Failure to raise a constitutional issue regarding the
5984	5984	20 application of a statute or regulations to the taxpayer shall
5985	5985	21 not preclude the taxpayer or the Department from raising those
5986	5986	22 issues at the appellate court level.
5987	5987	23 (Source: P.A. 97-1129, eff. 8-28-12; 98-463, eff. 8-16-13.)
5988	5988	24 Section 914. The Illinois Vehicle Code is amended by
5989	5989	25 changing Section 11-501 as follows:
5990	5990
5991	5991
5992	5992
5993	5993
5994	5994
5995	5995	SB2184 - 169 - LRB104 11945 RLC 22038 b
5996	5996
5997	5997
5998	5998	SB2184- 170 -LRB104 11945 RLC 22038 b SB2184 - 170 - LRB104 11945 RLC 22038 b
5999	5999	SB2184 - 170 - LRB104 11945 RLC 22038 b
6000	6000	1 (625 ILCS 5/11-501) (from Ch. 95 1/2, par. 11-501)
6001	6001	2 Sec. 11-501. Driving while under the influence of alcohol,
6002	6002	3 other drug or drugs, intoxicating compound or compounds or any
6003	6003	4 combination thereof.
6004	6004	5 (a) A person shall not drive or be in actual physical
6005	6005	6 control of any vehicle within this State while:
6006	6006	7 (1) the alcohol concentration in the person's blood,
6007	6007	8 other bodily substance, or breath is 0.08 or more based on
6008	6008	9 the definition of blood and breath units in Section
6009	6009	10 11-501.2;
6010	6010	11 (2) under the influence of alcohol;
6011	6011	12 (3) under the influence of any intoxicating compound
6012	6012	13 or combination of intoxicating compounds to a degree that
6013	6013	14 renders the person incapable of driving safely;
6014	6014	15 (4) under the influence of any other drug or
6015	6015	16 combination of drugs to a degree that renders the person
6016	6016	17 incapable of safely driving;
6017	6017	18 (5) under the combined influence of alcohol, other
6018	6018	19 drug or drugs, or intoxicating compound or compounds to a
6019	6019	20 degree that renders the person incapable of safely
6020	6020	21 driving;
6021	6021	22 (6) there is any amount of a drug, substance, or
6022	6022	23 compound in the person's breath, blood, other bodily
6023	6023	24 substance, or urine resulting from the unlawful use or
6024	6024	25 consumption of a controlled substance listed in the
6025	6025
6026	6026
6027	6027
6028	6028
6029	6029
6030	6030	SB2184 - 170 - LRB104 11945 RLC 22038 b
6031	6031
6032	6032
6033	6033	SB2184- 171 -LRB104 11945 RLC 22038 b SB2184 - 171 - LRB104 11945 RLC 22038 b
6034	6034	SB2184 - 171 - LRB104 11945 RLC 22038 b
6035	6035	1 Illinois Controlled Substances Act, an intoxicating
6036	6036	2 compound listed in the Use of Intoxicating Compounds Act,
6037	6037	3 or methamphetamine as listed in the Methamphetamine
6038	6038	4 Control and Community Protection Act, or psilocybin or
6039	6039	5 psilocin as defined in the Compassionate Use and Research
6040	6040	6 of Entheogens Act; or
6041	6041	7 (7) the person has, within 2 hours of driving or being
6042	6042	8 in actual physical control of a vehicle, a
6043	6043	9 tetrahydrocannabinol concentration in the person's whole
6044	6044	10 blood or other bodily substance as defined in paragraph 6
6045	6045	11 of subsection (a) of Section 11-501.2 of this Code.
6046	6046	12 Subject to all other requirements and provisions under
6047	6047	13 this Section, this paragraph (7) does not apply to the
6048	6048	14 lawful consumption of cannabis by a qualifying patient
6049	6049	15 licensed under the Compassionate Use of Medical Cannabis
6050	6050	16 Program Act who is in possession of a valid registry card
6051	6051	17 issued under that Act, unless that person is impaired by
6052	6052	18 the use of cannabis.
6053	6053	19 (b) The fact that any person charged with violating this
6054	6054	20 Section is or has been legally entitled to use alcohol,
6055	6055	21 cannabis under the Compassionate Use of Medical Cannabis
6056	6056	22 Program Act, other drug or drugs, or intoxicating compound or
6057	6057	23 compounds, or any combination thereof, shall not constitute a
6058	6058	24 defense against any charge of violating this Section.
6059	6059	25 (c) Penalties.
6060	6060	26 (1) Except as otherwise provided in this Section, any
6061	6061
6062	6062
6063	6063
6064	6064
6065	6065
6066	6066	SB2184 - 171 - LRB104 11945 RLC 22038 b
6067	6067
6068	6068
6069	6069	SB2184- 172 -LRB104 11945 RLC 22038 b SB2184 - 172 - LRB104 11945 RLC 22038 b
6070	6070	SB2184 - 172 - LRB104 11945 RLC 22038 b
6071	6071	1 person convicted of violating subsection (a) of this
6072	6072	2 Section is guilty of a Class A misdemeanor.
6073	6073	3 (2) A person who violates subsection (a) or a similar
6074	6074	4 provision a second time shall be sentenced to a mandatory
6075	6075	5 minimum term of either 5 days of imprisonment or 240 hours
6076	6076	6 of community service in addition to any other criminal or
6077	6077	7 administrative sanction.
6078	6078	8 (3) A person who violates subsection (a) is subject to
6079	6079	9 6 months of imprisonment, an additional mandatory minimum
6080	6080	10 fine of $1,000, and 25 days of community service in a
6081	6081	11 program benefiting children if the person was transporting
6082	6082	12 a person under the age of 16 at the time of the violation.
6083	6083	13 (4) A person who violates subsection (a) a first time,
6084	6084	14 if the alcohol concentration in his or her blood, breath,
6085	6085	15 other bodily substance, or urine was 0.16 or more based on
6086	6086	16 the definition of blood, breath, other bodily substance,
6087	6087	17 or urine units in Section 11-501.2, shall be subject, in
6088	6088	18 addition to any other penalty that may be imposed, to a
6089	6089	19 mandatory minimum of 100 hours of community service and a
6090	6090	20 mandatory minimum fine of $500.
6091	6091	21 (5) A person who violates subsection (a) a second
6092	6092	22 time, if at the time of the second violation the alcohol
6093	6093	23 concentration in his or her blood, breath, other bodily
6094	6094	24 substance, or urine was 0.16 or more based on the
6095	6095	25 definition of blood, breath, other bodily substance, or
6096	6096	26 urine units in Section 11-501.2, shall be subject, in
6097	6097
6098	6098
6099	6099
6100	6100
6101	6101
6102	6102	SB2184 - 172 - LRB104 11945 RLC 22038 b
6103	6103
6104	6104
6105	6105	SB2184- 173 -LRB104 11945 RLC 22038 b SB2184 - 173 - LRB104 11945 RLC 22038 b
6106	6106	SB2184 - 173 - LRB104 11945 RLC 22038 b
6107	6107	1 addition to any other penalty that may be imposed, to a
6108	6108	2 mandatory minimum of 2 days of imprisonment and a
6109	6109	3 mandatory minimum fine of $1,250.
6110	6110	4 (d) Aggravated driving under the influence of alcohol,
6111	6111	5 other drug or drugs, or intoxicating compound or compounds, or
6112	6112	6 any combination thereof.
6113	6113	7 (1) Every person convicted of committing a violation
6114	6114	8 of this Section shall be guilty of aggravated driving
6115	6115	9 under the influence of alcohol, other drug or drugs, or
6116	6116	10 intoxicating compound or compounds, or any combination
6117	6117	11 thereof if:
6118	6118	12 (A) the person committed a violation of subsection
6119	6119	13 (a) or a similar provision for the third or subsequent
6120	6120	14 time;
6121	6121	15 (B) the person committed a violation of subsection
6122	6122	16 (a) while driving a school bus with one or more
6123	6123	17 passengers on board;
6124	6124	18 (C) the person in committing a violation of
6125	6125	19 subsection (a) was involved in a motor vehicle crash
6126	6126	20 that resulted in great bodily harm or permanent
6127	6127	21 disability or disfigurement to another, when the
6128	6128	22 violation was a proximate cause of the injuries;
6129	6129	23 (D) the person committed a violation of subsection
6130	6130	24 (a) and has been previously convicted of violating
6131	6131	25 Section 9-3 of the Criminal Code of 1961 or the
6132	6132	26 Criminal Code of 2012 or a similar provision of a law
6133	6133
6134	6134
6135	6135
6136	6136
6137	6137
6138	6138	SB2184 - 173 - LRB104 11945 RLC 22038 b
6139	6139
6140	6140
6141	6141	SB2184- 174 -LRB104 11945 RLC 22038 b SB2184 - 174 - LRB104 11945 RLC 22038 b
6142	6142	SB2184 - 174 - LRB104 11945 RLC 22038 b
6143	6143	1 of another state relating to reckless homicide in
6144	6144	2 which the person was determined to have been under the
6145	6145	3 influence of alcohol, other drug or drugs, or
6146	6146	4 intoxicating compound or compounds as an element of
6147	6147	5 the offense or the person has previously been
6148	6148	6 convicted under subparagraph (C) or subparagraph (F)
6149	6149	7 of this paragraph (1);
6150	6150	8 (E) the person, in committing a violation of
6151	6151	9 subsection (a) while driving at any speed in a school
6152	6152	10 speed zone at a time when a speed limit of 20 miles per
6153	6153	11 hour was in effect under subsection (a) of Section
6154	6154	12 11-605 of this Code, was involved in a motor vehicle
6155	6155	13 crash that resulted in bodily harm, other than great
6156	6156	14 bodily harm or permanent disability or disfigurement,
6157	6157	15 to another person, when the violation of subsection
6158	6158	16 (a) was a proximate cause of the bodily harm;
6159	6159	17 (F) the person, in committing a violation of
6160	6160	18 subsection (a), was involved in a motor vehicle crash
6161	6161	19 or snowmobile, all-terrain vehicle, or watercraft
6162	6162	20 accident that resulted in the death of another person,
6163	6163	21 when the violation of subsection (a) was a proximate
6164	6164	22 cause of the death;
6165	6165	23 (G) the person committed a violation of subsection
6166	6166	24 (a) during a period in which the defendant's driving
6167	6167	25 privileges are revoked or suspended, where the
6168	6168	26 revocation or suspension was for a violation of
6169	6169
6170	6170
6171	6171
6172	6172
6173	6173
6174	6174	SB2184 - 174 - LRB104 11945 RLC 22038 b
6175	6175
6176	6176
6177	6177	SB2184- 175 -LRB104 11945 RLC 22038 b SB2184 - 175 - LRB104 11945 RLC 22038 b
6178	6178	SB2184 - 175 - LRB104 11945 RLC 22038 b
6179	6179	1 subsection (a) or a similar provision, Section
6180	6180	2 11-501.1, paragraph (b) of Section 11-401, or for
6181	6181	3 reckless homicide as defined in Section 9-3 of the
6182	6182	4 Criminal Code of 1961 or the Criminal Code of 2012;
6183	6183	5 (H) the person committed the violation while he or
6184	6184	6 she did not possess a driver's license or permit or a
6185	6185	7 restricted driving permit or a judicial driving permit
6186	6186	8 or a monitoring device driving permit;
6187	6187	9 (I) the person committed the violation while he or
6188	6188	10 she knew or should have known that the vehicle he or
6189	6189	11 she was driving was not covered by a liability
6190	6190	12 insurance policy;
6191	6191	13 (J) the person in committing a violation of
6192	6192	14 subsection (a) was involved in a motor vehicle crash
6193	6193	15 that resulted in bodily harm, but not great bodily
6194	6194	16 harm, to the child under the age of 16 being
6195	6195	17 transported by the person, if the violation was the
6196	6196	18 proximate cause of the injury;
6197	6197	19 (K) the person in committing a second violation of
6198	6198	20 subsection (a) or a similar provision was transporting
6199	6199	21 a person under the age of 16; or
6200	6200	22 (L) the person committed a violation of subsection
6201	6201	23 (a) of this Section while transporting one or more
6202	6202	24 passengers in a vehicle for-hire.
6203	6203	25 (2)(A) Except as provided otherwise, a person
6204	6204	26 convicted of aggravated driving under the influence of
6205	6205
6206	6206
6207	6207
6208	6208
6209	6209
6210	6210	SB2184 - 175 - LRB104 11945 RLC 22038 b
6211	6211
6212	6212
6213	6213	SB2184- 176 -LRB104 11945 RLC 22038 b SB2184 - 176 - LRB104 11945 RLC 22038 b
6214	6214	SB2184 - 176 - LRB104 11945 RLC 22038 b
6215	6215	1 alcohol, other drug or drugs, or intoxicating compound or
6216	6216	2 compounds, or any combination thereof is guilty of a Class
6217	6217	3 4 felony.
6218	6218	4 (B) A third violation of this Section or a similar
6219	6219	5 provision is a Class 2 felony. If at the time of the third
6220	6220	6 violation the alcohol concentration in his or her blood,
6221	6221	7 breath, other bodily substance, or urine was 0.16 or more
6222	6222	8 based on the definition of blood, breath, other bodily
6223	6223	9 substance, or urine units in Section 11-501.2, a mandatory
6224	6224	10 minimum of 90 days of imprisonment and a mandatory minimum
6225	6225	11 fine of $2,500 shall be imposed in addition to any other
6226	6226	12 criminal or administrative sanction. If at the time of the
6227	6227	13 third violation, the defendant was transporting a person
6228	6228	14 under the age of 16, a mandatory fine of $25,000 and 25
6229	6229	15 days of community service in a program benefiting children
6230	6230	16 shall be imposed in addition to any other criminal or
6231	6231	17 administrative sanction.
6232	6232	18 (C) A fourth violation of this Section or a similar
6233	6233	19 provision is a Class 2 felony, for which a sentence of
6234	6234	20 probation or conditional discharge may not be imposed. If
6235	6235	21 at the time of the violation, the alcohol concentration in
6236	6236	22 the defendant's blood, breath, other bodily substance, or
6237	6237	23 urine was 0.16 or more based on the definition of blood,
6238	6238	24 breath, other bodily substance, or urine units in Section
6239	6239	25 11-501.2, a mandatory minimum fine of $5,000 shall be
6240	6240	26 imposed in addition to any other criminal or
6241	6241
6242	6242
6243	6243
6244	6244
6245	6245
6246	6246	SB2184 - 176 - LRB104 11945 RLC 22038 b
6247	6247
6248	6248
6249	6249	SB2184- 177 -LRB104 11945 RLC 22038 b SB2184 - 177 - LRB104 11945 RLC 22038 b
6250	6250	SB2184 - 177 - LRB104 11945 RLC 22038 b
6251	6251	1 administrative sanction. If at the time of the fourth
6252	6252	2 violation, the defendant was transporting a person under
6253	6253	3 the age of 16 a mandatory fine of $25,000 and 25 days of
6254	6254	4 community service in a program benefiting children shall
6255	6255	5 be imposed in addition to any other criminal or
6256	6256	6 administrative sanction.
6257	6257	7 (D) A fifth violation of this Section or a similar
6258	6258	8 provision is a Class 1 felony, for which a sentence of
6259	6259	9 probation or conditional discharge may not be imposed. If
6260	6260	10 at the time of the violation, the alcohol concentration in
6261	6261	11 the defendant's blood, breath, other bodily substance, or
6262	6262	12 urine was 0.16 or more based on the definition of blood,
6263	6263	13 breath, other bodily substance, or urine units in Section
6264	6264	14 11-501.2, a mandatory minimum fine of $5,000 shall be
6265	6265	15 imposed in addition to any other criminal or
6266	6266	16 administrative sanction. If at the time of the fifth
6267	6267	17 violation, the defendant was transporting a person under
6268	6268	18 the age of 16, a mandatory fine of $25,000, and 25 days of
6269	6269	19 community service in a program benefiting children shall
6270	6270	20 be imposed in addition to any other criminal or
6271	6271	21 administrative sanction.
6272	6272	22 (E) A sixth or subsequent violation of this Section or
6273	6273	23 similar provision is a Class X felony. If at the time of
6274	6274	24 the violation, the alcohol concentration in the
6275	6275	25 defendant's blood, breath, other bodily substance, or
6276	6276	26 urine was 0.16 or more based on the definition of blood,
6277	6277
6278	6278
6279	6279
6280	6280
6281	6281
6282	6282	SB2184 - 177 - LRB104 11945 RLC 22038 b
6283	6283
6284	6284
6285	6285	SB2184- 178 -LRB104 11945 RLC 22038 b SB2184 - 178 - LRB104 11945 RLC 22038 b
6286	6286	SB2184 - 178 - LRB104 11945 RLC 22038 b
6287	6287	1 breath, other bodily substance, or urine units in Section
6288	6288	2 11-501.2, a mandatory minimum fine of $5,000 shall be
6289	6289	3 imposed in addition to any other criminal or
6290	6290	4 administrative sanction. If at the time of the violation,
6291	6291	5 the defendant was transporting a person under the age of
6292	6292	6 16, a mandatory fine of $25,000 and 25 days of community
6293	6293	7 service in a program benefiting children shall be imposed
6294	6294	8 in addition to any other criminal or administrative
6295	6295	9 sanction.
6296	6296	10 (F) For a violation of subparagraph (C) of paragraph
6297	6297	11 (1) of this subsection (d), the defendant, if sentenced to
6298	6298	12 a term of imprisonment, shall be sentenced to not less
6299	6299	13 than one year nor more than 12 years.
6300	6300	14 (G) A violation of subparagraph (F) of paragraph (1)
6301	6301	15 of this subsection (d) is a Class 2 felony, for which the
6302	6302	16 defendant, unless the court determines that extraordinary
6303	6303	17 circumstances exist and require probation, shall be
6304	6304	18 sentenced to: (i) a term of imprisonment of not less than 3
6305	6305	19 years and not more than 14 years if the violation resulted
6306	6306	20 in the death of one person; or (ii) a term of imprisonment
6307	6307	21 of not less than 6 years and not more than 28 years if the
6308	6308	22 violation resulted in the deaths of 2 or more persons.
6309	6309	23 (H) For a violation of subparagraph (J) of paragraph
6310	6310	24 (1) of this subsection (d), a mandatory fine of $2,500,
6311	6311	25 and 25 days of community service in a program benefiting
6312	6312	26 children shall be imposed in addition to any other
6313	6313
6314	6314
6315	6315
6316	6316
6317	6317
6318	6318	SB2184 - 178 - LRB104 11945 RLC 22038 b
6319	6319
6320	6320
6321	6321	SB2184- 179 -LRB104 11945 RLC 22038 b SB2184 - 179 - LRB104 11945 RLC 22038 b
6322	6322	SB2184 - 179 - LRB104 11945 RLC 22038 b
6323	6323	1 criminal or administrative sanction.
6324	6324	2 (I) A violation of subparagraph (K) of paragraph (1)
6325	6325	3 of this subsection (d), is a Class 2 felony and a mandatory
6326	6326	4 fine of $2,500, and 25 days of community service in a
6327	6327	5 program benefiting children shall be imposed in addition
6328	6328	6 to any other criminal or administrative sanction. If the
6329	6329	7 child being transported suffered bodily harm, but not
6330	6330	8 great bodily harm, in a motor vehicle crash, and the
6331	6331	9 violation was the proximate cause of that injury, a
6332	6332	10 mandatory fine of $5,000 and 25 days of community service
6333	6333	11 in a program benefiting children shall be imposed in
6334	6334	12 addition to any other criminal or administrative sanction.
6335	6335	13 (J) A violation of subparagraph (D) of paragraph (1)
6336	6336	14 of this subsection (d) is a Class 3 felony, for which a
6337	6337	15 sentence of probation or conditional discharge may not be
6338	6338	16 imposed.
6339	6339	17 (3) Any person sentenced under this subsection (d) who
6340	6340	18 receives a term of probation or conditional discharge must
6341	6341	19 serve a minimum term of either 480 hours of community
6342	6342	20 service or 10 days of imprisonment as a condition of the
6343	6343	21 probation or conditional discharge in addition to any
6344	6344	22 other criminal or administrative sanction.
6345	6345	23 (e) Any reference to a prior violation of subsection (a)
6346	6346	24 or a similar provision includes any violation of a provision
6347	6347	25 of a local ordinance or a provision of a law of another state
6348	6348	26 or an offense committed on a military installation that is
6349	6349
6350	6350
6351	6351
6352	6352
6353	6353
6354	6354	SB2184 - 179 - LRB104 11945 RLC 22038 b
6355	6355
6356	6356
6357	6357	SB2184- 180 -LRB104 11945 RLC 22038 b SB2184 - 180 - LRB104 11945 RLC 22038 b
6358	6358	SB2184 - 180 - LRB104 11945 RLC 22038 b
6359	6359	1 similar to a violation of subsection (a) of this Section.
6360	6360	2 (f) The imposition of a mandatory term of imprisonment or
6361	6361	3 assignment of community service for a violation of this
6362	6362	4 Section shall not be suspended or reduced by the court.
6363	6363	5 (g) Any penalty imposed for driving with a license that
6364	6364	6 has been revoked for a previous violation of subsection (a) of
6365	6365	7 this Section shall be in addition to the penalty imposed for
6366	6366	8 any subsequent violation of subsection (a).
6367	6367	9 (h) For any prosecution under this Section, a certified
6368	6368	10 copy of the driving abstract of the defendant shall be
6369	6369	11 admitted as proof of any prior conviction.
6370	6370	12 (Source: P.A. 101-363, eff. 8-9-19; 102-982, eff. 7-1-23.)
6371	6371	13 Section 915. The Illinois Controlled Substances Act is
6372	6372	14 amended by changing Sections 102 and 204 as follows:
6373	6373	15 (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102)
6374	6374	16 Sec. 102. Definitions. As used in this Act, unless the
6375	6375	17 context otherwise requires:
6376	6376	18 (a) "Person with a substance use disorder" means any
6377	6377	19 person who has a substance use disorder diagnosis defined as a
6378	6378	20 spectrum of persistent and recurring problematic behavior that
6379	6379	21 encompasses 10 separate classes of drugs: alcohol; caffeine;
6380	6380	22 cannabis; hallucinogens; inhalants; opioids; sedatives,
6381	6381	23 hypnotics and anxiolytics; stimulants; and tobacco; and other
6382	6382	24 unknown substances leading to clinically significant
6383	6383
6384	6384
6385	6385
6386	6386
6387	6387
6388	6388	SB2184 - 180 - LRB104 11945 RLC 22038 b
6389	6389
6390	6390
6391	6391	SB2184- 181 -LRB104 11945 RLC 22038 b SB2184 - 181 - LRB104 11945 RLC 22038 b
6392	6392	SB2184 - 181 - LRB104 11945 RLC 22038 b
6393	6393	1 impairment or distress.
6394	6394	2 (b) "Administer" means the direct application of a
6395	6395	3 controlled substance, whether by injection, inhalation,
6396	6396	4 ingestion, or any other means, to the body of a patient,
6397	6397	5 research subject, or animal (as defined by the Humane
6398	6398	6 Euthanasia in Animal Shelters Act) by:
6399	6399	7 (1) a practitioner (or, in his or her presence, by his
6400	6400	8 or her authorized agent),
6401	6401	9 (2) the patient or research subject pursuant to an
6402	6402	10 order, or
6403	6403	11 (3) a euthanasia technician as defined by the Humane
6404	6404	12 Euthanasia in Animal Shelters Act.
6405	6405	13 (c) "Agent" means an authorized person who acts on behalf
6406	6406	14 of or at the direction of a manufacturer, distributor,
6407	6407	15 dispenser, prescriber, or practitioner. It does not include a
6408	6408	16 common or contract carrier, public warehouseman or employee of
6409	6409	17 the carrier or warehouseman.
6410	6410	18 (c-1) "Anabolic Steroids" means any drug or hormonal
6411	6411	19 substance, chemically and pharmacologically related to
6412	6412	20 testosterone (other than estrogens, progestins,
6413	6413	21 corticosteroids, and dehydroepiandrosterone), and includes:
6414	6414	22 (i) 3[beta],17-dihydroxy-5a-androstane,
6415	6415	23 (ii) 3[alpha],17[beta]-dihydroxy-5a-androstane,
6416	6416	24 (iii) 5[alpha]-androstan-3,17-dione,
6417	6417	25 (iv) 1-androstenediol (3[beta],
6418	6418	26 17[beta]-dihydroxy-5[alpha]-androst-1-ene),
6419	6419
6420	6420
6421	6421
6422	6422
6423	6423
6424	6424	SB2184 - 181 - LRB104 11945 RLC 22038 b
6425	6425
6426	6426
6427	6427	SB2184- 182 -LRB104 11945 RLC 22038 b SB2184 - 182 - LRB104 11945 RLC 22038 b
6428	6428	SB2184 - 182 - LRB104 11945 RLC 22038 b
6429	6429	1 (v) 1-androstenediol (3[alpha],
6430	6430	2 17[beta]-dihydroxy-5[alpha]-androst-1-ene),
6431	6431	3 (vi) 4-androstenediol
6432	6432	4 (3[beta],17[beta]-dihydroxy-androst-4-ene),
6433	6433	5 (vii) 5-androstenediol
6434	6434	6 (3[beta],17[beta]-dihydroxy-androst-5-ene),
6435	6435	7 (viii) 1-androstenedione
6436	6436	8 ([5alpha]-androst-1-en-3,17-dione),
6437	6437	9 (ix) 4-androstenedione
6438	6438	10 (androst-4-en-3,17-dione),
6439	6439	11 (x) 5-androstenedione
6440	6440	12 (androst-5-en-3,17-dione),
6441	6441	13 (xi) bolasterone (7[alpha],17a-dimethyl-17[beta]-
6442	6442	14 hydroxyandrost-4-en-3-one),
6443	6443	15 (xii) boldenone (17[beta]-hydroxyandrost-
6444	6444	16 1,4,-diene-3-one),
6445	6445	17 (xiii) boldione (androsta-1,4-
6446	6446	18 diene-3,17-dione),
6447	6447	19 (xiv) calusterone (7[beta],17[alpha]-dimethyl-17
6448	6448	20 [beta]-hydroxyandrost-4-en-3-one),
6449	6449	21 (xv) clostebol (4-chloro-17[beta]-
6450	6450	22 hydroxyandrost-4-en-3-one),
6451	6451	23 (xvi) dehydrochloromethyltestosterone (4-chloro-
6452	6452	24 17[beta]-hydroxy-17[alpha]-methyl-
6453	6453	25 androst-1,4-dien-3-one),
6454	6454	26 (xvii) desoxymethyltestosterone
6455	6455
6456	6456
6457	6457
6458	6458
6459	6459
6460	6460	SB2184 - 182 - LRB104 11945 RLC 22038 b
6461	6461
6462	6462
6463	6463	SB2184- 183 -LRB104 11945 RLC 22038 b SB2184 - 183 - LRB104 11945 RLC 22038 b
6464	6464	SB2184 - 183 - LRB104 11945 RLC 22038 b
6465	6465	1 (17[alpha]-methyl-5[alpha]
6466	6466	2 -androst-2-en-17[beta]-ol)(a.k.a., madol),
6467	6467	3 (xviii) [delta]1-dihydrotestosterone (a.k.a.
6468	6468	4 '1-testosterone') (17[beta]-hydroxy-
6469	6469	5 5[alpha]-androst-1-en-3-one),
6470	6470	6 (xix) 4-dihydrotestosterone (17[beta]-hydroxy-
6471	6471	7 androstan-3-one),
6472	6472	8 (xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl-
6473	6473	9 5[alpha]-androstan-3-one),
6474	6474	10 (xxi) ethylestrenol (17[alpha]-ethyl-17[beta]-
6475	6475	11 hydroxyestr-4-ene),
6476	6476	12 (xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl-
6477	6477	13 1[beta],17[beta]-dihydroxyandrost-4-en-3-one),
6478	6478	14 (xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha],
6479	6479	15 17[beta]-dihydroxyandrost-1,4-dien-3-one),
6480	6480	16 (xxiv) furazabol (17[alpha]-methyl-17[beta]-
6481	6481	17 hydroxyandrostano[2,3-c]-furazan),
6482	6482	18 (xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one,
6483	6483	19 (xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy-
6484	6484	20 androst-4-en-3-one),
6485	6485	21 (xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]-
6486	6486	22 dihydroxy-estr-4-en-3-one),
6487	6487	23 (xxviii) mestanolone (17[alpha]-methyl-17[beta]-
6488	6488	24 hydroxy-5-androstan-3-one),
6489	6489	25 (xxix) mesterolone (1amethyl-17[beta]-hydroxy-
6490	6490	26 [5a]-androstan-3-one),
6491	6491
6492	6492
6493	6493
6494	6494
6495	6495
6496	6496	SB2184 - 183 - LRB104 11945 RLC 22038 b
6497	6497
6498	6498
6499	6499	SB2184- 184 -LRB104 11945 RLC 22038 b SB2184 - 184 - LRB104 11945 RLC 22038 b
6500	6500	SB2184 - 184 - LRB104 11945 RLC 22038 b
6501	6501	1 (xxx) methandienone (17[alpha]-methyl-17[beta]-
6502	6502	2 hydroxyandrost-1,4-dien-3-one),
6503	6503	3 (xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]-
6504	6504	4 dihydroxyandrost-5-ene),
6505	6505	5 (xxxii) methenolone (1-methyl-17[beta]-hydroxy-
6506	6506	6 5[alpha]-androst-1-en-3-one),
6507	6507	7 (xxxiii) 17[alpha]-methyl-3[beta], 17[beta]-
6508	6508	8 dihydroxy-5a-androstane,
6509	6509	9 (xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy
6510	6510	10 -5a-androstane,
6511	6511	11 (xxxv) 17[alpha]-methyl-3[beta],17[beta]-
6512	6512	12 dihydroxyandrost-4-ene),
6513	6513	13 (xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]-
6514	6514	14 methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one),
6515	6515	15 (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]-
6516	6516	16 hydroxyestra-4,9(10)-dien-3-one),
6517	6517	17 (xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]-
6518	6518	18 hydroxyestra-4,9-11-trien-3-one),
6519	6519	19 (xxxix) methyltestosterone (17[alpha]-methyl-17[beta]-
6520	6520	20 hydroxyandrost-4-en-3-one),
6521	6521	21 (xl) mibolerone (7[alpha],17a-dimethyl-17[beta]-
6522	6522	22 hydroxyestr-4-en-3-one),
6523	6523	23 (xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone
6524	6524	24 (17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]-
6525	6525	25 androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl-
6526	6526	26 1-testosterone'),
6527	6527
6528	6528
6529	6529
6530	6530
6531	6531
6532	6532	SB2184 - 184 - LRB104 11945 RLC 22038 b
6533	6533
6534	6534
6535	6535	SB2184- 185 -LRB104 11945 RLC 22038 b SB2184 - 185 - LRB104 11945 RLC 22038 b
6536	6536	SB2184 - 185 - LRB104 11945 RLC 22038 b
6537	6537	1 (xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one),
6538	6538	2 (xliii) 19-nor-4-androstenediol (3[beta], 17[beta]-
6539	6539	3 dihydroxyestr-4-ene),
6540	6540	4 (xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]-
6541	6541	5 dihydroxyestr-4-ene),
6542	6542	6 (xlv) 19-nor-5-androstenediol (3[beta], 17[beta]-
6543	6543	7 dihydroxyestr-5-ene),
6544	6544	8 (xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]-
6545	6545	9 dihydroxyestr-5-ene),
6546	6546	10 (xlvii) 19-nor-4,9(10)-androstadienedione
6547	6547	11 (estra-4,9(10)-diene-3,17-dione),
6548	6548	12 (xlviii) 19-nor-4-androstenedione (estr-4-
6549	6549	13 en-3,17-dione),
6550	6550	14 (xlix) 19-nor-5-androstenedione (estr-5-
6551	6551	15 en-3,17-dione),
6552	6552	16 (l) norbolethone (13[beta], 17a-diethyl-17[beta]-
6553	6553	17 hydroxygon-4-en-3-one),
6554	6554	18 (li) norclostebol (4-chloro-17[beta]-
6555	6555	19 hydroxyestr-4-en-3-one),
6556	6556	20 (lii) norethandrolone (17[alpha]-ethyl-17[beta]-
6557	6557	21 hydroxyestr-4-en-3-one),
6558	6558	22 (liii) normethandrolone (17[alpha]-methyl-17[beta]-
6559	6559	23 hydroxyestr-4-en-3-one),
6560	6560	24 (liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-
6561	6561	25 2-oxa-5[alpha]-androstan-3-one),
6562	6562	26 (lv) oxymesterone (17[alpha]-methyl-4,17[beta]-
6563	6563
6564	6564
6565	6565
6566	6566
6567	6567
6568	6568	SB2184 - 185 - LRB104 11945 RLC 22038 b
6569	6569
6570	6570
6571	6571	SB2184- 186 -LRB104 11945 RLC 22038 b SB2184 - 186 - LRB104 11945 RLC 22038 b
6572	6572	SB2184 - 186 - LRB104 11945 RLC 22038 b
6573	6573	1 dihydroxyandrost-4-en-3-one),
6574	6574	2 (lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene-
6575	6575	3 17[beta]-hydroxy-(5[alpha]-androstan-3-one),
6576	6576	4 (lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy-
6577	6577	5 (5[alpha]-androst-2-eno[3,2-c]-pyrazole),
6578	6578	6 (lviii) stenbolone (17[beta]-hydroxy-2-methyl-
6579	6579	7 (5[alpha]-androst-1-en-3-one),
6580	6580	8 (lix) testolactone (13-hydroxy-3-oxo-13,17-
6581	6581	9 secoandrosta-1,4-dien-17-oic
6582	6582	10 acid lactone),
6583	6583	11 (lx) testosterone (17[beta]-hydroxyandrost-
6584	6584	12 4-en-3-one),
6585	6585	13 (lxi) tetrahydrogestrinone (13[beta], 17[alpha]-
6586	6586	14 diethyl-17[beta]-hydroxygon-
6587	6587	15 4,9,11-trien-3-one),
6588	6588	16 (lxii) trenbolone (17[beta]-hydroxyestr-4,9,
6589	6589	17 11-trien-3-one).
6590	6590	18 Any person who is otherwise lawfully in possession of an
6591	6591	19 anabolic steroid, or who otherwise lawfully manufactures,
6592	6592	20 distributes, dispenses, delivers, or possesses with intent to
6593	6593	21 deliver an anabolic steroid, which anabolic steroid is
6594	6594	22 expressly intended for and lawfully allowed to be administered
6595	6595	23 through implants to livestock or other nonhuman species, and
6596	6596	24 which is approved by the Secretary of Health and Human
6597	6597	25 Services for such administration, and which the person intends
6598	6598	26 to administer or have administered through such implants,
6599	6599
6600	6600
6601	6601
6602	6602
6603	6603
6604	6604	SB2184 - 186 - LRB104 11945 RLC 22038 b
6605	6605
6606	6606
6607	6607	SB2184- 187 -LRB104 11945 RLC 22038 b SB2184 - 187 - LRB104 11945 RLC 22038 b
6608	6608	SB2184 - 187 - LRB104 11945 RLC 22038 b
6609	6609	1 shall not be considered to be in unauthorized possession or to
6610	6610	2 unlawfully manufacture, distribute, dispense, deliver, or
6611	6611	3 possess with intent to deliver such anabolic steroid for
6612	6612	4 purposes of this Act.
6613	6613	5 (d) "Administration" means the Drug Enforcement
6614	6614	6 Administration, United States Department of Justice, or its
6615	6615	7 successor agency.
6616	6616	8 (d-5) "Clinical Director, Prescription Monitoring Program"
6617	6617	9 means a Department of Human Services administrative employee
6618	6618	10 licensed to either prescribe or dispense controlled substances
6619	6619	11 who shall run the clinical aspects of the Department of Human
6620	6620	12 Services Prescription Monitoring Program and its Prescription
6621	6621	13 Information Library.
6622	6622	14 (d-10) "Compounding" means the preparation and mixing of
6623	6623	15 components, excluding flavorings, (1) as the result of a
6624	6624	16 prescriber's prescription drug order or initiative based on
6625	6625	17 the prescriber-patient-pharmacist relationship in the course
6626	6626	18 of professional practice or (2) for the purpose of, or
6627	6627	19 incident to, research, teaching, or chemical analysis and not
6628	6628	20 for sale or dispensing. "Compounding" includes the preparation
6629	6629	21 of drugs or devices in anticipation of receiving prescription
6630	6630	22 drug orders based on routine, regularly observed dispensing
6631	6631	23 patterns. Commercially available products may be compounded
6632	6632	24 for dispensing to individual patients only if both of the
6633	6633	25 following conditions are met: (i) the commercial product is
6634	6634	26 not reasonably available from normal distribution channels in
6635	6635
6636	6636
6637	6637
6638	6638
6639	6639
6640	6640	SB2184 - 187 - LRB104 11945 RLC 22038 b
6641	6641
6642	6642
6643	6643	SB2184- 188 -LRB104 11945 RLC 22038 b SB2184 - 188 - LRB104 11945 RLC 22038 b
6644	6644	SB2184 - 188 - LRB104 11945 RLC 22038 b
6645	6645	1 a timely manner to meet the patient's needs and (ii) the
6646	6646	2 prescribing practitioner has requested that the drug be
6647	6647	3 compounded.
6648	6648	4 (e) "Control" means to add a drug or other substance, or
6649	6649	5 immediate precursor, to a Schedule whether by transfer from
6650	6650	6 another Schedule or otherwise.
6651	6651	7 (f) "Controlled Substance" means (i) a drug, substance,
6652	6652	8 immediate precursor, or synthetic drug in the Schedules of
6653	6653	9 Article II of this Act or (ii) a drug or other substance, or
6654	6654	10 immediate precursor, designated as a controlled substance by
6655	6655	11 the Department through administrative rule. The term does not
6656	6656	12 include: distilled spirits, wine, malt beverages, or tobacco,
6657	6657	13 as those terms are defined or used in the Liquor Control Act of
6658	6658	14 1934 and the Tobacco Products Tax Act of 1995; or psilocybin or
6659	6659	15 a psilocybin product, as those terms are defined or used in the
6660	6660	16 Compassionate Use and Research of Entheogens Act.
6661	6661	17 (f-5) "Controlled substance analog" means a substance:
6662	6662	18 (1) the chemical structure of which is substantially
6663	6663	19 similar to the chemical structure of a controlled
6664	6664	20 substance in Schedule I or II;
6665	6665	21 (2) which has a stimulant, depressant, or
6666	6666	22 hallucinogenic effect on the central nervous system that
6667	6667	23 is substantially similar to or greater than the stimulant,
6668	6668	24 depressant, or hallucinogenic effect on the central
6669	6669	25 nervous system of a controlled substance in Schedule I or
6670	6670	26 II; or
6671	6671
6672	6672
6673	6673
6674	6674
6675	6675
6676	6676	SB2184 - 188 - LRB104 11945 RLC 22038 b
6677	6677
6678	6678
6679	6679	SB2184- 189 -LRB104 11945 RLC 22038 b SB2184 - 189 - LRB104 11945 RLC 22038 b
6680	6680	SB2184 - 189 - LRB104 11945 RLC 22038 b
6681	6681	1 (3) with respect to a particular person, which such
6682	6682	2 person represents or intends to have a stimulant,
6683	6683	3 depressant, or hallucinogenic effect on the central
6684	6684	4 nervous system that is substantially similar to or greater
6685	6685	5 than the stimulant, depressant, or hallucinogenic effect
6686	6686	6 on the central nervous system of a controlled substance in
6687	6687	7 Schedule I or II.
6688	6688	8 (g) "Counterfeit substance" means a controlled substance,
6689	6689	9 which, or the container or labeling of which, without
6690	6690	10 authorization bears the trademark, trade name, or other
6691	6691	11 identifying mark, imprint, number or device, or any likeness
6692	6692	12 thereof, of a manufacturer, distributor, or dispenser other
6693	6693	13 than the person who in fact manufactured, distributed, or
6694	6694	14 dispensed the substance.
6695	6695	15 (h) "Deliver" or "delivery" means the actual, constructive
6696	6696	16 or attempted transfer of possession of a controlled substance,
6697	6697	17 with or without consideration, whether or not there is an
6698	6698	18 agency relationship. "Deliver" or "delivery" does not include
6699	6699	19 the donation of drugs to the extent permitted under the
6700	6700	20 Illinois Drug Reuse Opportunity Program Act.
6701	6701	21 (i) "Department" means the Illinois Department of Human
6702	6702	22 Services (as successor to the Department of Alcoholism and
6703	6703	23 Substance Abuse) or its successor agency.
6704	6704	24 (j) (Blank).
6705	6705	25 (k) "Department of Corrections" means the Department of
6706	6706	26 Corrections of the State of Illinois or its successor agency.
6707	6707
6708	6708
6709	6709
6710	6710
6711	6711
6712	6712	SB2184 - 189 - LRB104 11945 RLC 22038 b
6713	6713
6714	6714
6715	6715	SB2184- 190 -LRB104 11945 RLC 22038 b SB2184 - 190 - LRB104 11945 RLC 22038 b
6716	6716	SB2184 - 190 - LRB104 11945 RLC 22038 b
6717	6717	1 (l) "Department of Financial and Professional Regulation"
6718	6718	2 means the Department of Financial and Professional Regulation
6719	6719	3 of the State of Illinois or its successor agency.
6720	6720	4 (m) "Depressant" means any drug that (i) causes an overall
6721	6721	5 depression of central nervous system functions, (ii) causes
6722	6722	6 impaired consciousness and awareness, and (iii) can be
6723	6723	7 habit-forming or lead to a substance misuse or substance use
6724	6724	8 disorder, including, but not limited to, alcohol, cannabis and
6725	6725	9 its active principles and their analogs, benzodiazepines and
6726	6726	10 their analogs, barbiturates and their analogs, opioids
6727	6727	11 (natural and synthetic) and their analogs, and chloral hydrate
6728	6728	12 and similar sedative hypnotics.
6729	6729	13 (n) (Blank).
6730	6730	14 (o) "Director" means the Director of the Illinois State
6731	6731	15 Police or his or her designated agents.
6732	6732	16 (p) "Dispense" means to deliver a controlled substance to
6733	6733	17 an ultimate user or research subject by or pursuant to the
6734	6734	18 lawful order of a prescriber, including the prescribing,
6735	6735	19 administering, packaging, labeling, or compounding necessary
6736	6736	20 to prepare the substance for that delivery.
6737	6737	21 (q) "Dispenser" means a practitioner who dispenses.
6738	6738	22 (r) "Distribute" means to deliver, other than by
6739	6739	23 administering or dispensing, a controlled substance.
6740	6740	24 (s) "Distributor" means a person who distributes.
6741	6741	25 (t) "Drug" means (1) substances recognized as drugs in the
6742	6742	26 official United States Pharmacopoeia, Official Homeopathic
6743	6743
6744	6744
6745	6745
6746	6746
6747	6747
6748	6748	SB2184 - 190 - LRB104 11945 RLC 22038 b
6749	6749
6750	6750
6751	6751	SB2184- 191 -LRB104 11945 RLC 22038 b SB2184 - 191 - LRB104 11945 RLC 22038 b
6752	6752	SB2184 - 191 - LRB104 11945 RLC 22038 b
6753	6753	1 Pharmacopoeia of the United States, or official National
6754	6754	2 Formulary, or any supplement to any of them; (2) substances
6755	6755	3 intended for use in diagnosis, cure, mitigation, treatment, or
6756	6756	4 prevention of disease in man or animals; (3) substances (other
6757	6757	5 than food) intended to affect the structure of any function of
6758	6758	6 the body of man or animals and (4) substances intended for use
6759	6759	7 as a component of any article specified in clause (1), (2), or
6760	6760	8 (3) of this subsection. It does not include devices or their
6761	6761	9 components, parts, or accessories.
6762	6762	10 (t-3) "Electronic health record" or "EHR" means an
6763	6763	11 electronic record of health-related information on an
6764	6764	12 individual that is created, gathered, managed, and consulted
6765	6765	13 by authorized health care clinicians and staff.
6766	6766	14 (t-3.5) "Electronic health record system" or "EHR system"
6767	6767	15 means any computer-based system or combination of federally
6768	6768	16 certified Health IT Modules (defined at 42 CFR 170.102 or its
6769	6769	17 successor) used as a repository for electronic health records
6770	6770	18 and accessed or updated by a prescriber or authorized
6771	6771	19 surrogate in the ordinary course of his or her medical
6772	6772	20 practice. For purposes of connecting to the Prescription
6773	6773	21 Information Library maintained by the Bureau of Pharmacy and
6774	6774	22 Clinical Support Systems or its successor, an EHR system may
6775	6775	23 connect to the Prescription Information Library directly or
6776	6776	24 through all or part of a computer program or system that is a
6777	6777	25 federally certified Health IT Module maintained by a third
6778	6778	26 party and used by the EHR system to secure access to the
6779	6779
6780	6780
6781	6781
6782	6782
6783	6783
6784	6784	SB2184 - 191 - LRB104 11945 RLC 22038 b
6785	6785
6786	6786
6787	6787	SB2184- 192 -LRB104 11945 RLC 22038 b SB2184 - 192 - LRB104 11945 RLC 22038 b
6788	6788	SB2184 - 192 - LRB104 11945 RLC 22038 b
6789	6789	1 database.
6790	6790	2 (t-4) "Emergency medical services personnel" has the
6791	6791	3 meaning ascribed to it in the Emergency Medical Services (EMS)
6792	6792	4 Systems Act.
6793	6793	5 (t-5) "Euthanasia agency" means an entity certified by the
6794	6794	6 Department of Financial and Professional Regulation for the
6795	6795	7 purpose of animal euthanasia that holds an animal control
6796	6796	8 facility license or animal shelter license under the Animal
6797	6797	9 Welfare Act. A euthanasia agency is authorized to purchase,
6798	6798	10 store, possess, and utilize Schedule II nonnarcotic and
6799	6799	11 Schedule III nonnarcotic drugs for the sole purpose of animal
6800	6800	12 euthanasia.
6801	6801	13 (t-10) "Euthanasia drugs" means Schedule II or Schedule
6802	6802	14 III substances (nonnarcotic controlled substances) that are
6803	6803	15 used by a euthanasia agency for the purpose of animal
6804	6804	16 euthanasia.
6805	6805	17 (u) "Good faith" means the prescribing or dispensing of a
6806	6806	18 controlled substance by a practitioner in the regular course
6807	6807	19 of professional treatment to or for any person who is under his
6808	6808	20 or her treatment for a pathology or condition other than that
6809	6809	21 individual's physical or psychological dependence upon a
6810	6810	22 controlled substance, except as provided herein: and
6811	6811	23 application of the term to a pharmacist shall mean the
6812	6812	24 dispensing of a controlled substance pursuant to the
6813	6813	25 prescriber's order which in the professional judgment of the
6814	6814	26 pharmacist is lawful. The pharmacist shall be guided by
6815	6815
6816	6816
6817	6817
6818	6818
6819	6819
6820	6820	SB2184 - 192 - LRB104 11945 RLC 22038 b
6821	6821
6822	6822
6823	6823	SB2184- 193 -LRB104 11945 RLC 22038 b SB2184 - 193 - LRB104 11945 RLC 22038 b
6824	6824	SB2184 - 193 - LRB104 11945 RLC 22038 b
6825	6825	1 accepted professional standards, including, but not limited
6826	6826	2 to, the following, in making the judgment:
6827	6827	3 (1) lack of consistency of prescriber-patient
6828	6828	4 relationship,
6829	6829	5 (2) frequency of prescriptions for same drug by one
6830	6830	6 prescriber for large numbers of patients,
6831	6831	7 (3) quantities beyond those normally prescribed,
6832	6832	8 (4) unusual dosages (recognizing that there may be
6833	6833	9 clinical circumstances where more or less than the usual
6834	6834	10 dose may be used legitimately),
6835	6835	11 (5) unusual geographic distances between patient,
6836	6836	12 pharmacist and prescriber,
6837	6837	13 (6) consistent prescribing of habit-forming drugs.
6838	6838	14 (u-0.5) "Hallucinogen" means a drug that causes markedly
6839	6839	15 altered sensory perception leading to hallucinations of any
6840	6840	16 type.
6841	6841	17 (u-1) "Home infusion services" means services provided by
6842	6842	18 a pharmacy in compounding solutions for direct administration
6843	6843	19 to a patient in a private residence, long-term care facility,
6844	6844	20 or hospice setting by means of parenteral, intravenous,
6845	6845	21 intramuscular, subcutaneous, or intraspinal infusion.
6846	6846	22 (u-5) "Illinois State Police" means the Illinois State
6847	6847	23 Police or its successor agency.
6848	6848	24 (v) "Immediate precursor" means a substance:
6849	6849	25 (1) which the Department has found to be and by rule
6850	6850	26 designated as being a principal compound used, or produced
6851	6851
6852	6852
6853	6853
6854	6854
6855	6855
6856	6856	SB2184 - 193 - LRB104 11945 RLC 22038 b
6857	6857
6858	6858
6859	6859	SB2184- 194 -LRB104 11945 RLC 22038 b SB2184 - 194 - LRB104 11945 RLC 22038 b
6860	6860	SB2184 - 194 - LRB104 11945 RLC 22038 b
6861	6861	1 primarily for use, in the manufacture of a controlled
6862	6862	2 substance;
6863	6863	3 (2) which is an immediate chemical intermediary used
6864	6864	4 or likely to be used in the manufacture of such controlled
6865	6865	5 substance; and
6866	6866	6 (3) the control of which is necessary to prevent,
6867	6867	7 curtail or limit the manufacture of such controlled
6868	6868	8 substance.
6869	6869	9 (w) "Instructional activities" means the acts of teaching,
6870	6870	10 educating or instructing by practitioners using controlled
6871	6871	11 substances within educational facilities approved by the State
6872	6872	12 Board of Education or its successor agency.
6873	6873	13 (x) "Local authorities" means a duly organized State,
6874	6874	14 County or Municipal peace unit or police force.
6875	6875	15 (y) "Look-alike substance" means a substance, other than a
6876	6876	16 controlled substance which (1) by overall dosage unit
6877	6877	17 appearance, including shape, color, size, markings or lack
6878	6878	18 thereof, taste, consistency, or any other identifying physical
6879	6879	19 characteristic of the substance, would lead a reasonable
6880	6880	20 person to believe that the substance is a controlled
6881	6881	21 substance, or (2) is expressly or impliedly represented to be
6882	6882	22 a controlled substance or is distributed under circumstances
6883	6883	23 which would lead a reasonable person to believe that the
6884	6884	24 substance is a controlled substance. For the purpose of
6885	6885	25 determining whether the representations made or the
6886	6886	26 circumstances of the distribution would lead a reasonable
6887	6887
6888	6888
6889	6889
6890	6890
6891	6891
6892	6892	SB2184 - 194 - LRB104 11945 RLC 22038 b
6893	6893
6894	6894
6895	6895	SB2184- 195 -LRB104 11945 RLC 22038 b SB2184 - 195 - LRB104 11945 RLC 22038 b
6896	6896	SB2184 - 195 - LRB104 11945 RLC 22038 b
6897	6897	1 person to believe the substance to be a controlled substance
6898	6898	2 under this clause (2) of subsection (y), the court or other
6899	6899	3 authority may consider the following factors in addition to
6900	6900	4 any other factor that may be relevant:
6901	6901	5 (a) statements made by the owner or person in control
6902	6902	6 of the substance concerning its nature, use or effect;
6903	6903	7 (b) statements made to the buyer or recipient that the
6904	6904	8 substance may be resold for profit;
6905	6905	9 (c) whether the substance is packaged in a manner
6906	6906	10 normally used for the illegal distribution of controlled
6907	6907	11 substances;
6908	6908	12 (d) whether the distribution or attempted distribution
6909	6909	13 included an exchange of or demand for money or other
6910	6910	14 property as consideration, and whether the amount of the
6911	6911	15 consideration was substantially greater than the
6912	6912	16 reasonable retail market value of the substance.
6913	6913	17 Clause (1) of this subsection (y) shall not apply to a
6914	6914	18 noncontrolled substance in its finished dosage form that was
6915	6915	19 initially introduced into commerce prior to the initial
6916	6916	20 introduction into commerce of a controlled substance in its
6917	6917	21 finished dosage form which it may substantially resemble.
6918	6918	22 Nothing in this subsection (y) prohibits the dispensing or
6919	6919	23 distributing of noncontrolled substances by persons authorized
6920	6920	24 to dispense and distribute controlled substances under this
6921	6921	25 Act, provided that such action would be deemed to be carried
6922	6922	26 out in good faith under subsection (u) if the substances
6923	6923
6924	6924
6925	6925
6926	6926
6927	6927
6928	6928	SB2184 - 195 - LRB104 11945 RLC 22038 b
6929	6929
6930	6930
6931	6931	SB2184- 196 -LRB104 11945 RLC 22038 b SB2184 - 196 - LRB104 11945 RLC 22038 b
6932	6932	SB2184 - 196 - LRB104 11945 RLC 22038 b
6933	6933	1 involved were controlled substances.
6934	6934	2 Nothing in this subsection (y) or in this Act prohibits
6935	6935	3 the manufacture, preparation, propagation, compounding,
6936	6936	4 processing, packaging, advertising or distribution of a drug
6937	6937	5 or drugs by any person registered pursuant to Section 510 of
6938	6938	6 the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
6939	6939	7 (y-1) "Mail-order pharmacy" means a pharmacy that is
6940	6940	8 located in a state of the United States that delivers,
6941	6941	9 dispenses or distributes, through the United States Postal
6942	6942	10 Service or other common carrier, to Illinois residents, any
6943	6943	11 substance which requires a prescription.
6944	6944	12 (z) "Manufacture" means the production, preparation,
6945	6945	13 propagation, compounding, conversion or processing of a
6946	6946	14 controlled substance other than methamphetamine, either
6947	6947	15 directly or indirectly, by extraction from substances of
6948	6948	16 natural origin, or independently by means of chemical
6949	6949	17 synthesis, or by a combination of extraction and chemical
6950	6950	18 synthesis, and includes any packaging or repackaging of the
6951	6951	19 substance or labeling of its container, except that this term
6952	6952	20 does not include:
6953	6953	21 (1) by an ultimate user, the preparation or
6954	6954	22 compounding of a controlled substance for his or her own
6955	6955	23 use;
6956	6956	24 (2) by a practitioner, or his or her authorized agent
6957	6957	25 under his or her supervision, the preparation,
6958	6958	26 compounding, packaging, or labeling of a controlled
6959	6959
6960	6960
6961	6961
6962	6962
6963	6963
6964	6964	SB2184 - 196 - LRB104 11945 RLC 22038 b
6965	6965
6966	6966
6967	6967	SB2184- 197 -LRB104 11945 RLC 22038 b SB2184 - 197 - LRB104 11945 RLC 22038 b
6968	6968	SB2184 - 197 - LRB104 11945 RLC 22038 b
6969	6969	1 substance:
6970	6970	2 (a) as an incident to his or her administering or
6971	6971	3 dispensing of a controlled substance in the course of
6972	6972	4 his or her professional practice; or
6973	6973	5 (b) as an incident to lawful research, teaching or
6974	6974	6 chemical analysis and not for sale; or
6975	6975	7 (3) the packaging, repackaging, or labeling of drugs
6976	6976	8 only to the extent permitted under the Illinois Drug Reuse
6977	6977	9 Opportunity Program Act.
6978	6978	10 (z-1) (Blank).
6979	6979	11 (z-5) "Medication shopping" means the conduct prohibited
6980	6980	12 under subsection (a) of Section 314.5 of this Act.
6981	6981	13 (z-10) "Mid-level practitioner" means (i) a physician
6982	6982	14 assistant who has been delegated authority to prescribe
6983	6983	15 through a written delegation of authority by a physician
6984	6984	16 licensed to practice medicine in all of its branches, in
6985	6985	17 accordance with Section 7.5 of the Physician Assistant
6986	6986	18 Practice Act of 1987, (ii) an advanced practice registered
6987	6987	19 nurse who has been delegated authority to prescribe through a
6988	6988	20 written delegation of authority by a physician licensed to
6989	6989	21 practice medicine in all of its branches or by a podiatric
6990	6990	22 physician, in accordance with Section 65-40 of the Nurse
6991	6991	23 Practice Act, (iii) an advanced practice registered nurse
6992	6992	24 certified as a nurse practitioner, nurse midwife, or clinical
6993	6993	25 nurse specialist who has been granted authority to prescribe
6994	6994	26 by a hospital affiliate in accordance with Section 65-45 of
6995	6995
6996	6996
6997	6997
6998	6998
6999	6999
7000	7000	SB2184 - 197 - LRB104 11945 RLC 22038 b
7001	7001
7002	7002
7003	7003	SB2184- 198 -LRB104 11945 RLC 22038 b SB2184 - 198 - LRB104 11945 RLC 22038 b
7004	7004	SB2184 - 198 - LRB104 11945 RLC 22038 b
7005	7005	1 the Nurse Practice Act, (iv) an animal euthanasia agency, or
7006	7006	2 (v) a prescribing psychologist.
7007	7007	3 (aa) "Narcotic drug" means any of the following, whether
7008	7008	4 produced directly or indirectly by extraction from substances
7009	7009	5 of vegetable origin, or independently by means of chemical
7010	7010	6 synthesis, or by a combination of extraction and chemical
7011	7011	7 synthesis:
7012	7012	8 (1) opium, opiates, derivatives of opium and opiates,
7013	7013	9 including their isomers, esters, ethers, salts, and salts
7014	7014	10 of isomers, esters, and ethers, whenever the existence of
7015	7015	11 such isomers, esters, ethers, and salts is possible within
7016	7016	12 the specific chemical designation; however the term
7017	7017	13 "narcotic drug" does not include the isoquinoline
7018	7018	14 alkaloids of opium;
7019	7019	15 (2) (blank);
7020	7020	16 (3) opium poppy and poppy straw;
7021	7021	17 (4) coca leaves, except coca leaves and extracts of
7022	7022	18 coca leaves from which substantially all of the cocaine
7023	7023	19 and ecgonine, and their isomers, derivatives and salts,
7024	7024	20 have been removed;
7025	7025	21 (5) cocaine, its salts, optical and geometric isomers,
7026	7026	22 and salts of isomers;
7027	7027	23 (6) ecgonine, its derivatives, their salts, isomers,
7028	7028	24 and salts of isomers;
7029	7029	25 (7) any compound, mixture, or preparation which
7030	7030	26 contains any quantity of any of the substances referred to
7031	7031
7032	7032
7033	7033
7034	7034
7035	7035
7036	7036	SB2184 - 198 - LRB104 11945 RLC 22038 b
7037	7037
7038	7038
7039	7039	SB2184- 199 -LRB104 11945 RLC 22038 b SB2184 - 199 - LRB104 11945 RLC 22038 b
7040	7040	SB2184 - 199 - LRB104 11945 RLC 22038 b
7041	7041	1 in subparagraphs (1) through (6).
7042	7042	2 (bb) "Nurse" means a registered nurse licensed under the
7043	7043	3 Nurse Practice Act.
7044	7044	4 (cc) (Blank).
7045	7045	5 (dd) "Opiate" means a drug derived from or related to
7046	7046	6 opium.
7047	7047	7 (ee) "Opium poppy" means the plant of the species Papaver
7048	7048	8 somniferum L., except its seeds.
7049	7049	9 (ee-5) "Oral dosage" means a tablet, capsule, elixir, or
7050	7050	10 solution or other liquid form of medication intended for
7051	7051	11 administration by mouth, but the term does not include a form
7052	7052	12 of medication intended for buccal, sublingual, or transmucosal
7053	7053	13 administration.
7054	7054	14 (ff) "Parole and Pardon Board" means the Parole and Pardon
7055	7055	15 Board of the State of Illinois or its successor agency.
7056	7056	16 (gg) "Person" means any individual, corporation,
7057	7057	17 mail-order pharmacy, government or governmental subdivision or
7058	7058	18 agency, business trust, estate, trust, partnership or
7059	7059	19 association, or any other entity.
7060	7060	20 (hh) "Pharmacist" means any person who holds a license or
7061	7061	21 certificate of registration as a registered pharmacist, a
7062	7062	22 local registered pharmacist or a registered assistant
7063	7063	23 pharmacist under the Pharmacy Practice Act.
7064	7064	24 (ii) "Pharmacy" means any store, ship or other place in
7065	7065	25 which pharmacy is authorized to be practiced under the
7066	7066	26 Pharmacy Practice Act.
7067	7067
7068	7068
7069	7069
7070	7070
7071	7071
7072	7072	SB2184 - 199 - LRB104 11945 RLC 22038 b
7073	7073
7074	7074
7075	7075	SB2184- 200 -LRB104 11945 RLC 22038 b SB2184 - 200 - LRB104 11945 RLC 22038 b
7076	7076	SB2184 - 200 - LRB104 11945 RLC 22038 b
7077	7077	1 (ii-5) "Pharmacy shopping" means the conduct prohibited
7078	7078	2 under subsection (b) of Section 314.5 of this Act.
7079	7079	3 (ii-10) "Physician" (except when the context otherwise
7080	7080	4 requires) means a person licensed to practice medicine in all
7081	7081	5 of its branches.
7082	7082	6 (jj) "Poppy straw" means all parts, except the seeds, of
7083	7083	7 the opium poppy, after mowing.
7084	7084	8 (kk) "Practitioner" means a physician licensed to practice
7085	7085	9 medicine in all its branches, dentist, optometrist, podiatric
7086	7086	10 physician, veterinarian, scientific investigator, pharmacist,
7087	7087	11 physician assistant, advanced practice registered nurse,
7088	7088	12 licensed practical nurse, registered nurse, emergency medical
7089	7089	13 services personnel, hospital, laboratory, or pharmacy, or
7090	7090	14 other person licensed, registered, or otherwise lawfully
7091	7091	15 permitted by the United States or this State to distribute,
7092	7092	16 dispense, conduct research with respect to, administer or use
7093	7093	17 in teaching or chemical analysis, a controlled substance in
7094	7094	18 the course of professional practice or research.
7095	7095	19 (ll) "Pre-printed prescription" means a written
7096	7096	20 prescription upon which the designated drug has been indicated
7097	7097	21 prior to the time of issuance; the term does not mean a written
7098	7098	22 prescription that is individually generated by machine or
7099	7099	23 computer in the prescriber's office.
7100	7100	24 (mm) "Prescriber" means a physician licensed to practice
7101	7101	25 medicine in all its branches, dentist, optometrist,
7102	7102	26 prescribing psychologist licensed under Section 4.2 of the
7103	7103
7104	7104
7105	7105
7106	7106
7107	7107
7108	7108	SB2184 - 200 - LRB104 11945 RLC 22038 b
7109	7109
7110	7110
7111	7111	SB2184- 201 -LRB104 11945 RLC 22038 b SB2184 - 201 - LRB104 11945 RLC 22038 b
7112	7112	SB2184 - 201 - LRB104 11945 RLC 22038 b
7113	7113	1 Clinical Psychologist Licensing Act with prescriptive
7114	7114	2 authority delegated under Section 4.3 of the Clinical
7115	7115	3 Psychologist Licensing Act, podiatric physician, or
7116	7116	4 veterinarian who issues a prescription, a physician assistant
7117	7117	5 who issues a prescription for a controlled substance in
7118	7118	6 accordance with Section 303.05, a written delegation, and a
7119	7119	7 written collaborative agreement required under Section 7.5 of
7120	7120	8 the Physician Assistant Practice Act of 1987, an advanced
7121	7121	9 practice registered nurse with prescriptive authority
7122	7122	10 delegated under Section 65-40 of the Nurse Practice Act and in
7123	7123	11 accordance with Section 303.05, a written delegation, and a
7124	7124	12 written collaborative agreement under Section 65-35 of the
7125	7125	13 Nurse Practice Act, an advanced practice registered nurse
7126	7126	14 certified as a nurse practitioner, nurse midwife, or clinical
7127	7127	15 nurse specialist who has been granted authority to prescribe
7128	7128	16 by a hospital affiliate in accordance with Section 65-45 of
7129	7129	17 the Nurse Practice Act and in accordance with Section 303.05,
7130	7130	18 or an advanced practice registered nurse certified as a nurse
7131	7131	19 practitioner, nurse midwife, or clinical nurse specialist who
7132	7132	20 has full practice authority pursuant to Section 65-43 of the
7133	7133	21 Nurse Practice Act.
7134	7134	22 (nn) "Prescription" means a written, facsimile, or oral
7135	7135	23 order, or an electronic order that complies with applicable
7136	7136	24 federal requirements, of a physician licensed to practice
7137	7137	25 medicine in all its branches, dentist, podiatric physician or
7138	7138	26 veterinarian for any controlled substance, of an optometrist
7139	7139
7140	7140
7141	7141
7142	7142
7143	7143
7144	7144	SB2184 - 201 - LRB104 11945 RLC 22038 b
7145	7145
7146	7146
7147	7147	SB2184- 202 -LRB104 11945 RLC 22038 b SB2184 - 202 - LRB104 11945 RLC 22038 b
7148	7148	SB2184 - 202 - LRB104 11945 RLC 22038 b
7149	7149	1 in accordance with Section 15.1 of the Illinois Optometric
7150	7150	2 Practice Act of 1987, of a prescribing psychologist licensed
7151	7151	3 under Section 4.2 of the Clinical Psychologist Licensing Act
7152	7152	4 with prescriptive authority delegated under Section 4.3 of the
7153	7153	5 Clinical Psychologist Licensing Act, of a physician assistant
7154	7154	6 for a controlled substance in accordance with Section 303.05,
7155	7155	7 a written delegation, and a written collaborative agreement
7156	7156	8 required under Section 7.5 of the Physician Assistant Practice
7157	7157	9 Act of 1987, of an advanced practice registered nurse with
7158	7158	10 prescriptive authority delegated under Section 65-40 of the
7159	7159	11 Nurse Practice Act who issues a prescription for a controlled
7160	7160	12 substance in accordance with Section 303.05, a written
7161	7161	13 delegation, and a written collaborative agreement under
7162	7162	14 Section 65-35 of the Nurse Practice Act, of an advanced
7163	7163	15 practice registered nurse certified as a nurse practitioner,
7164	7164	16 nurse midwife, or clinical nurse specialist who has been
7165	7165	17 granted authority to prescribe by a hospital affiliate in
7166	7166	18 accordance with Section 65-45 of the Nurse Practice Act and in
7167	7167	19 accordance with Section 303.05 when required by law, or of an
7168	7168	20 advanced practice registered nurse certified as a nurse
7169	7169	21 practitioner, nurse midwife, or clinical nurse specialist who
7170	7170	22 has full practice authority pursuant to Section 65-43 of the
7171	7171	23 Nurse Practice Act.
7172	7172	24 (nn-5) "Prescription Information Library" (PIL) means an
7173	7173	25 electronic library that contains reported controlled substance
7174	7174	26 data.
7175	7175
7176	7176
7177	7177
7178	7178
7179	7179
7180	7180	SB2184 - 202 - LRB104 11945 RLC 22038 b
7181	7181
7182	7182
7183	7183	SB2184- 203 -LRB104 11945 RLC 22038 b SB2184 - 203 - LRB104 11945 RLC 22038 b
7184	7184	SB2184 - 203 - LRB104 11945 RLC 22038 b
7185	7185	1 (nn-10) "Prescription Monitoring Program" (PMP) means the
7186	7186	2 entity that collects, tracks, and stores reported data on
7187	7187	3 controlled substances and select drugs pursuant to Section
7188	7188	4 316.
7189	7189	5 (oo) "Production" or "produce" means manufacture,
7190	7190	6 planting, cultivating, growing, or harvesting of a controlled
7191	7191	7 substance other than methamphetamine.
7192	7192	8 (pp) "Registrant" means every person who is required to
7193	7193	9 register under Section 302 of this Act.
7194	7194	10 (qq) "Registry number" means the number assigned to each
7195	7195	11 person authorized to handle controlled substances under the
7196	7196	12 laws of the United States and of this State.
7197	7197	13 (qq-5) "Secretary" means, as the context requires, either
7198	7198	14 the Secretary of the Department or the Secretary of the
7199	7199	15 Department of Financial and Professional Regulation, and the
7200	7200	16 Secretary's designated agents.
7201	7201	17 (rr) "State" includes the State of Illinois and any state,
7202	7202	18 district, commonwealth, territory, insular possession thereof,
7203	7203	19 and any area subject to the legal authority of the United
7204	7204	20 States of America.
7205	7205	21 (rr-5) "Stimulant" means any drug that (i) causes an
7206	7206	22 overall excitation of central nervous system functions, (ii)
7207	7207	23 causes impaired consciousness and awareness, and (iii) can be
7208	7208	24 habit-forming or lead to a substance use disorder, including,
7209	7209	25 but not limited to, amphetamines and their analogs,
7210	7210	26 methylphenidate and its analogs, cocaine, and phencyclidine
7211	7211
7212	7212
7213	7213
7214	7214
7215	7215
7216	7216	SB2184 - 203 - LRB104 11945 RLC 22038 b
7217	7217
7218	7218
7219	7219	SB2184- 204 -LRB104 11945 RLC 22038 b SB2184 - 204 - LRB104 11945 RLC 22038 b
7220	7220	SB2184 - 204 - LRB104 11945 RLC 22038 b
7221	7221	1 and its analogs.
7222	7222	2 (rr-10) "Synthetic drug" includes, but is not limited to,
7223	7223	3 any synthetic cannabinoids or piperazines or any synthetic
7224	7224	4 cathinones as provided for in Schedule I.
7225	7225	5 (ss) "Ultimate user" means a person who lawfully possesses
7226	7226	6 a controlled substance for his or her own use or for the use of
7227	7227	7 a member of his or her household or for administering to an
7228	7228	8 animal owned by him or her or by a member of his or her
7229	7229	9 household.
7230	7230	10 (Source: P.A. 102-389, eff. 1-1-22; 102-538, eff. 8-20-21;
7231	7231	11 102-813, eff. 5-13-22; 103-881, eff. 1-1-25.)
7232	7232	12 (720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
7233	7233	13 Sec. 204. (a) The controlled substances listed in this
7234	7234	14 Section are included in Schedule I.
7235	7235	15 (b) Unless specifically excepted or unless listed in
7236	7236	16 another schedule, any of the following opiates, including
7237	7237	17 their isomers, esters, ethers, salts, and salts of isomers,
7238	7238	18 esters, and ethers, whenever the existence of such isomers,
7239	7239	19 esters, ethers and salts is possible within the specific
7240	7240	20 chemical designation:
7241	7241	21 (1) Acetylmethadol;
7242	7242	22 (1.1) Acetyl-alpha-methylfentanyl
7243	7243	23 (N-[1-(1-methyl-2-phenethyl)-
7244	7244	24 4-piperidinyl]-N-phenylacetamide);
7245	7245	25 (2) Allylprodine;
7246	7246
7247	7247
7248	7248
7249	7249
7250	7250
7251	7251	SB2184 - 204 - LRB104 11945 RLC 22038 b
7252	7252
7253	7253
7254	7254	SB2184- 205 -LRB104 11945 RLC 22038 b SB2184 - 205 - LRB104 11945 RLC 22038 b
7255	7255	SB2184 - 205 - LRB104 11945 RLC 22038 b
7256	7256	1 (3) Alphacetylmethadol, except
7257	7257	2 levo-alphacetylmethadol (also known as levo-alpha-
7258	7258	3 acetylmethadol, levomethadyl acetate, or LAAM);
7259	7259	4 (4) Alphameprodine;
7260	7260	5 (5) Alphamethadol;
7261	7261	6 (6) Alpha-methylfentanyl
7262	7262	7 (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
7263	7263	8 propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
7264	7264	9 propanilido) piperidine;
7265	7265	10 (6.1) Alpha-methylthiofentanyl
7266	7266	11 (N-[1-methyl-2-(2-thienyl)ethyl-
7267	7267	12 4-piperidinyl]-N-phenylpropanamide);
7268	7268	13 (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
7269	7269	14 (7.1) PEPAP
7270	7270	15 (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
7271	7271	16 (8) Benzethidine;
7272	7272	17 (9) Betacetylmethadol;
7273	7273	18 (9.1) Beta-hydroxyfentanyl
7274	7274	19 (N-[1-(2-hydroxy-2-phenethyl)-
7275	7275	20 4-piperidinyl]-N-phenylpropanamide);
7276	7276	21 (10) Betameprodine;
7277	7277	22 (11) Betamethadol;
7278	7278	23 (12) Betaprodine;
7279	7279	24 (13) Clonitazene;
7280	7280	25 (14) Dextromoramide;
7281	7281	26 (15) Diampromide;
7282	7282
7283	7283
7284	7284
7285	7285
7286	7286
7287	7287	SB2184 - 205 - LRB104 11945 RLC 22038 b
7288	7288
7289	7289
7290	7290	SB2184- 206 -LRB104 11945 RLC 22038 b SB2184 - 206 - LRB104 11945 RLC 22038 b
7291	7291	SB2184 - 206 - LRB104 11945 RLC 22038 b
7292	7292	1 (16) Diethylthiambutene;
7293	7293	2 (17) Difenoxin;
7294	7294	3 (18) Dimenoxadol;
7295	7295	4 (19) Dimepheptanol;
7296	7296	5 (20) Dimethylthiambutene;
7297	7297	6 (21) Dioxaphetylbutyrate;
7298	7298	7 (22) Dipipanone;
7299	7299	8 (23) Ethylmethylthiambutene;
7300	7300	9 (24) Etonitazene;
7301	7301	10 (25) Etoxeridine;
7302	7302	11 (26) Furethidine;
7303	7303	12 (27) Hydroxpethidine;
7304	7304	13 (28) Ketobemidone;
7305	7305	14 (29) Levomoramide;
7306	7306	15 (30) Levophenacylmorphan;
7307	7307	16 (31) 3-Methylfentanyl
7308	7308	17 (N-[3-methyl-1-(2-phenylethyl)-
7309	7309	18 4-piperidyl]-N-phenylpropanamide);
7310	7310	19 (31.1) 3-Methylthiofentanyl
7311	7311	20 (N-[(3-methyl-1-(2-thienyl)ethyl-
7312	7312	21 4-piperidinyl]-N-phenylpropanamide);
7313	7313	22 (32) Morpheridine;
7314	7314	23 (33) Noracymethadol;
7315	7315	24 (34) Norlevorphanol;
7316	7316	25 (35) Normethadone;
7317	7317	26 (36) Norpipanone;
7318	7318
7319	7319
7320	7320
7321	7321
7322	7322
7323	7323	SB2184 - 206 - LRB104 11945 RLC 22038 b
7324	7324
7325	7325
7326	7326	SB2184- 207 -LRB104 11945 RLC 22038 b SB2184 - 207 - LRB104 11945 RLC 22038 b
7327	7327	SB2184 - 207 - LRB104 11945 RLC 22038 b
7328	7328	1 (36.1) Para-fluorofentanyl
7329	7329	2 (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
7330	7330	3 4-piperidinyl]propanamide);
7331	7331	4 (37) Phenadoxone;
7332	7332	5 (38) Phenampromide;
7333	7333	6 (39) Phenomorphan;
7334	7334	7 (40) Phenoperidine;
7335	7335	8 (41) Piritramide;
7336	7336	9 (42) Proheptazine;
7337	7337	10 (43) Properidine;
7338	7338	11 (44) Propiram;
7339	7339	12 (45) Racemoramide;
7340	7340	13 (45.1) Thiofentanyl
7341	7341	14 (N-phenyl-N-[1-(2-thienyl)ethyl-
7342	7342	15 4-piperidinyl]-propanamide);
7343	7343	16 (46) Tilidine;
7344	7344	17 (47) Trimeperidine;
7345	7345	18 (48) Beta-hydroxy-3-methylfentanyl (other name:
7346	7346	19 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
7347	7347	20 N-phenylpropanamide);
7348	7348	21 (49) Furanyl fentanyl (FU-F);
7349	7349	22 (50) Butyryl fentanyl;
7350	7350	23 (51) Valeryl fentanyl;
7351	7351	24 (52) Acetyl fentanyl;
7352	7352	25 (53) Beta-hydroxy-thiofentanyl;
7353	7353	26 (54) 3,4-dichloro-N-[2-
7354	7354
7355	7355
7356	7356
7357	7357
7358	7358
7359	7359	SB2184 - 207 - LRB104 11945 RLC 22038 b
7360	7360
7361	7361
7362	7362	SB2184- 208 -LRB104 11945 RLC 22038 b SB2184 - 208 - LRB104 11945 RLC 22038 b
7363	7363	SB2184 - 208 - LRB104 11945 RLC 22038 b
7364	7364	1 (dimethylamino)cyclohexyl]-N-
7365	7365	2 methylbenzamide (U-47700);
7366	7366	3 (55) 4-chloro-N-[1-[2-
7367	7367	4 (4-nitrophenyl)ethyl]-2-piperidinylidene]-
7368	7368	5 benzenesulfonamide (W-18);
7369	7369	6 (56) 4-chloro-N-[1-(2-phenylethyl)
7370	7370	7 -2-piperidinylidene]-benzenesulfonamide (W-15);
7371	7371	8 (57) acrylfentanyl (acryloylfentanyl).
7372	7372	9 (c) Unless specifically excepted or unless listed in
7373	7373	10 another schedule, any of the following opium derivatives, its
7374	7374	11 salts, isomers and salts of isomers, whenever the existence of
7375	7375	12 such salts, isomers and salts of isomers is possible within
7376	7376	13 the specific chemical designation:
7377	7377	14 (1) Acetorphine;
7378	7378	15 (2) Acetyldihydrocodeine;
7379	7379	16 (3) Benzylmorphine;
7380	7380	17 (4) Codeine methylbromide;
7381	7381	18 (5) Codeine-N-Oxide;
7382	7382	19 (6) Cyprenorphine;
7383	7383	20 (7) Desomorphine;
7384	7384	21 (8) Diacetyldihydromorphine (Dihydroheroin);
7385	7385	22 (9) Dihydromorphine;
7386	7386	23 (10) Drotebanol;
7387	7387	24 (11) Etorphine (except hydrochloride salt);
7388	7388	25 (12) Heroin;
7389	7389	26 (13) Hydromorphinol;
7390	7390
7391	7391
7392	7392
7393	7393
7394	7394
7395	7395	SB2184 - 208 - LRB104 11945 RLC 22038 b
7396	7396
7397	7397
7398	7398	SB2184- 209 -LRB104 11945 RLC 22038 b SB2184 - 209 - LRB104 11945 RLC 22038 b
7399	7399	SB2184 - 209 - LRB104 11945 RLC 22038 b
7400	7400	1 (14) Methyldesorphine;
7401	7401	2 (15) Methyldihydromorphine;
7402	7402	3 (16) Morphine methylbromide;
7403	7403	4 (17) Morphine methylsulfonate;
7404	7404	5 (18) Morphine-N-Oxide;
7405	7405	6 (19) Myrophine;
7406	7406	7 (20) Nicocodeine;
7407	7407	8 (21) Nicomorphine;
7408	7408	9 (22) Normorphine;
7409	7409	10 (23) Pholcodine;
7410	7410	11 (24) Thebacon.
7411	7411	12 (d) Unless specifically excepted or unless listed in
7412	7412	13 another schedule, any material, compound, mixture, or
7413	7413	14 preparation which contains any quantity of the following
7414	7414	15 hallucinogenic substances, or which contains any of its salts,
7415	7415	16 isomers and salts of isomers, whenever the existence of such
7416	7416	17 salts, isomers, and salts of isomers is possible within the
7417	7417	18 specific chemical designation (for the purposes of this
7418	7418	19 paragraph only, the term "isomer" includes the optical,
7419	7419	20 position and geometric isomers):
7420	7420	21 (1) 3,4-methylenedioxyamphetamine
7421	7421	22 (alpha-methyl,3,4-methylenedioxyphenethylamine,
7422	7422	23 methylenedioxyamphetamine, MDA);
7423	7423	24 (1.1) Alpha-ethyltryptamine
7424	7424	25 (some trade or other names: etryptamine;
7425	7425	26 MONASE; alpha-ethyl-1H-indole-3-ethanamine;
7426	7426
7427	7427
7428	7428
7429	7429
7430	7430
7431	7431	SB2184 - 209 - LRB104 11945 RLC 22038 b
7432	7432
7433	7433
7434	7434	SB2184- 210 -LRB104 11945 RLC 22038 b SB2184 - 210 - LRB104 11945 RLC 22038 b
7435	7435	SB2184 - 210 - LRB104 11945 RLC 22038 b
7436	7436	1 3-(2-aminobutyl)indole; a-ET; and AET);
7437	7437	2 (2) 3,4-methylenedioxymethamphetamine (MDMA);
7438	7438	3 (2.1) 3,4-methylenedioxy-N-ethylamphetamine
7439	7439	4 (also known as: N-ethyl-alpha-methyl-
7440	7440	5 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
7441	7441	6 and MDEA);
7442	7442	7 (2.2) N-Benzylpiperazine (BZP);
7443	7443	8 (2.2-1) Trifluoromethylphenylpiperazine (TFMPP);
7444	7444	9 (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
7445	7445	10 (4) 3,4,5-trimethoxyamphetamine (TMA);
7446	7446	11 (5) (Blank);
7447	7447	12 (6) Diethyltryptamine (DET);
7448	7448	13 (7) Dimethyltryptamine (DMT);
7449	7449	14 (7.1) 5-Methoxy-diallyltryptamine;
7450	7450	15 (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
7451	7451	16 (9) Ibogaine (some trade and other names:
7452	7452	17 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
7453	7453	18 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
7454	7454	19 indole; Tabernanthe iboga);
7455	7455	20 (10) Lysergic acid diethylamide;
7456	7456	21 (10.1) Salvinorin A;
7457	7457	22 (10.5) Salvia divinorum (meaning all parts of the
7458	7458	23 plant presently classified botanically as Salvia
7459	7459	24 divinorum, whether growing or not, the seeds thereof, any
7460	7460	25 extract from any part of that plant, and every compound,
7461	7461	26 manufacture, salts, isomers, and salts of isomers whenever
7462	7462
7463	7463
7464	7464
7465	7465
7466	7466
7467	7467	SB2184 - 210 - LRB104 11945 RLC 22038 b
7468	7468
7469	7469
7470	7470	SB2184- 211 -LRB104 11945 RLC 22038 b SB2184 - 211 - LRB104 11945 RLC 22038 b
7471	7471	SB2184 - 211 - LRB104 11945 RLC 22038 b
7472	7472	1 the existence of such salts, isomers, and salts of isomers
7473	7473	2 is possible within the specific chemical designation,
7474	7474	3 derivative, mixture, or preparation of that plant, its
7475	7475	4 seeds or extracts);
7476	7476	5 (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
7477	7477	6 (12) Peyote (meaning all parts of the plant presently
7478	7478	7 classified botanically as Lophophora williamsii Lemaire,
7479	7479	8 whether growing or not, the seeds thereof, any extract
7480	7480	9 from any part of that plant, and every compound,
7481	7481	10 manufacture, salts, derivative, mixture, or preparation of
7482	7482	11 that plant, its seeds or extracts);
7483	7483	12 (13) N-ethyl-3-piperidyl benzilate (JB 318);
7484	7484	13 (14) N-methyl-3-piperidyl benzilate;
7485	7485	14 (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
7486	7486	15 (also known as N-hydroxy-alpha-methyl-
7487	7487	16 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
7488	7488	17 (15) Parahexyl; some trade or other names:
7489	7489	18 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
7490	7490	19 dibenzo (b,d) pyran; Synhexyl;
7491	7491	20 (16) (Blank); Psilocybin;
7492	7492	21 (17) (Blank); Psilocyn;
7493	7493	22 (18) Alpha-methyltryptamine (AMT);
7494	7494	23 (19) 2,5-dimethoxyamphetamine
7495	7495	24 (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
7496	7496	25 (20) 4-bromo-2,5-dimethoxyamphetamine
7497	7497	26 (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
7498	7498
7499	7499
7500	7500
7501	7501
7502	7502
7503	7503	SB2184 - 211 - LRB104 11945 RLC 22038 b
7504	7504
7505	7505
7506	7506	SB2184- 212 -LRB104 11945 RLC 22038 b SB2184 - 212 - LRB104 11945 RLC 22038 b
7507	7507	SB2184 - 212 - LRB104 11945 RLC 22038 b
7508	7508	1 4-bromo-2,5-DMA);
7509	7509	2 (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
7510	7510	3 Some trade or other names: 2-(4-bromo-
7511	7511	4 2,5-dimethoxyphenyl)-1-aminoethane;
7512	7512	5 alpha-desmethyl DOB, 2CB, Nexus;
7513	7513	6 (21) 4-methoxyamphetamine
7514	7514	7 (4-methoxy-alpha-methylphenethylamine;
7515	7515	8 paramethoxyamphetamine; PMA);
7516	7516	9 (22) (Blank);
7517	7517	10 (23) Ethylamine analog of phencyclidine.
7518	7518	11 Some trade or other names:
7519	7519	12 N-ethyl-1-phenylcyclohexylamine,
7520	7520	13 (1-phenylcyclohexyl) ethylamine,
7521	7521	14 N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
7522	7522	15 (24) Pyrrolidine analog of phencyclidine. Some trade
7523	7523	16 or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
7524	7524	17 PHP;
7525	7525	18 (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
7526	7526	19 (26) 2,5-dimethoxy-4-ethylamphetamine
7527	7527	20 (another name: DOET);
7528	7528	21 (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
7529	7529	22 (another name: TCPy);
7530	7530	23 (28) (Blank);
7531	7531	24 (29) Thiophene analog of phencyclidine (some trade
7532	7532	25 or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
7533	7533	26 2-thienyl analog of phencyclidine; TPCP; TCP);
7534	7534
7535	7535
7536	7536
7537	7537
7538	7538
7539	7539	SB2184 - 212 - LRB104 11945 RLC 22038 b
7540	7540
7541	7541
7542	7542	SB2184- 213 -LRB104 11945 RLC 22038 b SB2184 - 213 - LRB104 11945 RLC 22038 b
7543	7543	SB2184 - 213 - LRB104 11945 RLC 22038 b
7544	7544	1 (29.1) Benzothiophene analog of phencyclidine. Some
7545	7545	2 trade or other names: BTCP or benocyclidine;
7546	7546	3 (29.2) 3-Methoxyphencyclidine (3-MeO-PCP);
7547	7547	4 (30) Bufotenine (some trade or other names:
7548	7548	5 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
7549	7549	6 3-(2-dimethylaminoethyl)-5-indolol;
7550	7550	7 5-hydroxy-N,N-dimethyltryptamine;
7551	7551	8 N,N-dimethylserotonin; mappine);
7552	7552	9 (31) (Blank);
7553	7553	10 (32) (Blank);
7554	7554	11 (33) (Blank);
7555	7555	12 (34) (Blank);
7556	7556	13 (34.5) (Blank);
7557	7557	14 (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
7558	7558	15 (2-methyloctan-2-yl)-6a,7,
7559	7559	16 10,10a-tetrahydrobenzo[c]chromen-1-ol
7560	7560	17 Some trade or other names: HU-210;
7561	7561	18 (35.5) (6aS,10aS)-9-(hydroxymethyl)-6,6-
7562	7562	19 dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
7563	7563	20 tetrahydrobenzo[c]chromen-1-ol, its isomers,
7564	7564	21 salts, and salts of isomers; Some trade or other
7565	7565	22 names: HU-210, Dexanabinol;
7566	7566	23 (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
7567	7567	24 6,6-dimethyl-3-(2-methyloctan-2-yl)-
7568	7568	25 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
7569	7569	26 Some trade or other names: HU-211;
7570	7570
7571	7571
7572	7572
7573	7573
7574	7574
7575	7575	SB2184 - 213 - LRB104 11945 RLC 22038 b
7576	7576
7577	7577
7578	7578	SB2184- 214 -LRB104 11945 RLC 22038 b SB2184 - 214 - LRB104 11945 RLC 22038 b
7579	7579	SB2184 - 214 - LRB104 11945 RLC 22038 b
7580	7580	1 (37) (Blank);
7581	7581	2 (38) (Blank);
7582	7582	3 (39) (Blank);
7583	7583	4 (40) (Blank);
7584	7584	5 (41) (Blank);
7585	7585	6 (42) Any compound structurally derived from
7586	7586	7 3-(1-naphthoyl)indole or
7587	7587	8 1H-indol-3-yl-(1-naphthyl)methane by substitution at the
7588	7588	9 nitrogen atom of the indole ring by alkyl, haloalkyl,
7589	7589	10 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
7590	7590	11 alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
7591	7591	12 2-(4-morpholinyl)ethyl whether or not further substituted
7592	7592	13 in the indole ring to any extent, whether or not
7593	7593	14 substituted in the naphthyl ring to any extent. Examples
7594	7594	15 of this structural class include, but are not limited to,
7595	7595	16 JWH-018, AM-2201, JWH-175, JWH-184, and JWH-185;
7596	7596	17 (43) Any compound structurally derived from
7597	7597	18 3-(1-naphthoyl)pyrrole by substitution at the nitrogen
7598	7598	19 atom of the pyrrole ring by alkyl, haloalkyl, alkenyl,
7599	7599	20 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7600	7600	21 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7601	7601	22 2-(4-morpholinyl)ethyl, whether or not further substituted
7602	7602	23 in the pyrrole ring to any extent, whether or not
7603	7603	24 substituted in the naphthyl ring to any extent. Examples
7604	7604	25 of this structural class include, but are not limited to,
7605	7605	26 JWH-030, JWH-145, JWH-146, JWH-307, and JWH-368;
7606	7606
7607	7607
7608	7608
7609	7609
7610	7610
7611	7611	SB2184 - 214 - LRB104 11945 RLC 22038 b
7612	7612
7613	7613
7614	7614	SB2184- 215 -LRB104 11945 RLC 22038 b SB2184 - 215 - LRB104 11945 RLC 22038 b
7615	7615	SB2184 - 215 - LRB104 11945 RLC 22038 b
7616	7616	1 (44) Any compound structurally derived from
7617	7617	2 1-(1-naphthylmethyl)indene by substitution at the
7618	7618	3 3-position of the indene ring by alkyl, haloalkyl,
7619	7619	4 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
7620	7620	5 alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
7621	7621	6 2-(4-morpholinyl)ethyl whether or not further substituted
7622	7622	7 in the indene ring to any extent, whether or not
7623	7623	8 substituted in the naphthyl ring to any extent. Examples
7624	7624	9 of this structural class include, but are not limited to,
7625	7625	10 JWH-176;
7626	7626	11 (45) Any compound structurally derived from
7627	7627	12 3-phenylacetylindole by substitution at the nitrogen atom
7628	7628	13 of the indole ring with alkyl, haloalkyl, alkenyl,
7629	7629	14 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7630	7630	15 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7631	7631	16 2-(4-morpholinyl)ethyl, whether or not further substituted
7632	7632	17 in the indole ring to any extent, whether or not
7633	7633	18 substituted in the phenyl ring to any extent. Examples of
7634	7634	19 this structural class include, but are not limited to,
7635	7635	20 JWH-167, JWH-250, JWH-251, and RCS-8;
7636	7636	21 (46) Any compound structurally derived from
7637	7637	22 2-(3-hydroxycyclohexyl)phenol by substitution at the
7638	7638	23 5-position of the phenolic ring by alkyl, haloalkyl,
7639	7639	24 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
7640	7640	25 alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
7641	7641	26 2-(4-morpholinyl)ethyl, whether or not substituted in the
7642	7642
7643	7643
7644	7644
7645	7645
7646	7646
7647	7647	SB2184 - 215 - LRB104 11945 RLC 22038 b
7648	7648
7649	7649
7650	7650	SB2184- 216 -LRB104 11945 RLC 22038 b SB2184 - 216 - LRB104 11945 RLC 22038 b
7651	7651	SB2184 - 216 - LRB104 11945 RLC 22038 b
7652	7652	1 cyclohexyl ring to any extent. Examples of this structural
7653	7653	2 class include, but are not limited to, CP 47, 497 and its
7654	7654	3 C8 homologue (cannabicyclohexanol);
7655	7655	4 (46.1) Any compound structurally derived from
7656	7656	5 3-(benzoyl) indole with substitution at the nitrogen atom
7657	7657	6 of the indole ring by an alkyl, haloalkyl, alkenyl,
7658	7658	7 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7659	7659	8 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7660	7660	9 2-(4-morpholinyl)ethyl group whether or not further
7661	7661	10 substituted in the indole ring to any extent and whether
7662	7662	11 or not substituted in the phenyl ring to any extent.
7663	7663	12 Examples of this structural class include, but are not
7664	7664	13 limited to, AM-630, AM-2233, AM-694, Pravadoline (WIN
7665	7665	14 48,098), and RCS-4;
7666	7666	15 (47) (Blank);
7667	7667	16 (48) (Blank);
7668	7668	17 (49) (Blank);
7669	7669	18 (50) (Blank);
7670	7670	19 (51) (Blank);
7671	7671	20 (52) (Blank);
7672	7672	21 (53) 2,5-Dimethoxy-4-(n)-propylthio-phenethylamine.
7673	7673	22 Some trade or other names: 2C-T-7;
7674	7674	23 (53.1) 4-ethyl-2,5-dimethoxyphenethylamine. Some
7675	7675	24 trade or other names: 2C-E;
7676	7676	25 (53.2) 2,5-dimethoxy-4-methylphenethylamine. Some
7677	7677	26 trade or other names: 2C-D;
7678	7678
7679	7679
7680	7680
7681	7681
7682	7682
7683	7683	SB2184 - 216 - LRB104 11945 RLC 22038 b
7684	7684
7685	7685
7686	7686	SB2184- 217 -LRB104 11945 RLC 22038 b SB2184 - 217 - LRB104 11945 RLC 22038 b
7687	7687	SB2184 - 217 - LRB104 11945 RLC 22038 b
7688	7688	1 (53.3) 4-chloro-2,5-dimethoxyphenethylamine. Some
7689	7689	2 trade or other names: 2C-C;
7690	7690	3 (53.4) 4-iodo-2,5-dimethoxyphenethylamine. Some trade
7691	7691	4 or other names: 2C-I;
7692	7692	5 (53.5) 4-ethylthio-2,5-dimethoxyphenethylamine. Some
7693	7693	6 trade or other names: 2C-T-2;
7694	7694	7 (53.6) 2,5-dimethoxy-4-isopropylthio-phenethylamine.
7695	7695	8 Some trade or other names: 2C-T-4;
7696	7696	9 (53.7) 2,5-dimethoxyphenethylamine. Some trade or
7697	7697	10 other names: 2C-H;
7698	7698	11 (53.8) 2,5-dimethoxy-4-nitrophenethylamine. Some
7699	7699	12 trade or other names: 2C-N;
7700	7700	13 (53.9) 2,5-dimethoxy-4-(n)-propylphenethylamine. Some
7701	7701	14 trade or other names: 2C-P;
7702	7702	15 (53.10) 2,5-dimethoxy-3,4-dimethylphenethylamine.
7703	7703	16 Some trade or other names: 2C-G;
7704	7704	17 (53.11) The N-(2-methoxybenzyl) derivative of any 2C
7705	7705	18 phenethylamine referred to in subparagraphs (20.1), (53),
7706	7706	19 (53.1), (53.2), (53.3), (53.4), (53.5), (53.6), (53.7),
7707	7707	20 (53.8), (53.9), and (53.10) including, but not limited to,
7708	7708	21 25I-NBOMe and 25C-NBOMe;
7709	7709	22 (54) 5-Methoxy-N,N-diisopropyltryptamine;
7710	7710	23 (55) (Blank);
7711	7711	24 (56) (Blank);
7712	7712	25 (57) (Blank);
7713	7713	26 (58) (Blank);
7714	7714
7715	7715
7716	7716
7717	7717
7718	7718
7719	7719	SB2184 - 217 - LRB104 11945 RLC 22038 b
7720	7720
7721	7721
7722	7722	SB2184- 218 -LRB104 11945 RLC 22038 b SB2184 - 218 - LRB104 11945 RLC 22038 b
7723	7723	SB2184 - 218 - LRB104 11945 RLC 22038 b
7724	7724	1 (59) 3-cyclopropoylindole with substitution at the
7725	7725	2 nitrogen atom of the indole ring by alkyl, haloalkyl,
7726	7726	3 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
7727	7727	4 alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
7728	7728	5 2-(4-morpholinyl)ethyl, whether or not further substituted
7729	7729	6 on the indole ring to any extent, whether or not
7730	7730	7 substituted on the cyclopropyl ring to any extent:
7731	7731	8 including, but not limited to, XLR11, UR144, FUB-144;
7732	7732	9 (60) 3-adamantoylindole with substitution at the
7733	7733	10 nitrogen atom of the indole ring by alkyl, haloalkyl,
7734	7734	11 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
7735	7735	12 alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
7736	7736	13 2-(4-morpholinyl)ethyl, whether or not further substituted
7737	7737	14 on the indole ring to any extent, whether or not
7738	7738	15 substituted on the adamantyl ring to any extent:
7739	7739	16 including, but not limited to, AB-001;
7740	7740	17 (61) N-(adamantyl)-indole-3-carboxamide with
7741	7741	18 substitution at the nitrogen atom of the indole ring by
7742	7742	19 alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
7743	7743	20 cycloalkylethyl, aryl halide, alkyl aryl halide,
7744	7744	21 1-(N-methyl-2-piperidinyl)methyl, or
7745	7745	22 2-(4-morpholinyl)ethyl, whether or not further substituted
7746	7746	23 on the indole ring to any extent, whether or not
7747	7747	24 substituted on the adamantyl ring to any extent:
7748	7748	25 including, but not limited to, APICA/2NE-1, STS-135;
7749	7749	26 (62) N-(adamantyl)-indazole-3-carboxamide with
7750	7750
7751	7751
7752	7752
7753	7753
7754	7754
7755	7755	SB2184 - 218 - LRB104 11945 RLC 22038 b
7756	7756
7757	7757
7758	7758	SB2184- 219 -LRB104 11945 RLC 22038 b SB2184 - 219 - LRB104 11945 RLC 22038 b
7759	7759	SB2184 - 219 - LRB104 11945 RLC 22038 b
7760	7760	1 substitution at a nitrogen atom of the indazole ring by
7761	7761	2 alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
7762	7762	3 cycloalkylethyl, aryl halide, alkyl aryl halide,
7763	7763	4 1-(N-methyl-2-piperidinyl)methyl, or
7764	7764	5 2-(4-morpholinyl)ethyl, whether or not further substituted
7765	7765	6 on the indazole ring to any extent, whether or not
7766	7766	7 substituted on the adamantyl ring to any extent:
7767	7767	8 including, but not limited to, AKB48, 5F-AKB48;
7768	7768	9 (63) 1H-indole-3-carboxylic acid 8-quinolinyl ester
7769	7769	10 with substitution at the nitrogen atom of the indole ring
7770	7770	11 by alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
7771	7771	12 cycloalkylethyl, aryl halide, alkyl aryl halide,
7772	7772	13 1-(N-methyl-2-piperidinyl)methyl, or
7773	7773	14 2-(4-morpholinyl)ethyl, whether or not further substituted
7774	7774	15 on the indole ring to any extent, whether or not
7775	7775	16 substituted on the quinoline ring to any extent:
7776	7776	17 including, but not limited to, PB22, 5F-PB22, FUB-PB-22;
7777	7777	18 (64) 3-(1-naphthoyl)indazole with substitution at the
7778	7778	19 nitrogen atom of the indazole ring by alkyl, haloalkyl,
7779	7779	20 alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
7780	7780	21 alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
7781	7781	22 2-(4-morpholinyl)ethyl, whether or not further substituted
7782	7782	23 on the indazole ring to any extent, whether or not
7783	7783	24 substituted on the naphthyl ring to any extent: including,
7784	7784	25 but not limited to, THJ-018, THJ-2201;
7785	7785	26 (65) 2-(1-naphthoyl)benzimidazole with substitution
7786	7786
7787	7787
7788	7788
7789	7789
7790	7790
7791	7791	SB2184 - 219 - LRB104 11945 RLC 22038 b
7792	7792
7793	7793
7794	7794	SB2184- 220 -LRB104 11945 RLC 22038 b SB2184 - 220 - LRB104 11945 RLC 22038 b
7795	7795	SB2184 - 220 - LRB104 11945 RLC 22038 b
7796	7796	1 at the nitrogen atom of the benzimidazole ring by alkyl,
7797	7797	2 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
7798	7798	3 aryl halide, alkyl aryl halide,
7799	7799	4 1-(N-methyl-2-piperidinyl)methyl, or
7800	7800	5 2-(4-morpholinyl)ethyl, whether or not further substituted
7801	7801	6 on the benzimidazole ring to any extent, whether or not
7802	7802	7 substituted on the naphthyl ring to any extent: including,
7803	7803	8 but not limited to, FUBIMINA;
7804	7804	9 (66)
7805	7805	10 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1H-indazole-
7806	7806	11 3-carboxamide with substitution on the nitrogen atom of
7807	7807	12 the indazole ring by alkyl, haloalkyl, alkenyl,
7808	7808	13 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7809	7809	14 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7810	7810	15 2-(4-morpholinyl)ethyl, whether or not further substituted
7811	7811	16 on the indazole ring to any extent: including, but not
7812	7812	17 limited to, AB-PINACA, AB-FUBINACA, AB-CHMINACA;
7813	7813	18 (67) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-
7814	7814	19 indazole-3-carboxamide with substitution on the nitrogen
7815	7815	20 atom of the indazole ring by alkyl, haloalkyl, alkenyl,
7816	7816	21 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7817	7817	22 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7818	7818	23 2-(4-morpholinyl)ethyl, whether or not further substituted
7819	7819	24 on the indazole ring to any extent: including, but not
7820	7820	25 limited to, ADB-PINACA, ADB-FUBINACA;
7821	7821	26 (68) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-
7822	7822
7823	7823
7824	7824
7825	7825
7826	7826
7827	7827	SB2184 - 220 - LRB104 11945 RLC 22038 b
7828	7828
7829	7829
7830	7830	SB2184- 221 -LRB104 11945 RLC 22038 b SB2184 - 221 - LRB104 11945 RLC 22038 b
7831	7831	SB2184 - 221 - LRB104 11945 RLC 22038 b
7832	7832	1 indole-3-carboxamide with substitution on the nitrogen
7833	7833	2 atom of the indole ring by alkyl, haloalkyl, alkenyl,
7834	7834	3 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7835	7835	4 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7836	7836	5 2-(4-morpholinyl)ethyl, whether or not further substituted
7837	7837	6 on the indole ring to any extent: including, but not
7838	7838	7 limited to, ADBICA, 5F-ADBICA;
7839	7839	8 (69) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1H-indole-
7840	7840	9 3-carboxamide with substitution on the nitrogen atom of
7841	7841	10 the indole ring by alkyl, haloalkyl, alkenyl,
7842	7842	11 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7843	7843	12 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7844	7844	13 2-(4-morpholinyl)ethyl, whether or not further substituted
7845	7845	14 on the indole ring to any extent: including, but not
7846	7846	15 limited to, ABICA, 5F-ABICA;
7847	7847	16 (70) Methyl 2-(1H-indazole-3-carboxamido)-3-
7848	7848	17 methylbutanoate with substitution on the nitrogen atom of
7849	7849	18 the indazole ring by alkyl, haloalkyl, alkenyl,
7850	7850	19 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7851	7851	20 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7852	7852	21 2-(4-morpholinyl)ethyl, whether or not further substituted
7853	7853	22 on the indazole ring to any extent: including, but not
7854	7854	23 limited to, AMB, 5F-AMB;
7855	7855	24 (71) Methyl 2-(1H-indazole-3-carboxamido)-3,3-
7856	7856	25 dimethylbutanoate with substitution on the nitrogen atom
7857	7857	26 of the indazole ring by alkyl, haloalkyl, alkenyl,
7858	7858
7859	7859
7860	7860
7861	7861
7862	7862
7863	7863	SB2184 - 221 - LRB104 11945 RLC 22038 b
7864	7864
7865	7865
7866	7866	SB2184- 222 -LRB104 11945 RLC 22038 b SB2184 - 222 - LRB104 11945 RLC 22038 b
7867	7867	SB2184 - 222 - LRB104 11945 RLC 22038 b
7868	7868	1 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7869	7869	2 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7870	7870	3 2-(4-morpholinyl)ethyl, whether or not further substituted
7871	7871	4 on the indazole ring to any extent: including, but not
7872	7872	5 limited to, 5-fluoro-MDMB-PINACA, MDMB-FUBINACA;
7873	7873	6 (72) Methyl 2-(1H-indole-3-carboxamido)-3-
7874	7874	7 methylbutanoate with substitution on the nitrogen atom of
7875	7875	8 the indole ring by alkyl, haloalkyl, alkenyl,
7876	7876	9 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7877	7877	10 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7878	7878	11 2-(4-morpholinyl)ethyl, whether or not further substituted
7879	7879	12 on the indazole ring to any extent: including, but not
7880	7880	13 limited to, MMB018, MMB2201, and AMB-CHMICA;
7881	7881	14 (73) Methyl 2-(1H-indole-3-carboxamido)-3,3-
7882	7882	15 dimethylbutanoate with substitution on the nitrogen atom
7883	7883	16 of the indole ring by alkyl, haloalkyl, alkenyl,
7884	7884	17 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7885	7885	18 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7886	7886	19 2-(4-morpholinyl)ethyl, whether or not further substituted
7887	7887	20 on the indazole ring to any extent: including, but not
7888	7888	21 limited to, MDMB-CHMICA;
7889	7889	22 (74) N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1H-
7890	7890	23 indazole-3-carboxamide with substitution on the nitrogen
7891	7891	24 atom of the indazole ring by alkyl, haloalkyl, alkenyl,
7892	7892	25 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7893	7893	26 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7894	7894
7895	7895
7896	7896
7897	7897
7898	7898
7899	7899	SB2184 - 222 - LRB104 11945 RLC 22038 b
7900	7900
7901	7901
7902	7902	SB2184- 223 -LRB104 11945 RLC 22038 b SB2184 - 223 - LRB104 11945 RLC 22038 b
7903	7903	SB2184 - 223 - LRB104 11945 RLC 22038 b
7904	7904	1 2-(4-morpholinyl)ethyl, whether or not further substituted
7905	7905	2 on the indazole ring to any extent: including, but not
7906	7906	3 limited to, APP-CHMINACA, 5-fluoro-APP-PINACA;
7907	7907	4 (75) N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1H-indole-
7908	7908	5 3-carboxamide with substitution on the nitrogen atom of
7909	7909	6 the indole ring by alkyl, haloalkyl, alkenyl,
7910	7910	7 cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7911	7911	8 halide, 1-(N-methyl-2-piperidinyl)methyl, or
7912	7912	9 2-(4-morpholinyl)ethyl, whether or not further substituted
7913	7913	10 on the indazole ring to any extent: including, but not
7914	7914	11 limited to, APP-PICA and 5-fluoro-APP-PICA;
7915	7915	12 (76) 4-Acetoxy-N,N-dimethyltryptamine: trade name
7916	7916	13 4-AcO-DMT;
7917	7917	14 (77) 5-Methoxy-N-methyl-N-isopropyltryptamine: trade
7918	7918	15 name 5-MeO-MIPT;
7919	7919	16 (78) 4-hydroxy Diethyltryptamine (4-HO-DET);
7920	7920	17 (79) 4-hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET);
7921	7921	18 (80) 4-hydroxy-N,N-diisopropyltryptamine (4-HO-DiPT);
7922	7922	19 (81) 4-hydroxy-N-methyl-N-isopropyltryptamine
7923	7923	20 (4-HO-MiPT);
7924	7924	21 (82) Fluorophenylpiperazine;
7925	7925	22 (83) Methoxetamine;
7926	7926	23 (84) 1-(Ethylamino)-2-phenylpropan-2-one (iso-
7927	7927	24 ethcathinone).
7928	7928	25 (e) Unless specifically excepted or unless listed in
7929	7929	26 another schedule, any material, compound, mixture, or
7930	7930
7931	7931
7932	7932
7933	7933
7934	7934
7935	7935	SB2184 - 223 - LRB104 11945 RLC 22038 b
7936	7936
7937	7937
7938	7938	SB2184- 224 -LRB104 11945 RLC 22038 b SB2184 - 224 - LRB104 11945 RLC 22038 b
7939	7939	SB2184 - 224 - LRB104 11945 RLC 22038 b
7940	7940	1 preparation which contains any quantity of the following
7941	7941	2 substances having a depressant effect on the central nervous
7942	7942	3 system, including its salts, isomers, and salts of isomers
7943	7943	4 whenever the existence of such salts, isomers, and salts of
7944	7944	5 isomers is possible within the specific chemical designation:
7945	7945	6 (1) mecloqualone;
7946	7946	7 (2) methaqualone; and
7947	7947	8 (3) gamma hydroxybutyric acid.
7948	7948	9 (f) Unless specifically excepted or unless listed in
7949	7949	10 another schedule, any material, compound, mixture, or
7950	7950	11 preparation which contains any quantity of the following
7951	7951	12 substances having a stimulant effect on the central nervous
7952	7952	13 system, including its salts, isomers, and salts of isomers:
7953	7953	14 (1) Fenethylline;
7954	7954	15 (2) N-ethylamphetamine;
7955	7955	16 (3) Aminorex (some other names:
7956	7956	17 2-amino-5-phenyl-2-oxazoline; aminoxaphen;
7957	7957	18 4-5-dihydro-5-phenyl-2-oxazolamine) and its
7958	7958	19 salts, optical isomers, and salts of optical isomers;
7959	7959	20 (4) Methcathinone (some other names:
7960	7960	21 2-methylamino-1-phenylpropan-1-one;
7961	7961	22 Ephedrone; 2-(methylamino)-propiophenone;
7962	7962	23 alpha-(methylamino)propiophenone; N-methylcathinone;
7963	7963	24 methycathinone; Monomethylpropion; UR 1431) and its
7964	7964	25 salts, optical isomers, and salts of optical isomers;
7965	7965	26 (5) Cathinone (some trade or other names:
7966	7966
7967	7967
7968	7968
7969	7969
7970	7970
7971	7971	SB2184 - 224 - LRB104 11945 RLC 22038 b
7972	7972
7973	7973
7974	7974	SB2184- 225 -LRB104 11945 RLC 22038 b SB2184 - 225 - LRB104 11945 RLC 22038 b
7975	7975	SB2184 - 225 - LRB104 11945 RLC 22038 b
7976	7976	1 2-aminopropiophenone; alpha-aminopropiophenone;
7977	7977	2 2-amino-1-phenyl-propanone; norephedrone);
7978	7978	3 (6) N,N-dimethylamphetamine (also known as:
7979	7979	4 N,N-alpha-trimethyl-benzeneethanamine;
7980	7980	5 N,N-alpha-trimethylphenethylamine);
7981	7981	6 (7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
7982	7982	7 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine);
7983	7983	8 (8) 3,4-Methylenedioxypyrovalerone (MDPV);
7984	7984	9 (9) Halogenated amphetamines and
7985	7985	10 methamphetamines - any compound derived from either
7986	7986	11 amphetamine or methamphetamine through the substitution
7987	7987	12 of a halogen on the phenyl ring, including, but not
7988	7988	13 limited to, 2-fluoroamphetamine, 3-
7989	7989	14 fluoroamphetamine and 4-fluoroamphetamine;
7990	7990	15 (10) Aminopropylbenzofuran (APB):
7991	7991	16 including 4-(2-Aminopropyl) benzofuran, 5-
7992	7992	17 (2-Aminopropyl)benzofuran, 6-(2-Aminopropyl)
7993	7993	18 benzofuran, and 7-(2-Aminopropyl) benzofuran;
7994	7994	19 (11) Aminopropyldihydrobenzofuran (APDB):
7995	7995	20 including 4-(2-Aminopropyl)-2,3- dihydrobenzofuran,
7996	7996	21 5-(2-Aminopropyl)-2, 3-dihydrobenzofuran,
7997	7997	22 6-(2-Aminopropyl)-2,3-dihydrobenzofuran,
7998	7998	23 and 7-(2-Aminopropyl)-2,3-dihydrobenzofuran;
7999	7999	24 (12) Methylaminopropylbenzofuran
8000	8000	25 (MAPB): including 4-(2-methylaminopropyl)
8001	8001	26 benzofuran, 5-(2-methylaminopropyl)benzofuran,
8002	8002
8003	8003
8004	8004
8005	8005
8006	8006
8007	8007	SB2184 - 225 - LRB104 11945 RLC 22038 b
8008	8008
8009	8009
8010	8010	SB2184- 226 -LRB104 11945 RLC 22038 b SB2184 - 226 - LRB104 11945 RLC 22038 b
8011	8011	SB2184 - 226 - LRB104 11945 RLC 22038 b
8012	8012	1 6-(2-methylaminopropyl)benzofuran
8013	8013	2 and 7-(2-methylaminopropyl)benzofuran.
8014	8014	3 (g) Temporary listing of substances subject to emergency
8015	8015	4 scheduling. Any material, compound, mixture, or preparation
8016	8016	5 that contains any quantity of the following substances:
8017	8017	6 (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
8018	8018	7 (benzylfentanyl), its optical isomers, isomers, salts, and
8019	8019	8 salts of isomers;
8020	8020	9 (2) N-[1(2-thienyl) methyl-4-piperidyl]-N-
8021	8021	10 phenylpropanamide (thenylfentanyl), its optical isomers,
8022	8022	11 salts, and salts of isomers.
8023	8023	12 (h) Synthetic cathinones. Unless specifically excepted,
8024	8024	13 any chemical compound which is not approved by the United
8025	8025	14 States Food and Drug Administration or, if approved, is not
8026	8026	15 dispensed or possessed in accordance with State or federal
8027	8027	16 law, not including bupropion, structurally derived from
8028	8028	17 2-aminopropan-1-one by substitution at the 1-position with
8029	8029	18 either phenyl, naphthyl, or thiophene ring systems, whether or
8030	8030	19 not the compound is further modified in one or more of the
8031	8031	20 following ways:
8032	8032	21 (1) by substitution in the ring system to any extent
8033	8033	22 with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or
8034	8034	23 halide substituents, whether or not further substituted in
8035	8035	24 the ring system by one or more other univalent
8036	8036	25 substituents. Examples of this class include, but are not
8037	8037	26 limited to, 3,4-Methylenedioxycathinone (bk-MDA);
8038	8038
8039	8039
8040	8040
8041	8041
8042	8042
8043	8043	SB2184 - 226 - LRB104 11945 RLC 22038 b
8044	8044
8045	8045
8046	8046	SB2184- 227 -LRB104 11945 RLC 22038 b SB2184 - 227 - LRB104 11945 RLC 22038 b
8047	8047	SB2184 - 227 - LRB104 11945 RLC 22038 b
8048	8048	1 (2) by substitution at the 3-position with an acyclic
8049	8049	2 alkyl substituent. Examples of this class include, but are
8050	8050	3 not limited to, 2-methylamino-1-phenylbutan-1-one
8051	8051	4 (buphedrone); or
8052	8052	5 (3) by substitution at the 2-amino nitrogen atom with
8053	8053	6 alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by
8054	8054	7 inclusion of the 2-amino nitrogen atom in a cyclic
8055	8055	8 structure. Examples of this class include, but are not
8056	8056	9 limited to, Dimethylcathinone, Ethcathinone, and
8057	8057	10 a-Pyrrolidinopropiophenone (a-PPP); or
8058	8058	11 Any other synthetic cathinone which is not approved by the
8059	8059	12 United States Food and Drug Administration or, if approved, is
8060	8060	13 not dispensed or possessed in accordance with State or federal
8061	8061	14 law.
8062	8062	15 (i) Synthetic cannabinoids or piperazines. Any synthetic
8063	8063	16 cannabinoid or piperazine which is not approved by the United
8064	8064	17 States Food and Drug Administration or, if approved, which is
8065	8065	18 not dispensed or possessed in accordance with State and
8066	8066	19 federal law.
8067	8067	20 (j) Unless specifically excepted or listed in another
8068	8068	21 schedule, any chemical compound which is not approved by the
8069	8069	22 United States Food and Drug Administration or, if approved, is
8070	8070	23 not dispensed or possessed in accordance with State or federal
8071	8071	24 law, and is derived from the following structural classes and
8072	8072	25 their salts:
8073	8073	26 (1) Benzodiazepine class: A fused 1,4-diazepine and
8074	8074
8075	8075
8076	8076
8077	8077
8078	8078
8079	8079	SB2184 - 227 - LRB104 11945 RLC 22038 b
8080	8080
8081	8081
8082	8082	SB2184- 228 -LRB104 11945 RLC 22038 b SB2184 - 228 - LRB104 11945 RLC 22038 b
8083	8083	SB2184 - 228 - LRB104 11945 RLC 22038 b
8084	8084	1 benzene ring structure with a phenyl connected to the
8085	8085	2 1,4-diazepine ring, with any substitution(s) or
8086	8086	3 replacement(s) on the 1,4-diazepine or benzene ring, any
8087	8087	4 substitution(s) on the phenyl ring, or any combination
8088	8088	5 thereof. Examples of this class include but are not
8089	8089	6 limited to: Clonazolam, Flualprazolam; or
8090	8090	7 (2) Thienodiazepine class: A fused 1,4-diazepine and
8091	8091	8 thiophene ring structure with a phenyl connected to the
8092	8092	9 1,4-diazepine ring, with any substitution(s) or
8093	8093	10 replacement(s) on the 1,4-diazepine or thiophene ring, any
8094	8094	11 substitution(s) on the phenyl ring, or any combination
8095	8095	12 thereof. Examples of this class include but are not
8096	8096	13 limited to: Etizolam.
8097	8097	14 (Source: P.A. 103-245, eff. 1-1-24.)
8098	8098	15 Section 999. Effective date. This Act takes effect upon
8099	8099	16 becoming law.
8100	8100	SB2184- 229 -LRB104 11945 RLC 22038 b 1 INDEX 2 Statutes amended in order of appearance SB2184- 229 -LRB104 11945 RLC 22038 b SB2184 - 229 - LRB104 11945 RLC 22038 b 1 INDEX 2 Statutes amended in order of appearance
8101	8101	SB2184- 229 -LRB104 11945 RLC 22038 b SB2184 - 229 - LRB104 11945 RLC 22038 b
8102	8102	SB2184 - 229 - LRB104 11945 RLC 22038 b
8103	8103	1 INDEX
8104	8104	2 Statutes amended in order of appearance
8105	8105
8106	8106
8107	8107
8108	8108
8109	8109
8110	8110	SB2184 - 228 - LRB104 11945 RLC 22038 b
8111	8111
8112	8112
8113	8113
8114	8114	SB2184- 229 -LRB104 11945 RLC 22038 b SB2184 - 229 - LRB104 11945 RLC 22038 b
8115	8115	SB2184 - 229 - LRB104 11945 RLC 22038 b
8116	8116	1 INDEX
8117	8117	2 Statutes amended in order of appearance
8118	8118
8119	8119
8120	8120
8121	8121
8122	8122
8123	8123	SB2184 - 229 - LRB104 11945 RLC 22038 b